<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF
 xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns:owl="http://www.w3.org/2002/07/owl#"
 xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"
 xml:base="http://www.reactome.org/biopax/91/74160#">
<owl:Ontology rdf:about="">
 <owl:imports rdf:resource="http://www.biopax.org/release/biopax-level3.owl#" />
</owl:Ontology>

<bp:Catalysis rdf:ID="Catalysis208">
 <bp:controlled rdf:resource="#BiochemicalReaction1128" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis207">
 <bp:controlled rdf:resource="#BiochemicalReaction1127" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis204">
 <bp:controlled rdf:resource="#BiochemicalReaction1124" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis203">
 <bp:controlled rdf:resource="#BiochemicalReaction1122" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis206">
 <bp:controlled rdf:resource="#BiochemicalReaction1126" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis205">
 <bp:controlled rdf:resource="#BiochemicalReaction1125" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis200">
 <bp:controlled rdf:resource="#BiochemicalReaction1115" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis202">
 <bp:controlled rdf:resource="#BiochemicalReaction1121" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis201">
 <bp:controlled rdf:resource="#BiochemicalReaction1120" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence900">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence901">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence911">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence912">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence910">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1">
 <bp:evidence rdf:resource="#Evidence4" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cleavage of the 3&apos;-end of the Histone Pre-mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2">
 <bp:evidence rdf:resource="#Evidence5" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cleavage of Intronless Pre-mRNA at 3&apos;-end</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction5">
 <bp:evidence rdf:resource="#Evidence9" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of RNA Polymerase II Holoenzyme by TFIIF to the pol II promoter:TFIID:TFIIA:TFIIB complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction6">
 <bp:evidence rdf:resource="#Evidence10" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of the closed pre-initiation complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction3">
 <bp:evidence rdf:resource="#Evidence6" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cleavage of mRNA at the 3&apos;-end</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction4">
 <bp:evidence rdf:resource="#Evidence7" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cleavage of the 3&apos;-end of Replication Dependent Histone Pre-mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction9">
 <bp:evidence rdf:resource="#Evidence13" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of TFIIA and TFIIB to the pol II promoter:TFIID complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence904">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence905">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction7">
 <bp:evidence rdf:resource="#Evidence11" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of TFIIE to the growing preinitiation complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence902">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction8">
 <bp:evidence rdf:resource="#Evidence12" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recognition and Binding of Core Promoter Elements by TFIID</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence903">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence908">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence909">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence906">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence907">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence922">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence923">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence920">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence921">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence915">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence916">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence913">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence914">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence919">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence917">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence918">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence930">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence933">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence934">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence931">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence932">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence926">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence927">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence924">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence925">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence928">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence929">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence940">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence941">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence944">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence945">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence942">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence943">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence937">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence938">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence935">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence936">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence939">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence951">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence952">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence950">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence955">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence956">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence953">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence954">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence948">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence949">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence946">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence947">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence962">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence963">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence960">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence961">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence966">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence967">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence964">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence965">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep570">
 <bp:stepProcess rdf:resource="#BiochemicalReaction513" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep571">
 <bp:stepProcess rdf:resource="#Pathway59" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep572">
 <bp:stepProcess rdf:resource="#Pathway60" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep573">
 <bp:stepProcess rdf:resource="#BiochemicalReaction514" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction224">
 <bp:evidence rdf:resource="#Evidence254" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MTA2-NuRD complex deacetylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep567">
 <bp:stepProcess rdf:resource="#BiochemicalReaction510" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction223">
 <bp:evidence rdf:resource="#Evidence253" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BRD7 binds TP53 and EP300</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep568">
 <bp:stepProcess rdf:resource="#BiochemicalReaction511" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction226">
 <bp:evidence rdf:resource="#Evidence257" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TMEM55B translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep569">
 <bp:stepProcess rdf:resource="#BiochemicalReaction512" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction225">
 <bp:evidence rdf:resource="#Evidence256" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ING2 binds PI5P</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction220">
 <bp:evidence rdf:resource="#Evidence249" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDK5 phosphorylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep563">
 <bp:stepProcess rdf:resource="#BiochemicalReaction506" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep564">
 <bp:stepProcess rdf:resource="#BiochemicalReaction507" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction222">
 <bp:evidence rdf:resource="#Evidence252" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates KAT6A</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep565">
 <bp:stepProcess rdf:resource="#BiochemicalReaction508" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction221">
 <bp:evidence rdf:resource="#Evidence250" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ATM phosphorylates TP53 at S15</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep566">
 <bp:stepProcess rdf:resource="#BiochemicalReaction509" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence959">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence957">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence958">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction228">
 <bp:evidence rdf:resource="#Evidence259" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP2K6 phosphorylates PIP4K2B</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction227">
 <bp:evidence rdf:resource="#Evidence258" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI(4,5)P2 is dephosphorylated to PI5P by TMEM55B in the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction229">
 <bp:evidence rdf:resource="#Evidence260" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIN1 binds phosphorylated PIP4K2B</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence973">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence974">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence971">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence972">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence977">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence978">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence975">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence976">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep581">
 <bp:stepProcess rdf:resource="#BiochemicalReaction522" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep582">
 <bp:stepProcess rdf:resource="#BiochemicalReaction523" />
 <bp:stepProcess rdf:resource="#Catalysis109" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep583">
 <bp:stepProcess rdf:resource="#BiochemicalReaction524" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep584">
 <bp:stepProcess rdf:resource="#BiochemicalReaction525" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence970">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep580">
 <bp:stepProcess rdf:resource="#BiochemicalReaction521" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction235">
 <bp:evidence rdf:resource="#Evidence266" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KAT6A acetylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep578">
 <bp:stepProcess rdf:resource="#BiochemicalReaction519" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction234">
 <bp:evidence rdf:resource="#Evidence265" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BRD7 promotes EP300-mediated acetylation of TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep579">
 <bp:stepProcess rdf:resource="#BiochemicalReaction520" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction237">
 <bp:evidence rdf:resource="#Evidence269" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PHF20 binds TP53 dimethylated on K370 and K382</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction236">
 <bp:evidence rdf:resource="#Evidence268" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds ZNF385A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction231">
 <bp:evidence rdf:resource="#Evidence262" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ING2-bound EP300 acetylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep574">
 <bp:stepProcess rdf:resource="#BiochemicalReaction515" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction230">
 <bp:evidence rdf:resource="#Evidence261" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI5P is phosphorylated to PI(4,5)P2 by PIP4K2 dimers in the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep575">
 <bp:stepProcess rdf:resource="#BiochemicalReaction516" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction233">
 <bp:evidence rdf:resource="#Evidence264" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KAT6A and PML bind TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep576">
 <bp:stepProcess rdf:resource="#BiochemicalReaction517" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction232">
 <bp:evidence rdf:resource="#Evidence263" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ING2 recruits EP300 to TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep577">
 <bp:stepProcess rdf:resource="#BiochemicalReaction518" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence968">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence969">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction239">
 <bp:evidence rdf:resource="#Evidence271" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds ZNF385A gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction238">
 <bp:evidence rdf:resource="#Evidence270" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds POU4F1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence984">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence985">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence982">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence983">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence988">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence989">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence986">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence987">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction240">
 <bp:evidence rdf:resource="#Evidence272" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds PPP1R13L</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep550">
 <bp:stepProcess rdf:resource="#BiochemicalReaction494" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep551">
 <bp:stepProcess rdf:resource="#BiochemicalReaction495" />
 <bp:stepProcess rdf:resource="#Catalysis108" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence980">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence981">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction246">
 <bp:evidence rdf:resource="#Evidence280" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates ARID3A gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep545">
 <bp:stepProcess rdf:resource="#BiochemicalReaction489" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction245">
 <bp:evidence rdf:resource="#Evidence277" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BANP binds TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep546">
 <bp:stepProcess rdf:resource="#BiochemicalReaction490" />
 <bp:stepProcess rdf:resource="#Catalysis107" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction248">
 <bp:evidence rdf:resource="#Evidence282" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the E2F7 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep547">
 <bp:stepProcess rdf:resource="#BiochemicalReaction491" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction247">
 <bp:evidence rdf:resource="#Evidence281" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F8 forms homodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep548">
 <bp:stepProcess rdf:resource="#BiochemicalReaction492" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction242">
 <bp:evidence rdf:resource="#Evidence274" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates ZNF385A transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep541">
 <bp:stepProcess rdf:resource="#BiochemicalReaction485" />
 <bp:stepProcess rdf:resource="#Catalysis105" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction241">
 <bp:evidence rdf:resource="#Evidence273" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 family members bind PPP1R13B or TP53BP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep542">
 <bp:stepProcess rdf:resource="#BiochemicalReaction486" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction244">
 <bp:evidence rdf:resource="#Evidence276" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates PHF20</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep543">
 <bp:stepProcess rdf:resource="#BiochemicalReaction487" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction243">
 <bp:evidence rdf:resource="#Evidence275" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds POU4F2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep544">
 <bp:stepProcess rdf:resource="#BiochemicalReaction488" />
 <bp:stepProcess rdf:resource="#Catalysis106" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence979">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep549">
 <bp:stepProcess rdf:resource="#BiochemicalReaction493" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction249">
 <bp:evidence rdf:resource="#Evidence283" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F7 forms homodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence995">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence996">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence993">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence994">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence999">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence997">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence998">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep560">
 <bp:stepProcess rdf:resource="#BiochemicalReaction503" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction251">
 <bp:evidence rdf:resource="#Evidence285" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PCBP4 binds the CDKN1A mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep561">
 <bp:stepProcess rdf:resource="#BiochemicalReaction504" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction250">
 <bp:evidence rdf:resource="#Evidence284" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F7 and E2F8 homo- and heterodimers bind the E2F1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep562">
 <bp:stepProcess rdf:resource="#BiochemicalReaction505" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence991">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence992">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence990">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction257">
 <bp:evidence rdf:resource="#Evidence291" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inactivation of Cyclin E:Cdk2 complexes by p27/p21</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep556">
 <bp:stepProcess rdf:resource="#BiochemicalReaction500" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction256">
 <bp:evidence rdf:resource="#Evidence290" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates CDKN1A (p21) transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep557">
 <bp:stepProcess rdf:resource="#BiochemicalReaction501" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction259">
 <bp:evidence rdf:resource="#Evidence293" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the ARID3A gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep558">
 <bp:stepProcess rdf:resource="#BiochemicalReaction502" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction258">
 <bp:evidence rdf:resource="#Evidence292" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inactivation of Cyclin A:Cdk2 complexes by p27/p21</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep559">
 <bp:stepProcess rdf:resource="#Pathway58" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction253">
 <bp:evidence rdf:resource="#Evidence287" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PCBP4 modulates CDKN1A translation</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep552">
 <bp:stepProcess rdf:resource="#BiochemicalReaction496" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction252">
 <bp:evidence rdf:resource="#Evidence286" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates PCBP4 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep553">
 <bp:stepProcess rdf:resource="#BiochemicalReaction497" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction255">
 <bp:evidence rdf:resource="#Evidence289" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the PCBP4 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep554">
 <bp:stepProcess rdf:resource="#BiochemicalReaction498" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction254">
 <bp:evidence rdf:resource="#Evidence288" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F7 and E2F8 homo- and heterodimers inhibit E2F1 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep555">
 <bp:stepProcess rdf:resource="#BiochemicalReaction499" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction260">
 <bp:evidence rdf:resource="#Evidence294" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates E2F7 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction262">
 <bp:evidence rdf:resource="#Evidence296" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 in complex with ZNF385A binds the CDKN1A promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction261">
 <bp:evidence rdf:resource="#Evidence295" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F7 binds E2F8</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction268">
 <bp:evidence rdf:resource="#Evidence303" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLK2 phosphorylates NPM1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep523">
 <bp:stepProcess rdf:resource="#BiochemicalReaction469" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction267">
 <bp:evidence rdf:resource="#Evidence302" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates RGCC expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep524">
 <bp:stepProcess rdf:resource="#BiochemicalReaction470" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep525">
 <bp:stepProcess rdf:resource="#BiochemicalReaction471" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction269">
 <bp:evidence rdf:resource="#Evidence304" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the RGCC gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep526">
 <bp:stepProcess rdf:resource="#BiochemicalReaction472" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction264">
 <bp:evidence rdf:resource="#Evidence299" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the BTG2 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction263">
 <bp:evidence rdf:resource="#Evidence298" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates PLK2 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep520">
 <bp:stepProcess rdf:resource="#BiochemicalReaction467" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction266">
 <bp:evidence rdf:resource="#Evidence301" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates BTG2 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep521">
 <bp:stepProcess rdf:resource="#BiochemicalReaction468" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction265">
 <bp:evidence rdf:resource="#Evidence300" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLK2 phosphorylates CENPJ</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep522">
 <bp:stepProcess rdf:resource="#Pathway55" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep527">
 <bp:stepProcess rdf:resource="#Pathway56" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep528">
 <bp:stepProcess rdf:resource="#BiochemicalReaction473" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep529">
 <bp:stepProcess rdf:resource="#BiochemicalReaction474" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction271">
 <bp:evidence rdf:resource="#Evidence306" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the PLK2 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction270">
 <bp:evidence rdf:resource="#Evidence305" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates PLAGL1 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction273">
 <bp:evidence rdf:resource="#Evidence308" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the PLAGL1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction272">
 <bp:evidence rdf:resource="#Evidence307" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the PLK3 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep540">
 <bp:stepProcess rdf:resource="#BiochemicalReaction484" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction279">
 <bp:evidence rdf:resource="#Evidence315" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 in complex with EP300, PRMT1 and CARM1 stimulates GADD45A transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep534">
 <bp:stepProcess rdf:resource="#BiochemicalReaction479" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction278">
 <bp:evidence rdf:resource="#Evidence314" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 and E2F4 inhibit CDC25C expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep535">
 <bp:stepProcess rdf:resource="#BiochemicalReaction480" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep536">
 <bp:stepProcess rdf:resource="#BiochemicalReaction481" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep537">
 <bp:stepProcess rdf:resource="#BiochemicalReaction482" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction275">
 <bp:evidence rdf:resource="#Evidence310" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BTG2 binds CCR4-NOT complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep530">
 <bp:stepProcess rdf:resource="#BiochemicalReaction475" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction274">
 <bp:evidence rdf:resource="#Evidence309" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLK3 phosphorylates CDC25C</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep531">
 <bp:stepProcess rdf:resource="#BiochemicalReaction476" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction277">
 <bp:evidence rdf:resource="#Evidence313" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 and E2F4 bind the CDC25C gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep532">
 <bp:stepProcess rdf:resource="#BiochemicalReaction477" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction276">
 <bp:evidence rdf:resource="#Evidence311" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates PLK3 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep533">
 <bp:stepProcess rdf:resource="#BiochemicalReaction478" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep538">
 <bp:stepProcess rdf:resource="#BiochemicalReaction483" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep539">
 <bp:stepProcess rdf:resource="#Pathway57" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction282">
 <bp:evidence rdf:resource="#Evidence318" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the SFN gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction281">
 <bp:evidence rdf:resource="#Evidence317" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SFN dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction284">
 <bp:evidence rdf:resource="#Evidence320" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GADD45A binds AURKA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction283">
 <bp:evidence rdf:resource="#Evidence319" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SFN dimer binds CDK1 and CCNB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction280">
 <bp:evidence rdf:resource="#Evidence316" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates SFN expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep501">
 <bp:stepProcess rdf:resource="#BiochemicalReaction448" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction289">
 <bp:evidence rdf:resource="#Evidence327" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the CASP10 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep502">
 <bp:stepProcess rdf:resource="#BiochemicalReaction449" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep503">
 <bp:stepProcess rdf:resource="#BiochemicalReaction450" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep504">
 <bp:stepProcess rdf:resource="#BiochemicalReaction451" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction286">
 <bp:evidence rdf:resource="#Evidence322" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GADD45A binds PCNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction285">
 <bp:evidence rdf:resource="#Evidence321" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SFN dimer binds BAX</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction288">
 <bp:evidence rdf:resource="#Evidence326" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIDD1 translocates to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction287">
 <bp:evidence rdf:resource="#Evidence323" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 in complex with EP300, PRMT1 and CARM1 binds the GADD45A promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep500">
 <bp:stepProcess rdf:resource="#BiochemicalReaction447" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep509">
 <bp:stepProcess rdf:resource="#BiochemicalReaction456" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep505">
 <bp:stepProcess rdf:resource="#BiochemicalReaction452" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep506">
 <bp:stepProcess rdf:resource="#BiochemicalReaction453" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep507">
 <bp:stepProcess rdf:resource="#BiochemicalReaction454" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep508">
 <bp:stepProcess rdf:resource="#BiochemicalReaction455" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction293">
 <bp:evidence rdf:resource="#Evidence331" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The PIDDosome binds CASP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction292">
 <bp:evidence rdf:resource="#Evidence330" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The PIDDosome activates CASP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction295">
 <bp:evidence rdf:resource="#Evidence333" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates APAF1 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction294">
 <bp:evidence rdf:resource="#Evidence332" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the CASP6 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction291">
 <bp:evidence rdf:resource="#Evidence329" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates CASP10 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction290">
 <bp:evidence rdf:resource="#Evidence328" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIDD1 associates with CRADD</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep512">
 <bp:stepProcess rdf:resource="#BiochemicalReaction459" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep513">
 <bp:stepProcess rdf:resource="#BiochemicalReaction460" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep514">
 <bp:stepProcess rdf:resource="#BiochemicalReaction461" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep515">
 <bp:stepProcess rdf:resource="#BiochemicalReaction462" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction297">
 <bp:evidence rdf:resource="#Evidence335" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the PIDD1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction296">
 <bp:evidence rdf:resource="#Evidence334" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the APAF1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction299">
 <bp:evidence rdf:resource="#Evidence337" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the NLRC4 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep510">
 <bp:stepProcess rdf:resource="#BiochemicalReaction457" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction298">
 <bp:evidence rdf:resource="#Evidence336" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ATM phosphorylates PIDD1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep511">
 <bp:stepProcess rdf:resource="#BiochemicalReaction458" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep516">
 <bp:stepProcess rdf:resource="#BiochemicalReaction463" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep517">
 <bp:stepProcess rdf:resource="#BiochemicalReaction464" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep518">
 <bp:stepProcess rdf:resource="#BiochemicalReaction465" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep519">
 <bp:stepProcess rdf:resource="#BiochemicalReaction466" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence104">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence105">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence102">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence103">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence108">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence109">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence106">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence107">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence100">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence101">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence115">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence116">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence113">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence114">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence119">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence117">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence118">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence111">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence112">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence110">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence126">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence127">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence124">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence125">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence128">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence129">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence122">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence123">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence120">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence121">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence137">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence138">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence135">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence136">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence139">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence130">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence133">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence134">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence131">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence132">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence148">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence149">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence146">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence147">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence140">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep592">
 <bp:stepProcess rdf:resource="#BiochemicalReaction533" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence141">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep593">
 <bp:stepProcess rdf:resource="#BiochemicalReaction534" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep594">
 <bp:stepProcess rdf:resource="#BiochemicalReaction535" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep595">
 <bp:stepProcess rdf:resource="#BiochemicalReaction536" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence144">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence145">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence142">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep590">
 <bp:stepProcess rdf:resource="#BiochemicalReaction531" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence143">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep591">
 <bp:stepProcess rdf:resource="#BiochemicalReaction532" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction202">
 <bp:evidence rdf:resource="#Evidence231" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ATM phosphorylates DYRK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep589">
 <bp:stepProcess rdf:resource="#BiochemicalReaction530" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction201">
 <bp:evidence rdf:resource="#Evidence230" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ATR phosphorylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction204">
 <bp:evidence rdf:resource="#Evidence233" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AURKA phosphorylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction203">
 <bp:evidence rdf:resource="#Evidence232" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STK11 (LKB1) phosphorylates NUAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep585">
 <bp:stepProcess rdf:resource="#BiochemicalReaction526" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep586">
 <bp:stepProcess rdf:resource="#BiochemicalReaction527" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction200">
 <bp:evidence rdf:resource="#Evidence229" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLK3 phosphorylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep587">
 <bp:stepProcess rdf:resource="#BiochemicalReaction528" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep588">
 <bp:stepProcess rdf:resource="#BiochemicalReaction529" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction209">
 <bp:evidence rdf:resource="#Evidence238" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds HIPK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction206">
 <bp:evidence rdf:resource="#Evidence235" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDK2 phosphorylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction205">
 <bp:evidence rdf:resource="#Evidence234" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds STK11 and NUAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction208">
 <bp:evidence rdf:resource="#Evidence237" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK5 phosphorylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction207">
 <bp:evidence rdf:resource="#Evidence236" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HIPK2 phosphorylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence159">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence157">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence158">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence151">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence152">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence150">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence155">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence156">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence153">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence154">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction213">
 <bp:evidence rdf:resource="#Evidence242" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CK2:FACT phosphorylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction212">
 <bp:evidence rdf:resource="#Evidence241" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CK2 binds FACT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction215">
 <bp:evidence rdf:resource="#Evidence244" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHEK1 phosphorylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction214">
 <bp:evidence rdf:resource="#Evidence243" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AURKB binds TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep596">
 <bp:stepProcess rdf:resource="#BiochemicalReaction537" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep597">
 <bp:stepProcess rdf:resource="#BiochemicalReaction538" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction211">
 <bp:evidence rdf:resource="#Evidence240" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53INP1 and HIPK2 bind TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep598">
 <bp:stepProcess rdf:resource="#BiochemicalReaction539" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction210">
 <bp:evidence rdf:resource="#Evidence239" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AURKB phosphorylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep599">
 <bp:stepProcess rdf:resource="#BiochemicalReaction540" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction217">
 <bp:evidence rdf:resource="#Evidence246" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHEK2 phosphorylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction216">
 <bp:evidence rdf:resource="#Evidence245" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAF1 phosphorylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction219">
 <bp:evidence rdf:resource="#Evidence248" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AMPK phosphorylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction218">
 <bp:evidence rdf:resource="#Evidence247" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NUAK1 phosphorylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence168">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence169">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence162">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence163">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence160">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence161">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence166">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence167">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence164">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence165">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence179">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence173">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence174">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence171">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence172">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence177">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence178">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence175">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence176">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence170">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence184">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence185">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence182">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence183">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence188">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence189">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence186">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence187">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence180">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence181">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence195">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence196">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence193">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence194">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence199">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence197">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence198">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence191">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence192">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence190">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1016">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1015">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1014">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1013">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1012">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1011">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1010">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1009">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1008">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1007">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1006">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1">
 <bp:stepProcess rdf:resource="#Pathway2" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1005">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1004">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1003">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1002">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1001">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1000">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1030">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1038">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1037">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1036">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1035">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1034">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1033">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1032">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1031">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1029">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1028">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep3">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2">
 <bp:stepProcess rdf:resource="#Pathway3" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep5">
 <bp:stepProcess rdf:resource="#Catalysis1" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction3" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep4">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep7">
 <bp:stepProcess rdf:resource="#Pathway4" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep6">
 <bp:stepProcess rdf:resource="#BiochemicalReaction4" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep9">
 <bp:stepProcess rdf:resource="#BiochemicalReaction6" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep8">
 <bp:stepProcess rdf:resource="#BiochemicalReaction5" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1027">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1026">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1025">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1024">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1023">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1022">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1021">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1020">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1019">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1018">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1017">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep600">
 <bp:stepProcess rdf:resource="#BiochemicalReaction541" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep601">
 <bp:stepProcess rdf:resource="#BiochemicalReaction542" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep602">
 <bp:stepProcess rdf:resource="#BiochemicalReaction543" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep603">
 <bp:stepProcess rdf:resource="#BiochemicalReaction544" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep608">
 <bp:stepProcess rdf:resource="#Pathway61" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep609">
 <bp:stepProcess rdf:resource="#Pathway62" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep604">
 <bp:stepProcess rdf:resource="#BiochemicalReaction545" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep605">
 <bp:stepProcess rdf:resource="#BiochemicalReaction546" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep606">
 <bp:stepProcess rdf:resource="#BiochemicalReaction547" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep607">
 <bp:stepProcess rdf:resource="#BiochemicalReaction548" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep611">
 <bp:stepProcess rdf:resource="#BiochemicalReaction550" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep612">
 <bp:stepProcess rdf:resource="#Pathway63" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep613">
 <bp:stepProcess rdf:resource="#BiochemicalReaction551" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep614">
 <bp:stepProcess rdf:resource="#BiochemicalReaction552" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep610">
 <bp:stepProcess rdf:resource="#BiochemicalReaction549" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep619">
 <bp:stepProcess rdf:resource="#BiochemicalReaction557" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep615">
 <bp:stepProcess rdf:resource="#BiochemicalReaction553" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep616">
 <bp:stepProcess rdf:resource="#BiochemicalReaction554" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep617">
 <bp:stepProcess rdf:resource="#BiochemicalReaction555" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep618">
 <bp:stepProcess rdf:resource="#BiochemicalReaction556" />
</bp:PathwayStep>

<bp:Provenance rdf:ID="Provenance1">
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Reactome</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.reactome.org</bp:comment>
</bp:Provenance>

<bp:PathwayStep rdf:ID="PathwayStep691">
 <bp:stepProcess rdf:resource="#Catalysis117" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction623" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep692">
 <bp:stepProcess rdf:resource="#BiochemicalReaction624" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep693">
 <bp:stepProcess rdf:resource="#BiochemicalReaction625" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep694">
 <bp:stepProcess rdf:resource="#BiochemicalReaction626" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep690">
 <bp:stepProcess rdf:resource="#BiochemicalReaction622" />
 <bp:stepProcess rdf:resource="#Catalysis116" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction345">
 <bp:evidence rdf:resource="#Evidence385" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the TP53AIP1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep688">
 <bp:stepProcess rdf:resource="#BiochemicalReaction620" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction344">
 <bp:evidence rdf:resource="#Evidence384" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates AIFM2 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep689">
 <bp:stepProcess rdf:resource="#BiochemicalReaction621" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction347">
 <bp:evidence rdf:resource="#Evidence387" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates and ZNF420 inhibits TP53AIP1 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction346">
 <bp:evidence rdf:resource="#Evidence386" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates PMAIP1 (NOXA) expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction341">
 <bp:evidence rdf:resource="#Evidence381" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates expression of TP53INP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep684">
 <bp:stepProcess rdf:resource="#BiochemicalReaction616" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction340">
 <bp:evidence rdf:resource="#Evidence380" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the TRIAP1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep685">
 <bp:stepProcess rdf:resource="#BiochemicalReaction617" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction343">
 <bp:evidence rdf:resource="#Evidence383" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the STEAP3 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep686">
 <bp:stepProcess rdf:resource="#Catalysis115" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction618" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction342">
 <bp:evidence rdf:resource="#Evidence382" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the AIFM2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep687">
 <bp:stepProcess rdf:resource="#BiochemicalReaction619" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction349">
 <bp:evidence rdf:resource="#Evidence390" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the IGFBP3 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction348">
 <bp:evidence rdf:resource="#Evidence388" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIAP1 binds PRELID1, PRELID3A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction350">
 <bp:evidence rdf:resource="#Evidence391" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates IGFBP3 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction356">
 <bp:evidence rdf:resource="#Evidence398" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">glutathione (oxidized) + NADPH + H+ =&gt; 2 glutathione (reduced) + NADP+</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep699">
 <bp:stepProcess rdf:resource="#BiochemicalReaction631" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction355">
 <bp:evidence rdf:resource="#Evidence396" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 family members bind the FAS gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction358">
 <bp:evidence rdf:resource="#Evidence400" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the GLS2 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction357">
 <bp:evidence rdf:resource="#Evidence399" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-26A microRNAs bind PTEN mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction352">
 <bp:evidence rdf:resource="#Evidence393" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IGFBP3 binds TMEM219</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep695">
 <bp:stepProcess rdf:resource="#BiochemicalReaction627" />
 <bp:stepProcess rdf:resource="#Catalysis118" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction351">
 <bp:evidence rdf:resource="#Evidence392" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 family members stimulate FAS gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep696">
 <bp:stepProcess rdf:resource="#Catalysis119" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction628" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction354">
 <bp:evidence rdf:resource="#Evidence395" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds TNFRSF10A,TNFRSF10B,TNFRSF10C,TNFRSF10D genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep697">
 <bp:stepProcess rdf:resource="#BiochemicalReaction629" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction353">
 <bp:evidence rdf:resource="#Evidence394" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates transcription of TNFRSF10A, TNFRSF10B,TNFRSF10C and TNFRSF10D genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep698">
 <bp:stepProcess rdf:resource="#BiochemicalReaction630" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction359">
 <bp:evidence rdf:resource="#Evidence401" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S939,T1462-TSC2 binding to 14-3-3 dimer is negatively regulated by DDIT4</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep670">
 <bp:stepProcess rdf:resource="#BiochemicalReaction603" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction361">
 <bp:evidence rdf:resource="#Evidence403" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPI dimer isomerizes Fru(6)P to G6P</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep671">
 <bp:stepProcess rdf:resource="#BiochemicalReaction604" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction360">
 <bp:evidence rdf:resource="#Evidence402" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates GLS2 transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep672">
 <bp:stepProcess rdf:resource="#BiochemicalReaction605" />
 <bp:stepProcess rdf:resource="#Catalysis112" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction367">
 <bp:evidence rdf:resource="#Evidence409" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates TSC2, inhibiting it</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep666">
 <bp:stepProcess rdf:resource="#BiochemicalReaction599" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction366">
 <bp:evidence rdf:resource="#Evidence408" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">glutamine + H2O =&gt; glutamate + NH4+ (GLS)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep667">
 <bp:stepProcess rdf:resource="#BiochemicalReaction600" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction369">
 <bp:evidence rdf:resource="#Evidence411" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds regulatory elements of SESN1,2,3 genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep668">
 <bp:stepProcess rdf:resource="#BiochemicalReaction601" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction368">
 <bp:evidence rdf:resource="#Evidence410" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTEN mRNA translation negatively regulated by microRNAs</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep669">
 <bp:stepProcess rdf:resource="#BiochemicalReaction602" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction363">
 <bp:evidence rdf:resource="#Evidence405" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Electron transfer from reduced cytochrome c to molecular oxygen</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep662">
 <bp:stepProcess rdf:resource="#BiochemicalReaction595" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction362">
 <bp:evidence rdf:resource="#Evidence404" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SESN1,2,3 bind overoxidized PRDX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep663">
 <bp:stepProcess rdf:resource="#BiochemicalReaction596" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction365">
 <bp:evidence rdf:resource="#Evidence407" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SESN1,2,3 bind AMPK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep664">
 <bp:stepProcess rdf:resource="#BiochemicalReaction597" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction364">
 <bp:evidence rdf:resource="#Evidence406" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates expression of SESN1,2,3 genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep665">
 <bp:stepProcess rdf:resource="#BiochemicalReaction598" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction370">
 <bp:evidence rdf:resource="#Evidence412" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP63/TP53 stimulates transcription of DDIT4 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep680">
 <bp:stepProcess rdf:resource="#BiochemicalReaction612" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep681">
 <bp:stepProcess rdf:resource="#BiochemicalReaction613" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction372">
 <bp:evidence rdf:resource="#Evidence414" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP63/TP53 bind the DDIT4 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep682">
 <bp:stepProcess rdf:resource="#BiochemicalReaction614" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction371">
 <bp:evidence rdf:resource="#Evidence413" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRDX1 overoxidizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep683">
 <bp:stepProcess rdf:resource="#BiochemicalReaction615" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction378">
 <bp:evidence rdf:resource="#Evidence420" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRDX1,2,5 catalyze TXN reduced + H2O2 =&gt; TXN oxidized + 2H2O</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep677">
 <bp:stepProcess rdf:resource="#BiochemicalReaction609" />
 <bp:stepProcess rdf:resource="#Catalysis114" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction377">
 <bp:evidence rdf:resource="#Evidence419" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates SCO2 gene transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep678">
 <bp:stepProcess rdf:resource="#BiochemicalReaction610" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep679">
 <bp:stepProcess rdf:resource="#BiochemicalReaction611" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction379">
 <bp:evidence rdf:resource="#Evidence421" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPX2 catalyzes 2 glutathione, reduced + H2O2 =&gt; glutathione, oxidized + 2 H2O</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction374">
 <bp:evidence rdf:resource="#Evidence416" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the RRM2B gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep673">
 <bp:stepProcess rdf:resource="#BiochemicalReaction606" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction373">
 <bp:evidence rdf:resource="#Evidence415" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the SCO2 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep674">
 <bp:stepProcess rdf:resource="#BiochemicalReaction607" />
 <bp:stepProcess rdf:resource="#Catalysis113" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction376">
 <bp:evidence rdf:resource="#Evidence418" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates transcription of RRM2B gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep675">
 <bp:stepProcess rdf:resource="#Pathway69" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction375">
 <bp:evidence rdf:resource="#Evidence417" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">alpha-D-glucose 6-phosphate + NADP+ =&gt; D-glucono-1,5-lactone 6-phosphate + NADPH + H+</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep676">
 <bp:stepProcess rdf:resource="#BiochemicalReaction608" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction381">
 <bp:evidence rdf:resource="#Evidence423" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates TIGAR expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction380">
 <bp:evidence rdf:resource="#Evidence422" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">thioredoxin, oxidized + NADPH + H+ =&gt; thioredoxin, reduced + NADP+</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction383">
 <bp:evidence rdf:resource="#Evidence425" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the TIGAR gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction382">
 <bp:evidence rdf:resource="#Evidence424" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTEN gene transcription is stimulated by TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep650">
 <bp:stepProcess rdf:resource="#BiochemicalReaction583" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction389">
 <bp:evidence rdf:resource="#Evidence431" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the PTEN promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep644">
 <bp:stepProcess rdf:resource="#Pathway68" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction388">
 <bp:evidence rdf:resource="#Evidence430" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TIGAR converts D-fructose-2,6-bisphosphate to D-fructose 6-phosphate</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep645">
 <bp:stepProcess rdf:resource="#BiochemicalReaction578" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep646">
 <bp:stepProcess rdf:resource="#BiochemicalReaction579" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep647">
 <bp:stepProcess rdf:resource="#Catalysis110" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction580" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction385">
 <bp:evidence rdf:resource="#Evidence427" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DDIT4 binds 14-3-3 dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep640">
 <bp:stepProcess rdf:resource="#BiochemicalReaction574" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction384">
 <bp:evidence rdf:resource="#Evidence426" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RHEB in mTORC1:RHEB:GTP hydrolyses GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep641">
 <bp:stepProcess rdf:resource="#BiochemicalReaction575" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction387">
 <bp:evidence rdf:resource="#Evidence429" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-AMPK phosphorylates TSC1:TSC2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep642">
 <bp:stepProcess rdf:resource="#BiochemicalReaction576" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction386">
 <bp:evidence rdf:resource="#Evidence428" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of TSC1:TSC2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep643">
 <bp:stepProcess rdf:resource="#BiochemicalReaction577" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep648">
 <bp:stepProcess rdf:resource="#BiochemicalReaction581" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep649">
 <bp:stepProcess rdf:resource="#BiochemicalReaction582" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction392">
 <bp:evidence rdf:resource="#Evidence436" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ITGAL gene,(ITGA4 gene) expression is stimulated by RUNX3:CBFB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction391">
 <bp:evidence rdf:resource="#Evidence435" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RORC gene expression is stimulated by RUNX3:CBFB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction394">
 <bp:evidence rdf:resource="#Evidence438" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPP1 gene expression is stimulated by RUNX3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep660">
 <bp:stepProcess rdf:resource="#BiochemicalReaction593" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction393">
 <bp:evidence rdf:resource="#Evidence437" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3:CBFB binds the RORC gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep661">
 <bp:stepProcess rdf:resource="#BiochemicalReaction594" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction390">
 <bp:evidence rdf:resource="#Evidence434" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3:CBFB binds the ITGAL gene,(ITGA4 gene) promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep655">
 <bp:stepProcess rdf:resource="#BiochemicalReaction588" />
 <bp:stepProcess rdf:resource="#Catalysis111" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction399">
 <bp:evidence rdf:resource="#Evidence445" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 binds SMAD3 and SMAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep656">
 <bp:stepProcess rdf:resource="#BiochemicalReaction589" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep657">
 <bp:stepProcess rdf:resource="#BiochemicalReaction590" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep658">
 <bp:stepProcess rdf:resource="#BiochemicalReaction591" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction396">
 <bp:evidence rdf:resource="#Evidence441" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BCL2L11 (BIM) gene transcription is stimulated by RUNX3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep651">
 <bp:stepProcess rdf:resource="#BiochemicalReaction584" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction395">
 <bp:evidence rdf:resource="#Evidence440" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 binds the BCL2L11 (BIM) gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep652">
 <bp:stepProcess rdf:resource="#BiochemicalReaction585" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction398">
 <bp:evidence rdf:resource="#Evidence444" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 binds TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep653">
 <bp:stepProcess rdf:resource="#BiochemicalReaction586" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction397">
 <bp:evidence rdf:resource="#Evidence443" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDKN1A gene expression is synergistically activated by RUNX3, SMAD3 and SMAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep654">
 <bp:stepProcess rdf:resource="#BiochemicalReaction587" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep659">
 <bp:stepProcess rdf:resource="#BiochemicalReaction592" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep622">
 <bp:stepProcess rdf:resource="#BiochemicalReaction560" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep623">
 <bp:stepProcess rdf:resource="#Pathway64" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep624">
 <bp:stepProcess rdf:resource="#BiochemicalReaction561" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep625">
 <bp:stepProcess rdf:resource="#BiochemicalReaction562" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep620">
 <bp:stepProcess rdf:resource="#BiochemicalReaction558" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep621">
 <bp:stepProcess rdf:resource="#BiochemicalReaction559" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep626">
 <bp:stepProcess rdf:resource="#BiochemicalReaction563" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep627">
 <bp:stepProcess rdf:resource="#BiochemicalReaction564" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep628">
 <bp:stepProcess rdf:resource="#BiochemicalReaction565" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep629">
 <bp:stepProcess rdf:resource="#BiochemicalReaction566" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep633">
 <bp:stepProcess rdf:resource="#Pathway65" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep634">
 <bp:stepProcess rdf:resource="#BiochemicalReaction570" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep635">
 <bp:stepProcess rdf:resource="#BiochemicalReaction571" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep636">
 <bp:stepProcess rdf:resource="#Pathway66" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep630">
 <bp:stepProcess rdf:resource="#BiochemicalReaction567" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep631">
 <bp:stepProcess rdf:resource="#BiochemicalReaction568" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep632">
 <bp:stepProcess rdf:resource="#BiochemicalReaction569" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep637">
 <bp:stepProcess rdf:resource="#BiochemicalReaction572" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep638">
 <bp:stepProcess rdf:resource="#Pathway67" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep639">
 <bp:stepProcess rdf:resource="#BiochemicalReaction573" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence203">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence204">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence201">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence202">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence207">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence208">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence205">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence206">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence200">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence214">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence215">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence212">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence213">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence218">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence219">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence216">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence217">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence210">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence211">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence209">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence225">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence226">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence223">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence224">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence229">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence227">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence228">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence221">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence222">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence220">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence236">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence237">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence234">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence235">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence238">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence239">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence232">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence233">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence230">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence231">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence247">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence248">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence245">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence246">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence249">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence240">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence243">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence244">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence241">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence242">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction301">
 <bp:evidence rdf:resource="#Evidence339" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates CASP6 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction300">
 <bp:evidence rdf:resource="#Evidence338" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates PIDD1 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction303">
 <bp:evidence rdf:resource="#Evidence341" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 family members bind the CASP1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction302">
 <bp:evidence rdf:resource="#Evidence340" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 family members stimulate CASP1 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction309">
 <bp:evidence rdf:resource="#Evidence348" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates RABGGTA expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction308">
 <bp:evidence rdf:resource="#Evidence347" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 inhibits BIRC5 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction305">
 <bp:evidence rdf:resource="#Evidence344" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the BIRC5 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction304">
 <bp:evidence rdf:resource="#Evidence342" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates NLRC4 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction307">
 <bp:evidence rdf:resource="#Evidence346" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 or TP63 binds the PERP gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction306">
 <bp:evidence rdf:resource="#Evidence345" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 family members bind the TP53I3 (PIG3) gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence258">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence259">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence256">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence257">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence250">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence251">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence254">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence255">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence252">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence253">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction312">
 <bp:evidence rdf:resource="#Evidence351" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53I3 oxidoreductase generates unstable semiquinones</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction311">
 <bp:evidence rdf:resource="#Evidence350" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53I3 dimerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction314">
 <bp:evidence rdf:resource="#Evidence353" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHM binds RGGT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction313">
 <bp:evidence rdf:resource="#Evidence352" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Semiquinone reacts with oxygen</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction310">
 <bp:evidence rdf:resource="#Evidence349" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RABGGTA binds RABGGTB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction319">
 <bp:evidence rdf:resource="#Evidence358" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the RABGGTA gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction316">
 <bp:evidence rdf:resource="#Evidence355" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates NDRG1 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction315">
 <bp:evidence rdf:resource="#Evidence354" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates expression of the TP53I3 (PIG3) gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction318">
 <bp:evidence rdf:resource="#Evidence357" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the BCL2L14 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction317">
 <bp:evidence rdf:resource="#Evidence356" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 or TP63 stimulates PERP gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence269">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence267">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence268">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence261">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence262">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence260">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence265">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence266">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence263">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence264">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction323">
 <bp:evidence rdf:resource="#Evidence362" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates BCL6 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction322">
 <bp:evidence rdf:resource="#Evidence361" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates BCL2L14 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction325">
 <bp:evidence rdf:resource="#Evidence365" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the PMAIP1 (NOXA) promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction324">
 <bp:evidence rdf:resource="#Evidence364" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 family members stimulate BAX transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction321">
 <bp:evidence rdf:resource="#Evidence360" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the BCL6 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction320">
 <bp:evidence rdf:resource="#Evidence359" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the NDRG1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction327">
 <bp:evidence rdf:resource="#Evidence367" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ZNF420 binds TP53AIP1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction326">
 <bp:evidence rdf:resource="#Evidence366" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIAP1:PRELID1, PRELID3A transports PA from the outer to the inner mitochondrial membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction329">
 <bp:evidence rdf:resource="#Evidence369" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates BBC3 (PUMA) expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction328">
 <bp:evidence rdf:resource="#Evidence368" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates STEAP3 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence278">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence279">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence272">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence273">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence270">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence271">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence276">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence277">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence274">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence275">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction334">
 <bp:evidence rdf:resource="#Evidence374" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the BID gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction333">
 <bp:evidence rdf:resource="#Evidence373" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 and CREBBP bind BNIP3L gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction336">
 <bp:evidence rdf:resource="#Evidence376" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates TRIAP1 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction335">
 <bp:evidence rdf:resource="#Evidence375" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates BNIP3L expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction330">
 <bp:evidence rdf:resource="#Evidence370" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STEAP3 binds BNIP3L</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction332">
 <bp:evidence rdf:resource="#Evidence372" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the BBC3 (PUMA) promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction331">
 <bp:evidence rdf:resource="#Evidence371" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 family members bind the BAX promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction338">
 <bp:evidence rdf:resource="#Evidence378" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the TP53INP1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction337">
 <bp:evidence rdf:resource="#Evidence377" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates BID gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction339">
 <bp:evidence rdf:resource="#Evidence379" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ATM phosphorylates ZNF420</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1173">
 <bp:stepProcess rdf:resource="#Pathway115" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1174">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1060" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence289">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1171">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1058" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1172">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1059" />
 <bp:stepProcess rdf:resource="#Catalysis179" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1170">
 <bp:stepProcess rdf:resource="#Catalysis178" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1057" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence283">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1029">
 <bp:evidence rdf:resource="#Evidence1136" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">UHRF1 binds chromatin with hemimethylated cytosine</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence284">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1028">
 <bp:evidence rdf:resource="#Evidence1135" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DNMT3B:DNMT3L binds chromatin</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence281">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence282">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence287">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1025">
 <bp:evidence rdf:resource="#Evidence1131" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAXIP1:PAGR1 complex, NCOA6 and KDM6A bind MLL3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence288">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1024">
 <bp:evidence rdf:resource="#Evidence1130" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAXIP1 binds PAGR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence285">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1027">
 <bp:evidence rdf:resource="#Evidence1134" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DNMT1 methylates cytosine in hemimethylated DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence286">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1026">
 <bp:evidence rdf:resource="#Evidence1133" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DNMT3A:DNMT3L methylates cytosine in DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1032">
 <bp:evidence rdf:resource="#Evidence1139" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DNMT3B:DNMT3L methylates cytosine in DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1031">
 <bp:evidence rdf:resource="#Evidence1138" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">UHRF1:Chromatin binds DNMT1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1034">
 <bp:evidence rdf:resource="#Evidence1142" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TET1,2,3 oxidizes 5-methylcytosine to 5-hydroxymethylcytosine</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1033">
 <bp:evidence rdf:resource="#Evidence1141" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TDG excises 5-carboxylcytosine</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence280">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1030">
 <bp:evidence rdf:resource="#Evidence1137" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DNMT3A:DNMT3L binds chromatin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction903">
 <bp:evidence rdf:resource="#Evidence996" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The PRC1L4 complex binds the UXT gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction902">
 <bp:evidence rdf:resource="#Evidence995" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">UXT gene expression is repressed by the PRC1L4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction905">
 <bp:evidence rdf:resource="#Evidence998" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F6.com-1 complex binds the E2F1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1179">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1065" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction904">
 <bp:evidence rdf:resource="#Evidence997" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The PRC1L4 complex binds the CDC7 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1177">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1063" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1178">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1064" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction901">
 <bp:evidence rdf:resource="#Evidence994" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F6 binds TFDP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1175">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1061" />
 <bp:stepProcess rdf:resource="#Catalysis180" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction900">
 <bp:evidence rdf:resource="#Evidence993" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F6 forms the PRC1L4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1176">
 <bp:stepProcess rdf:resource="#Catalysis181" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1062" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1162">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1052" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1163">
 <bp:stepProcess rdf:resource="#Pathway112" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1160">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1050" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1161">
 <bp:stepProcess rdf:resource="#Catalysis175" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1051" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction907">
 <bp:evidence rdf:resource="#Evidence1000" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F6 binds APAF1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction906">
 <bp:evidence rdf:resource="#Evidence999" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F6 binds the PRC1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction909">
 <bp:evidence rdf:resource="#Evidence1002" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDC7 gene expression is repressed by the PRC1L4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction908">
 <bp:evidence rdf:resource="#Evidence1001" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F6 binds RRM2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence294">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1018">
 <bp:evidence rdf:resource="#Evidence1124" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ABL1 binds PPARG2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence295">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1017">
 <bp:evidence rdf:resource="#Evidence1123" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDK4 gene expression is stimulated by PPARG:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence292">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence293">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1019">
 <bp:evidence rdf:resource="#Evidence1125" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PPARG2 transcription is stimulated by PPARG2:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence298">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1014">
 <bp:evidence rdf:resource="#Evidence1120" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RXRA binds ligands</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence299">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1013">
 <bp:evidence rdf:resource="#Evidence1119" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CEBPA gene expression is stimulated by PPARG:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence296">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1016">
 <bp:evidence rdf:resource="#Evidence1122" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MLL4-ASCOM,(MLL3-ASCOM) complex is recruited to ligand- and coactivator-bound PPARG:RXRA heterodimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence297">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1015">
 <bp:evidence rdf:resource="#Evidence1121" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LPL gene expression is stimulated by PPARG:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence4">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1021">
 <bp:evidence rdf:resource="#Evidence1127" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Unliganded PPARG:RXRA heterodimer recruits corepressors to target gene loci</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence3">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1020">
 <bp:evidence rdf:resource="#Evidence1126" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Corepressors are released from liganded PPARG:RXRA heterodimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence6">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1023">
 <bp:evidence rdf:resource="#Evidence1129" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAXIP1:PAGR1 complex, NCOA6 and KDM6A bind MLL4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence5">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1022">
 <bp:evidence rdf:resource="#Evidence1128" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PPARG binds RXRA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence8">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence290">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence7">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence291">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence9">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction914">
 <bp:evidence rdf:resource="#Evidence1007" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBX3 and PRC1.6 associate with E2F6.com-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction913">
 <bp:evidence rdf:resource="#Evidence1006" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F6 binds RBBP8 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction916">
 <bp:evidence rdf:resource="#Evidence1009" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BRCA1 gene expression is inhibited by E2F6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1168">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1055" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction915">
 <bp:evidence rdf:resource="#Evidence1008" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHEK1 phosphorylates E2F6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1169">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1056" />
 <bp:stepProcess rdf:resource="#Catalysis177" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction910">
 <bp:evidence rdf:resource="#Evidence1003" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F6 binds RAD51 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1166">
 <bp:stepProcess rdf:resource="#Pathway113" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1167">
 <bp:stepProcess rdf:resource="#Pathway114" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence2">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction912">
 <bp:evidence rdf:resource="#Evidence1005" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RRM2 gene expression is stimulated by E2F1 and inhibited by E2F6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1164">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1053" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction911">
 <bp:evidence rdf:resource="#Evidence1004" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F6:TFDP1:EPC1 binds the PRC2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1165">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1054" />
 <bp:stepProcess rdf:resource="#Catalysis176" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1195">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1076" />
 <bp:stepProcess rdf:resource="#Catalysis186" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1196">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1077" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1193">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1074" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1194">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1075" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction918">
 <bp:evidence rdf:resource="#Evidence1011" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F6 binds BRCA1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1191">
 <bp:stepProcess rdf:resource="#Pathway120" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction917">
 <bp:evidence rdf:resource="#Evidence1010" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F6:TFDP1/2 binds the E2F1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1192">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1073" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction919">
 <bp:evidence rdf:resource="#Evidence1012" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of TRAP coactivator complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1190">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1072" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1115">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1114">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1113">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1112">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1111">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1047">
 <bp:evidence rdf:resource="#Evidence1158" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MPHOSPH8 of the HUSH complex bound to retroelement chromatin binds ZCCHC8 of the NEXT complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1110">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1046">
 <bp:evidence rdf:resource="#Evidence1157" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">me3-K16-ATF7IP:SETDB1 and MORC2 bind MPHOSPH8 (MPP8) in HUSH complex:L1 RNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1049">
 <bp:evidence rdf:resource="#Evidence1160" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EHMT1,EHMT2 trimethylates lysine-16 of ATF7IP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1048">
 <bp:evidence rdf:resource="#Evidence1159" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MPHOSPH8 (MPP8) in HUSH complex binds histone H3 trimethyl-lysine 9 (H3K9me3) in L1HS,L1PA2,3 heterochromatin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1054">
 <bp:evidence rdf:resource="#Evidence1166" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DNMT3A:DNMT3L in nascent RNA transcript:MeR-PIWIL4:2&apos;-O-methyl-piRNA:SPOCD1:DNMT3A:DNMT3L methylates cytosine in DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1053">
 <bp:evidence rdf:resource="#Evidence1165" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIWIL4:piRNA binds nascent LINE1 pre-RNA and recruits SPOCD1, C19ORF84, DNMT3A, DNMT3L, the NURD complex, and the BAF complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1056">
 <bp:evidence rdf:resource="#Evidence1170" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">eNoSC deacetylates histone H3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1109">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1055">
 <bp:evidence rdf:resource="#Evidence1169" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of energy-dependent Nucleolar Silencing Complex (eNoSC)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1108">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1050">
 <bp:evidence rdf:resource="#Evidence1161" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">me3-K16-ATF7IP:SETDB1 and MORC2 bind MPHOSPH8 (MPP8) in HUSH complex:L1HS,L1PA2,3 heterochromatin</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1107">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1106">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1052">
 <bp:evidence rdf:resource="#Evidence1163" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HUSH complex binds LINE1 (L1) RNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1105">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1051">
 <bp:evidence rdf:resource="#Evidence1162" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SETDB1 in me3-K16-ATF7IP:SETDB1:MORC2:HUSH complex:L1 RNA trimethylates lysine-9 of histone H3 (H3K9me3)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction925">
 <bp:evidence rdf:resource="#Evidence1020" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Addition of nucleotides between position +11 and +30</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction924">
 <bp:evidence rdf:resource="#Evidence1019" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Unwinding of DNA for the Nascent Transcript: Second Transition</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction927">
 <bp:evidence rdf:resource="#Evidence1022" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Addition of Nucleotides 5 through 9 on the growing Transcript</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction926">
 <bp:evidence rdf:resource="#Evidence1021" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Addition of nucleotides 10 and 11 on the growing transcript: Third Transition</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction921">
 <bp:evidence rdf:resource="#Evidence1016" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Addition of the fourth nucleotide on the Nascent Transcript: Second Transition</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1199">
 <bp:stepProcess rdf:resource="#Catalysis187" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1079" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction920">
 <bp:evidence rdf:resource="#Evidence1014" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase II Promoter Opening: First Transition</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction923">
 <bp:evidence rdf:resource="#Evidence1018" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Unwinding DNA for the nascent transcript</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1197">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1078" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction922">
 <bp:evidence rdf:resource="#Evidence1017" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Addition of the third nucleotide on the nascent transcript</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1198">
 <bp:stepProcess rdf:resource="#Pathway121" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1184">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1069" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1185">
 <bp:stepProcess rdf:resource="#Catalysis184" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1070" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1182">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1067" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1183">
 <bp:stepProcess rdf:resource="#Catalysis183" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1068" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction929">
 <bp:evidence rdf:resource="#Evidence1025" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Newly Formed Phosphodiester Bond Stabilized and PPi Released</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1180">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1066" />
 <bp:stepProcess rdf:resource="#Catalysis182" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction928">
 <bp:evidence rdf:resource="#Evidence1024" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nucleophillic Attack by 3&apos;-hydroxyl Oxygen of nascent transcript on the Alpha Phosphate of NTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1181">
 <bp:stepProcess rdf:resource="#Pathway116" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1104">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1103">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1039">
 <bp:evidence rdf:resource="#Evidence1149" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NuRD complex binds SUMO2-6K-TRIM28:KRAB-ZNF:retroelement</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1102">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1101">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1100">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1036">
 <bp:evidence rdf:resource="#Evidence1144" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TET1,2,3 oxidizes 5-hydroxymethylcytosine to 5-formylcytosine</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1035">
 <bp:evidence rdf:resource="#Evidence1143" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TET1,2,3 oxidizes 5-formylcytosine to 5-carboxylcytosine</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1038">
 <bp:evidence rdf:resource="#Evidence1148" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBX5 (HP-1alpha) binds TRIM28 (KAP1) in SUMO2-6K-TRIM28:KRAB-ZFP:retroelement chromatin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1037">
 <bp:evidence rdf:resource="#Evidence1145" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TDG excises 5-formylcytosine</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1043">
 <bp:evidence rdf:resource="#Evidence1153" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIM28 in TRIM28:KRAB-ZFP:retroelement chromatin autoSUMOylates with SUMO2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1042">
 <bp:evidence rdf:resource="#Evidence1152" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIM28 (KAP1) binds KRAB-ZFP in KRAB-ZFP:retroelement chromatin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction930">
 <bp:evidence rdf:resource="#Evidence1026" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NTP Binds Active Site of RNA Polymerase II</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1045">
 <bp:evidence rdf:resource="#Evidence1156" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SETDB1 in me3-K16-ATF7IP:SETDB1:MORC2:HUSH complex:L1HS,L1PA2,3 heterochromatin trimethylates lysine-9 of histone H3 in adjacent nucleosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1044">
 <bp:evidence rdf:resource="#Evidence1154" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ATF7IP:SETDB1 binds SUMO2-6K-TRIM28:KRAB-ZFP:retroelement chromatin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1041">
 <bp:evidence rdf:resource="#Evidence1151" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KRAB-ZFP binds retroelement DNA in chromatin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1040">
 <bp:evidence rdf:resource="#Evidence1150" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SETDB1 in ATF7IP:SETDB1:SUMO2-6K-TRIM28:KRAB-ZFP:retroelement trimethylates lysine-9 of histone H3 in nucleosomes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction936">
 <bp:evidence rdf:resource="#Evidence1033" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of DSIF complex </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction935">
 <bp:evidence rdf:resource="#Evidence1032" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of NELF complex </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction938">
 <bp:evidence rdf:resource="#Evidence1035" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Abortive Initiation After Second Transition</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction937">
 <bp:evidence rdf:resource="#Evidence1034" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Elongin BC complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction932">
 <bp:evidence rdf:resource="#Evidence1029" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Fall Back to Closed Pre-initiation Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1188">
 <bp:stepProcess rdf:resource="#Pathway119" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction931">
 <bp:evidence rdf:resource="#Evidence1028" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Abortive initiation after formation of the first phosphodiester bond</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1189">
 <bp:stepProcess rdf:resource="#Catalysis185" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1071" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction934">
 <bp:evidence rdf:resource="#Evidence1031" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Elongating transcript encounters a lesion in the template</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1186">
 <bp:stepProcess rdf:resource="#Pathway117" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction933">
 <bp:evidence rdf:resource="#Evidence1030" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Elongin complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1187">
 <bp:stepProcess rdf:resource="#Pathway118" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1130">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1025" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction939">
 <bp:evidence rdf:resource="#Evidence1036" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Abortive Initiation Before Second Transition</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1137">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1136">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1135">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1134">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1133">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1132">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1131">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1130">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction941">
 <bp:evidence rdf:resource="#Evidence1038" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of FACT complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction940">
 <bp:evidence rdf:resource="#Evidence1037" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of P-TEFb complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1129">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1128">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1139">
 <bp:stepProcess rdf:resource="#Pathway108" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1127">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction947">
 <bp:evidence rdf:resource="#Evidence1044" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Abortive termination of early transcription elongation by DSIF:NELF</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1137">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1031" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction946">
 <bp:evidence rdf:resource="#Evidence1043" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">2-4 nt.backtracking of Pol II complex on the template leading to elongation pausing</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1138">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1032" />
 <bp:stepProcess rdf:resource="#Catalysis165" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction949">
 <bp:evidence rdf:resource="#Evidence1049" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">B-WICH complex binds rDNA promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1135">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1029" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction948">
 <bp:evidence rdf:resource="#Evidence1048" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">B-WICH:histone acetyltransferase acetylates histone H3 at lysine-9</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1136">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1030" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction943">
 <bp:evidence rdf:resource="#Evidence1040" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Resumption of elongation after recovery from pausing</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1133">
 <bp:stepProcess rdf:resource="#Catalysis164" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1027" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction942">
 <bp:evidence rdf:resource="#Evidence1039" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Abortive termination of elongation after arrest</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1134">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1028" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction945">
 <bp:evidence rdf:resource="#Evidence1042" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFIIS-mediated recovery of elongation from arrest</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1131">
 <bp:stepProcess rdf:resource="#Pathway107" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction944">
 <bp:evidence rdf:resource="#Evidence1041" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">7-14 nt. Backtracking of Pol II complex on the template leading to elongation arrest</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1132">
 <bp:stepProcess rdf:resource="#Catalysis163" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1026" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1126">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1125">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1124">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1123">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1122">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1121">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1120">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction950">
 <bp:evidence rdf:resource="#Evidence1050" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">B-WICH recruits histone acetyltransferases</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction952">
 <bp:evidence rdf:resource="#Evidence1053" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of ERCC6 (CSB), EHMT2 (G9a), and NuRD to the promoter of rRNA gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction951">
 <bp:evidence rdf:resource="#Evidence1052" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TTF1:rRNA promoter:ERCC6:EHMT2 complex dimethylates histone H3 at lysine-9</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1119">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1118">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1117">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1128">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1023" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1116">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1129">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1024" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction958">
 <bp:evidence rdf:resource="#Evidence1061" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAXIP1 binds PAGR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1126">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1021" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction957">
 <bp:evidence rdf:resource="#Evidence1060" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cleaved KMT2A dimers translocate to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1127">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1022" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1124">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1019" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction959">
 <bp:evidence rdf:resource="#Evidence1062" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cleaved KMT2B dimers translocate to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1125">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1020" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction954">
 <bp:evidence rdf:resource="#Evidence1055" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBX3 (HP1gamma) binds histone H3 dimethylated at lysine-9</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1122">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1017" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction953">
 <bp:evidence rdf:resource="#Evidence1054" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TTF-I binds to the Sal Box</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1123">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1018" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction956">
 <bp:evidence rdf:resource="#Evidence1059" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TASP1 cleaves KMT2B</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1120">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1015" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction955">
 <bp:evidence rdf:resource="#Evidence1058" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of the MLL1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1121">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1016" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1151">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1151">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1042" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1150">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1152">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1043" />
 <bp:stepProcess rdf:resource="#Catalysis172" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1150">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1041" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1007">
 <bp:evidence rdf:resource="#Evidence1113" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PPARG binds ligands</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1159">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1006">
 <bp:evidence rdf:resource="#Evidence1112" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ELOVL5 gene expression is stimulated by PPARG2:RXRA:MLL4(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1158">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1009">
 <bp:evidence rdf:resource="#Evidence1115" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FABP4 gene expression is stimulated by PPARG:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1157">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1008">
 <bp:evidence rdf:resource="#Evidence1114" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLIN1 gene expression is stimulated by PPARG:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1156">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1003">
 <bp:evidence rdf:resource="#Evidence1109" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ACSS3 gene expression is stimulated by PPARG2:RXRA:MLL4(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1155">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1002">
 <bp:evidence rdf:resource="#Evidence1108" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Coactivators are recruited to liganded PPARG:RXRA heterodimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1154">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1005">
 <bp:evidence rdf:resource="#Evidence1111" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ANGPTL4 gene expression is stimulated by PPARG:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1153">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1004">
 <bp:evidence rdf:resource="#Evidence1110" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KMT2D,(KMT2C) complex monomethylates nucleosomes at PPARG:RXRA-bound enhancers</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1152">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction961">
 <bp:evidence rdf:resource="#Evidence1064" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of the MLL3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1010">
 <bp:evidence rdf:resource="#Evidence1116" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLIN2 gene expression is stimulated by PPARG:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction960">
 <bp:evidence rdf:resource="#Evidence1063" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of the MLL2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction963">
 <bp:evidence rdf:resource="#Evidence1066" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TASP1 cleaves KMT2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1012">
 <bp:evidence rdf:resource="#Evidence1118" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PEX11A gene expression is stimulated by PPARG:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction962">
 <bp:evidence rdf:resource="#Evidence1065" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of the NSL complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1011">
 <bp:evidence rdf:resource="#Evidence1117" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPAM gene expression is stimulated by PPARG2:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1149">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction969">
 <bp:evidence rdf:resource="#Evidence1072" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKAP8L binds MLL2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1159">
 <bp:stepProcess rdf:resource="#Catalysis174" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1049" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction968">
 <bp:evidence rdf:resource="#Evidence1071" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BOD1 binds SET1B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1157">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1047" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1158">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1048" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction965">
 <bp:evidence rdf:resource="#Evidence1068" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of the RBBP5:ASH2L heterodimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1155">
 <bp:stepProcess rdf:resource="#Catalysis173" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1045" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction964">
 <bp:evidence rdf:resource="#Evidence1067" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PSIP1 binds MEN1 associated with MLL2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1156">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1046" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction967">
 <bp:evidence rdf:resource="#Evidence1070" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PSIP1 binds MLL1 and MEN1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1153">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1044" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction966">
 <bp:evidence rdf:resource="#Evidence1069" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of the WRAD complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1154">
 <bp:stepProcess rdf:resource="#Pathway111" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1140">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1140">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1033" />
 <bp:stepProcess rdf:resource="#Catalysis166" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1141">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1034" />
 <bp:stepProcess rdf:resource="#Catalysis167" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1148">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1147">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1146">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1145">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1144">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1143">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1142">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1141">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction972">
 <bp:evidence rdf:resource="#Evidence1075" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of the GCN5-ATAC complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction971">
 <bp:evidence rdf:resource="#Evidence1074" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of the PCAF-ATAC complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction974">
 <bp:evidence rdf:resource="#Evidence1077" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKAP8L binds MLL1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1001">
 <bp:evidence rdf:resource="#Evidence1107" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">THRSP gene expression is stimulated by PPARG2:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction973">
 <bp:evidence rdf:resource="#Evidence1076" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MEN1 binds MLL1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1000">
 <bp:evidence rdf:resource="#Evidence1106" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PPARG:RXRA heterodimer binds target gene loci</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction970">
 <bp:evidence rdf:resource="#Evidence1073" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HCFC1, HCFC2 bind the MLL1:MEN1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1139">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1138">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1148">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1039" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction979">
 <bp:evidence rdf:resource="#Evidence1082" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CXXC1 and WDR82 bind SET1A complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1149">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1040" />
 <bp:stepProcess rdf:resource="#Catalysis171" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1146">
 <bp:stepProcess rdf:resource="#Pathway110" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1147">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1038" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction976">
 <bp:evidence rdf:resource="#Evidence1079" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAXIP1:PAGR1 complex, NCOA6 and KDM6A bind MLL3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1144">
 <bp:stepProcess rdf:resource="#Catalysis170" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1037" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction975">
 <bp:evidence rdf:resource="#Evidence1078" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MEN1 binds MLL2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1145">
 <bp:stepProcess rdf:resource="#Pathway109" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction978">
 <bp:evidence rdf:resource="#Evidence1081" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of the SET1A complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1142">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1035" />
 <bp:stepProcess rdf:resource="#Catalysis168" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction977">
 <bp:evidence rdf:resource="#Evidence1080" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CXXC1 and WDR82 bind SET1B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1143">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1036" />
 <bp:stepProcess rdf:resource="#Catalysis169" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep721">
 <bp:stepProcess rdf:resource="#BiochemicalReaction651" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep722">
 <bp:stepProcess rdf:resource="#Pathway72" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep723">
 <bp:stepProcess rdf:resource="#BiochemicalReaction652" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep724">
 <bp:stepProcess rdf:resource="#BiochemicalReaction653" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep720">
 <bp:stepProcess rdf:resource="#BiochemicalReaction650" />
 <bp:stepProcess rdf:resource="#Catalysis123" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep729">
 <bp:stepProcess rdf:resource="#BiochemicalReaction656" />
 <bp:stepProcess rdf:resource="#Catalysis125" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep725">
 <bp:stepProcess rdf:resource="#Pathway73" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep726">
 <bp:stepProcess rdf:resource="#Pathway74" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep727">
 <bp:stepProcess rdf:resource="#BiochemicalReaction654" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep728">
 <bp:stepProcess rdf:resource="#BiochemicalReaction655" />
 <bp:stepProcess rdf:resource="#Catalysis124" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep732">
 <bp:stepProcess rdf:resource="#BiochemicalReaction659" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep733">
 <bp:stepProcess rdf:resource="#BiochemicalReaction660" />
 <bp:stepProcess rdf:resource="#Catalysis128" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep734">
 <bp:stepProcess rdf:resource="#BiochemicalReaction661" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep735">
 <bp:stepProcess rdf:resource="#BiochemicalReaction662" />
 <bp:stepProcess rdf:resource="#Catalysis129" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep730">
 <bp:stepProcess rdf:resource="#Catalysis126" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction657" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep731">
 <bp:stepProcess rdf:resource="#Catalysis127" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction658" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep736">
 <bp:stepProcess rdf:resource="#Pathway75" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep737">
 <bp:stepProcess rdf:resource="#BiochemicalReaction663" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep738">
 <bp:stepProcess rdf:resource="#BiochemicalReaction664" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep739">
 <bp:stepProcess rdf:resource="#BiochemicalReaction665" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep700">
 <bp:stepProcess rdf:resource="#BiochemicalReaction632" />
 <bp:stepProcess rdf:resource="#Catalysis120" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep701">
 <bp:stepProcess rdf:resource="#BiochemicalReaction633" />
 <bp:stepProcess rdf:resource="#Catalysis121" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep702">
 <bp:stepProcess rdf:resource="#BiochemicalReaction634" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1119">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1014" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1117">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1012" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1118">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1013" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep707">
 <bp:stepProcess rdf:resource="#BiochemicalReaction639" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1115">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1010" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep708">
 <bp:stepProcess rdf:resource="#Pathway70" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1116">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1011" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep709">
 <bp:stepProcess rdf:resource="#BiochemicalReaction640" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1113">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1008" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1114">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1009" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep703">
 <bp:stepProcess rdf:resource="#BiochemicalReaction635" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1111">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1006" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep704">
 <bp:stepProcess rdf:resource="#BiochemicalReaction636" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1112">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1007" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep705">
 <bp:stepProcess rdf:resource="#BiochemicalReaction637" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep706">
 <bp:stepProcess rdf:resource="#BiochemicalReaction638" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1110">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1005" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep710">
 <bp:stepProcess rdf:resource="#BiochemicalReaction641" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep711">
 <bp:stepProcess rdf:resource="#BiochemicalReaction642" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep712">
 <bp:stepProcess rdf:resource="#BiochemicalReaction643" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep713">
 <bp:stepProcess rdf:resource="#BiochemicalReaction644" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1108">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1003" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1109">
 <bp:stepProcess rdf:resource="#Catalysis162" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1004" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1106">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1001" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1107">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1002" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep718">
 <bp:stepProcess rdf:resource="#BiochemicalReaction648" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1104">
 <bp:stepProcess rdf:resource="#BiochemicalReaction999" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep719">
 <bp:stepProcess rdf:resource="#BiochemicalReaction649" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1105">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1000" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1102">
 <bp:stepProcess rdf:resource="#BiochemicalReaction997" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1103">
 <bp:stepProcess rdf:resource="#BiochemicalReaction998" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep714">
 <bp:stepProcess rdf:resource="#BiochemicalReaction645" />
 <bp:stepProcess rdf:resource="#Catalysis122" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1100">
 <bp:stepProcess rdf:resource="#BiochemicalReaction995" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep715">
 <bp:stepProcess rdf:resource="#BiochemicalReaction646" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1101">
 <bp:stepProcess rdf:resource="#BiochemicalReaction996" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep716">
 <bp:stepProcess rdf:resource="#BiochemicalReaction647" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep717">
 <bp:stepProcess rdf:resource="#Pathway71" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence33">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence32">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence31">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence30">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence37">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence36">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence35">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence34">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence29">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence28">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence27">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence40">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence44">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence43">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence42">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence41">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence48">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence47">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence46">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence45">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence39">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence38">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway102">
 <bp:pathwayOrder rdf:resource="#PathwayStep1056" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1087" />
 <bp:pathwayComponent rdf:resource="#Pathway104" />
 <bp:pathwayComponent rdf:resource="#Pathway103" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1056" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Epigenetic regulation by WDR5-containing histone modifying complexes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string"> WDR5 is a component of six histone methyltransferases and three histone acetyltransferases involved in epigenetic regulation of gene expression (reviewed in Guarnaccia and Tansey 2018).  The WDR5 histone methyltransferase complexes (KMT2 complexes) include the Mixed Lineage Leukemia (MLL) 1-4, SET1A, and SET1B. All KMT2 complexes consist of a histone methyltransferase (KMT2A, KMT2B, KMT2C, KMT2D, SETD1A, or SETD1B, respectively) and the WRAD subcomplex composed of WDR5, RBBP5, ASH2L, and DPY30. The WRAD complex regulates the enzymatic activity of histone methyltransferases and enables their recruitment to chromatin. Additional transcription cofactors associate with each KMT2 histone methyltransferase complex, enabling their functional diversification. All KMT2 complexes methylate lysine K5 of histone H3 (K4 in mature histone H3 peptides, as the initiator methionine is removed), which is associated with transcriptional activation. Different KMT2 complexes preferentially monomethylate, dimethylate, or trimethylate H3K4, depending on the presence of accessory subunits, transcriptional co-factors, and posttranslational modifications. The KMT2A and KMT2B complexes preferentially methylate H3K4 at a limited number of target gene promoters, while KMT2C and KMT2D complexes preferentially methylate H3K4 at a limited number of target gene enhancers. SETD1A and SETD1B complexes are responsible for the bulk of cellular H3K4 methylation and show less target specificity. For a detailed overview, please refer to Cho et al. 2007, Song and Kingston 2008, Patel et al. 2009, Wang et al. 2009, Takahashi et al. 2011, Couture and Skiniotis 2013, van Nuland et al. 2013, Rao and Dou 2015, Klonou et al. 2021.  WDR5 is also a component of three histone acetyltransferase complexes, GCN5-ATAC, PCAF-ATAC, and MOF/KAT8-NSL. The role of WDR5 in epigenetic regulation of gene expression through histone acetylation is under investigation (reviewed in Guarnaccia and Tansey 2018).  The KMT2C (MLL3) complex, together with the related KMT2D (MLL4) complex, is most similar to Drosophila Trr (Trithorax-related) and mediates hitone H3 lysine-4 (H3K4 - lysine 5 in nascent histone H3) monomethylation, with the establishment of the H3K4me1 epigenetic marks, at transcription enhancers throughout the human genome, with estimates ranging from approximately 12,000 to over 20,000 sites, depending on the cell type and developmental stage. While H3K4 monomethylation by MLL3 and MLL4 complexes may not be essential for expression of developmental genes, it is likely important for fine tuning of transcription levels and timing, both during normal development and in cancer. For review, please refer to Hu et al. 2013, Piunti and Shilatifard 2016, Fagan and Dingwall 2019, and Klonou et al. 2021.  Based on mouse studies, MLL3 and MLL4 complexes play an important role in adipogenesis and myogenesis. During adipogenesis, the KMT2D (MLL4) complex preferentially localizes to active enhancers, marked by the presence of mono- or dimethylated histone H3 lysine-4 (H3K4me1/2, residue K4 corresponds to residue K5 in nascent histone H3), acetylated H3 lysine-27 (H3K27ac), and the presence of RNA Pol II. KMT2D localizes to these active enhancers together with the adipogenic transcription factors CEBPB, CEBPA, and PPARG, and is especially enriched at high confidence enhancers that are both CEBP and PPARG positive (Lee et al. 2013). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway101">
 <bp:pathwayOrder rdf:resource="#PathwayStep1052" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1053" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1051" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1054" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction952" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction951" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction954" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction953" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1051" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">About half of the rRNA genes in the genome are actively expressed, being transcribed by RNA polymerase I (reviewed in Nemeth and Langst 2008, Bartova et al. 2010, Goodfellow and Zomerdijk 2012, Grummt and Langst 2013). As inferred from mouse, those genes that are expressed are activated by ERCC6 (also known as Cockayne Syndrome protein, CSB) which interacts with TTF-I bound to the T0 terminator region (also know as the Sal Box) of rRNA genes (Yuan et al. 2007, reviewed in Birch and Zomerdijk 2008, Grummt and Langst 2013). ERCC6 recruits the histone methyltransferase EHMT2 (also known as G9a) which dimethylates histone H3 at lysine-9 in the coding region of rRNA genes. The dimethylated lysine is bound by CBX3 (also known as Heterochromatic Protein-1gamma, HP1gamma) and increases expression of the rRNA gene. Continuing dimethylation depends on continuing transcription. Mutations in CSB result in dysregulation of RNA polymerase I transcription, which plays a role in the symptoms of Cockayne Syndrome (reviewed in Hannan et al. 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway104">
 <bp:pathwayOrder rdf:resource="#PathwayStep1130" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1128" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1129" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1088" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1023" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1025" />
 <bp:pathwayComponent rdf:resource="#Pathway105" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1024" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1088" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Epigenetic regulation of gene expression by MLL3 and MLL4 complexes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The KMT2C (MLL3) complex, together with the related KMT2D (MLL4) complex, is most similar to Drosophila Trr (Trithorax-related) and mediates hitone H3 lysine-4 (H3K4 - lysine 5 in nascent histone H3) monomethylation, with the establishment of the H3K4me1 epigenetic marks, at transcription enhancers throughout the human genome (For review, please refer to Hu et al. 2013, Piunti and Shilatifard 2016, Klonou et al. 2021).  The MLL3 and MLL4 complexes monomethylate H3K4 at transcription enhancers throughout the human genome, with estimates ranging from approximately 12,000 to over 20,000 sites, depending on the cell type and developmental stage. Full activation of gene expression through MLL3 and MLL4 complex target enhancers appears to require simultaneous monomethylation of H3K4 by MLL3 and/or MLL4 complexes, and acetylation of H3K27 by the histone acetyltransferase p300/CBP, recruited to enhancers through direct interactions with the MLL3 and MLL4 complexes. KDM6A (also known as UTX), a lysine demethylase that acts as an accessory subunit of MLL3 and MLL4 complexes, facilitates H3K27 acetylation by removing inhibitory methyl groups from H3K27, deposited by the Polycomb repressor PRC2 complex (reviewed in Fagan and Dingwall 2019).  KMT2C (also known as MLL3), the catalytic subunit of the MLL3 complex, contains two closely related plant homeodomain (PHD) zinc finger clusters, with 6-7 zinc fingers, in the N-terminal region, and a single PHD zinc finger near the C-terminus, which are involved in protein-protein interactions. The HMG domain in KMT2C enables DNA binding, while the SET domain provides catalytic activity. KMT2C possesses multiple nuclear receptor (NR) interaction motifs (LLXXL or LXXLL), which are important for recruitment of the MLL3 complex to NR-regulated enhancers (reviewed in Fagan and Dingwall 2019).  While H3K4 monomethylation by MLL3 and MLL4 complexes may not be essential for expression of developmental genes, it is likely important for fine tuning of transcription levels and timing, both during normal development and in cancer. Although a broad dispersion of cancer mutations in the coding regions of the KMT2C and KMT2D genes, as well as the presence of many truncating mutations, imply a tumor suppressor role, activating mutations in the SET domains have also been reported, suggesting that a tumor suppressive vs. oncogenic role is context-dependent (reviewed in Fagan and Dingwall 2019).  KMT2C is frequently mutated in cancer. KMT2C may be important for driving hormone-stimulated proliferation of breast cancer cells that are ESR1-positive and ERBB2-negative. In mice, simultaneous overexpression of Pik3ca and inactivation of the Kmt2c blocks differentiation of the mammary gland and leads to increased stem cell self-renewal through HIF pathway activation (reviewed in Fagan and Dingwall 2019).  Non-small cell lung cancer (NSCLC) is characterized by frequent co-occurrence of mutations in KMT2C and KMT2D (also known as MLL4, the catalytic subunit of the MLL4 complex) (reviewed in Fagan and Dingwall 2019).  DNA damage-induced transcription of TP53 target genes requires both KMT2C and KMT2D. KMT2C is also implicated in TP53-dependent DNA double strand break repair in a transcription-independent manner. KTM2C and KMT2D contribute to maintenance of epithelial cell states by negatively regulating the epithelial-to-mesenchymal transition. KMT2C mutations in lung and breast cancer are frequently found in the first PHD that is involved in the interaction with the BAP1 histone deubiquitinating complex, linked to Polycomb repressor complex-dependent gene silencing (reviewed in Fagan and Dingwall 2019).  Heterozygous germline LOF mutations in KTM2C are associated with Kleefstra syndrome-2 and autism spectrum disorder (reviewed in Fagan and Dingwall 2019).  In mouse, Kmt2c and Kmt2d are implicated in enhancer priming and de novo enhancer activation during embryonic development. This function is not essential for the maintenance of cell identity and self-renewal of embryonic stem cells (ESCs) and somatic cells but is necessary for ESC reprogramming during differentiation and for production of induced pluripotent stem cells (iPSCs) (reviewed in Fagan and Dingwall 2019).   Knockout of KMT2D, the catalytic subunit of the MLL4 complex, in human colon carcinoma cell line HCT116, which already harbors inactivating mutations in both alleles of KMT2C (the catalytic subunit of the MLL3 complex), leads to significant global reduction of H3K4 monomethylation (Hu et al. 2013). Knockout studies of KMT2C and KMT2D in HCT116 cells and mouse embryonic fibroblasts (MEFs) implicate at least partially redundant roles of MLL3 and MLL4 complexes in H3K4 monomethylation (Hu et al. 2013). Genome-wide ChIP-seq analysis in both HCT116 cells and MEFs showed that ~80% of the MLL4 peaks are enriched at intergenic and intragenic regions, while only ~20% of the peaks map to transcription start sites (TSS) (Hu et al. 2013). MLL4 binding sites at SAE1 and AP3B1 gene loci in HCT116 cells, and at Nanog and Lefty1 loci in MEFs, are co-occupied by enhancer region markers H3K4me1, EP300, and acetylated H3K27 (Hu et al. 2013). Many of the genes associated with MLL3/MLL4-bound enhancers in HCT116 cells are implicated in intracellular signaling, while genes associated with MLL3/MLL4-independent enhancers tend to be implicated in regulation of gene expression (Hu et al. 2013).  HOXA9, encoded by a target gene of KMT2A (MLL1) and KMT2B (MLL2) complexes, may function as a pioneer factor at de novo enhancers in acute myeloid leukemia (AML) and recruit CEBPA and the MLL3 and MLL4 complexes to enhancers of leukemogenesis-promoting genes (Sun et al. 2018).  KMT2D is frequently mutated in cancer (reviewed in Dhar and Lee 2021) and is one of the most frequently mutated genes in non-Hodgkin lymphoma, such as follicular lymphoma and diffuse large B cell lymphoma, where loss-of-function (LOF) of KMT2D appears to be an early event that cooperates with the over-expression of the BCL2 oncogene. Knockout of Kmt2d in mouse B cell progenitors impairs their differentiation and promotes lymphoma development. KMT2D LOF in lymphoma is associated with reduced H3K4me1 mark at enhancers of multiple tumor suppressor genes (reviewed in Fagan and Dingwall 2019).  KMT2D chromatin enrichment sites significantly overlap with TP53 binding sites. Aberrant transcription associated with TP53 mutations in colon carcinoma is dependent on KMT2D-mediated H3K4 monomethylation. KMT2D can be inactivated through phosphorylation by SGK1, a PI3K effector kinase closely related to AKT1. SGK1 is the estrogen-inducible kinase, whose transcription is collaboratively activated by ESR1 and KMT2D. SGK1-mediated phosphorylation on KMT2D on serine S1331 near the second PHD results in downregulation of H3K4 monomethylation at ESR1-target genes, thus constituting a negative feedback loop (reviewed in Fagan and Dingwall 2019).  Heterozygous germline LOF mutations in KMT2D are associated with Kabuki syndrome-1. Kabuki syndrome patients have a modestly increased predisposition to cancer, in particular lymphoma, Wilms tumor, hepatoblastoma, synovial sarcoma and neuroblastoma. Mice with brain-specific knockout of Kmt2d (Mll4) develop medulloblastoma that shows hyperactivation of Ras and Notch signaling (reviewed in Fagan and Dingwall 2019).  Based on mouse studies, MLL3 and MLL4 complexes play an important role in adipogenesis and myogenesis. Kmt2c KO mice die around birth with no obvious morphological abnormalities in embryonic development, while Kmt2d KO mice show early embryonic lethality around E9.5 (Lee et al. 2013). Pups with Kmt2d KO in precursors of brown preadipocytes and skeletal myocytes are obtained at the expected Mendelian ratio but display marked reduction in back muscles and die immediately after birth due to breathing malfunction, also showing a decrease in brown adipose tissue mass (Lee et al. 2013). In cultured mouse brown preadipocytes, KO of Kmt2d leads to a moderate differentiation defect along with a transient up-regulation of Kmt2c expression, whereas KO of Kmt2c has no effect on adipogenesis, suggesting a more prominent role of KMT2D in development and a partial compensation of KMT2D loss by KMT2C (Lee et al. 2013). KO of Kmt2d 3T3-L1 mouse white preadipocytes inhibits adipogenesis, and Kmt2c and Kmt2d are also required for adipogenesis in mouse embryonic fibroblasts (Lee et al. 2013). By ChIP-seq, the average length of Kmt2d binding regions is between 350 and 400 bp, and the binding regions change dramatically from the preadipocytes stage to the onset of adipogenesis, but are then Kmt2d-binding regions were largely non-overlapping between brown adipocytes and skeletal myocytes (Lee et al. 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway103">
 <bp:pathwayOrder rdf:resource="#PathwayStep1074" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1075" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1072" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1073" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1070" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1071" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1058" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1059" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1078" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1057" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1079" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1076" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1077" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1063" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1085" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1064" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1086" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1061" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1083" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1062" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1084" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1081" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1060" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1082" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1080" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1069" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1067" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1068" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1065" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1066" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction961" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction983" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction960" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction982" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction963" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction962" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction984" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction981" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction980" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction969" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction968" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction965" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction964" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction967" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction966" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction972" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction971" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction974" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction973" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction970" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction958" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction957" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction979" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction959" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction976" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction975" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction956" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction978" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction955" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction977" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1057" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of WDR5-containing histone-modifying complexes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WDR5 is a component of six mammalian histone methyltransferase KMT2 complexes: Mixed Lineage Leukemia (MLL) 1-4, SET1A, and SET1B. All KMT2 complexes consist of a histone methyltransferase (KMT2A, KMT2B, KMT2C, KMT2D, SETD1A, or SETD1B, respectively) and the WRAD subcomplex composed of WDR5, RBBP5, ASH2L, and DPY30. The WRAD complex regulates the enzymatic activity of histone methyltransferases and enables their recruitment to chromatin. Additional transcription cofactors associate with each KMT2 histone methyltransferase complex, enabling their functional diversification. For a detailed overview, please refer to Cho et al. 2007, Song and Kingston 2008, Takahashi et al. 2011, Couture and Skiniotis 2013, van Nuland et al. 2013, Klonou et al. 2021.  The KMT2 complexes are evolutionarily conserved. While a single SET1/COMPASS complex is present in yeast, three distinct complexes are present in Drosophila: trithorax (Trx), trithorax-related (Trr), and Set1. In mammals, due to gene duplication, two Trx-like complexes (one with KMT2A and another with KMT2B as the catalytic subunit), as well as two Trr-like complexes (one with KMT2C and another with KMT2D as the catalytic subunit), and two Set1-like complexes (one with SETD1A and another with SETD1B as the catalytic subunit) are formed. For review, please refer to Rao and Dou 2015.  All KMT2 complexes methylate lysine K5 of histone H3 (K4 in mature histone H3 peptides, as the initiator methionine is removed), which is associated with transcriptional activation. Different KMT2 complexes preferentially monomethylate, dimethylate, or trimethylate H3K4, depending on the presence of accessory subunits, transcriptional co-factors, and posttranslational modifications. The catalytic activity of KMT2 complexes may differ between endogenous complexes and complexes reconstituted in vitro by mammalian proteins expressed and produced in bacterial or insect cells. The KMT2A and KMT2B complexes preferentially methylate H3K4 at a limited number of target gene promoters, while KMT2C and KMT2D complexes preferentially methylate H3K4 at a limited number of target gene enhancers. SETD1A and SETD1B complexes are responsible for the bulk of cellular H3K4 methylation and show less target specificity. For overview, please refer to Patel et al. 2009, Wang et al. 2009, Rao and Dou 2015.  In both Drosophila and vertebrates, KMT2 complexes control the expression of evolutionarily conserved Hox genes which serve as master regulators of embryonic patterning (reviewed in Soshnikova and Duboule 2009).  Germline mutations in human KMT2 complexes are the underlying cause of several chromatinopathies. Germline loss-of-function (LOF) mutations in KMT2A cause Weideman-Steiner syndrome, a rare autosomal-dominant disorder characterized by intellectual disability, developmental delay, pre- and post-natal growth delay, hypertrichosis, short stature, hypotonia, distinctive facial features, skeletal abnormalities, feeding problems and behavioral difficulties (reviewed in Castiglioni et al. 2022). Germline LOF mutations in KMT2B cause dystonia-28 (DYT28) and intellectual developmental, autosomal dominant disorder-68 (MRD68). DYT28 is an autosomal dominant neurologic disorder characterized by onset of progressive dystonia in the first decade of life (reviewed in Zech et al. 2019), while MRD68 is an autosomal dominant disorder characterized by developmental delay/intellectual disability, microcephaly, poor growth, feeding difficulties, and dysmorphic features (Cif et al. 2020). Germline LOF mutations in KMT2C cause Kleefstra syndrome-2 (KLEFS2), an autosomal dominant neurodevelopmental disorder characterized by delayed psychomotor development, variable intellectual disability, and mild dysmorphic features (reviewed in Lavery et al. 2020). Germline LOF mutations in KMT2D cause Kabuki syndrome 1, a congenital mental retardation syndrome with postnatal dwarfism, a facial dysmorphism and skeletal abnormalities (reviewed in Lavery et al. 2020). Germline LOF mutations in SETD1A cause early-onset epilepsy with or without developmental delay (EPEDD), an autosomal dominant neurologic disorder (Yu et al. 2019), and neurodevelopmental disorder with speech impairment and dysmorphic facies (NEDSID) (Kummeling et al. 2021). Germline LOF mutations in SETD1B cause intellectual developmental disorder with seizures and language delay (IDDSELD) (Roston et al. 2021).  Somatic mutations in KMT2 genes contribute to cancer development. They were first discovered in Mixed Lineage Leukemia (MLL), characterized by chromosomal translocations that involve the KMT2A gene locus on chromosome 11 (chromosomal band 11q23) and result in the expression of fusion proteins with oncogenic properties. Besides gene fusions, other types of KMT2A mutations are also present in blood cancers (most frequently in high-grade B-cell lymphoma, T-cell lymphoblastic leukemia, and acute myeloid leukemia) and solid tumors (most often reported in lung adenocarcinoma, colon adenocarcinoma, and bladder urothelial carcinoma). Somatic cancer mutations in other KMT2 genes (KMT2B, KMT2C, KMT2D, SETD1A and SETD1B) are less characterized but most frequently affect the catalytic SET domain and show different distributions between different cancer types. For review, please refer to Rao and Dou 2015, Castiglioni et al. 2022. Several anti-cancer therapeutics are being developed that affect the association of KMT2 enzymes with components of the WRAD complex, in particular WDR5 (reviewed in Vedadi et al. 2017; Siladi et al. 2022).  WDR5 is also a component of three histone acetyltransferase complexes, GCN5-ATAC, PCAF-ATAC, and MOF/KAT8-NSL. The role of WDR5 in epigenetic regulation of gene expression through histone acetylation is under investigation (reviewed in Guarnaccia and Tansey 2018).  The function of WDR5-containing histone modifying complexes is currently depicted in the following Reactome pathways: &quot;Transcriptional regulation of granulopoiesis&quot; (MLL1 complex), &quot;Transcriptional regulation by RUNX1&quot; (MLL1 complex), &quot;Activation of anterior HOX genes in hindbrain development during early embryogenesis&quot; (MLL3 complex and MLL4 complex), &quot;TCF dependent signaling in response to WNT&quot; (MLL4 complex), and &quot;Chromatin organization&quot; (MLL1 complex, MLL2 complex, MLL3 complex, MLL4 complex, SET1A complex, SET1B complex, GCN5-ATAC complex, PCAF-ATAC complex, and MOF/KAT8-NSL complex). Please note that there is an inconsistency in naming of MLL2 and MLL4 complexes in the literature and in Reactome pathways, as MLL2 and MLL4 have been used as synonyms for both KMT2B and KMT2D, depending on whether the numbering of MLLs referred to order of cloning or whether it referred to similarity to founding MLL1 (MLL, KMT2A) enzyme. The current UniProt standard is for MLL2 to be used as the preferred synonym of KMT2B, and for MLL4 to be used as the preferred synonym of KMT2D. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway100">
 <bp:pathwayOrder rdf:resource="#PathwayStep1049" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1047" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1048" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction950" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction949" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction948" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1047" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">B-WICH complex positively regulates rRNA expression</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The B-WICH complex is a large 3 Mdalton complex containing SMARCA5 (SNF2H), BAZ1B (WSTF), ERCC6 (CSB), MYO1C (Nuclear myosin 1c), SF3B1, DEK, MYBBP1A, and DDX21 (Cavellan et al. 2006, Percipalle et al. 2006, Vintermist et al. 2001, Sarshad et al. 2013, Shen et al. 2013, reviewed in Percipalle and Farrants 2006). B-WICH is found at active rRNA genes as well as at 5S rRNA and 7SL RNA genes. B-WICH appears to remodel chromatin and recruit histone acetyltransferases that modify histones to transcriptionally active states.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence11">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep790">
 <bp:stepProcess rdf:resource="#BiochemicalReaction714" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence10">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep791">
 <bp:stepProcess rdf:resource="#BiochemicalReaction715" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep792">
 <bp:stepProcess rdf:resource="#BiochemicalReaction716" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep793">
 <bp:stepProcess rdf:resource="#BiochemicalReaction717" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence15">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence14">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence13">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence12">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep787">
 <bp:stepProcess rdf:resource="#BiochemicalReaction711" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep788">
 <bp:stepProcess rdf:resource="#BiochemicalReaction712" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep789">
 <bp:stepProcess rdf:resource="#BiochemicalReaction713" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep783">
 <bp:stepProcess rdf:resource="#BiochemicalReaction707" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep784">
 <bp:stepProcess rdf:resource="#BiochemicalReaction708" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep785">
 <bp:stepProcess rdf:resource="#BiochemicalReaction709" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep786">
 <bp:stepProcess rdf:resource="#BiochemicalReaction710" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway109">
 <bp:pathwayOrder rdf:resource="#PathwayStep1163" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1146" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1154" />
 <bp:pathwayComponent rdf:resource="#Pathway112" />
 <bp:pathwayComponent rdf:resource="#Pathway111" />
 <bp:pathwayComponent rdf:resource="#Pathway110" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1146" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of endogenous retroelements</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transposable elements (TEs) constitute about 48.34% of the human genome (Osmanski et al. 2023) and can be classified by their transposition mechanisms: DNA transposons (about 3% of the human genome) transpose by excising a DNA intermediate and inserting it into a new location; retrotransposons (about 33% of the human genome) transpose by transcribing an element, reverse transcribing the RNA to DNA, and inserting the DNA copy into a new location. Retrotransposons can be divided into those that contain long terminal repeats (LTRs) and those that lack LTRs. Retrotransposons that contain LTRs are believed to be remnants of retroviruses, are therefore called endogenous retroviruses, and constitute about 9.45% of the human genome (Lander et al. 2001, Osmanski et al. 2023). No endogenous retroviruses are known to be currently transpositionally active in humans, with the most recent transpositions estimated to have occurred about 0.67 million years ago (Wildschutte et al. 2016). Retrotransposons that lack LTRs constitute about 34% of the human genome and mostly have uncertain origins: Long interspersed nuclear elements (LINEs, about 18,99% of the genome) encode two proteins, an RNA-binding protein (ORF1p) and a reverse transcriptase/endonuclease (ORF2p), that confer autonomous transposition activity; short interspersed nuclear elements (SINEs, about 14.66% of the genome) do not encode proteins and require proteins produced in trans by LINEs for transposition (Lander et al. 2001). Of the 3 families of LINEs, only the LINE1 family is known to be currently active (Lander et al. 2001, Beck et al. 2010). Of the SINEs, only Alu elements, which evolved from the 7SL RNA of the signal recognition particle, are known to be currently active (Lander et al. 2001, Bennett et al. 2008). Surprisingly, although retroelements can cause deleterious mutations due to insertions and recombination, their genomic elements and expression are required for embryogenesis. The envelope proteins ERVW-1 (Syncytin-1) of the HERV-W endogenous retrovirus and ERVFRD-1 (Syncytin-2) of the HERV-FRD endogenous retrovirus act to fuse cells in the trophoblast (reviewed in Gholami Barzoki et al. 2023). TEs contain binding sites for pluripotency factors (for example OCT4, SOX2, and NANOG) as well as cell lineage-specific factors (Pontis et al. 2022), In humans, a hominid-specific TE family, LTR5Hs, become transcriptionally active during specification of primordial germ cells (PGCs) and serve to bind PGC transcription factors (Xiang et al. 2022). In mice, the retroviral MERVL element is transcribed in cleavage-stage embryos and during this time MERVL regulatory DNA elements activate expression of more than one hundred genes involved in zygotic genome activation (Macfarlan et al. 2012, Sakashita et al. 2023, Yang et al. 2024). In mouse embryos, transcripts from LINE1 retroelements are required to exit the 2-cell stage by serving as scaffolds for Nucleolin (NCL) and TRIM28 (KAP1) to repress Dux expression and activate rRNA expression (Percharde et al. 2018, Chen et al. 2021). LINE1 elements are also active in expressing cell type-specific transcripts in the developing and adult human brain (Garza et al. 2023). By binding transcription activators, retroelements such as LTR5 and LTR7 can also act as cis-regulatory networks in somatic cells (reviewed in Sundaram and Wysocka 2020, Low et al. 2021, Fueyo et al. 2022). Retroelements are generally silenced transcriptionally by DNA methylation and histone modifications (reviewed in Geis and Goff 2020, Carotti et al. 2023, Stamidis and Zylicz 2023) or post-transcriptionally by RNA interference (reviewed in Geis and Goff 2020), however repressive chromatin marks are lost and retroelements are transcribed at two points during mammalian development: in early germ cells prior to meiosis and in zygotes immediately after fertilization (reviewed in Low et al. 2021). In germ cells, small RNAs of 24-31 nucleotides known as PIWI-interacting RNAs (piRNAs) are generated from transcripts of retroelements and, when bound to PIWI proteins, guide post-transcriptional decay of retroelement transcripts and re-impose chromatin modifications that repress transcription of retroelements. Endogenous retroelements are also transcriptionally silenced by zinc finger-containing proteins, KRAB-ZFPs, that bind specific DNA sequences (reviewed in Yang et al. 2017). The human genome contains 423 KRAB-ZFP genes that encode 742 KRAB-ZFP proteins that appear to evolve in response to invasion by retroelements (reviewed in Huntley et al. 2006, Lupo et al. 2013). Specific KRAB-ZFPs bind specific families of retroelements and recruit the TRIM28 scaffold protein (also known as KAP1), which assembles a complex containing the histone methylase SETDB1 and the NuRD repressor complex to silence transcription of the retroelements (reviewed in Almeida et al. 2022). The Human Silencing Hub (HUSH) complex directly binds RNA of LINE1 elements and trimethylates lysine-9 of histone H3 (H3K9) of nucleosomes assembled on the LINE1 that produced the RNA (reviewed in Seczynska and Lehner 2023). Trimethyl H3K9 (H3K9me3) is a repressive mark thus the result is de novo formation of heterochromatin at LINE1 elements. The HUSH complex also binds H3K9me3 and trimethylates H3K9 of adjacent nucleosomes, resulting in propagation of heterochromatin (reviewed in Seczynska and Lehner 2023). In mice, N6 methylation of adenosine residues in RNAs can cause destabilization of the RNA (Chelmicki et al. 2021) and transcriptional silencing of the locus that produced the RNA (Xu et al. 2021, Liu et al. 2021). The effect of N6-methyladenosine on expression of human retroelements is less clear. Xiong et al. (2021) observed that N6-methyladenosine in transcripts of young LINE1 elements increased RNA expression while N6-methyladenosine in transcripts of ancient LINE1 elements decreased RNA expression. The mechanism responsible for the difference may involve the promotion of translation of young LINE1 elements by N6-methyladenosine residues located in the 5&apos; untranslated region (Hwang et al. 2021).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway106">
 <bp:pathwayOrder rdf:resource="#PathwayStep1096" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1097" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1094" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1095" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1092" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1093" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1090" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1091" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1119" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1117" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1118" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1115" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1116" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1113" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1114" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1111" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1112" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1098" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1099" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1110" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1108" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1109" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1106" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1107" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1104" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1126" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1105" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1127" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1102" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1124" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1103" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1125" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1100" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1122" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1101" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1123" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1120" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1121" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1007" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1006" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1009" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1008" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1003" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1002" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1005" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1004" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1010" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction985" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1012" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1011" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction987" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction986" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction989" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction988" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1018" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1017" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1019" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1014" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1013" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1016" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1015" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction994" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1021" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction993" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1020" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction996" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1001" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction995" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1000" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1022" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction990" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction992" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction991" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction998" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction997" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction999" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1090" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The ligand-activated complex of a master transcription regulator of adipogenesis, nuclear receptor PPARG, and its partner, nuclear receptor RXRA, recruits MLL3 and MLL4 complexes to target gene loci, leading to establishment of activating epigenetic chromatin marks. The existing experimental evidence implies that MLL3-ASCOM and MLL4-ASCOM complexes are recruited to PPARG:RXRA-target loci, as described below.  PPARG isoform PPARG2-positive adipocyte nuclei isolated from visceral adipose tissue show significantly higher expression level of KMT2C, the catalytic subunit of the MLL3 complex, and PAXIP1, a cofactor of MLL3 and KMT2D (MLL4) complexes, than PPARG2-negative nuclei (Yu et al. 2016). Based on mouse studies, PAXIP1 (PTIP), an accessory subunit of MLL3 and MLL4 complexes, is required for adipogenesis in mouse embryonic fibroblasts (MEFs) and primary preadipocytes. PAXIP1-deficient MEFs show significant defects in both PPARG- and CEBPA-stimulated adipogenesis (Cho et al. 2009). Knockout of Paxip1 gene in brown adipose tissue (BAT) leads to significant decrease of BAT in knockout mice, and a significant decrease of expression of markers shared between white adipose tissue and BAT, such as Pparg, Cebpa, and Fabp4, as well as BAT-specific/prevalent markers Prdm16, Cidea, Mpzl2 (Eva1), Ntrk3, Ucp1, Ppargc1a (Pgc1a), Cox5b and Cox8b (Cho et al. 2009). Paxip1 BAT knockout mice are cold intolerant, with impaired cold-mediated induction of genes involved in fatty acid catabolism, such as Cpt1a, Lpl, and Mlycd (Mcd) (Cho et al. 2009).  In prostate cancer, KMT2D and PPARG are overexpressed at the protein level relative to the normal tissue (Zhai et al. 2022). KMT2D knockdown significantly reduces the lipid droplet content in prostate cancer cell lines (Zhai et al. 2022). In prostate cancer tumors, KMT2D mRNA expression significantly correlates with mRNA expression of lipid metabolism genes FASN, ACC, SCD, and ACLY (Zhai et al. 2022). KMT2D knockdown in prostate cancer cell lines leads to significant decrease in the mRNA levels of ACC, ACLY, and FASN (Zhai et al. 2022). Stimulation of PPARG by the synthetic agonist rosiglitazone stimulates lipid synthesis in prostate cancer cell lines, but the effect of rosiglitazone is diminished upon KMT2D knockdown (Zhai et al. 2022).  In addition to regulating genes involved in lipid metabolism, the PPARG:RXRA complex (Nielsen et al. 2008) and MLL3/MLL4 complexes (Jang et al. 2019: supplementary information) may also regulate expression of some of the genes involved in glucose metabolism and the tricarboxylic acid (TCA) cycle.  Hepatic steatosis represents the synthesis and accumulation of triglycerides in hepatocytes which can, if prolonged, lead to the development of non-alcoholic fatty liver disease (NAFLD) that can progress to non-alcoholic steatohepatitis (NASH), ultimately resulting in liver cirrhosis (Hardy et al. 2016). Like Kmt2c (Mll3) delta/delta mice, which express catalytically inactive Kmt2c (Lee, Saha et al. 2008; Lee S., Lee J. et al. 2008), Kmt2d (Mll4)+/- mice, with deletion of one allele of Kmt2d, are resistant to high fat diet-induced hepatic steatosis, with Kmt2d+/- livers accumulating much less fat relative to wild type littermate controls in response to high fat diet feeding (Kim et al. 2016). Bulk transcriptomic analysis of Kmt2d+/- mouse livers shows that the expression of a large portion of high fat diet controlled genes requires Kmt2d (Kim et al. 2016). Among the defined hepatic steatotic transcription factors, which include MLXIPL (ChREBP), SREBF1 (SREBP1) isoform SREBP1c (SREBP 1C), the liver X receptors (LXRs) &#8211; NR1H3 (LXRA) and NR1H2 (LXRB), and PPARG, KMT2D has been reported to associate with LXRs (Lee S., Lee J. et al. 2008) and PPARG (Lee, Saha et al. 2008). No association between mouse orthologs of KMT2D and MLXIPL or SREBP1c could be detected (Kim et al. 2016).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway105">
 <bp:pathwayOrder rdf:resource="#PathwayStep1089" />
 <bp:pathwayComponent rdf:resource="#Pathway106" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1089" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">During adipogenesis, the KMT2D (MLL4) complex preferentially localizes to active enhancers, marked by the presence of mono- or dimethylated histone H3 lysine-4 (H3K4me1/2, residue K4 corresponds to residue K5 in nascent histone H3), acetylated H3 lysine-27 (H3K27ac), and the presence of RNA Pol II. KMT2D localizes to these active enhancers together with the adipogenic transcription factors CEBPB, CEBPA, and PPARG, and is especially enriched at high confidence enhancers that are both CEBP and PPARG positive (Lee et al. 2013). Single Kmt2c (Mll3) knockout in mouse brown preadipocytes led to a modest decrease of H3K4me1, while double Kmt2c;Kmt2d (Mll4) knockout led to a global decrease of H3K4me1/2 (Lee et al. 2013). Most MLL4-binding sites are marked by both H3K4me1 and H3K4me2 during adipogenesis (Lee et al. 2013). Double knockout of Kmt2c and Kmt2d in differentiating mouse adipocytes prevented increase in H3K4me1/2, H3K27ac, Mediator complex and RNA Pol II on adipogenic enhancers, specifically on Cebpa and Pparg gene loci (Lee et al. 2013). KMT2D-dependent deposition of H3K4me1/2 marks was also detected on some adipogenic promoters, but was less pronounced than on adipogenic enhancers (Lee et al. 2013). Deletion of Kmt2d significantly decreased expression of genes associated with Kmt2d+ adipogenic enhancers (Lee et al. 2013). The expression of KMT2C, the catalytic subunit of the MLL3 complex, is upregulated during brown adipocyte differentiation (Son et al. 2016).  Transgenic mice that express catalytically inactive form of Kmt2c (Lee, Saha et al. 2008; Lee, Lee et al. 2008) or that have a heterozygous loss of Kmt2d (Kim et al. 2016) are resistant to fatty liver formation induced by high-fat diet. Expression of a large portion of high-fat diet induced genes in mouse liver requires Kmt2d (Kim et al. 2016). Among the defined transcription factors that promote high-fat diet-induced hepatic steatosis (ChREBP, SREBP1c, LXRs, and PPARG), ChREBP and SREBP1c do not interact with KMT2C/D (Kim et al. 2016).  Gomisin N, a lignin isolated from magnolia-vine (Schisandra chinensis) was shown to inhibit, without cytotoxic effects, differentiation of mouse 3T3-L1 preadipocytes by inhibiting mitotic clonal expansion during early adipogenesis (Jang et al. 2017). Gomisin N treatment reduces KMT2D but not KMT2C mRNA levels, and also reduces the mRNA level of adipogenic transcription factors CEBPB, CEBPA, and PPARG, as well as their targets FABP4 (aP2) and FASN (FAS), inhibiting lipid accumulation and formation of lipid droplets, both in 3T3-L1 preadipocytes and in adipose tissue of mice on high fat diet. Gomisin N ameliorates hepatic steatosis in obese mice on high fat diet (Jang et al. 2017).  The epigenomic reader BRD4, essential for both white and brown adipose tissue development but dispensable for adipose tissue maintenance, is enriched on active enhancers during the initial stages of adipogenesis and on promoters that associate with enhancers at terminal stages of adipogenesis (Lee et al. 2017). More than 90% of Brd4 genomic binding sites lose Brd4 in mouse preadipocytes that are double knockout for Kmt2c and Kmt2d (Lee et al. 2017). The majority of Brd4-bound enhancers are co-occupied by Kmt2d, Ep300, Cebpa or Cebpb, and Pparg (Lee et al. 2017). Brd4 knockout does not affect binding of Cebpb and Kmt2d to adipogenesis target genes nor does it affect deposition of activating epigenetic marks, H3K4me1 and H3K27ac, at these genes, but it reduces binding of transcriptional machinery (e.g. Med1, Tbp, RNA Pol II, Cdk9) and mRNA synthesis (Lee et al. 2017). Brd2 and Brd3 may be able to partially compensate for the loss of Brd4 (Lee et al. 2017). Inhibition of Brd proteins by synthetic inhibitor JQ1 inhibits expression of Pparg targets Cepba, Fabp4 and Adipoq induced by rosiglitazone, a synthetic Pparg agonist (Lee et al. 2017). Brd4 was shown to physically associate with Cebpb (Lee et al. 2017). Conditional knockout mice in which Brd4 gene is deleted in progenitor cells of brown adipose tissue and muscle lineages die immediately after birth because of breathing impairment, exhibiting severe reduction in muscle mass and brown adipose tissue (Lee et al. 2017).  Based on mouse studies, at the onset of white and brown adipogenesis the accessory subunit of MLL3 and MLL4 complexes, PAGR1 (also known as PA1) is needed for induction of CEBPB and CEBPD transcription factors (Lee et al. 2020). Based on a study in immortalized mouse brown adipocytes, PAGR1 is recruited to the CEBPB gene promoter by activated CREB1, which is phosphorylated at serine residue S133 (p-S133-CREB1) (Lee et al. 2020). Based on a study in mouse white preadipocyte cell line 3T3-L1, PAGR1 is recruited to CEBPD gene promoter by ligand-activated glucocorticoid receptor (GR) (Lee et al. 2020).  Based on a study conducted using the mouse 3T3-L1 white preadipocyte cell line as a model system, dehydroleucodine, a sesquiterpene lactone isolated from Artemisia douglasiana (California mugwort) halts mitotic clonal expansion at the initiation of white adipogenesis (Abood et al. 2017). Dehydroleucodine decreases the phosphorylation of ERKs and AKT, as well as levels of CCNA, CCND, CDK2, and CDK4, while increasing the level of p27 (CDKN1B), resulting in G0/G1 cell cycle arrest of mouse white preadipocytes (Abood et al. 2017). Dehydroleucodine also downregulates JMJD2B and KMT2D, leading to downregulation of CEBPB and PPARG, respectively (Abood et al. 2017).  Expression of the histone 3 mutant H3.3 K4M in mouse brown preadipocytes impairs adipose tissue development, but when H3.3 K4M is expressed in already differentiated mouse brown adipocytes, the maintenance and thermogenic function of brown adipose tissue are not affected (Jang et al. 2019). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway108">
 <bp:pathwayOrder rdf:resource="#PathwayStep1140" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1141" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1144" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1142" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1143" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1034" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1033" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1036" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1035" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1037" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1140" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TET1,2,3 and TDG demethylate DNA</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">About 2-6% of all cytosine residues and 70-80% of cytosine residues in CG dinucleotides in mammalian cells are methylated at the 5 position of the pyrimidine ring. The cytosine residues are methylated by DNA methyltransferases after DNA replication and can be demethylated by passive dilution during subsequent replication or by active modification of the 5-methylcytosine base. Cytosine demethylation is developmentally regulated: one wave of demethylation occurs in primordial germ cells and one wave occurs by active demethylation in the male pronucleus after fertilization. Some mechanisms of active demethylation remain controversial, however progressive oxidation of the methyl group of 5-methylcytosine followed by base excision by thymine DNA glycosylase (TDG) has been reproducibly demonstrated in vivo (reviewed in Wu and Zhang 2011, Franchini et al 2012, Cadet and Wagner 2013, Kohli and Zhang 2013, Ponnaluri et al. 2013, Rasmussen and Helin 2016). Ten-eleven translocation proteins TET1, TET2, and TET3 are dioxygenases that first oxidize 5-methylcytosine to 5-hydroxymethylcytosine (5-hmC) (Tahiliani et al. 2009, Ito et al. 2010), which is found in significant quantities and specific genomic locations in stem cells and neurons (Kinney and Pradhan 2013). TET proteins can further oxidize 5-hmC to 5-formylcytosine (5-fC) and then 5-carboxylcytosine (5-caC) (He et al. 2011, Ito et al. 2011). G:5-fC and G:5-caC base pairs are recognized by TDG, which excises the 5-fC or 5-caC and leaves an abasic site. TET1 in mouse is expressed in neurons and its expression depends on neuronal activity (Guo et al. 2011, Kaas et al. 2013, Zhang et al. 2013). TET1 is also found in embryonic stem cells (Ficz et al. 2011, Koh et al. 2011, Wu et al. 2011) and in primordial germ cells of mice, where it plays a role in erasure of imprinting (Yamaguchi et al. 2013). TET3 is expressed in oocytes and zygotes of mice and is required for demethylation in the male pronucleus (Gu et al. 2011, Iqbal et al. 2011). TET2 is the most highly expressed TET family protein in hemopoietic stem cells and appears to act as a tumor suppressor. TET2 is also expressed in embryonic stem cells (Koh et al. 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway107">
 <bp:pathwayOrder rdf:resource="#PathwayStep1137" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1138" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1135" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1136" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1133" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1134" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1132" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1032" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1031" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1030" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1029" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1028" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1027" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1026" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1132" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DNA methylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Methylation of cytosine is catalyzed by a family of DNA methyltransferases (DNMTs): DNMT1, DNMT3A, and DNMT3B transfer methyl groups from S-adenosylmethionine to cytosine, producing 5-methylcytosine and homocysteine (reviewed in Klose and Bird 2006, Ooi et al. 2009, Jurkowska et al. 2011, Moore et al. 2013). (DNMT2 appears to methylate RNA rather than DNA.) DNMT1, the first enzyme discovered, preferentially methylates hemimethylated CG motifs that are produced by replication (template strand methylated, synthesized strand unmethylated). Thus it maintains existing methylation through cell division. DNMT3A and DNMT3B catalyze de novo methylation at unmethylated sites that include both CG dinucleotides and non-CG motifs. DNA from adult humans contains about 0.76 to 1.00 mole percent 5-methylcytosine (Ehrlich et al. 1982, reviewed in Klose and Bird 2006, Ooi et al. 2009, Moore et al. 2013). Methylation of DNA occurs at cytosines that are mainly located in CG dinucleotides. CG dinucleotides are unevenly distributed in the genome. Promoter regions tend to have a high CG-content, forming so-called CG-islands (CGIs), while the CG-content in the remaining part of the genome is much lower. CGIs tend to be unmethylated, while the majority of CGs outside CGIs are methylated. Methylation in promoters and first exons tends to repress transcription while methylation in gene bodies (regions of genes downstream of the promoter and first exon) correlates with transcription (reviewed in Ehrlich and Lacey 2013, Kulis et al. 2013). Proteins such as MeCP2 and MBDs specifically bind 5-methylcytosine and may recruit other factors. Mammalian development has two major episodes of genome-wide demethylation and remethylation (reviewed in Zhou 2012, Guibert and Weber 2013, Hackett and Surani 2013, Dean 2014). In mice about 1 day after fertilization the paternal genome is actively demethylated by TET proteins together with thymine DNA glycosylase and the maternal genome is demethylated by passive dilution during replication, however methylation at imprinted sites is maintained. The genome has its lowest methylation level about 3.5 days post-fertilization. Remethylation occurs by 6.5 days post-fertilization. The second demethylation-remethylation event occurs in primordial germ cells of the developing embryo about 12.5 days post-fertilization. DNMT3A and DNMT3B, together with the non-catalytic DNMT3L, play major roles in the remethylation events (reviewed in Chen and Chan 2014). How the methyltransferases are directed to particular regions of the genome remains an area of active research. The mechanisms at each locus may differ in detail but a connection between histone modifications and DNA methylation has been observed (reviewed in Rose and Klose 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence22">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway9">
 <bp:pathwayOrder rdf:resource="#PathwayStep37" />
 <bp:pathwayOrder rdf:resource="#PathwayStep38" />
 <bp:pathwayOrder rdf:resource="#PathwayStep35" />
 <bp:pathwayOrder rdf:resource="#PathwayStep36" />
 <bp:pathwayOrder rdf:resource="#PathwayStep33" />
 <bp:pathwayOrder rdf:resource="#PathwayStep34" />
 <bp:pathwayOrder rdf:resource="#PathwayStep31" />
 <bp:pathwayOrder rdf:resource="#PathwayStep32" />
 <bp:pathwayOrder rdf:resource="#PathwayStep40" />
 <bp:pathwayOrder rdf:resource="#PathwayStep41" />
 <bp:pathwayOrder rdf:resource="#PathwayStep39" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction26" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction25" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction24" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction23" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction29" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction28" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction27" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction33" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction32" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction31" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction30" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence31" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA polymerase II transcribes snRNA genes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Small nuclear RNAs (snRNAs) play key roles in splicing and some of them, specifically the U1 and U2 snRNAs, are encoded by multicopy snRNA gene clusters containing tandem arrays of genes, about 30 in the RNU1 cluster (Bernstein et al. 1985) and about 10-20 in the RNU2 cluster (Van Ardsell and Weiner 1984). Whereas U6 snRNA genes are transcribed by RNA polymerase III, U1,U2, U4, U4atac, U5, U11, and U12 genes are transcribed by RNA polymerase II. Transcription of the U1 and U2 genes has been most extensively studied and the other snRNA genes as well as other genes with similar promoter structures, for example the SNORD13 gene, are inferred to be transcribed by similar reactions. The snRNA genes transcribed by RNA polymerase II are distinguished from mRNA-encoding genes by the presence of a proximal sequence element (PSE) rather than a TATA box and the presence of the Integrator complex rather than the Mediator complex (reviewed in Egloff et al. 2008, Jawdeker and Henry 2008). The snRNA genes are among the most rapidly transcribed genes in the genome. The 5&apos; transcribed region of the U2 snRNA gene is largely single-stranded during interphase and metaphase (Pavelitz et al. 2008) and chromatin within the transcribed region is cleared of nucleosomes (O&apos;Reilly et al. 2014). Transcriptional activation of the RNA polymerase II transcribed snRNA genes begins with binding of transcription factors to the distal sequence element (DSE) of the promoter (reviewed in Hernandez 2001, Egloff et al. 2008, Jawdeker and Henry 2008). The factors, which include POU2F1 (Oct-1), POU2F2 (Oct-2), ZNF143 (Staf) and Sp1, promote binding of the SNAPc complex (also known as PTF and PBP) to the PSE. SNAPc helps clear the gene of nucleosomes (O&apos;Reilly et al. 2014) and recruits initiation factors (TFIIA, TFIIB, TFIIE, TFIIF, and snTAFc:TBP) which recruit RNA polymerase II. Phosphorylation of the C-terminal domain (CTD) of RNA polymerase II (reviewed in Egloff and Murphy 2008) by CDK7 recruits RPAP2 and the Integrator complex, which is required for later processing of the 3&apos; end of the pre-snRNA transcript (reviewed in Chen and Wagner 2010, Baillat and Wagner 2015). The Little Elongation Complex (LEC) also appears to bind around the time of transcription initiation (Hu et al. 2013). As transcription proceeds, RPAP2 dephosphorylates serine-5 and P-TEFb phosphorylates serine-2 of the CTD. As transcription reaches the end of the snRNA gene serine-7 of the CTD is phosphorylated. These marks serve to bind protein complexes and are required for 3&apos; processing of the pre-snRNA (reviewed in Egloff and Murphy 2008). After transcription proceeds through the conserved 3&apos; processing sequence of the pre-snRNA the Integrator complex cleaves the pre-snRNA. Transcription then terminates downstream in a less well characterized reaction that requires elements of the polyadenylation system.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence21">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway8">
 <bp:pathwayOrder rdf:resource="#PathwayStep26" />
 <bp:pathwayOrder rdf:resource="#PathwayStep27" />
 <bp:pathwayOrder rdf:resource="#PathwayStep25" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction19" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction18" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction20" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence25" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of the Early Elongation Complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcription elongation by RNA polymerase II (RNAPII) is controlled by a number of trans-acting transcription elongation factors as well as by cis-acting elements.  Transcription elongation is a rate-limiting step for proper mRNA production in which the phosphorylation of Pol II CTD is a crucial biochemical event.  The role of CTD phosphorylation in transcription by Pol II is greatly impaired by protein kinase inhibitors such as 5,6-dichloro-1- ribofuranosylbenzimidazole (DRB), which block CTD phosphorylation and induce arrest of elongating Pol II.  DRB-sensitive activation Pol II CTD during elongation has enabled the isolation of two sets of factors  -Negative Elongation Factors (NELF) and DRB sensitivity inducing factor (DSIF).  P-Tefb is a DRB-sensitive, cyclin-dependent CTD kinase composed of Cdk9 that carries out Serine-2 phosphorylation of Pol II CTD during elongation. The mechanism by which DSIF, NELF and P-TEFb act together in Pol II-regulated elongation is yet to be fully understood. Various biochemical evidences point to a model in which DSIF and NELF negatively regulate elongation through interactions with polymerase containing a hypophosphorylated CTD. Subsequent phosphorylation of the Pol II CTD by P-Tefb might promote elongation by inhibiting interactions of DSIF and NELF with the elongation complex. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence20">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway7">
 <bp:pathwayOrder rdf:resource="#PathwayStep22" />
 <bp:pathwayOrder rdf:resource="#PathwayStep21" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction15" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction16" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence21" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of RNA Pol II elongation complex </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFIIS is a transcription factor involved in different phases of transcription, occurring in a major ubiquitous form and other tissue specific forms.  TFIIS stimulates RNA Pol II complex out of elongation arrest.   Other transcription factors like ELL, Elongin family members and TFIIF interact directly with elongating Pol II and increase its elongation rate.  These factors have been observed to act on naked DNA templates by suppressing transient pausing by the enzyme at all or most steps of nucleotide addition. In Drosophila, ELL is found at a large number of  transcriptionally active sites on polytene chromosomes.  In general, ELL is suspected to have more unidentified functions.  Elongin is a heterotrimeric protein complex that stimulates the overall rate of elongation.  In addition, Elongin may act as an E3 Ubiquitin ligase. Ubiquitylation of RNA Pol II occurs rapidly after genotoxic assault by UV light or chemicals, and results in degradation by proteasome.  The  FACT complex appears to promote elongation by facilitating passage of polymerase through chromatin.  All these factors contribute to the formation of a processive elongation complex centered around the RNA Pol II complex positioned on the DNA:RNA hybrid.  This enables the RNA Pol II elongation complex to function as a platform that coordinates mRNA processing and export (Reviewed by Shilatifard et al., 2003).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway6">
 <bp:pathwayOrder rdf:resource="#PathwayStep24" />
 <bp:pathwayOrder rdf:resource="#PathwayStep23" />
 <bp:pathwayOrder rdf:resource="#PathwayStep20" />
 <bp:pathwayOrder rdf:resource="#PathwayStep28" />
 <bp:pathwayOrder rdf:resource="#PathwayStep29" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction17" />
 <bp:pathwayComponent rdf:resource="#Pathway8" />
 <bp:pathwayComponent rdf:resource="#Pathway7" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction22" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction21" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence20" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase II Transcription Elongation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mechanisms governing the process of elongation during eukaryotic mRNA synthesis are being unraveled by recent studies. These studies have led to the expected discovery of a diverse collection of transcription factors that directly regulate the activities of RNA Polymerase II and unexpected discovery of roles for many elongation factors in other basic processes like DNA repair, recombination, etc. The transcription machinery and structural features of the major RNA polymerases are conserved across species. The genes active during elongation fall under different classes like, housekeeping, cell-cycle regulated, development and differentiation specific genes etc. The list of genes involved in elongation has been growing in recent times, and include: -TFIIS,DSIF, NELF, P-Tefb etc. that are involved in drug induced or sequence-dependent arrest - TFIIF, ELL, elongin, elongator etc. that are involved in increasing the catalytic rate of elongation by altering the Km and/or the Vmax of Pol II -FACT, Paf1 and other factors that are involved chromatin modification - DNA repair proteins, RNA processing and export factors, the 19S proteasome and a host of other factors like Spt5-Spt5, Paf1, and NELF complexes, FCP1P etc. (Arndt and Kane, 2003).  Elongation also represents processive phase of transcription in which the activities of several mRNA processing factors are coupled to transcription through their binding to RNA polymerase (Pol II). One of the key events that enables this interaction is the differential phosphorylation of Pol II CTD. Phosphorylation pattern of CTD changes during transcription, most significantly at the beginning and during elongation process. TFIIH-dependent Ser5 phosphorylation is observed primarily at promoter regions while P-Tefb mediated Ser2 phosphorylation is seen mainly in the coding regions, during elongation. Experimental evidence suggests a dynamic association of RNA processing factors with differently modified forms of the polymerase during the transcription cycle. (Komarnitsky et al., 2000). [Komarnitsky et al 2000, Arndt    Kane 2003, Shilatifard et al 2003]</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence26">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence25">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence24">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence23">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway1">
 <bp:pathwayOrder rdf:resource="#PathwayStep1260" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1206" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1212" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1186" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1044" />
 <bp:pathwayComponent rdf:resource="#Pathway123" />
 <bp:pathwayComponent rdf:resource="#Pathway126" />
 <bp:pathwayComponent rdf:resource="#Pathway98" />
 <bp:pathwayComponent rdf:resource="#Pathway133" />
 <bp:pathwayComponent rdf:resource="#Pathway2" />
 <bp:pathwayComponent rdf:resource="#Pathway117" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gene expression (Transcription)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gene expression encompasses transcription and translation and the regulation of these processes. RNA Polymerase I Transcription produces the large preribosomal RNA transcript (45S pre-rRNA) that is processed to yield 18S rRNA, 28S rRNA, and 5.8S rRNA, accounting for about half the RNA in a cell. RNA Polymerase II transcription produces messenger RNAs (mRNA) as well as a subset of non-coding RNAs including many small nucleolar RNAs (snRNA) and microRNAs (miRNA). RNA Polymerase III Transcription produces transfer RNAs (tRNA), 5S RNA, 7SL RNA, and U6 snRNA. Transcription from mitochondrial promoters is performed by the mitochondrial RNA polymerase, POLRMT, to yield long transcripts from each DNA strand that are processed to yield 12S rRNA, 16S rRNA, tRNAs, and a few RNAs encoding components of the electron transport chain. Regulation of gene expression can be divided into epigenetic regulation, transcriptional regulation, and post-transcription regulation (comprising translational efficiency and RNA stability). Epigenetic regulation of gene expression is the result of heritable chemical modifications to DNA and DNA-binding proteins such as histones. Epigenetic changes result in altered chromatin complexes that influence transcription. Gene Silencing by RNA mostly occurs post-transcriptionally but can also affect transcription. Small RNAs originating from the genome (miRNAs) or from exogenous RNA (siRNAs) are processed and transferred to the RNA-induced silencing complex (RISC), which interacts with complementary RNA to cause cleavage, translational inhibition, or transcriptional inhibition.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence19">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep798">
 <bp:stepProcess rdf:resource="#BiochemicalReaction722" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence18">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep799">
 <bp:stepProcess rdf:resource="#BiochemicalReaction723" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence17">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence16">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway5">
 <bp:pathwayOrder rdf:resource="#PathwayStep15" />
 <bp:pathwayOrder rdf:resource="#PathwayStep16" />
 <bp:pathwayOrder rdf:resource="#PathwayStep14" />
 <bp:pathwayOrder rdf:resource="#PathwayStep17" />
 <bp:pathwayOrder rdf:resource="#PathwayStep18" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction14" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction13" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction12" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction11" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction10" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence14" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Pol II CTD phosphorylation and interaction with CE</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">To facilitate co-transcriptional capping, and thereby restrict the cap structure to RNAs made by RNA polymerase II, the capping enzymes bind directly to the RNA polymerase II.  The C-terminal domain of the largest Pol II subunit contains several phosphorylation sites on its heptapeptide repeats.  The capping enzyme guanylyltransferase and the methyltransferase bind  specifically to CTD phosphorylated at Serine 5 within the CTD.  Kinase subunit of TFIIH, Cdk7, catalyzes this phosphorylation event that occurs near the promoter.  In addition, it has been shown that binding of capping enzyme to the Serine-5 phosphorylated CTD stimulates guanylyltransferase activity in vitro.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep794">
 <bp:stepProcess rdf:resource="#BiochemicalReaction718" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway4">
 <bp:pathwayOrder rdf:resource="#PathwayStep11" />
 <bp:pathwayOrder rdf:resource="#PathwayStep12" />
 <bp:pathwayOrder rdf:resource="#PathwayStep9" />
 <bp:pathwayOrder rdf:resource="#PathwayStep8" />
 <bp:pathwayOrder rdf:resource="#PathwayStep10" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction5" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction6" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction9" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction7" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction8" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence8" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase II Transcription Pre-Initiation And Promoter Opening</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of the pre-initiation complex proceeds in five steps, recognition and binding of core promoter elements by TFIID, binding of TFIIA and TFIIB to the pol II promoter:TFIID complex, recruitment of RNA Polymerase II Holoenzyme by TFIIF to the pol II promoter:TFIID:TFIIA:TFIIB complex, binding of TFIIE to the growing preinitiation complex, and formation of the closed pre-initiation complex (Orphanides et al. 1997).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep795">
 <bp:stepProcess rdf:resource="#BiochemicalReaction719" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway3">
 <bp:pathwayOrder rdf:resource="#PathwayStep3" />
 <bp:pathwayOrder rdf:resource="#PathwayStep5" />
 <bp:pathwayOrder rdf:resource="#PathwayStep4" />
 <bp:pathwayOrder rdf:resource="#PathwayStep6" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction3" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction4" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase II Transcription Termination</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This section includes the cleavage of both polyadenylated and non-polyadenylated transcripts.  In the former case polyadenylation has to precede transcript cleavage, while in the latter case there is no polyadenylation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep796">
 <bp:stepProcess rdf:resource="#BiochemicalReaction720" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway2">
 <bp:pathwayOrder rdf:resource="#PathwayStep2" />
 <bp:pathwayOrder rdf:resource="#PathwayStep13" />
 <bp:pathwayOrder rdf:resource="#PathwayStep7" />
 <bp:pathwayOrder rdf:resource="#PathwayStep42" />
 <bp:pathwayOrder rdf:resource="#PathwayStep30" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1026" />
 <bp:pathwayOrder rdf:resource="#PathwayStep19" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1012" />
 <bp:pathwayComponent rdf:resource="#Pathway94" />
 <bp:pathwayComponent rdf:resource="#Pathway5" />
 <bp:pathwayComponent rdf:resource="#Pathway10" />
 <bp:pathwayComponent rdf:resource="#Pathway4" />
 <bp:pathwayComponent rdf:resource="#Pathway97" />
 <bp:pathwayComponent rdf:resource="#Pathway3" />
 <bp:pathwayComponent rdf:resource="#Pathway9" />
 <bp:pathwayComponent rdf:resource="#Pathway6" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase II Transcription</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA polymerase II (Pol II) is the central enzyme that catalyses DNA- directed mRNA synthesis during the transcription of protein-coding genes. Pol II consists of a 10-subunit catalytic core, which alone is capable of elongating the RNA transcript, and a complex of two subunits, Rpb4/7, that is required for transcription initiation.    The transcription cycle is divided in three major phases: initiation, elongation, and termination. Transcription initiation include promoter DNA binding, DNA melting, and initial synthesis of short RNA transcripts. The transition from initiation to elongation, is referred to as promoter escape and leads to a stable elongation complex that is characterized by an open DNA region or transcription bubble. The bubble contains the DNA-RNA hybrid, a heteroduplex of eight to nine base pairs. The growing 3-end of the RNA is engaged with the polymerase complex active site. Ultimately transcription terminates and Pol II dissocitates from the template.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep797">
 <bp:stepProcess rdf:resource="#BiochemicalReaction721" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway124">
 <bp:pathwayOrder rdf:resource="#PathwayStep1208" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1085" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1208" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mitochondrial transcription termination</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcription of the heavy (H)-strand of mitochondrial DNA (mtDNA) involves two overlapping transcription units  (Montoyaet al.,1982; Montoya et al., 1983). The first unit starts right upstream of the tRNAPhe gene and spans the tRNAPhe, rRNA 12S, rRNA 16S and tRNAVal genes (initiation site IH1). The other starts about 100 bp further downstream (initiation site IH2), at the boundary between tRNAPhe and rRNA12S genes, and produces a single polycistronic RNA that encompasses almost the entire length of the H-strand. The ribosomal transcription unit is transcribed at a much higher rate compared to the other transcription unit and control of its expression is exerted both at the level of initiation and termination (Gelfand and Attardi, 1981; Attardi et al., 1990). A central role in the control of termination has been attributed to the mitochondrial transcription termination factor (mTERF), a 39-kDa protein that binds to a 28-base pair region of mtDNA located within the tRNALeu(UUR) gene, at a position immediately downstream of the rRNA 16S gene  (Fernandez-Silva et al.,1997; Kruse et al., 1989).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway123">
 <bp:pathwayOrder rdf:resource="#PathwayStep1209" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1207" />
 <bp:pathwayComponent rdf:resource="#Pathway124" />
 <bp:pathwayComponent rdf:resource="#Pathway125" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1207" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcription from mitochondrial promoters</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Thirteen of the ~80 different proteins present in the respiratory chain of human mitochondria are encoded by the mitochondrial genome (mtDNA). The circular mtDNA, which is present in 1000 to 10000 copies in the human cell, also encodes for 2 ribosomal RNAs, and 22 transfer RNAs. The double-stranded mitochondrial genome lacks introns and the longer non-coding region contains the control elements for transcription and replication of mtDNA  (Shadel and Clayton,  1997).   The two mtDNA strands are referred to as the heavy  (H-strand) and the light  (L-strand) due to their differing  G+T content.  In human cells, each strand contains one single promoter for transcriptional initiation, the light-strand promoter (LSP) or the heavy-strand promoter (HSP). Transcription from the mitochondrial promoters produce polycistronic precursor RNA encompassing all the genetic information encoded in each of the specific strands. The primary transcripts are processed to produce the individual tRNA and mRNA molecules (Clayton, 1991; Ojala et al., 1981). There is likely a second initiation site for heavy strand transcription, which produces RNAs spanning the rDNA region. The resulting transcript  including  the genes for the two mitochondrial rRNAs and ends at the boundary between the 16 S rRNA and the tRNALeu(UUR) genes (Montoya et al., 1982; Montoya et al.,1983; Christianson and Clayton 1986). The existence of such a separate transcription unit may explain why the steady-state levels of rRNAs are much higher than the steady state levels of mRNAs.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway126">
 <bp:pathwayOrder rdf:resource="#PathwayStep1219" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1238" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1228" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1213" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1232" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1255" />
 <bp:pathwayComponent rdf:resource="#Pathway131" />
 <bp:pathwayComponent rdf:resource="#Pathway130" />
 <bp:pathwayComponent rdf:resource="#Pathway132" />
 <bp:pathwayComponent rdf:resource="#Pathway128" />
 <bp:pathwayComponent rdf:resource="#Pathway127" />
 <bp:pathwayComponent rdf:resource="#Pathway129" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1213" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Gene Silencing by RNA</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In this module, the biology of various types of regulatory non-coding RNAs are described. Biogenesis and functions of small interfering RNAs (siRNAs) and microRNAs (miRNAs) are annotated. Biogenesis of PIWI-interacting small RNAs (piRNAs) and tRNA-derived small RNAs (tsRNAs) are also annotated.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway125">
 <bp:pathwayOrder rdf:resource="#PathwayStep1210" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1211" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1087" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1086" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1210" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mitochondrial transcription initiation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Human mtDNA is transcribed by a dedicated mitochondrial RNA polymerase (POLRMT), which displays significant sequence similarity to the monomeric RNA polymerases found in bacteriophages. In contrast to the phage T7 RNA polymerase, POLRMT cannot interact with promoter DNA and initiate transcription on its own, but requires the presence of the mitochondrial transcription factor A (TFAM), and either transcription factor B1 (TFB1M) or B2 (TFB2M). The 4 proteins of the basal mitochondrial transcription machinery have been purified in recombinant form and used to reconstitute transcription in vitro with a promoter containing DNA fragment (Falkenberg et al., 2002). Although both TFB1M and TFB2M can support in vitro transcription with POLRMT, TFB2M is at least two orders of magnitude more active than TFB1M and the physiological role of TFB1M in mitochondrial transcription has not yet been completely defined. The  TFB1M and TFB2M display primary sequence similarity to a family of rRNA methyltransferases, which dimethylates two adjacent adenosine bases near the 3&apos; end of the small subunit rRNA during ribosome biogenesis (Falkenberg et al., 2002; McCulloch et al., 2002). Human TFB1M is, in fact, a dual function protein, which not only support mitochondrial transcription in vitro, but also acts as a rRNA methyltransferase (Seidel-Rogol et al., 2003). The methyltransferase activity is not required for transcription, since point mutations in conserved methyltransferase motifs of  TFB1M revealed that it stimulates transcription in vitro independently of S-adenosylmethionine binding and rRNA methyltransferase activity.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence73">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway120">
 <bp:pathwayOrder rdf:resource="#PathwayStep1195" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1196" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1193" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1194" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1192" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1197" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1076" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1075" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1078" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1077" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1074" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1073" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1192" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase I Transcription Initiation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">During initiation the double-stranded DNA must be melted and transcription begins. SL1 forms and interacts with UBF-1 and the rDNA promoter. It is this platform that will recruit active RNA polymerase I to the SL1:phosphorlated UBF-1:rDNA promoter complex. Mammalian rRNA genes are preceded by a terminator element that is recognized by the SL1 complex. This SL1 modulated acetylation of the basal Pol I transcription machinery has functional consequences suggesting that the reversible acetylation may be one way to regulate rDNA transcription.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence72">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence71">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway122">
 <bp:pathwayOrder rdf:resource="#PathwayStep1205" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1203" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1204" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1202" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1083" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1082" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1084" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1081" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1202" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase I Transcription Termination</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Termination of transcription by RNA polymerase I  is a 4 step process. Initially TTF-1 binds the template rDNA. This complex pauses polymerase I allowing PTRF to interact with the quaternary complex releasing both pre-rRNA and Pol I from the template and TTF-1.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence70">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway121">
 <bp:pathwayOrder rdf:resource="#PathwayStep1199" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1200" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1080" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1079" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1199" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase I Promoter Opening</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The activity of the upstream binding factor (UBF-1) plays an important role in the regulation of rRNA synthesis. Studies reveal that phosphorylation of UBF-1 is required for its interaction with the RNA polymerase I complex, suggesting that phosphorylation of UBF-1 bound to the rDNA promoter during promoter opening modulates the assembly of the transcription initiation complex.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence77">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence76">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence75">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep770">
 <bp:stepProcess rdf:resource="#BiochemicalReaction695" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence74">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep771">
 <bp:stepProcess rdf:resource="#BiochemicalReaction696" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence79">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence78">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep765">
 <bp:stepProcess rdf:resource="#BiochemicalReaction690" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep766">
 <bp:stepProcess rdf:resource="#BiochemicalReaction691" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep767">
 <bp:stepProcess rdf:resource="#BiochemicalReaction692" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep768">
 <bp:stepProcess rdf:resource="#BiochemicalReaction693" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep761">
 <bp:stepProcess rdf:resource="#BiochemicalReaction686" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep762">
 <bp:stepProcess rdf:resource="#BiochemicalReaction687" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep763">
 <bp:stepProcess rdf:resource="#BiochemicalReaction688" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep764">
 <bp:stepProcess rdf:resource="#BiochemicalReaction689" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep769">
 <bp:stepProcess rdf:resource="#BiochemicalReaction694" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway128">
 <bp:pathwayOrder rdf:resource="#PathwayStep1227" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1225" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1226" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1223" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1224" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1221" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1222" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1220" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1098" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1097" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1100" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1099" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1094" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1093" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1096" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1095" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1220" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MicroRNA (miRNA) biogenesis</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Biogenesis of microRNAs (miRNAs) can be summarized in five steps (reviewed in Ketting 2011, Nowotny and Yang 2009, Kim et al. 2009, Chua et al. 2009, Hannon and He 2004): 1. Transcription. miRNA transcripts may come from autonomously transcribed genes, they may be contained in cotranscripts with other genes, or they may be located in introns of host genes. Most miRNAs are transcribed by RNA polymerase II, however a few miRNAs originate as RNA polymerase III cotranscripts with neighboring repetitive elements. The initial transcript, termed a primary microRNA (pri-miRNA), contains an imperfectly double-stranded region within a hairpin loop. Longer sequences extend from the 5&apos; and 3&apos; ends of the hairpin and may also contain double-stranded regions.  2. Cleavage by DROSHA. The 5&apos; and 3&apos; ends of the pri-miRNA are removed during endoribonucleolytic cleavage by the DROSHA nuclease in a complex with the RNA-binding protein DGCR8 (the Microprocessor complex). The cleavage product is a short hairpin of about 60 to 70 nt called the pre-microRNA (pre-miRNA).  3. Nuclear export by Exportin-5. The resulting pre-miRNA is bound by Exportin-5 in a complex with Ran and GTP. The complex translocates the pre-miRNA through the nuclear pore into the cytoplasm.  4. Cleavage by DICER1. Once in the cytoplasm the pre-miRNA is bound by the RISC loading complex which contains DICER1, an Argonaute protein and either TARBP2 or PRKRA. DICER1 cleaves the pre-miRNA to yield an imperfectly double-stranded miRNA of about 21 to 23 nucleotides. At this stage the double-stranded miRNA has protruding single-stranded 3&apos; ends of 2-3 nt.  5. Incorporation into RNA-Induced Silencing Complex (RISC) and strand selection. The double-stranded miRNA is passed to a Argonaute protein contained in the RISC loading complex. One strand, the passenger strand, will be removed and degraded; the other strand, the guide strand, will be retained and will guide the Argonaute:miRNA complex (RISC) to target mRNAs. The human genome encodes 4 Argonaute proteins (AGO1 (EIF2C1), AGO2 (EIF2C2), AGO3 (EIF2C3), AGO4 (EIF2C4)), however only AGO2 (EIF2C2) can cleave target mRNAs with perfect or nearly perfect complementarity to the guide miRNA. For complexes that contain AGO2, cleavage of the passenger strand of the double-stranded miRNA accompanies removal of the passenger strand. Complexes containing other Argonautes may use a helicase to remove the passenger strand but this is not fully known. The resulting miRNA-loaded AGO2 is predominantly located in complexes with TARBP2 or PRKRA at the cytosolic face of the rough endoplasmic reticulum. AGO2, TARBP2, and DICER1 are also observed in the nucleus.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway127">
 <bp:pathwayOrder rdf:resource="#PathwayStep1218" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1216" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1217" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1214" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1215" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1089" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1088" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1090" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1092" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1091" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1214" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Small interfering RNA (siRNA) biogenesis</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Small interfering RNAs (siRNAs) are 21-25 nucleotide single-stranded RNAs produced by cleavage of longer double-stranded RNAs by the enzyme DICER1 within the RISC loading complex containing DICER1, an Argonaute protein, and either TARBP2 or PRKRA (PACT). Typically the long double-stranded substrates originate from viruses or repetitive elements in the genome and the two strands of the substrate are exactly complementary. After cleavage by DICER1 the 21-25 nucleotide double-stranded product is loaded into an Argonuate protein (humans contain 4 Argonautes) and rendered single-stranded by a mechanism that is not well characterized. siRNA-loaded AGO2 is predominantly located at the cytosolic face of the rough endoplasmic reticulum and has also been observed in the nucleus.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway129">
 <bp:pathwayOrder rdf:resource="#PathwayStep1229" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1230" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1231" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1102" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1101" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1103" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1229" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Post-transcriptional silencing by small RNAs</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Small RNAs act with components of the RNA-induced silencing complex (RISC) to post-transcriptionally repress expression of mRNAs (reviewed in Nowotny and Yang 2009, Chua et al. 2009). Two mechanisms exist: 1) cleavage of target RNAs by complexes containing Argonaute2 (AGO2, EIF2C2) and a guide RNA that exactly matches the target mRNA and 2) inhibition of translation of target RNAs by complexes containing AGO2 and an inexactly matching guide RNA or by complexes containing a nonendonucleolytic Argonaute (AGO1 (EIF2C1), AGO3 (EIF2C3), or AGO4 (EIF2C4)) and a guide RNA of exact or inexact match. Small interfering RNAs (siRNAs) and microRNAs (miRNAs) can serve as guide RNAs in both types of mechanism.  RNAi also appears to direct chromatin modifications that cause transcriptional gene silencing (reviewed in Verdel et al. 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence80">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway113">
 <bp:pathwayOrder rdf:resource="#PathwayStep1173" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1167" />
 <bp:pathwayComponent rdf:resource="#Pathway115" />
 <bp:pathwayComponent rdf:resource="#Pathway114" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1167" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Negative epigenetic regulation of rRNA expression</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcription of rRNA genes is controlled by epigenetic activation and repression (reviewed in McStay and Grummt 2008, Goodfellow and Zomerdijk 2012, Grummt and Langst 2013). About half of the roughly 400 rRNA genes are expressed and these have the modifications of active chromatin: unmethylated DNA and acetylated histones. Repressed genes generally have methylated DNA and histone H3 methylated at lysine-9. Regulators of repression include the eNoSC complex, SIRT1, and the NoRC complex.  SIRT1 negatively regulates rRNA expression as a subunit of the eNoSC complex, which deacetylates histone H3 and dimethylates lysine-9 of histone H3 (H3K9me2). NoRC negatively regulates rRNA expression by shifting a nucleosome near the start of rRNA transcription into a more repressive location and recruiting Histone Deacetylase 1 and 2 (HDAC1, HDAC2) and DNA Methyltransferase 1 and 3b (DNMT1, DNMT3b). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway112">
 <bp:pathwayOrder rdf:resource="#PathwayStep1164" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1165" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1054" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1053" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1164" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIWI-interacting RNAs (piRNAs) are short RNAs of 24-31 nucleotides that are produced by cleavage of longer RNAs and amplification by a &quot;ping-pong&quot; mechanism involving rounds of strand hybridization and cleavage (reviewed in Sun et al. 2022). The piRNAs are loaded onto PIWI proteins (PIWIL1, PIWIL2, PIWIL4) that are then guided by base-pairing of the piRNAs to nascent and mature transcripts, where the PIWI:piRNA complexes initiate transcriptional and post-transcriptional silencing, respectively (reviewed in Czech et al. 2018, Onishi et al. 2021, Wang et al. 2023). In mice, sources of piRNAs include transposon RNAs, long non-coding RNAs, exon transcripts, and RNAs from unannotated regions of the genome (Aravin et al. 2007, 2008). Two populations of piRNAs are observed during mouse development: pre-pachytene piRNAs and pachytene piRNAs (Aravin et al. 2008, Gan et al. 2011). Pre-pachytene piRNAs are present prenatally in prospermatogonial cells and postnatally in spermatogonial cells. Pachytene piRNAs are present in more mature postnatal spermatocytes and spermatids. The piRNAs derived from retroelements comprise about half (Aravin et al. 2008) or less (Gan et al. 2011) of the total pre-pachytene piRNAs and the portion falls sharply from pre-pachytene to pachytene (Gan et al. 2011). In mice, PIWIL2 (MILI, Piwil2 gene) is first detected in primordial germ cells that have reached the genital ridge and expression persists through meiosis in adults. PIWIL4 (MIWI2, PIWIl4 gene) is present in mouse germ cells during de novo DNA methylation shortly before and after birth. PIWIL1 (MIWI, PIWIL1 gene) is present during later stages of meiosis after birth (Aravin et al. 2008). PIWIL4 and PIWIL2 participate in re-methylation of the genome in mouse germ cells and consequent repression of transposable elements (Carmell et al. 2007, Aravin et al. 2008, Kuramochi-Miyagawa et al. 2008, Zoch et al. 2020). In mice, the piRNAs bound by PIWIL4 bind nascent transcripts of transposable elements and connects to the de novo DNA methylation machinery via SPOCD1 and C19ORF84 to direct DNA methylation to the transposable elements (Zoch et al. 2020, 2024). Mutations in SPOCD1 are associated with infertility in men (Zoch et al. 2024)</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway115">
 <bp:pathwayOrder rdf:resource="#PathwayStep1174" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1180" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1179" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1177" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1178" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1175" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1176" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1065" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1064" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1066" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1061" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1060" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1063" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1062" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1174" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NoRC negatively regulates rRNA expression</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Nucleolar Remodeling Complex (NoRC) comprising TIP5 (BAZ2A) and the chromatin remodeller SNF2H (SMARCA5) silences rRNA gene (reviewed in Santoro and Grummt 2001, Grummt 2007, Preuss and Pikaard 2007, Birch and Zommerdijk 2008, McStay and Grummt 2008, Grummt and Langst 2013). The TAM domain of TIP5 (BAZ2A) binds promoter-associated RNA (pRNA) transcribed from the intergenic spacer region of rDNA. The pRNA bound by TIP5 is required to direct the complex to the main promoter of the rRNA gene possibly by triple helix formation between pRNA and the rDNA. The PHD domain of TIP5 binds histone H4 acetylated at lysine-16. Transcription Termination Factor-I (TTF-I) binds to a promoter-proximal terminator (T0 site) in the rDNA and interacts with the TIP5 subunit of NoRC. NoRC also interacts with the SIN3-HDAC complex, HDAC1, HDAC2, DNMT1, and DNMT3B. DNMT3B interacts with a triple helix formed by pRNA and the rDNA. HDAC1, DNMT1, and DNMT3B have been shown to be required for proper DNA methylation of silenced rRNA gene copies, although the catalytic activity of DNMT3B was not required.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway114">
 <bp:pathwayOrder rdf:resource="#PathwayStep1171" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1172" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1170" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1168" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1169" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1056" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1055" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1058" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1057" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1059" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1168" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SIRT1 negatively regulates rRNA expression</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of rRNA genes is coupled to the overall metabolism of the cell by the NAD-dependent histone deacetylase SIRT1, a component of the Energy-dependent Nucleolar Silencing Complex (eNoSC) (Murayama et al. 2008, reviewed in Salminen and Kaarniranta 2009, Grummt and Voit 2010). eNoSC comprises Nucleomethylin (NML), SIRT1, and the histone methylase SUV39H1 (Murayama et al. 2008). Deacetylation and methylation of histone H3 in the chromatin of a rRNA gene by eNoSC causes reduced expression of the gene.  When glucose is low, NAD is high (NADH is low), activity of SIRT1 is high, and activity of rRNA genes is reduced. It is hypothesized that eNoSC forms on a nucleosome containing dimethylated lysine-9 on histone H3 (H3K9me2) and then eNoSC deacetylates and dimethylates the adjacent nucleosome, thus catalyzing spreading of H3K9me2 throughout the gene.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence84">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence83">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence82">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway111">
 <bp:pathwayOrder rdf:resource="#PathwayStep1162" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1160" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1161" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1159" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1157" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1158" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1155" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1156" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1045" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1050" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1052" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1051" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1047" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1046" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1049" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1048" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1155" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Human Silencing Hub (HUSH) complex comprises MPHOSPH8 (MPP8), Periphilin (PHPLN1), and TASOR, which appears to act as a scaffold that binds the other subunits (reviewed in Seczynska and Lehner 2023). The HUSH complex preferentially represses transcription of young LINE1 retroelements (Liu et al. 2018, Robbez-Masson et al. 2018) and some HIV integrants (Tchasovnikarova et al. 2015, Zhu et al. 2018, Chougui and Margottin-Goguet 2019). The HUSH complex creates repressive chromatin in two ways (reviewed in Seczynska and Lehner 2023). Firstly, HUSH can cause spreading of existing heterochromatin by binding existing trimethylated H3K9 and recruiting SETDB1 to trimethylate H3K9 of adjacent nucleosomes (Tchasovnikarova et al. 2015). Secondly, HUSH can initiate heterochromatin by binding nascent transcripts via its PHPLN1 subunit and recruiting SETDB1 to trimethylate lysine-9 of histone H3 (H3K9) at the locus being transcribed (Seczynska et al. 2022). By an uncharacterized mechanism, the HUSH complex targets long intronless cDNAs, such as those produced by retroelements, as well as unusually long exons of normal cellular genes (Seczynska et al. 2022). Introns somehow protect against silencing by HUSH, though actual splicing is not required (Seczynska et al. 2022). In mice, ZNF638 (NP220, Znf638 gene) recruits the HUSH complex to unintegrated murine leukemia virus (MLV) (Zhu et al. 2018) and in human cells ZNF638 (NP220) and HUSH silence recombinant adeno-associated viruses (Das et al. 2022). The potential recruitment of HUSH by ZNF638 to human retroelements is not yet demonstrated.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence81">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway110">
 <bp:pathwayOrder rdf:resource="#PathwayStep1151" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1152" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1150" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1148" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1149" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1147" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1153" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1043" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1042" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1044" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1041" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1040" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1039" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1038" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1147" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of endogenous retroelements by KRAB-ZFP proteins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Kr&#252;ppel-associated box domain (KRAB) zinc finger proteins (KRAB-ZFPs) contain a transcriptionally repressive N-terminal domain, the KRAB domain, and a C-terminal domain, the ZFP domain, that contains 2-40 zinc fingers and binds specific sequences of DNA (reviewed in Ecco et al. 2017, Yang et al. 2017). The human genome contains about 352 (Lukic et al. 2014), 378 (de Tribolet-Hardy et al. 2023), or 423 (Huntley et al. 2006) KRAB-ZFP genes, making them the largest family of transcription regulators. About two thirds or more of KRAB-ZFPs bind transposable elements (Schmitges et al. 2016, Imbeault et al. 2017, de Tribolet-Hardy et al. 2023) and KRAB-ZFPs appear to coevolve with retroelements such that a KRAB-ZFP binds and transcriptionally silences a specific set of retroelements (reviewed in Ecco et al. 2017). The number of KRAB-ZFP genes correlates with the number of retroelements in mammalian genomes and younger retroelements bind fewer KRAB-ZFPs, suggesting an &quot;arms race&quot; in which the evolution of new KRAB-ZFPs is driven by and lags the appearance of new transposable elements (Thomas and Schneider 2011, Jacobs et al. 2014, Imbeault et al. 2017, reviewed in Ecco et al. 2017, Yang et al. 2017). The repressive action of KRAB-ZFPs is mediated by the scaffold protein TRIM28 (also called KAP1), the RBCC domain of which binds the N-terminal KRAB domains of KRAB-ZFPs (Friedman et al. 1996). TRIM28 autoSUMOylates and recruits effectors, such as the histone H3 lysine-9 trimethyltransferase SETDB1 (also called ESET) (Schultz et al. 2002) and the NuRD repressor complex (Schultz et al. 2001). The HUSH complex (MPHOSPH8:TASOR:PPHLN1) plays a nonredundant role with TRIM28 in silencing some young LINE1 retroelements, which are only weakly repressed by TRIM28 or HUSH alone (Robbez-Masson et al. 2018).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence88">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence87">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep780">
 <bp:stepProcess rdf:resource="#BiochemicalReaction704" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence86">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep781">
 <bp:stepProcess rdf:resource="#BiochemicalReaction705" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence85">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep782">
 <bp:stepProcess rdf:resource="#BiochemicalReaction706" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence89">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep776">
 <bp:stepProcess rdf:resource="#BiochemicalReaction701" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep777">
 <bp:stepProcess rdf:resource="#Pathway77" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep778">
 <bp:stepProcess rdf:resource="#BiochemicalReaction702" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep779">
 <bp:stepProcess rdf:resource="#BiochemicalReaction703" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep772">
 <bp:stepProcess rdf:resource="#BiochemicalReaction697" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep773">
 <bp:stepProcess rdf:resource="#BiochemicalReaction698" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep774">
 <bp:stepProcess rdf:resource="#BiochemicalReaction699" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep775">
 <bp:stepProcess rdf:resource="#BiochemicalReaction700" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway117">
 <bp:pathwayOrder rdf:resource="#PathwayStep1201" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1187" />
 <bp:pathwayComponent rdf:resource="#Pathway122" />
 <bp:pathwayComponent rdf:resource="#Pathway118" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1187" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase I Transcription</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA polymerase (Pol) I (one of three eukaryotic nuclear RNA polymerases) is devoted to the transcription of the ribosomal DNA genes, which are found in multiple arrayed copies in every eukaryotic cell. These genes encode for the large ribosomal RNA precursor, which is then processed into the three largest subunits of the ribosomal RNA, the 18S, 28S, and 5.8S RNAs. In human cells the rDNA gene clusters are localized on the short arm of the five pairs of the acrocentric chromosomes.  The rRNA promoter has two essential and specially spaced sequences: a CORE element and an upstream control element (UCE, also called UPE). The CORE element of the human promoter overlaps with the transcription start site, extending from 20 to 45, and is required for specific initiation of transcription.   The polymerase is a multisubunit complex, composed of two large subunits (the most conserved portions include the catalytic site that shares similarity with other eukaryotic and bacterial multisubunit RNA polymerases) and a number of smaller subunits. Under a number of experimental conditions the core is competent to mediate ribonucleic acid synthesis, in vivo however, it requires additional factors to select the appropriate template. In humans the RNA transcript (45S) is approximately 13,000 nucleotides long. Before leaving the nucleus as assembled ribosomal particles, the 45S rRNA is cleaved to give one copy each of the 28S rRNA, the 18S rRNA, and the 5.8S rRNA. Equal quantities of the three rRNAs are produced by initially transcribing them as one transcript.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway116">
 <bp:pathwayOrder rdf:resource="#PathwayStep1184" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1185" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1182" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1183" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1067" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1070" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1069" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1068" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1182" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRC2 methylates histones and DNA</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Polycomb group proteins are responsible for the heritable repression of genes during development (Lee et al. 2006, Ku et al. 2008, reviewed in Simon and Kingston 2009, Margueron and Reinberg 2011, Di Croce and Helin 2013). Two major families of Polycomb complexes exist: Polycomb Repressive Complex 1 (PRC1) and Polycomb Repressive Complex 2 (PRC2). PRC1 and PRC2 each appear to comprise sets of distinct complexes that contain common core subunits and distinct accessory subunits (reviewed in Nayak et al. 2011). PRC2, through its component EZH2 or, in some complexes, EZH1 produces the initial molecular mark of repression, the trimethylation of lysine-27 of histone H3 (H3K27me3). How PRC2 is initially recruited to a locus remains unknown, however cytosine-guanine (CpG) motifs and transcripts have been suggested. Different mechanisms may be used at different loci. The trimethylated H3K27 produced by PRC2 is bound by the Polycomb subunit of PRC1. PRC1 ubiquitinates histone H2A and maintains repression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway119">
 <bp:pathwayOrder rdf:resource="#PathwayStep1190" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1189" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1072" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1071" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1189" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase I Promoter Escape</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">As the active RNA Polymerase I complex leaves the promoter Rrn3 dissociates from the complex. RNA polymerase I Promoter Clearance is complete and Chain Elongation begins (Milkereit and Tschochner, 1998). The assembly of the initiation complex on the promoter and the transition from a closed to an open complex is then followed by promoter clearance and transcription elongation by RNA Pol I. Unlike the RNA polymerase II system, RNA polymerase I transcription does not require a form of energy such as ATP for initiation and elongation. Regulatory mechanisms operating at both the level of transcription initiation and elongation probably concurrently to adjust the level of rRNA synthesis to the need of the cell.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway118">
 <bp:pathwayOrder rdf:resource="#PathwayStep1191" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1188" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1198" />
 <bp:pathwayComponent rdf:resource="#Pathway120" />
 <bp:pathwayComponent rdf:resource="#Pathway121" />
 <bp:pathwayComponent rdf:resource="#Pathway119" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1188" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase I Promoter Clearance</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Promoter clearance is one of the rate-limiting steps in Polymerase I transcription. This step is composed of three phases,  promoter opening, transcription initiation and promoter escape.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence302">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence303">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence300">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence301">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence51">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence306">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence50">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence307">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence304">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence305">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence55">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence54">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence53">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway140">
 <bp:pathwayOrder rdf:resource="#PathwayStep1298" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1296" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1297" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1157" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1159" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1158" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1296" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Chain Elongation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pol III initiation complexes open the promoter spontaneously similar to the mechanism employed in archaeal and bacterial transcription. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence52">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence59">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence58">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence57">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence56">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep743">
 <bp:stepProcess rdf:resource="#BiochemicalReaction668" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep744">
 <bp:stepProcess rdf:resource="#BiochemicalReaction669" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep745">
 <bp:stepProcess rdf:resource="#BiochemicalReaction670" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence49">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep746">
 <bp:stepProcess rdf:resource="#BiochemicalReaction671" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep740">
 <bp:stepProcess rdf:resource="#BiochemicalReaction666" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep741">
 <bp:stepProcess rdf:resource="#Catalysis130" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction667" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep742">
 <bp:stepProcess rdf:resource="#Pathway76" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep747">
 <bp:stepProcess rdf:resource="#BiochemicalReaction672" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep748">
 <bp:stepProcess rdf:resource="#BiochemicalReaction673" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep749">
 <bp:stepProcess rdf:resource="#BiochemicalReaction674" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence313">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway135">
 <bp:pathwayOrder rdf:resource="#PathwayStep1267" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1265" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1266" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1263" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1264" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1131" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1130" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1133" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1132" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1129" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1263" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Transcription Initiation From Type 1 Promoter</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The type 1 promoters recruit TFIIIA, the founding member of the C2H2 zinc finger family of DNA-binding proteins (Engelke et al., 1980; Sakonju et al., 1981).  The binding of TFIIIA then allows the binding of TFIIC (Lassar et al., 1983), a complex consisting of five subunits (which differs from the six subunits in S. cerevisiae) in human cells and S. pombe.  Once the DNA/TFIIIA/TFIIIC complex is formed, Brf1-TFIIIB joins the complex and this in turn allows the recruitment of RNA polymerase III (Bieker et al., 1985; Setzer and Brown, 1985).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence314">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway134">
 <bp:pathwayOrder rdf:resource="#PathwayStep1262" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1273" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1268" />
 <bp:pathwayComponent rdf:resource="#Pathway135" />
 <bp:pathwayComponent rdf:resource="#Pathway137" />
 <bp:pathwayComponent rdf:resource="#Pathway136" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1262" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Transcription Initiation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">There are three basic types of RNA polymerase III promoters.  The three types of RNA polymerase III promoters are known as type 1, type 2, and type 3 promoters.  Type 1 promoters are found in the 5S genes and consist of a gene-internal element called the internal control region (ICR), that is subdivided into A block, intermediate element, and C block (Bogenhagen, 1985; Sakonju et al., 1980).  Type 2 promoters are found in tRNA genes, Adenovirus 2 VAI gene, and other genes (Galli et al., 1981; Sharp et al., 1981).  These promoters consists of two gene-internal elements called the A and the B boxes.  Type 3 promoters consist of a distal sequence element (DSE) that serves as an enhancer, a proximal sequence element (PSE), and a TATA box (Baer et al., 1989; Lobo and Hernandez, 1989).  Some promoters combine elements from type 2 and 3 promoters.  For example, the  S. cerevisiae  U6 promoter, also shown in the figure, contains the TATA box typical of type 3 promoters and the A and B boxes typical of type 2 promoters.  Moreover,  in  S. pombe, nearly all tRNA and 5S genes contain a TATA box  in addition to gene-internal elements, and the TATA box is required for transcription.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence311">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway137">
 <bp:pathwayOrder rdf:resource="#PathwayStep1276" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1277" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1274" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1275" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1141" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1140" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1139" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1138" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1274" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Transcription Initiation From Type 2 Promoter</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The type 2 promoters can recruit TFIIIC without the help of TFIIIA because TFIIIC binds directly to the A and B boxes.  As for the type 1 promoters, this then allows the binding of Brf1-TFIIIB and RNA polymerase III.  Importantly, in the yeast system, once Brf1-TFIIIB has been recruited to type 1 or 2 promoters, TFIIIA and/or TFIIIC can be stripped from the DNA with high salt or heparin treatment.  Brf1-TFIIIB remains bound to the DNA and is sufficient to direct multiple rounds of transcription .</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence312">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway136">
 <bp:pathwayOrder rdf:resource="#PathwayStep1272" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1270" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1271" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1269" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1135" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1134" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1137" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1136" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1269" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Transcription Initiation From Type 3 Promoter</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The metazoan-specific type 3 promoters, which are exemplified by the human U6 promoter, recruit a complex variously called the snRNA activating protein complex (SNAPc) (Sadowski et al., 1993), the PSE binding protein (PBP) (Waldschmidt et al., 1991), or the PSE transcription factor (PTF) (Murphy et al., 1992).  The complex contains five types of subunits and binds to the PSE.  Type 3 promoters also recruit Brf2-TFIIIB through a combination of protein-protein contacts with SNAPc and a direct association of the TBP component of Brf2-TFIIIB with the TATA box.  This then allows RNA polymerase III to join the complex. The down stream element (DSE) of type 3 promoters, which enhances transcription from the core promoter, almost invariably contains an octamer sequence and an SPH element (also called NONOCT element)(Cheung et al., 1993; Danzeiser et al., 1993; Kunkel et al., 1996; Myslinski et al., 1992).  The octamer sequence recruits the POU domain protein Oct-1 (Herr et al., 1988; Sturm et al., 1988), and the SPH element recruits a zinc finger protein known as Staf or SPH binding factor (SBF), which has been cloned from humans (Myslinski et al., 1998; Rincon et al., 1998).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence62">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence317">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway131">
 <bp:pathwayOrder rdf:resource="#PathwayStep1250" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1240" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1251" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1249" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1239" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1247" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1248" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1245" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1246" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1243" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1254" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1244" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1241" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1252" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1242" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1253" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1109" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1117" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1116" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1119" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1118" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1113" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1124" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1112" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1123" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1115" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1114" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1120" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1111" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1122" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1110" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1121" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1239" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIWI-interacting RNA (piRNA) biogenesis</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In germ cells of humans and mice, precursors of PIWI-interacting RNAs (piRNAs) are transcribed from a few hundred sequence clusters, as well as individual transposons, intergenic regions, and genes in the genome. These longer transcripts are processed to yield piRNAs of 26-30 nucleotides independently of DICER, the enzyme responsible for microRNAs (miRNAs) and small interfering RNAs (siRNAs) (reviewed in Girard and Hannon 2008, Siomi et al. 2011, Ishizu et al. 2012, Pillai and Chuma 2012, Bortvin 2013, Chuma and Nakano 2013, Sato and Siomi 2013). The initial step in processing long transcripts to piRNAs is cleavage by PLD6 (MitoPLD), which generates the mature 5&apos; end. The cleavage products of PLD6 are bound by either PIWIL1 (HIWI, MIWI) or PIWIL2 (HILI, MILI) in complexes with several other proteins. The 3&apos; end is trimmed by an unknown exonuclease to generate the mature piRNA. PIWIL1:piRNA complexes appear to be involved in post-transcriptional silencing in the cytosol while PIWIL2:piRNA complexes generate further piRNAs from transposon transcripts and other transcripts in the cytosol. Cleavage products from PIWIL2:piRNA may be loaded into either PIWIL2 or PIWIL4 (HIWI2, MIWI2). Loading into PIWIL2 forms a step in a cytosolic amplification loop called the &quot;ping-pong cycle&quot; which yields further PIWIL2:piRNA complexes from cleaved precursor RNAs. Loading into PIWIL4 yields a complex also containing TDRD9 that translocates to the nucleus and directs DNA methylation of cognate loci, causing transcriptional silencing during spermatogenesis. Transcriptional silencing by piRNAs is necessary to limit transposition of endogenous transposons such as L1 elements in the genome.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence61">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence318">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway130">
 <bp:pathwayOrder rdf:resource="#PathwayStep1236" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1237" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1234" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1235" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1233" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1106" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1105" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1108" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1107" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1104" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1233" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcriptional regulation by small RNAs</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recent evidence indicates that small RNAs participate in transcriptional regulation in addition to post-transcriptional silencing. Components of the RNAi machinery (ARGONAUTE1 (AGO1, EIF2C1), AGO2 (EIF2C2), AGO3 (EIF2C3), AGO4 (EIF2C4), TNRC6A, and DICER) are observed associated with microRNAs (miRNAs) in both the cytosol and the nucleus (Robb et al. 2005, Weinmann et al. 2009, Doyle et al. 2013, Nishi et al. 2013, Gagnon et al. 2014). The AGO:miRNA complexes are imported into the nucleus by IMPORTIN-8 (IPO8, IMP8, RANBP8) and also by an unknown importin while associated with the nuclear shuttling protein TNRC6A (reviewed in Schraivogel and Meister 2014). Within the nucleus, AGO2, TNRC6A, and DICER may associate in a complex (Gagnon et al. 2014). Nuclear AGO1 and AGO2 in complexes with small RNAs are observed to activate transcription (RNA activation, RNAa) or repress transcription (Transcriptional Gene Silencing, TGS) of genes that contain sequences matching the small RNAs (reviewed in Malecova and Morris 2010, Huang and Li 2012, Gagnon and Corey 2012, Huang and Li 2014, Salmanidis et al. 2014, Stroynowska-Czerwinska et al. 2014). TGS is associated with methylation of cytosine in DNA and methylation of histone H3 at lysine-9 and lysine-27 (Castanotto et al. 2005, Suzuki et al. 2005, Kim et al. 2006, Weinberg et al. 2006, Kim et al. 2008, reviewed in Malecova and Morris 2010, Li et al. 2014); RNAa is associated with methylation of histone H3 at lysine-4 (Huang et al. 2012, reviewed in Li et al. 2014). Small RNAs in the nucleus have also been shown to play roles in alternative splicing (Liu et al., 2012, Ameyar-Zazoua et al., 2012) and DNA damage repair (Wei  et al., 2012; Francia et al., 2012). Nevertheless, elucidation of the detailed mechanisms of small RNA action requires further research.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence60">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence315">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway133">
 <bp:pathwayOrder rdf:resource="#PathwayStep1261" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1295" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1292" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1278" />
 <bp:pathwayComponent rdf:resource="#Pathway134" />
 <bp:pathwayComponent rdf:resource="#Pathway140" />
 <bp:pathwayComponent rdf:resource="#Pathway139" />
 <bp:pathwayComponent rdf:resource="#Pathway138" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1261" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Transcription</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA polymerase III is one of three types of nuclear RNA polymerases present in eucaryotic cells.  About 10% of the total transcription in dividing cells can be attributed to its activity.  It synthesizes an eclectic collection of catalytic or structural RNA molecules, some of which are involved in protein synthesis, pre-mRNA splicing, tRNA processing, and the control of RNA polymerase II elongation, whereas some others have still unknown functions.  Like other RNA polymerases, RNA polymerase III cannot recognize its target promoters directly.  Instead it is recruited to specific promoter sequences through the help of transcription factors.  There are three basic types of RNA polymerase III promoters, called types 1, 2, and 3(Geiduschek and Kassavetis, 1992).  Although in vivo, RNA polymerase III may be recruited to these promoters as part of a large complex (holo RNA polymerase III) containing the polymerase and its initiation factors (Wang et al., 1997), in vitro the reaction can be divided into several steps.  First, the promoter elements are recognized by DNA binding factors, which then recruit a factor known as TFIIIB.  TFIIIB itself then directly contacts RNA polymerase III.  In human cells but not in  S. cerevisiae , there are at least two versions of TFIIIB.  One contains TBP, Bdp1, and Brf1 (Brf1-TFIIIB), and the other TBP, Bdp1, and Brf2 (Brf2-TFIIIB) (Schramm et al., 2000; Teichmann et al., 2000).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence316">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway132">
 <bp:pathwayOrder rdf:resource="#PathwayStep1258" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1259" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1256" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1257" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1128" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1127" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1126" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1125" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1256" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Defined fragments of tRNAs, termed tRNA&#8209;derived small RNAs (tsRNAs), have been observed in particular cell types and in response to biological conditions such as exposure to sex hormone or stresses such as hypoxia, starvation, oxidative stress, and virus infection (reviewed in Keam and Hutvagner 2015, Kumar et al. 2016, Oberbauer and Schaefer 2018, Park et al. 2020, Su et al. 2020, Xie et al. 2020, Zhu et al. 2020). Rather than being the random products of tRNA degradation, tsRNAs appear to be the specific products of ribonucleases. Two categories of tRNA&#8209;derived small RNAs (tsRNAs) have been described: (1) longer (31&#8209;40nt) tsRNAs known as tRNA halves or stress&#8209;induced tsRNAs (tiRNAs) that are produced by single cleavage of tRNAs within or near the anticodon and (2) shorter (15&#8209;30 nt) tsRNAs termed tRNA-related fragments (tRFs) that result from cleavage closer to the 5&apos; or 3&apos; end of the tRNA. tRF-3s are derived from the 3&apos; region of the tRNA, approximately the region from the T loop to the 3&apos; terminus. tRF-5s are derived from the 5&apos; region of the tRNA, approximately the region from the D loop to the 5&apos; terminus. tRF2&#8209;type tRFs (also called internal tRFs) are derived from the central region of the tRNA, approximately the region between the D loop and the T loop and containing the anticodon. tRF-1s, also known as Type II tRFs or 3&#8217;U tRFs, are the 3&apos; trailers of particular tRNAs that persist after processing. In most cases the enzymes responsible for the cleavages are not yet known, however several ribonucleases involved in cleavage of tRNA have been identified: the secreted and endocytosed ribonuclease A family members angiogenin (ANG) and RNase 1; the interferon-induced ribonucleases RNase L, Schlafen 11 (SLFN11) and Schlafen13 (SLFN13 or RNase S13); the cytosolic ribonuclease III&#8209;like (double strand RNA&#8209;specific) enzyme DICER1; and the RNA processing enzyme ELAC2. ANG is secreted, binds receptors on cell membranes, is endocytosed, and translocates to the nucleus. ANG cleaves within the anticodon loop to produce tRNA halves and the cleavage is thought to occur while ANG is transiently located in the cytosol (Lee and Vallee 1989, Saxena et al. 1992, Fu et al. 2009, Yamasaki et al. 2009, Emara et al. 2010, Ivanov et al. 2011). Cleavage by ANG is observed in response to cellular stresses such as starvation (Fu et al. 2009, Yamasaki et al. 2009, Emara et al. 2010, Ivanov et al. 2011). However, ANG knockout cells continue to produce stress-induced tRNA halves, suggesting that other enzymes are also involved in producing the halves (Su et al. 2019).  Similar to ANG as an RNase A member, the secreted endoribonuclease RNase 1 cleaves tRNAs at the anticodon loop in the extracellular space (Nechooshtan et al. 2020).  Interferon-induced RNases can also cleave tRNAs. RNase L is responsive to double stranded RNAs and cleaves at the tRNA anticodon loop (Donovan et al. 2017). Schlafen family members SLFN11 and SLFN13 can also cleave tRNAs (Li et al. 2018, Yang et al. 2018). DICER1 cleaves double&#8209;stranded regions of tRNAs near the 5&apos; terminus or 3&apos; terminus to produce short tRFs (Cole et al. 2009, Yeung et al. 2009, Maute et al. 2013, Hasler et al. 2016). The mechanism that dissociates the double&#8209;stranded products of DICER1 to yield single&#8209;stranded tRFs may be the same as that for miRNAs, but this has not yet been demonstrated. Furthermore, the bulk of the short tRFs is still detected in DICER1-null cells (Kumar 2014, Kuscu    Kumar et al. 2018), suggesting other unknown factors are involved in their biogenesis. ELAC2 in the cytosol cleaves the 3&apos; trailers of precursors of tRNA Ser TGA, tRNA Ser GTC, and tRNA Asp GTC, and tRNA Asp GTC (Lee et al. 2009). The trailers (also called tRF-1s) then persist in the cytosol (Kumar et al. 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence66">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence65">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence64">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence63">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep760">
 <bp:stepProcess rdf:resource="#BiochemicalReaction685" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence69">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence310">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence68">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence67">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep754">
 <bp:stepProcess rdf:resource="#BiochemicalReaction679" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep755">
 <bp:stepProcess rdf:resource="#BiochemicalReaction680" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep756">
 <bp:stepProcess rdf:resource="#BiochemicalReaction681" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep757">
 <bp:stepProcess rdf:resource="#BiochemicalReaction682" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep750">
 <bp:stepProcess rdf:resource="#BiochemicalReaction675" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep751">
 <bp:stepProcess rdf:resource="#BiochemicalReaction676" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep752">
 <bp:stepProcess rdf:resource="#BiochemicalReaction677" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep753">
 <bp:stepProcess rdf:resource="#BiochemicalReaction678" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence308">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence309">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep758">
 <bp:stepProcess rdf:resource="#BiochemicalReaction683" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway139">
 <bp:pathwayOrder rdf:resource="#PathwayStep1294" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1293" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1155" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1156" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1293" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Transcription Termination</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">At the end of the cycle, the elongation complex (EC) must be destabilized to release its transcript and DNA. Analogous to initiation, cis-signals and protein factors are required to mediate EC destabilization and release of the transcript from the grip of the RNA polymerase (RNAP). RNAP III achieves efficient termination despite the apparent simplicity of its cis-acting DNA terminator element, a stretch of five or more T residues on the non-template (NT) strand, which directs termination within this site without need for additional cis-elements or trans-acting factors.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep759">
 <bp:stepProcess rdf:resource="#BiochemicalReaction684" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway138">
 <bp:pathwayOrder rdf:resource="#PathwayStep1283" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1284" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1281" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1282" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1290" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1280" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1291" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1289" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1279" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1287" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1288" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1285" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1286" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1149" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1146" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1145" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1148" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1147" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1142" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1153" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1152" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1144" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1143" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1154" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1151" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1150" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1279" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Abortive And Retractive Initiation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Abortive initiation, the repetitive formation of short oligonucleotides, is a ubiquitous feature of transcriptional initiation.  This Pathway contains events inferred from events in Saccharomyces cerevisiae.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence324">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1052">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence325">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1051">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence322">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1050">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence323">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence328">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence329">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence326">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence327">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1059">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1058">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1057">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence320">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1056">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence321">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1055">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1054">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1053">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction862">
 <bp:evidence rdf:resource="#Evidence952" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-20a binds RUNX1 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction861">
 <bp:evidence rdf:resource="#Evidence951" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-378 binds RUNX1 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction864">
 <bp:evidence rdf:resource="#Evidence955" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 and ESR1 bind the KCTD6 gene enhancer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction863">
 <bp:evidence rdf:resource="#Evidence954" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESR1 binds the AXIN1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction860">
 <bp:evidence rdf:resource="#Evidence950" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CCND3,(CCND1,CCND2) binds RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction869">
 <bp:evidence rdf:resource="#Evidence960" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds ESR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence319">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction866">
 <bp:evidence rdf:resource="#Evidence957" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 and ESR1 bind the AXIN1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction865">
 <bp:evidence rdf:resource="#Evidence956" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 and ESR1 bind the GPAM gene enhancer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction868">
 <bp:evidence rdf:resource="#Evidence959" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KCTD6 gene expression is stimulated by RUNX1 and ESR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction867">
 <bp:evidence rdf:resource="#Evidence958" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPAM gene expression is stimulated by RUNX1 and ESR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence335">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1041">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence336">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1040">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence333">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence334">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence339">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence337">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence338">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1049">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1048">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1047">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1046">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence331">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1045">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence332">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1044">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1043">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence330">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1042">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction873">
 <bp:evidence rdf:resource="#Evidence965" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">26S proteasome degrades TP73 polyubiquitinated by ITCH</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction872">
 <bp:evidence rdf:resource="#Evidence964" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ABL1 phosphorylates YAP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction875">
 <bp:evidence rdf:resource="#Evidence967" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1:CBFB:KMT2A binds SPI1 (PU.1) gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction874">
 <bp:evidence rdf:resource="#Evidence966" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds YAP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction871">
 <bp:evidence rdf:resource="#Evidence963" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KMT2A trimethylates nucleosomes at the SPI1 gene locus producing H3K4Me3 mark</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction870">
 <bp:evidence rdf:resource="#Evidence961" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AXIN1 gene expression is inhibited by ESR1 and stimulated by RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1039">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction877">
 <bp:evidence rdf:resource="#Evidence969" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds the core TAL1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction876">
 <bp:evidence rdf:resource="#Evidence968" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP73 tetramer translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction879">
 <bp:evidence rdf:resource="#Evidence971" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">YAP1 binds TP73</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction878">
 <bp:evidence rdf:resource="#Evidence970" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KMT2A (MLL) binds RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence91">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence346">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1074">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence90">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence347">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1073">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence344">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1072">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence345">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1071">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence95">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1070">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence94">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence93">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence348">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence92">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence349">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence99">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence98">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence97">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence96">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1079">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence342">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1078">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence343">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1077">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence340">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1076">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence341">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1075">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction884">
 <bp:evidence rdf:resource="#Evidence976" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1-containing TAL1 complex binds the MYB gene enhancer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction883">
 <bp:evidence rdf:resource="#Evidence975" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ITCH gene expression is stimulated by RUNX1 and YAP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction886">
 <bp:evidence rdf:resource="#Evidence979" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F6 binds TFDP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction885">
 <bp:evidence rdf:resource="#Evidence977" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The complex of RUNX1 and YAP1 binds the ITCH gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction880">
 <bp:evidence rdf:resource="#Evidence972" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MYB gene transcription is stimulated by the RUNX1-containing TAL1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction882">
 <bp:evidence rdf:resource="#Evidence974" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ITCH polyubiquitinates TP73</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction881">
 <bp:evidence rdf:resource="#Evidence973" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPI1 (PU.1) gene transcription is stimulated by RUNX1:CBFB:KMT2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction888">
 <bp:evidence rdf:resource="#Evidence981" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RBBP8 gene expression is inhibited by E2F6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction887">
 <bp:evidence rdf:resource="#Evidence980" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F1 binds RAD51 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction889">
 <bp:evidence rdf:resource="#Evidence982" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">APAF1 gene expression is stimulated by E2F1 and inhibited by E2F6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence357">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1063">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence358">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1062">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence355">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1061">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence356">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1060">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence359">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence350">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1069">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1068">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence353">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1067">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence354">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1066">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence351">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1065">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence352">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1064">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction895">
 <bp:evidence rdf:resource="#Evidence988" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F1 binds APAF1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction894">
 <bp:evidence rdf:resource="#Evidence987" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F6:TFDP1 binds to MGA:MAX</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction897">
 <bp:evidence rdf:resource="#Evidence990" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAD51 gene expression is stimulated by E2F1 and inhibited by E2F6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction896">
 <bp:evidence rdf:resource="#Evidence989" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F6 binds CBX5 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction891">
 <bp:evidence rdf:resource="#Evidence984" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F6 binds RBBP4 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction890">
 <bp:evidence rdf:resource="#Evidence983" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EHMT1:EHMT2 complex binds E2F6.com-1 core</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction893">
 <bp:evidence rdf:resource="#Evidence986" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RBBP4 gene expression is inhibited by E2F6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction892">
 <bp:evidence rdf:resource="#Evidence985" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F6:TFDP1 binds EPC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction899">
 <bp:evidence rdf:resource="#Evidence992" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F1 gene transcription is inhibited by E2F6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction898">
 <bp:evidence rdf:resource="#Evidence991" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBX5 gene expression is inhibited by E2F6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence368">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1096">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence369">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1095">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence366">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1094">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence367">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1093">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1092">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1091">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1090">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence360">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence361">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence364">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1069">
 <bp:evidence rdf:resource="#Evidence1185" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRC2 recruits DNA methyltransferases</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence365">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1099">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1068">
 <bp:evidence rdf:resource="#Evidence1184" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DNMT1,3A,3B:PRC2 methylates cytosine and histone H3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence362">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1098">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence363">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1097">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1076">
 <bp:evidence rdf:resource="#Evidence1196" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Acetylation of SL1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1075">
 <bp:evidence rdf:resource="#Evidence1195" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of Acetylated SL1 to phosUBF-1:rDNA Promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1078">
 <bp:evidence rdf:resource="#Evidence1198" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of SL1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1077">
 <bp:evidence rdf:resource="#Evidence1197" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Assembly of RNA Polymerase I Holoenzyme (human)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1072">
 <bp:evidence rdf:resource="#Evidence1191" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Loss of Rrn3 from RNA Polymerase I promoter escape complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1071">
 <bp:evidence rdf:resource="#Evidence1190" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Elongation of pre-rRNA transcript</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1074">
 <bp:evidence rdf:resource="#Evidence1194" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of RRN3 to RNA Polymerase I</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1073">
 <bp:evidence rdf:resource="#Evidence1193" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of Active RNA Polymerase I to SL1:phos.UBF-1:rDNA Promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1070">
 <bp:evidence rdf:resource="#Evidence1186" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRC2 trimethylates histone H3 at lysine-27</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence379">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1085">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1084">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence377">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1083">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence378">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1082">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1081">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1080">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence371">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence372">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence370">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence375">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1089">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1058">
 <bp:evidence rdf:resource="#Evidence1172" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RRP8 binds RNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence376">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1088">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1057">
 <bp:evidence rdf:resource="#Evidence1171" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SIRT1 deacetylates TAF1B in SL1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence373">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1087">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence374">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1086">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1059">
 <bp:evidence rdf:resource="#Evidence1173" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">eNoSC dimethylates histone H3 at lysine-9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1065">
 <bp:evidence rdf:resource="#Evidence1180" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cleavage of intergenic spacer RNA to yield fragments of 150-300 nucleotides</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1064">
 <bp:evidence rdf:resource="#Evidence1179" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nucleolar Remodelling Complex (NoRC) binds intergenic region of rDNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1067">
 <bp:evidence rdf:resource="#Evidence1183" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Polycomb Repressive Complex 2 (PRC2) Is recruited to chromatin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1066">
 <bp:evidence rdf:resource="#Evidence1181" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcription of intergenic spacer of the rRNA gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1061">
 <bp:evidence rdf:resource="#Evidence1176" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NoRC:HDAC:DNMT deacetylates histone H4 and methylates histone H3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1060">
 <bp:evidence rdf:resource="#Evidence1175" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MBD2 binds methylcytosine in chromatin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1063">
 <bp:evidence rdf:resource="#Evidence1178" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TTF-I binds to the Sal Box</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1062">
 <bp:evidence rdf:resource="#Evidence1177" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NoRC:HDAC:DNMT methylates cytosine of the rRNA genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence388">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence389">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence382">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence383">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence380">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence381">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence386">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence387">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence384">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence385">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1098">
 <bp:evidence rdf:resource="#Evidence1226" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Removal of miRNA passenger strand</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1097">
 <bp:evidence rdf:resource="#Evidence1225" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Duplex miRNA is loaded into Argonaute</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1099">
 <bp:evidence rdf:resource="#Evidence1227" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BCDIN3D dimethylates 5&apos; phosphate of pre-miR-145</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1094">
 <bp:evidence rdf:resource="#Evidence1222" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exportin complex translocates pre-miRNA to cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1093">
 <bp:evidence rdf:resource="#Evidence1221" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exportin-5 recognizes 3&apos; overhang of pre-miRNA </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1096">
 <bp:evidence rdf:resource="#Evidence1224" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Microprocessor complex cleaves pri-miRNA to pre-miRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1095">
 <bp:evidence rdf:resource="#Evidence1223" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dicer cleaves pre-miRNA to yield duplex miRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1090">
 <bp:evidence rdf:resource="#Evidence1217" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dicer cleaves double-stranded RNA to yield double-stranded siRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1092">
 <bp:evidence rdf:resource="#Evidence1219" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Duplex siRNA is loaded into Argonaute</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1091">
 <bp:evidence rdf:resource="#Evidence1218" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AGO2 cleaves passenger strand of duplex siRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence399">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence393">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence394">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence391">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence392">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence397">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence398">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1079">
 <bp:evidence rdf:resource="#Evidence1200" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of UBF-1:rDNA Promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence395">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence396">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1087">
 <bp:evidence rdf:resource="#Evidence1212" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Association of TFAM:mt promoter complex with POLRMT:TFB2M</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1086">
 <bp:evidence rdf:resource="#Evidence1211" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAM binds to mitochondrial promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1089">
 <bp:evidence rdf:resource="#Evidence1216" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Removal of siRNA passenger strand</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1088">
 <bp:evidence rdf:resource="#Evidence1215" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C3PO hydrolyzes cleaved passenger strand</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1083">
 <bp:evidence rdf:resource="#Evidence1205" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of PTRF:Polymerase I/Nascent Pre rRNA Complex:TTF-I:Sal Box</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence390">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1082">
 <bp:evidence rdf:resource="#Evidence1204" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Polymerase I Transcription Complex/Nascent Pre rRNA Complex pauses at the TTF-I:Sal Box</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1085">
 <bp:evidence rdf:resource="#Evidence1209" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Association of mTERF with the termination sequence</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1084">
 <bp:evidence rdf:resource="#Evidence1206" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTRF Binds the Polymerase I Transcription Complex/Nascent Pre rRNA Complex paused at the TTF-I:Sal Box</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1081">
 <bp:evidence rdf:resource="#Evidence1203" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TTF-I binds to the Sal Box</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1080">
 <bp:evidence rdf:resource="#Evidence1201" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">UBF-1 Binds rDNA Promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1294">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1156" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1295">
 <bp:stepProcess rdf:resource="#Pathway140" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1292">
 <bp:stepProcess rdf:resource="#Pathway139" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1293">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1155" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1290">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1153" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1291">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1154" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1214">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1213">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1212">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1211">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1210">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1209">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1208">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1207">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1206">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1205">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1204">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1298">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1159" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1296">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1157" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1297">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1158" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1283">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1146" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1284">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1147" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1281">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1144" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1282">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1145" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1280">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1143" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1203">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1202">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1201">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1200">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1289">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1152" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1287">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1150" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1288">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1151" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1285">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1148" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1286">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1149" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1236">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1235">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1234">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1233">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1232">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1231">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1230">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1229">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1228">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1227">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1226">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis109">
 <bp:controlled rdf:resource="#BiochemicalReaction523" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis108">
 <bp:controlled rdf:resource="#BiochemicalReaction495" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis105">
 <bp:controlled rdf:resource="#BiochemicalReaction485" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1225">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis104">
 <bp:controlled rdf:resource="#BiochemicalReaction426" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1224">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis107">
 <bp:controlled rdf:resource="#BiochemicalReaction490" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1223">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis106">
 <bp:controlled rdf:resource="#BiochemicalReaction488" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1222">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis101">
 <bp:controlled rdf:resource="#BiochemicalReaction419" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1221">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis100">
 <bp:controlled rdf:resource="#BiochemicalReaction415" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1220">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis103">
 <bp:controlled rdf:resource="#BiochemicalReaction425" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis102">
 <bp:controlled rdf:resource="#BiochemicalReaction424" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1219">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1218">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1217">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1216">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1215">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1250">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1250">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1120" />
 <bp:stepProcess rdf:resource="#Catalysis201" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1251">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1121" />
 <bp:stepProcess rdf:resource="#Catalysis202" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis119">
 <bp:controlled rdf:resource="#BiochemicalReaction628" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis116">
 <bp:controlled rdf:resource="#BiochemicalReaction622" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1258">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis115">
 <bp:controlled rdf:resource="#BiochemicalReaction618" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1257">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis118">
 <bp:controlled rdf:resource="#BiochemicalReaction627" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1256">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis117">
 <bp:controlled rdf:resource="#BiochemicalReaction623" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1255">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis112">
 <bp:controlled rdf:resource="#BiochemicalReaction605" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1254">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis111">
 <bp:controlled rdf:resource="#BiochemicalReaction588" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1253">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis114">
 <bp:controlled rdf:resource="#BiochemicalReaction609" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1252">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis113">
 <bp:controlled rdf:resource="#BiochemicalReaction607" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1251">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis110">
 <bp:controlled rdf:resource="#BiochemicalReaction580" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1249">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1248">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1258">
 <bp:stepProcess rdf:resource="#Catalysis207" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1127" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1259">
 <bp:stepProcess rdf:resource="#Catalysis208" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1128" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1256">
 <bp:stepProcess rdf:resource="#Catalysis205" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1125" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1257">
 <bp:stepProcess rdf:resource="#Catalysis206" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1126" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1254">
 <bp:stepProcess rdf:resource="#Catalysis204" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1124" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1255">
 <bp:stepProcess rdf:resource="#Pathway132" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1252">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1122" />
 <bp:stepProcess rdf:resource="#Catalysis203" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1253">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1123" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1240">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1110" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis127">
 <bp:controlled rdf:resource="#BiochemicalReaction658" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1247">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis126">
 <bp:controlled rdf:resource="#BiochemicalReaction657" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1246">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis129">
 <bp:controlled rdf:resource="#BiochemicalReaction662" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1245">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis128">
 <bp:controlled rdf:resource="#BiochemicalReaction660" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1244">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis123">
 <bp:controlled rdf:resource="#BiochemicalReaction650" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1243">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis122">
 <bp:controlled rdf:resource="#BiochemicalReaction645" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1242">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis125">
 <bp:controlled rdf:resource="#BiochemicalReaction656" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1241">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis124">
 <bp:controlled rdf:resource="#BiochemicalReaction655" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1240">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis121">
 <bp:controlled rdf:resource="#BiochemicalReaction633" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis120">
 <bp:controlled rdf:resource="#BiochemicalReaction632" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1239">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1238">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1249">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1119" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1237">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1247">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1117" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1248">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1118" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1245">
 <bp:stepProcess rdf:resource="#Catalysis200" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1115" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1246">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1116" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1243">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1113" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1244">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1114" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1241">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1111" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1242">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1112" />
 <bp:stepProcess rdf:resource="#Catalysis199" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1272">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1272">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1137" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1271">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1273">
 <bp:stepProcess rdf:resource="#Pathway137" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1270">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1270">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1135" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1271">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1136" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis138">
 <bp:controlled rdf:resource="#BiochemicalReaction788" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis137">
 <bp:controlled rdf:resource="#BiochemicalReaction783" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1279">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1278">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis139">
 <bp:controlled rdf:resource="#BiochemicalReaction790" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1277">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis134">
 <bp:controlled rdf:resource="#BiochemicalReaction772" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1276">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis133">
 <bp:controlled rdf:resource="#BiochemicalReaction770" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1275">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis136">
 <bp:controlled rdf:resource="#BiochemicalReaction782" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1274">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis135">
 <bp:controlled rdf:resource="#BiochemicalReaction780" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1273">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis130">
 <bp:controlled rdf:resource="#BiochemicalReaction667" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis132">
 <bp:controlled rdf:resource="#BiochemicalReaction767" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis131">
 <bp:controlled rdf:resource="#BiochemicalReaction764" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1278">
 <bp:stepProcess rdf:resource="#Pathway138" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1279">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1142" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1276">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1140" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1277">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1141" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1274">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1138" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1275">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1139" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1261">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1261">
 <bp:stepProcess rdf:resource="#Pathway134" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1260">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1262">
 <bp:stepProcess rdf:resource="#Pathway135" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1260">
 <bp:stepProcess rdf:resource="#Pathway133" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis149">
 <bp:controlled rdf:resource="#BiochemicalReaction920" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1269">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis148">
 <bp:controlled rdf:resource="#BiochemicalReaction915" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1268">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1267">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1266">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis145">
 <bp:controlled rdf:resource="#BiochemicalReaction872" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1265">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis144">
 <bp:controlled rdf:resource="#BiochemicalReaction871" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1264">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis147">
 <bp:controlled rdf:resource="#BiochemicalReaction882" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1263">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis146">
 <bp:controlled rdf:resource="#BiochemicalReaction873" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1262">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis141">
 <bp:controlled rdf:resource="#BiochemicalReaction801" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis140">
 <bp:controlled rdf:resource="#BiochemicalReaction799" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis143">
 <bp:controlled rdf:resource="#BiochemicalReaction851" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis142">
 <bp:controlled rdf:resource="#BiochemicalReaction848" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1259">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1269">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1134" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1267">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1133" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1268">
 <bp:stepProcess rdf:resource="#Pathway136" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1265">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1131" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1266">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1132" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1263">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1129" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1264">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1130" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction183">
 <bp:evidence rdf:resource="#Evidence210" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates MDM2 transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction182">
 <bp:evidence rdf:resource="#Evidence209" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of MDM4 by CHEK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis159">
 <bp:controlled rdf:resource="#BiochemicalReaction956" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction185">
 <bp:evidence rdf:resource="#Evidence212" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP2 binds the heterodimer of MDM2 and MDM4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction184">
 <bp:evidence rdf:resource="#Evidence211" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PP2A-PP2R5C dephosphorylates MDM2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis156">
 <bp:controlled rdf:resource="#BiochemicalReaction927" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis155">
 <bp:controlled rdf:resource="#BiochemicalReaction926" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction181">
 <bp:evidence rdf:resource="#Evidence208" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PDPK1 phosphorylates SGK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis158">
 <bp:controlled rdf:resource="#BiochemicalReaction951" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction180">
 <bp:evidence rdf:resource="#Evidence207" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MDM2 translocates to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis157">
 <bp:controlled rdf:resource="#BiochemicalReaction948" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep842">
 <bp:stepProcess rdf:resource="#BiochemicalReaction761" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis152">
 <bp:controlled rdf:resource="#BiochemicalReaction923" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep843">
 <bp:stepProcess rdf:resource="#BiochemicalReaction762" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis151">
 <bp:controlled rdf:resource="#BiochemicalReaction922" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep844">
 <bp:stepProcess rdf:resource="#BiochemicalReaction763" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis154">
 <bp:controlled rdf:resource="#BiochemicalReaction925" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep845">
 <bp:stepProcess rdf:resource="#Pathway83" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis153">
 <bp:controlled rdf:resource="#BiochemicalReaction924" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction187">
 <bp:evidence rdf:resource="#Evidence214" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the MDM2 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1218">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1092" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction186">
 <bp:evidence rdf:resource="#Evidence213" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ATM phosphorylates MDM2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1219">
 <bp:stepProcess rdf:resource="#Pathway128" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction189">
 <bp:evidence rdf:resource="#Evidence216" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNF34 or RFFL ubiquitinates phosphorylated TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep840">
 <bp:stepProcess rdf:resource="#BiochemicalReaction759" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis150">
 <bp:controlled rdf:resource="#BiochemicalReaction921" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1216">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1090" />
 <bp:stepProcess rdf:resource="#Catalysis189" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction188">
 <bp:evidence rdf:resource="#Evidence215" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TORC2 complex phosphorylates SGK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep841">
 <bp:stepProcess rdf:resource="#BiochemicalReaction760" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1217">
 <bp:stepProcess rdf:resource="#Catalysis190" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1091" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1214">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1088" />
 <bp:stepProcess rdf:resource="#Catalysis188" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1215">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1089" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1212">
 <bp:stepProcess rdf:resource="#Pathway126" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1213">
 <bp:stepProcess rdf:resource="#Pathway127" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep846">
 <bp:stepProcess rdf:resource="#BiochemicalReaction764" />
 <bp:stepProcess rdf:resource="#Catalysis131" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1210">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1086" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep847">
 <bp:stepProcess rdf:resource="#BiochemicalReaction765" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1211">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1087" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep848">
 <bp:stepProcess rdf:resource="#BiochemicalReaction766" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep849">
 <bp:stepProcess rdf:resource="#Catalysis132" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction767" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction194">
 <bp:evidence rdf:resource="#Evidence222" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates PRDM1 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction193">
 <bp:evidence rdf:resource="#Evidence221" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the PRDM1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction196">
 <bp:evidence rdf:resource="#Evidence225" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53RK phosphorylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction195">
 <bp:evidence rdf:resource="#Evidence223" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRDM1 binds the TP53 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction190">
 <bp:evidence rdf:resource="#Evidence217" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP7 deubiquitinates TP53 and counteracts MDM2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis167">
 <bp:controlled rdf:resource="#BiochemicalReaction1034" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis166">
 <bp:controlled rdf:resource="#BiochemicalReaction1033" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction192">
 <bp:evidence rdf:resource="#Evidence220" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRDM1 represses TP53 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis169">
 <bp:controlled rdf:resource="#BiochemicalReaction1036" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction191">
 <bp:evidence rdf:resource="#Evidence219" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 forms homotetramers</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis168">
 <bp:controlled rdf:resource="#BiochemicalReaction1035" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep853">
 <bp:stepProcess rdf:resource="#BiochemicalReaction771" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis163">
 <bp:controlled rdf:resource="#BiochemicalReaction1026" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep854">
 <bp:stepProcess rdf:resource="#BiochemicalReaction772" />
 <bp:stepProcess rdf:resource="#Catalysis134" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis162">
 <bp:controlled rdf:resource="#BiochemicalReaction1004" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep855">
 <bp:stepProcess rdf:resource="#BiochemicalReaction773" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis165">
 <bp:controlled rdf:resource="#BiochemicalReaction1032" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1209">
 <bp:stepProcess rdf:resource="#Pathway125" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep856">
 <bp:stepProcess rdf:resource="#BiochemicalReaction774" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis164">
 <bp:controlled rdf:resource="#BiochemicalReaction1027" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction198">
 <bp:evidence rdf:resource="#Evidence227" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOC2L binds TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1207">
 <bp:stepProcess rdf:resource="#Pathway124" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction197">
 <bp:evidence rdf:resource="#Evidence226" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DYRK2 phosphorylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep850">
 <bp:stepProcess rdf:resource="#BiochemicalReaction768" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1208">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1085" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep851">
 <bp:stepProcess rdf:resource="#BiochemicalReaction769" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis161">
 <bp:controlled rdf:resource="#BiochemicalReaction992" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1205">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1084" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction199">
 <bp:evidence rdf:resource="#Evidence228" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MDM2 ubiquitinates DYRK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep852">
 <bp:stepProcess rdf:resource="#BiochemicalReaction770" />
 <bp:stepProcess rdf:resource="#Catalysis133" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis160">
 <bp:controlled rdf:resource="#BiochemicalReaction963" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1206">
 <bp:stepProcess rdf:resource="#Pathway123" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1203">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1082" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1204">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1083" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1201">
 <bp:stepProcess rdf:resource="#Pathway122" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1202">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1081" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep857">
 <bp:stepProcess rdf:resource="#BiochemicalReaction775" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep858">
 <bp:stepProcess rdf:resource="#BiochemicalReaction776" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1200">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1080" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep859">
 <bp:stepProcess rdf:resource="#BiochemicalReaction777" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis178">
 <bp:controlled rdf:resource="#BiochemicalReaction1057" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis177">
 <bp:controlled rdf:resource="#BiochemicalReaction1056" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis179">
 <bp:controlled rdf:resource="#BiochemicalReaction1059" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep820">
 <bp:stepProcess rdf:resource="#BiochemicalReaction742" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis174">
 <bp:controlled rdf:resource="#BiochemicalReaction1049" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep821">
 <bp:stepProcess rdf:resource="#BiochemicalReaction743" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis173">
 <bp:controlled rdf:resource="#BiochemicalReaction1045" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep822">
 <bp:stepProcess rdf:resource="#BiochemicalReaction744" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis176">
 <bp:controlled rdf:resource="#BiochemicalReaction1054" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep823">
 <bp:stepProcess rdf:resource="#BiochemicalReaction745" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis175">
 <bp:controlled rdf:resource="#BiochemicalReaction1051" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis170">
 <bp:controlled rdf:resource="#BiochemicalReaction1037" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis172">
 <bp:controlled rdf:resource="#BiochemicalReaction1043" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1238">
 <bp:stepProcess rdf:resource="#Pathway131" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis171">
 <bp:controlled rdf:resource="#BiochemicalReaction1040" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1239">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1109" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep828">
 <bp:stepProcess rdf:resource="#BiochemicalReaction750" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1236">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1107" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep829">
 <bp:stepProcess rdf:resource="#BiochemicalReaction751" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1237">
 <bp:stepProcess rdf:resource="#Catalysis198" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1108" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1234">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1105" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1235">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1106" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep824">
 <bp:stepProcess rdf:resource="#BiochemicalReaction746" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1232">
 <bp:stepProcess rdf:resource="#Pathway130" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep825">
 <bp:stepProcess rdf:resource="#BiochemicalReaction747" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1233">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1104" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep826">
 <bp:stepProcess rdf:resource="#BiochemicalReaction748" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1230">
 <bp:stepProcess rdf:resource="#Catalysis197" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1102" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep827">
 <bp:stepProcess rdf:resource="#BiochemicalReaction749" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1231">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1103" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis189">
 <bp:controlled rdf:resource="#BiochemicalReaction1090" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis188">
 <bp:controlled rdf:resource="#BiochemicalReaction1088" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep831">
 <bp:stepProcess rdf:resource="#Pathway81" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis185">
 <bp:controlled rdf:resource="#BiochemicalReaction1071" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep832">
 <bp:stepProcess rdf:resource="#BiochemicalReaction752" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis184">
 <bp:controlled rdf:resource="#BiochemicalReaction1070" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep833">
 <bp:stepProcess rdf:resource="#BiochemicalReaction753" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis187">
 <bp:controlled rdf:resource="#BiochemicalReaction1079" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep834">
 <bp:stepProcess rdf:resource="#BiochemicalReaction754" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis186">
 <bp:controlled rdf:resource="#BiochemicalReaction1076" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis181">
 <bp:controlled rdf:resource="#BiochemicalReaction1062" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1229">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1101" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis180">
 <bp:controlled rdf:resource="#BiochemicalReaction1061" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis183">
 <bp:controlled rdf:resource="#BiochemicalReaction1068" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1227">
 <bp:stepProcess rdf:resource="#Catalysis196" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1100" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep830">
 <bp:stepProcess rdf:resource="#Pathway80" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis182">
 <bp:controlled rdf:resource="#BiochemicalReaction1066" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1228">
 <bp:stepProcess rdf:resource="#Pathway129" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep839">
 <bp:stepProcess rdf:resource="#BiochemicalReaction758" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1225">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1098" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1226">
 <bp:stepProcess rdf:resource="#Catalysis195" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1099" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1223">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1096" />
 <bp:stepProcess rdf:resource="#Catalysis194" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1224">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1097" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep835">
 <bp:stepProcess rdf:resource="#BiochemicalReaction755" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1221">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1094" />
 <bp:stepProcess rdf:resource="#Catalysis192" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep836">
 <bp:stepProcess rdf:resource="#Pathway82" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1222">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1095" />
 <bp:stepProcess rdf:resource="#Catalysis193" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep837">
 <bp:stepProcess rdf:resource="#BiochemicalReaction756" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep838">
 <bp:stepProcess rdf:resource="#BiochemicalReaction757" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1220">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1093" />
 <bp:stepProcess rdf:resource="#Catalysis191" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis199">
 <bp:controlled rdf:resource="#BiochemicalReaction1112" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis196">
 <bp:controlled rdf:resource="#BiochemicalReaction1100" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis195">
 <bp:controlled rdf:resource="#BiochemicalReaction1099" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep800">
 <bp:stepProcess rdf:resource="#Pathway78" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis198">
 <bp:controlled rdf:resource="#BiochemicalReaction1108" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep801">
 <bp:stepProcess rdf:resource="#BiochemicalReaction724" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis197">
 <bp:controlled rdf:resource="#BiochemicalReaction1102" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis192">
 <bp:controlled rdf:resource="#BiochemicalReaction1094" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis191">
 <bp:controlled rdf:resource="#BiochemicalReaction1093" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis194">
 <bp:controlled rdf:resource="#BiochemicalReaction1096" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis193">
 <bp:controlled rdf:resource="#BiochemicalReaction1095" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep806">
 <bp:stepProcess rdf:resource="#BiochemicalReaction729" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep807">
 <bp:stepProcess rdf:resource="#BiochemicalReaction730" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep808">
 <bp:stepProcess rdf:resource="#BiochemicalReaction731" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis190">
 <bp:controlled rdf:resource="#BiochemicalReaction1091" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep809">
 <bp:stepProcess rdf:resource="#BiochemicalReaction732" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep802">
 <bp:stepProcess rdf:resource="#BiochemicalReaction725" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep803">
 <bp:stepProcess rdf:resource="#BiochemicalReaction726" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep804">
 <bp:stepProcess rdf:resource="#BiochemicalReaction727" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep805">
 <bp:stepProcess rdf:resource="#BiochemicalReaction728" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep810">
 <bp:stepProcess rdf:resource="#BiochemicalReaction733" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep811">
 <bp:stepProcess rdf:resource="#BiochemicalReaction734" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep812">
 <bp:stepProcess rdf:resource="#BiochemicalReaction735" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep817">
 <bp:stepProcess rdf:resource="#BiochemicalReaction739" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep818">
 <bp:stepProcess rdf:resource="#BiochemicalReaction740" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep819">
 <bp:stepProcess rdf:resource="#BiochemicalReaction741" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep813">
 <bp:stepProcess rdf:resource="#BiochemicalReaction736" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep814">
 <bp:stepProcess rdf:resource="#BiochemicalReaction737" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep815">
 <bp:stepProcess rdf:resource="#BiochemicalReaction738" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep816">
 <bp:stepProcess rdf:resource="#Pathway79" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction103">
 <bp:evidence rdf:resource="#Evidence120" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VEGFA gene expression is inhibited by the TFAP2A homodimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction102">
 <bp:evidence rdf:resource="#Evidence119" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2A,TFAP2C homodimers bind the CGB gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction105">
 <bp:evidence rdf:resource="#Evidence122" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2A,(TFAP2B,TFAP2C) homo- and heterodimers and YY1 stimulate ERBB2 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction104">
 <bp:evidence rdf:resource="#Evidence121" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ATAD2 binds ESR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction101">
 <bp:evidence rdf:resource="#Evidence118" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2A,TFAP2C homodimers stimulate ESR1 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction100">
 <bp:evidence rdf:resource="#Evidence117" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EGFR gene expression is stimulated by TFAP2C</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction107">
 <bp:evidence rdf:resource="#Evidence124" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2A,TFAP2C homodimers stimulate CGA gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction106">
 <bp:evidence rdf:resource="#Evidence123" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2A,(TFAP2B) homodimers bind the KIT gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction109">
 <bp:evidence rdf:resource="#Evidence126" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2A homodimer binds the TGFA gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction108">
 <bp:evidence rdf:resource="#Evidence125" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2A,TFAP2C homodimers bind ESR1 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction114">
 <bp:evidence rdf:resource="#Evidence132" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2B homodimer binds YEATS4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction113">
 <bp:evidence rdf:resource="#Evidence131" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2C translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction116">
 <bp:evidence rdf:resource="#Evidence134" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AP-2 (TFAP2) transcription factors form homo- and heterodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction115">
 <bp:evidence rdf:resource="#Evidence133" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2 homo- and heterodimers bind CITED and EP300/CREBBP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction110">
 <bp:evidence rdf:resource="#Evidence127" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2A,TFAP2C homodimers bind the CGA gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction112">
 <bp:evidence rdf:resource="#Evidence129" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DEK binds TFAP2A homodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction111">
 <bp:evidence rdf:resource="#Evidence128" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KIT gene expression is stimulated by TFAP2A,(TFAP2B) homodimers </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction118">
 <bp:evidence rdf:resource="#Evidence137" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2A,TFAP2C homodimers:CITED2 binds PITX2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction117">
 <bp:evidence rdf:resource="#Evidence136" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PITX2 gene expression is stimulated by TFAP2A,TFAP2C homodimers:CITED2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction119">
 <bp:evidence rdf:resource="#Evidence139" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The NOP2 gene expression is repressed by the complex of NPM1 and TFAP2A homodimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction125">
 <bp:evidence rdf:resource="#Evidence145" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFPA2A homodimer and NPM1 bind the NOP2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction124">
 <bp:evidence rdf:resource="#Evidence144" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFPA2A homodimer and NPM1 bind the HSPD1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction127">
 <bp:evidence rdf:resource="#Evidence148" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KCTD15 binds TFAP2 homo- and heterodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction126">
 <bp:evidence rdf:resource="#Evidence147" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SUMOylation of TFAP2C with SUMO1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction121">
 <bp:evidence rdf:resource="#Evidence141" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The MYBL2 gene expression is repressed by the complex of NPM1 and TFAP2A homodimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction120">
 <bp:evidence rdf:resource="#Evidence140" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFPA2A homodimer and NPM1 bind the MYBL2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction123">
 <bp:evidence rdf:resource="#Evidence143" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HSPD1 gene expression is repressed by the complex of NPM1 and TFAP2A homodimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction122">
 <bp:evidence rdf:resource="#Evidence142" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPM1 binds TFAP2A homodimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction129">
 <bp:evidence rdf:resource="#Evidence150" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SUMOylation of TFAP2B with SUMO1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction128">
 <bp:evidence rdf:resource="#Evidence149" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWOX binds TFAP2C</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction130">
 <bp:evidence rdf:resource="#Evidence151" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SUMOylation of TFAP2A with SUMO1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction136">
 <bp:evidence rdf:resource="#Evidence159" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the MLH1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction135">
 <bp:evidence rdf:resource="#Evidence158" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CCNK binds CDK12</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction138">
 <bp:evidence rdf:resource="#Evidence161" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CCNK binds CDK13</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction137">
 <bp:evidence rdf:resource="#Evidence160" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 and AP-1 bind the MSH2 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction132">
 <bp:evidence rdf:resource="#Evidence155" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates CCNK expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction131">
 <bp:evidence rdf:resource="#Evidence152" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KCTD1 binds TFAP2 homo- and heterodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction134">
 <bp:evidence rdf:resource="#Evidence157" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates PMS2 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction133">
 <bp:evidence rdf:resource="#Evidence156" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDK12 phosphorylates RNA Pol II CTD at DNA repair genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction139">
 <bp:evidence rdf:resource="#Evidence162" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the CCNK gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence401">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence402">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence400">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence405">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence406">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence403">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence404">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep890">
 <bp:stepProcess rdf:resource="#BiochemicalReaction806" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction141">
 <bp:evidence rdf:resource="#Evidence164" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates DDB2 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep891">
 <bp:stepProcess rdf:resource="#BiochemicalReaction807" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction140">
 <bp:evidence rdf:resource="#Evidence163" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the PMS2 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep892">
 <bp:stepProcess rdf:resource="#Pathway86" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction147">
 <bp:evidence rdf:resource="#Evidence170" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates FANCC expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep886">
 <bp:stepProcess rdf:resource="#BiochemicalReaction802" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction146">
 <bp:evidence rdf:resource="#Evidence169" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 and AP-1 stimulate MSH2 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep887">
 <bp:stepProcess rdf:resource="#BiochemicalReaction803" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction149">
 <bp:evidence rdf:resource="#Evidence174" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JMY, TTC5 and EP300 bind</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep888">
 <bp:stepProcess rdf:resource="#BiochemicalReaction804" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction148">
 <bp:evidence rdf:resource="#Evidence171" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates MLH1 expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep889">
 <bp:stepProcess rdf:resource="#BiochemicalReaction805" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction143">
 <bp:evidence rdf:resource="#Evidence166" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the DDB2 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep882">
 <bp:stepProcess rdf:resource="#Catalysis140" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction799" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction142">
 <bp:evidence rdf:resource="#Evidence165" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the FANCC gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep883">
 <bp:stepProcess rdf:resource="#BiochemicalReaction800" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction145">
 <bp:evidence rdf:resource="#Evidence168" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDK12 stimulates expression of DNA repair genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep884">
 <bp:stepProcess rdf:resource="#Catalysis141" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction801" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction144">
 <bp:evidence rdf:resource="#Evidence167" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CCNK:CDK12 binds RNA Pol II at DNA repair genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep885">
 <bp:stepProcess rdf:resource="#Pathway85" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence412">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence413">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence410">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence411">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence416">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence417">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence414">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence415">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction150">
 <bp:evidence rdf:resource="#Evidence175" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ATM phosphorylates TTC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction152">
 <bp:evidence rdf:resource="#Evidence177" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SETD9 methylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction151">
 <bp:evidence rdf:resource="#Evidence176" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the complex of JMY, EP300 and TTC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction158">
 <bp:evidence rdf:resource="#Evidence183" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMYD2 methylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep897">
 <bp:stepProcess rdf:resource="#BiochemicalReaction812" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction157">
 <bp:evidence rdf:resource="#Evidence182" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRMT5 binds TTC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep898">
 <bp:stepProcess rdf:resource="#BiochemicalReaction813" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep899">
 <bp:stepProcess rdf:resource="#BiochemicalReaction814" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction159">
 <bp:evidence rdf:resource="#Evidence184" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EHMT1:EHMT2 dimethylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction154">
 <bp:evidence rdf:resource="#Evidence179" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRMT5 methylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep893">
 <bp:stepProcess rdf:resource="#BiochemicalReaction808" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction153">
 <bp:evidence rdf:resource="#Evidence178" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">L3MBTL1 binds TP53 monomethylated on K382</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep894">
 <bp:stepProcess rdf:resource="#BiochemicalReaction809" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction156">
 <bp:evidence rdf:resource="#Evidence181" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SETD8 methylates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep895">
 <bp:stepProcess rdf:resource="#BiochemicalReaction810" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction155">
 <bp:evidence rdf:resource="#Evidence180" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MDM2 ubiquitinates JMY</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep896">
 <bp:stepProcess rdf:resource="#BiochemicalReaction811" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence409">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence407">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence408">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence423">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence424">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence421">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence422">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence427">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence428">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence425">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence426">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction161">
 <bp:evidence rdf:resource="#Evidence188" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CCNG1 recruits PP2A-PPP2R5C to MDM2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction160">
 <bp:evidence rdf:resource="#Evidence185" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHEK2 phosphorylates TTC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction163">
 <bp:evidence rdf:resource="#Evidence190" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAXX binds Ub-MDM2 and USP7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction162">
 <bp:evidence rdf:resource="#Evidence189" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates MDM2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep870">
 <bp:stepProcess rdf:resource="#Catalysis138" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction788" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence420">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction169">
 <bp:evidence rdf:resource="#Evidence196" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">(CDK1,CDK2):CCNA phosphorylates MDM2 at T218</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep864">
 <bp:stepProcess rdf:resource="#BiochemicalReaction782" />
 <bp:stepProcess rdf:resource="#Catalysis136" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction168">
 <bp:evidence rdf:resource="#Evidence195" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the CCNG1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep865">
 <bp:stepProcess rdf:resource="#BiochemicalReaction783" />
 <bp:stepProcess rdf:resource="#Catalysis137" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep866">
 <bp:stepProcess rdf:resource="#BiochemicalReaction784" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep867">
 <bp:stepProcess rdf:resource="#BiochemicalReaction785" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction165">
 <bp:evidence rdf:resource="#Evidence192" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates CCNG1 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep860">
 <bp:stepProcess rdf:resource="#BiochemicalReaction778" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction164">
 <bp:evidence rdf:resource="#Evidence191" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of MDM4 by ATM</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep861">
 <bp:stepProcess rdf:resource="#BiochemicalReaction779" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction167">
 <bp:evidence rdf:resource="#Evidence194" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MDM2 ubiquitinates phosphorylated MDM4</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep862">
 <bp:stepProcess rdf:resource="#BiochemicalReaction780" />
 <bp:stepProcess rdf:resource="#Catalysis135" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction166">
 <bp:evidence rdf:resource="#Evidence193" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP7 deubiquitinates MDM2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep863">
 <bp:stepProcess rdf:resource="#BiochemicalReaction781" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence418">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence419">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep868">
 <bp:stepProcess rdf:resource="#BiochemicalReaction786" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep869">
 <bp:stepProcess rdf:resource="#BiochemicalReaction787" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence434">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence435">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence432">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence433">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence438">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence439">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence436">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence437">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction172">
 <bp:evidence rdf:resource="#Evidence199" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MDM2 forms homo- or heterodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction171">
 <bp:evidence rdf:resource="#Evidence198" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p14ARF forms a ternary complex with MDM2 and TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction174">
 <bp:evidence rdf:resource="#Evidence201" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SGK1 phosphorylates MDM2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep880">
 <bp:stepProcess rdf:resource="#BiochemicalReaction797" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction173">
 <bp:evidence rdf:resource="#Evidence200" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP2 deubiquitinates MDM2,MDM4</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep881">
 <bp:stepProcess rdf:resource="#BiochemicalReaction798" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence430">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence431">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction170">
 <bp:evidence rdf:resource="#Evidence197" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MDM2 binds TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep875">
 <bp:stepProcess rdf:resource="#BiochemicalReaction793" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction179">
 <bp:evidence rdf:resource="#Evidence206" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitinated TP53 translocates to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep876">
 <bp:stepProcess rdf:resource="#BiochemicalReaction794" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep877">
 <bp:stepProcess rdf:resource="#BiochemicalReaction795" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep878">
 <bp:stepProcess rdf:resource="#BiochemicalReaction796" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction176">
 <bp:evidence rdf:resource="#Evidence203" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MDM2 translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep871">
 <bp:stepProcess rdf:resource="#BiochemicalReaction789" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction175">
 <bp:evidence rdf:resource="#Evidence202" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p14ARF sequesters MDM2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep872">
 <bp:stepProcess rdf:resource="#BiochemicalReaction790" />
 <bp:stepProcess rdf:resource="#Catalysis139" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction178">
 <bp:evidence rdf:resource="#Evidence205" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MDM2 homodimers auto-ubiquitinate</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep873">
 <bp:stepProcess rdf:resource="#BiochemicalReaction791" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction177">
 <bp:evidence rdf:resource="#Evidence204" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MDM2 ubiquitinates TP53</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep874">
 <bp:stepProcess rdf:resource="#BiochemicalReaction792" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence429">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep879">
 <bp:stepProcess rdf:resource="#Pathway84" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence445">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1173">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence446">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1172">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence443">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1171">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence444">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1170">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence449">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence447">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence448">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1179">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1178">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence441">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1177">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence442">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1176">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1175">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence440">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1174">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction983">
 <bp:evidence rdf:resource="#Evidence1086" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BOD1L1 binds SET1A complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction982">
 <bp:evidence rdf:resource="#Evidence1085" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HCFC1 binds SET1A complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction985">
 <bp:evidence rdf:resource="#Evidence1091" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LIPE gene expression is stimulated by PPARG:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction984">
 <bp:evidence rdf:resource="#Evidence1087" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of the MLL4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction981">
 <bp:evidence rdf:resource="#Evidence1084" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of the SET1B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction980">
 <bp:evidence rdf:resource="#Evidence1083" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAXIP1:PAGR1 complex, NCOA6 and KDM6A bind MLL4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction987">
 <bp:evidence rdf:resource="#Evidence1093" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADIPOQ gene expression is stimulated by PPARG:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction986">
 <bp:evidence rdf:resource="#Evidence1092" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PHLDA1 binds PPARG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction989">
 <bp:evidence rdf:resource="#Evidence1095" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DGAT2 gene expression is stimulated by PPARG:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction988">
 <bp:evidence rdf:resource="#Evidence1094" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCD gene expression is stimulated by PPARG:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence456">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1162">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence457">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1161">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence454">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1160">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence455">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence458">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence459">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1169">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1168">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1167">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence452">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1166">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence453">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1165">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence450">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1164">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence451">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1163">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction994">
 <bp:evidence rdf:resource="#Evidence1100" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CIDEC gene expression is stimulated by PPARG:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction993">
 <bp:evidence rdf:resource="#Evidence1099" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCD5 gene expression is stimulated by PPARG2:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction996">
 <bp:evidence rdf:resource="#Evidence1102" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD36 gene expression is stimulated by PPARG:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction995">
 <bp:evidence rdf:resource="#Evidence1101" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AGPAT2 gene expression is stimulated by PPARG:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction990">
 <bp:evidence rdf:resource="#Evidence1096" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LPIN1 gene expression is stimulated by PPARG:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction992">
 <bp:evidence rdf:resource="#Evidence1098" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ABL1 phosphorylates PPARG2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction991">
 <bp:evidence rdf:resource="#Evidence1097" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLIN4 gene expression is stimulated by PPARG:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction998">
 <bp:evidence rdf:resource="#Evidence1104" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MGLL gene expression is stimulated by PPARG:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction997">
 <bp:evidence rdf:resource="#Evidence1103" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PNPLA2 gene expression is stimulated by PPARG:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction999">
 <bp:evidence rdf:resource="#Evidence1105" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ACSL1 gene expression is stimulated by PPARG:RXRA:MLL4,(MLL3)-ASCOM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence467">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1195">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence468">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1194">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence465">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1193">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence466">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1192">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1191">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1190">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence469">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence460">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence463">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1199">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence464">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1198">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence461">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1197">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence462">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1196">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence478">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1184">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence479">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1183">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence476">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1182">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence477">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1181">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1180">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence470">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence471">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1189">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence474">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1188">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence475">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1187">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence472">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1186">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence473">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1185">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence489">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence487">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence488">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence481">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence482">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence480">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence485">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence486">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence483">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence484">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence498">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence499">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence492">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence493">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence490">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence491">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence496">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence497">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence494">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence495">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway10">
 <bp:pathwayOrder rdf:resource="#PathwayStep152" />
 <bp:pathwayOrder rdf:resource="#PathwayStep571" />
 <bp:pathwayOrder rdf:resource="#PathwayStep622" />
 <bp:pathwayOrder rdf:resource="#PathwayStep633" />
 <bp:pathwayOrder rdf:resource="#PathwayStep721" />
 <bp:pathwayOrder rdf:resource="#PathwayStep623" />
 <bp:pathwayOrder rdf:resource="#PathwayStep722" />
 <bp:pathwayOrder rdf:resource="#PathwayStep977" />
 <bp:pathwayOrder rdf:resource="#PathwayStep101" />
 <bp:pathwayOrder rdf:resource="#PathwayStep431" />
 <bp:pathwayOrder rdf:resource="#PathwayStep97" />
 <bp:pathwayOrder rdf:resource="#PathwayStep488" />
 <bp:pathwayOrder rdf:resource="#PathwayStep43" />
 <bp:pathwayOrder rdf:resource="#PathwayStep98" />
 <bp:pathwayOrder rdf:resource="#PathwayStep830" />
 <bp:pathwayOrder rdf:resource="#PathwayStep725" />
 <bp:pathwayOrder rdf:resource="#PathwayStep816" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1011" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction919" />
 <bp:pathwayComponent rdf:resource="#Pathway80" />
 <bp:pathwayComponent rdf:resource="#Pathway72" />
 <bp:pathwayComponent rdf:resource="#Pathway93" />
 <bp:pathwayComponent rdf:resource="#Pathway73" />
 <bp:pathwayComponent rdf:resource="#Pathway43" />
 <bp:pathwayComponent rdf:resource="#Pathway65" />
 <bp:pathwayComponent rdf:resource="#Pathway53" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction560" />
 <bp:pathwayComponent rdf:resource="#Pathway64" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction651" />
 <bp:pathwayComponent rdf:resource="#Pathway11" />
 <bp:pathwayComponent rdf:resource="#Pathway22" />
 <bp:pathwayComponent rdf:resource="#Pathway14" />
 <bp:pathwayComponent rdf:resource="#Pathway79" />
 <bp:pathwayComponent rdf:resource="#Pathway15" />
 <bp:pathwayComponent rdf:resource="#Pathway59" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction85" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence43" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Generic Transcription Pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string"> OVERVIEW OF TRANSCRIPTION REGULATION:     Detailed studies of gene transcription regulation in a wide variety of eukaryotic systems has revealed the general principles and mechanisms by which cell- or tissue-specific regulation of differential gene transcription is mediated (reviewed in Naar, 2001. Kadonaga, 2004, Maston, 2006, Barolo, 2002; Roeder, 2005, Rosenfeld, 2006).  Of the three major classes of DNA polymerase involved in eukaryotic gene transcription, Polymerase II generally regulates protein-encoding genes.   Figure 1 shows a diagram of the various components involved in cell-specific regulation of Pol-II gene transcription.   Core Promoter: Pol II-regulated genes typically have a Core Promoter where Pol II and a variety of general factors bind to specific DNA motifs:     i: the TATA box (TATA DNA sequence), which is bound by the &quot;TATA-binding protein&quot; (TBP).    ii: the Initiator motif (INR), where Pol II and certain other core factors bind, is present in many Pol II-regulated genes.    iii: the Downstream Promoter Element (DPE), which is present in a subset of Pol II genes, and where additional core factors bind.   The core promoter binding factors are generally ubiquitously expressed, although there are exceptions to this.  Proximal Promoter: immediately upstream (5&apos;) of the core promoter, Pol II target genes often have a Proximal Promoter region that spans up to 500 base pairs (b.p.), or even to 1000 b.p..  This region contains a number of functional DNA binding sites for a specific set of transcription activator (TA) and transcription repressor (TR) proteins.  These TA and TR factors are generally cell- or tissue-specific in expression, rather than ubiquitous, so that the presence of their cognate binding sites in the proximal promoter region programs cell- or tissue-specific expression of the target gene, perhaps in conjunction with TA and TR complexes bound in distal enhancer regions.    Distal Enhancer(s): many or most Pol II regulated genes in higher eukaryotes have one or more distal Enhancer regions which are essential for proper regulation of the gene, often in a cell or tissue-specific pattern.  Like the proximal promoter region, each of the distal enhancer regions typically contain a cluster of binding sites for specific TA and/or TR DNA-binding factors, rather than just a single site.      Enhancers generally have three defining characteristics:      i: They can be located very long distances from the promoter of the target gene they regulate, sometimes as far as 100 Kb, or more.      ii: They can be either upstream (5&apos;) or downstream (3&apos;) of the target gene, including within introns of that gene.      iii: They can function in either orientation in the DNA.  Combinatorial mechanisms of transcription regulation: The specific combination of TA and TR binding sites within the proximal promoter and/or distal enhancer(s) provides a &quot;combinatorial transcription code&quot; that mediates cell- or tissue-specific expression of the associated target gene.  Each promoter or enhancer region mediates expression in a specific subset of the overall expression pattern.  In at least some cases, each enhancer region functions completely independently of the others, so that the overall expression pattern is a linear combination of the expression patterns of each of the enhancer modules.  Co-Activator and Co-Repressor Complexes:  DNA-bound TA and TR proteins typically recruit the assembly of specific Co-Activator (Co-A) and Co-Repressor (Co-R) Complexes, respectively, which are essential for regulating target gene transcription.  Both Co-A&apos;s and Co-R&apos;s  are multi-protein complexes that contain several specific protein components.  Co-Activator complexes generally contain at lease one component protein that has Histone Acetyl Transferase (HAT) enzymatic activity.  This functions to acetylate Histones and/or other chromatin-associated factors, which typically increases that transcription activation of the target gene.  By contrast, Co-Repressor complexes generally contain at lease one component protein that has Histone De-Acetylase (HDAC) enzymatic activity.  This functions to de-acetylate Histones and/or other chromatin-associated factors. This typically increases the transcription repression of the target gene.  Adaptor (Mediator) complexes: In addition to the co-activator complexes that assemble on particular cell-specific TA factors,  - there are at least two additional transcriptional co-activator complexes common to most cells.  One of these is the Mediator complex, which functions as an &quot;adaptor&quot; complex that bridges between the tissue-specific co-activator complexes assembled in the proximal promoter (or distal enhancers).  The human Mediator complex has been shown to contain at least 19 protein distinct components.  Different combinations of these co-activator proteins are also found to be components of specific transcription Co-Activator complexes, such as the DRIP, TRAP and ARC complexes described below.    TBP/TAF complex: Another large Co-A complex is the &quot;TBP-associated factors&quot; (TAFs) that assemble on TBP (TATA-Binding Protein), which is bound to the TATA box present in many promoters.  There are at least 23 human TAF proteins that have been identified.  Many of these are ubiquitously expressed, but TAFs can also be expressed in a cell or tissue-specific pattern.       Specific Coactivator Complexes for DNA-binding Transcription Factors.      A number of specific co-activator complexes for DNA-binding transcription factors have been identified, including DRIP, TRAP, and ARC (reviewed in Bourbon, 2004, Blazek, 2005, Conaway, 2005, and Malik, 2005).  The DRIP co-activator complex was originally identified and named as a specific complex associated with the Vitamin D Receptor member of the nuclear receptor family of transcription factors (Rachez, 1998).  Similarly, the TRAP co-activator complex was originally identified as a complex that associates with the thyroid receptor (Yuan, 1998).   It was later determined that all of the components of the DRIP complex are also present in the TRAP complex, and the ARC complex (discussed further below).  For example, the DRIP205 and TRAP220 proteins were show to be identical, as were specific pairs of the other components of these complexes (Rachez, 1999).  In addition, these various transcription co-activator proteins identified in mammalian cells were found to be the orthologues or homologues of the Mediator (&quot;adaptor&quot;) complex proteins (reviewed in Bourbon, 2004).  The Mediator proteins were originally identified in yeast  by Kornberg and colleagues, as complexes associated with DNA polymerase (Kelleher, 1990).  In higher organisms, Adapter complexes bridge between the basal transcription factors (including Pol II) and tissue-specific transcription factors (TFs) bound to sites within upstream Proximal Promoter regions or distal Enhancer regions (Figure 1).  However, many of the Mediator homologues can also be found in complexes associated with specific transcription factors in higher organisms.  A unified nomenclature system for these adapter / co-activator proteins now labels them Mediator 1 through Mediator 31 (Bourbon, 2004).  For example, the DRIP205 / TRAP220 proteins are now identified as Mediator 1 (Rachez, 1999), based on homology with yeast Mediator 1.    Example Pathway: Specific Regulation of Target Genes During Notch Signaling:    One well-studied example of cell-specific regulation of gene transcription is selective regulation of target genes during Notch signaling.  Notch signaling was first identified in Drosophila, where it has been studied in detail at the genetic, molecular, biochemical and cellular levels (reviewed in Justice, 2002; Bray, 2006; Schweisguth, 2004; Louvri, 2006).  In Drosophila, Notch signaling to the nucleus is thought always to be mediated by one specific DNA binding transcription factor, Suppressor of Hairless.  In mammals, the homologous genes are called CBF1 (or RBPJkappa), while in worms they are called Lag-1, so that the acronym &quot;CSL&quot; has been given to this conserved transcription factor family.  There are at least two human CSL homologues, which are now named RBPJ and RBPJL.    In Drosophila, Su(H) is known to be bifunctional, in that it represses target gene transcription in the absence of Notch signaling, but activates target genes during Notch signaling.  At least some of the mammalian CSL homologues are believed also to be bifunctional, and to mediate target gene repression in the absence of Notch signaling, and activation in the presence of Notch signaling.  Notch Co-Activator and Co-Repressor complexes: This repression is mediated by at least one specific co-repressor complexes (Co-R) bound to CSL in the absence of Notch signaling.  In Drosophila, this co-repressor complex consists of at least three distinct co-repressor proteins: Hairless, Groucho, and dCtBP (Drosophila C-terminal Binding Protein).  Hairless has been show to bind directly to Su(H), and Groucho and dCtBP have been shown to bind directly to Hairless (Barolo, 2002).  All three of the co-repressor proteins have been shown to be necessary for proper gene regulation during Notch signaling in vivo (Nagel, 2005).  In mammals, the same general pathway and mechanisms are observed, where CSL proteins are bifunctional DNA binding transcription factors (TFs), that bind to Co-Repressor complexes to mediate repression in the absence of Notch signaling, and bind to Co-Activator  complexes to mediate activation in the presence of Notch signaling.  However, in mammals, there may be multiple co-repressor complexes, rather than the single Hairless co-repressor complex that has been observed in Drosophila.    During Notch signaling in all systems, the Notch transmembrane receptor is cleaved and the Notch intracellular domain (NICD) translocates to the nucleus, where it there functions as a specific transcription co-activator for CSL proteins.  In the nucleus, NICD replaces the Co-R complex bound to CSL, thus resulting in de-repression of  Notch target genes in the nucleus (Figure 2).  Once bound to CSL, NICD and CSL proteins recruit an additional co-activator protein, Mastermind, to form a CSL-NICD-Mam ternary co-activator (Co-A) complex.  This Co-R  complex was initially thought to be sufficient to mediate activation of  at least some Notch target genes.  However, there now is evidence that still other co-activators and additional DNA-binding transcription factors are required in at least some contexts (reviewed in Barolo, 2002).    Thus, CSL is a good example of a bifunctional DNA-binding transcription factor that mediates repression of specific targets genes in one context, but activation of the same targets in another context.  This bifunctionality is mediated by the association of specific Co-Repressor complexes vs. specific Co-Activator complexes in different contexts, namely in the absence or presence of Notch signaling.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway12">
 <bp:pathwayOrder rdf:resource="#PathwayStep51" />
 <bp:pathwayOrder rdf:resource="#PathwayStep62" />
 <bp:pathwayOrder rdf:resource="#PathwayStep52" />
 <bp:pathwayOrder rdf:resource="#PathwayStep63" />
 <bp:pathwayOrder rdf:resource="#PathwayStep60" />
 <bp:pathwayOrder rdf:resource="#PathwayStep50" />
 <bp:pathwayOrder rdf:resource="#PathwayStep61" />
 <bp:pathwayOrder rdf:resource="#PathwayStep48" />
 <bp:pathwayOrder rdf:resource="#PathwayStep59" />
 <bp:pathwayOrder rdf:resource="#PathwayStep49" />
 <bp:pathwayOrder rdf:resource="#PathwayStep46" />
 <bp:pathwayOrder rdf:resource="#PathwayStep57" />
 <bp:pathwayOrder rdf:resource="#PathwayStep68" />
 <bp:pathwayOrder rdf:resource="#PathwayStep47" />
 <bp:pathwayOrder rdf:resource="#PathwayStep58" />
 <bp:pathwayOrder rdf:resource="#PathwayStep55" />
 <bp:pathwayOrder rdf:resource="#PathwayStep66" />
 <bp:pathwayOrder rdf:resource="#PathwayStep45" />
 <bp:pathwayOrder rdf:resource="#PathwayStep56" />
 <bp:pathwayOrder rdf:resource="#PathwayStep67" />
 <bp:pathwayOrder rdf:resource="#PathwayStep53" />
 <bp:pathwayOrder rdf:resource="#PathwayStep64" />
 <bp:pathwayOrder rdf:resource="#PathwayStep54" />
 <bp:pathwayOrder rdf:resource="#PathwayStep65" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction37" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction48" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction36" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction47" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction35" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction46" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction57" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction34" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction45" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction56" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction39" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction38" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction49" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction40" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction51" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction50" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction44" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction55" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction43" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction54" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction42" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction53" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction41" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction52" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence45" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">After phosphorylated SMAD2 and/or SMAD3 form a heterotrimer with SMAD4, SMAD2/3:SMAD4 complex translocates to the nucleus (Xu et al. 2000, Kurisaki et al. 2001, Xiao et al. 2003). In the nucleus, linker regions of SMAD2 and SMAD3 within SMAD2/3:SMAD4 complex can be phosphorylated by CDK8 associated with cyclin C (CDK8:CCNC) or CDK9 associated with cyclin T (CDK9:CCNT). CDK8/CDK9-mediated phosphorylation of SMAD2/3 enhances transcriptional activity of SMAD2/3:SMAD4 complex, but also primes it for ubiquitination and consequent degradation (Alarcon et al. 2009).   The transfer of SMAD2/3:SMAD4 complex to the nucleus can be assisted by other proteins, such as WWTR1. In human embryonic cells, WWTR1 (TAZ) binds SMAD2/3:SMAD4 heterotrimer and mediates TGF-beta-dependent nuclear accumulation of SMAD2/3:SMAD4. The complex of WWTR1 and SMAD2/3:SMAD4 binds promoters of SMAD7 and SERPINE1 (PAI-1 i.e. plasminogen activator inhibitor 1) genes and stimulates their transcription (Varelas et al. 2008). Stimulation of SMAD7 transcription by SMAD2/3:SMAD4 represents a negative feedback loop in TGF-beta receptor signaling. SMAD7 can be downregulated by RNF111 ubiquitin ligase (Arkadia), which binds and ubiquitinates SMAD7, targeting it for degradation (Koinuma et al. 2003).   SMAD2/3:SMAD4 heterotrimer also binds the complex of RBL1 (p107), E2F4/5 and TFDP1/2 (DP1/2). The resulting complex binds MYC promoter and inhibits MYC transcription. Inhibition of MYC transcription contributes to anti-proliferative effect of TGF-beta (Chen et al. 2002). SMAD2/3:SMAD4 heterotrimer also associates with transcription factor SP1. SMAD2/3:SMAD4:SP1 complex stimulates transcription of a CDK inhibitor CDKN2B (p15-INK4B), also contributing to the anti-proliferative effect of TGF-beta (Feng et al. 2000).   MEN1 (menin), a transcription factor tumor suppressor mutated in a familial cancer syndrome multiple endocrine neoplasia type 1, forms a complex with SMAD2/3:SMAD4 heterotrimer, but transcriptional targets of SMAD2/3:SMAD4:MEN1 have not been elucidated (Kaji et al. 2001, Sowa et al. 2004, Canaff et al. 2012).   JUNB is also an established transcriptional target of SMAD2/3:SMAD4 complex (Wong et al. 1999).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway11">
 <bp:pathwayOrder rdf:resource="#PathwayStep69" />
 <bp:pathwayOrder rdf:resource="#PathwayStep44" />
 <bp:pathwayComponent rdf:resource="#Pathway12" />
 <bp:pathwayComponent rdf:resource="#Pathway13" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence44" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In the nucleus, SMAD2/3:SMAD4 heterotrimer complex acts as a transcriptional regulator. The activity of SMAD2/3 complex is regulated both positively and negatively by association with other transcription factors (Chen et al. 2002, Varelas et al. 2008, Stroschein et al. 1999, Wotton et al. 1999). In addition, the activity of SMAD2/3:SMAD4 complex can be inhibited by nuclear protein phosphatases and ubiquitin ligases (Lin et al. 2006, Dupont et al. 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway14">
 <bp:pathwayOrder rdf:resource="#PathwayStep99" />
 <bp:pathwayOrder rdf:resource="#PathwayStep100" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction87" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction86" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence99" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Notch-HLH transcription pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string"> THE NOTCH-HLH TRANSCRIPTION PATHWAY:      Notch signaling was first identified in Drosophila, where it has been studied in detail at the genetic, molecular, biochemical and cellular levels (reviewed in Justice, 2002; Bray, 2006; Schweisguth, 2004; Louvri, 2006).  In Drosophila, Notch signaling to the nucleus is thought always to be mediated by one specific DNA binding transcription factor, Suppressor of Hairless.  In mammals, the homologous genes are called CBF1 (or RBPJkappa), while in worms they are called Lag-1, so that the acronym &quot;CSL&quot; has been given to this conserved transcription factor family.  There are at least two human CSL homologues, which are now named RBPJ and RBPJL.  CSL is an example of a bifunctional DNA-binding transcription factor that mediates repression of specific target genes in one context, but activation of the same targets in another context.  This bifunctionality is mediated by the association of specific Co-Repressor complexes vs. specific Co-Activator complexes in different contexts, namely in the absence or presence of Notch signaling.  In Drosophila, Su(H) represses target gene transcription in the absence of Notch signaling, but activates target genes during Notch signaling.  At least some of the mammalian CSL homologues are believed also to be bifunctional, and to mediate target gene repression in the absence of Notch signaling, and activation in the presence of Notch signaling.  Notch Co-Activator and Co-Repressor complexes: This repression is mediated by at least one specific co-repressor complexes (Co-R) bound to CSL in the absence of Notch signaling.  In Drosophila, this co-repressor complex consists of at least three distinct co-repressor proteins: Hairless, Groucho, and dCtBP (Drosophila C-terminal Binding Protein).  Hairless has been show to bind directly to Su(H), and Groucho and dCtBP have been shown to bind directly to Hairless (Barolo, 2002).  All three of the co-repressor proteins have been shown to be necessary for proper gene regulation during Notch signaling in vivo (Nagel, 2005).  In mammals, the same general pathway and mechanisms are observed, where CSL proteins are bifunctional DNA binding transcription factors (TFs), that bind to Co-Repressor complexes to mediate repression in the absence of Notch signaling, and bind to Co-Activator  complexes to mediate activation in the presence of Notch signaling.  However, in mammals, there may be multiple co-repressor complexes, rather than the single Hairless co-repressor complex that has been observed in Drosophila.    During Notch signaling in all systems, the Notch transmembrane receptor is cleaved and the Notch intracellular domain (NICD) translocates to the nucleus, where it there functions as a specific transcription co-activator for CSL proteins.  In the nucleus, NICD replaces the Co-R complex bound to CSL, thus resulting in de-repression of  Notch target genes in the nucleus.  Once bound to CSL, NICD and CSL proteins recruit an additional co-activator protein, Mastermind, to form a CSL-NICD-Mam ternary co-activator (Co-A) complex.  This Co-A complex was initially thought to be sufficient to mediate activation of  at least some Notch target genes.  However, there now is evidence that still other co-activators and additional DNA-binding transcription factors are required in at least some contexts (reviewed in Barolo, 2002).  Mammalian CSL Corepressor Complexes: In the absence of activated Notch signaling, DNA-bound CSL proteins recruit a corepressor complex to maintain target genes in the repressed state until Notch is specifically activated. The mammalian corepressor complexes include NCOR complexes, but may also include additional corepressor proteins, such as SHARP (reviewed in Mumm, 2000 and Kovall, 2007). The exact composition of the CSL NCOR complex is not known, but in other pathways the &quot;core&quot; NCOR corepressor complex includes at least one NCOR protein (NCOR1, NCOR2, CIR), one Histone Deacetylase protein (HDAC1, HDAC2, HDAC3, etc), and one TBL1 protein (TBL1X, TBL1XR1) (reviewed in Rosenfeld, 2006). In some contexts, the core NCOR corepressor complex may also recruit additional corepressor proteins or complexes, such as the SIN3 complex, which consists of SIN3 (SIN3A, SIN3B), and SAP30, or other SIN3-associated proteins. An additional CSL - NCOR binding corepressor, SHARP, may also contribute to the CSL corepressor complex in some contexts (Oswald, 2002). The CSL corepressor complex also includes a bifunctional cofactor, SKIP, that is present in both CSL corepressor complexes and CSL coactivator complexes, and may function in the binding of NICD and displacement of the corepressor complex during activated Notch signaling (Zhou, 2000).  Mammalian CSL Coactivator Complexes: Upon activation of Notch signaling, cleavage of the transmembrane Notch receptor releases the Notch Intracellular Domain (NICD), which translocates to the nucleus, where it binds to CSL and displaces the corepressor complex from CSL (reviewed in Mumm, 2000 and Kovall, 2007). The resulting CSL-NICD &quot;binary complex&quot; then recruits an additional coactivator, Mastermind (Mam), to form a ternary complex. The ternary complex then recruits additional, more general coactivators, such as CREB Binding Protein (CBP), or the related p300 coactivator, and a number of Histone Acetytransferase (HAT) proteins, including GCN5 and PCAF (Fryer, 2002). There is evidence that Mam also can subsequently recruit specific kinases that phosphorylate NICD, to downregulate its function and turn off Notch signaling (Fryer, 2004).  Combinatorial Complexity in Transcription Cofactor Complexes: HDAC9 has at least 7 splice isoforms, with some having distinct interaction and functional properties. Isoforms 6 and 7 interact with NCOR1. Isoforms 1 and 4 interact with MEF2 (Sparrow, 1999), which is a specific DNA-binding cofactor for a subset of HLH proteins. Isoform 3 interacts with both NCOR1 and MEF2. Although many HDACs only have one or two isoforms, this complexity for HDAC9 illustrates the level of transcript complexity and functional specificity that such &quot;general&quot; transcriptional cofactors can have.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway13">
 <bp:pathwayOrder rdf:resource="#PathwayStep73" />
 <bp:pathwayOrder rdf:resource="#PathwayStep95" />
 <bp:pathwayOrder rdf:resource="#PathwayStep74" />
 <bp:pathwayOrder rdf:resource="#PathwayStep96" />
 <bp:pathwayOrder rdf:resource="#PathwayStep71" />
 <bp:pathwayOrder rdf:resource="#PathwayStep93" />
 <bp:pathwayOrder rdf:resource="#PathwayStep72" />
 <bp:pathwayOrder rdf:resource="#PathwayStep94" />
 <bp:pathwayOrder rdf:resource="#PathwayStep91" />
 <bp:pathwayOrder rdf:resource="#PathwayStep70" />
 <bp:pathwayOrder rdf:resource="#PathwayStep92" />
 <bp:pathwayOrder rdf:resource="#PathwayStep90" />
 <bp:pathwayOrder rdf:resource="#PathwayStep79" />
 <bp:pathwayOrder rdf:resource="#PathwayStep77" />
 <bp:pathwayOrder rdf:resource="#PathwayStep78" />
 <bp:pathwayOrder rdf:resource="#PathwayStep75" />
 <bp:pathwayOrder rdf:resource="#PathwayStep76" />
 <bp:pathwayOrder rdf:resource="#PathwayStep84" />
 <bp:pathwayOrder rdf:resource="#PathwayStep85" />
 <bp:pathwayOrder rdf:resource="#PathwayStep82" />
 <bp:pathwayOrder rdf:resource="#PathwayStep83" />
 <bp:pathwayOrder rdf:resource="#PathwayStep80" />
 <bp:pathwayOrder rdf:resource="#PathwayStep81" />
 <bp:pathwayOrder rdf:resource="#PathwayStep88" />
 <bp:pathwayOrder rdf:resource="#PathwayStep89" />
 <bp:pathwayOrder rdf:resource="#PathwayStep86" />
 <bp:pathwayOrder rdf:resource="#PathwayStep87" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction59" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction58" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction79" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction78" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction80" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction62" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction84" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction61" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction83" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction60" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction82" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction81" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction66" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction65" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction64" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction63" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction69" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction68" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction67" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction73" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction72" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction71" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction70" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction77" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction76" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction75" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction74" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence70" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Downregulation of SMAD2/3:SMAD4 transcriptional activity</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcriptional activity of SMAD2/3:SMAD4 heterotrimer can be inhibited by formation of a complex with SKI or SKIL (SNO), where SKI or SKIL recruit NCOR and possibly other transcriptional repressors to SMAD-binding promoter elements (Sun et al. 1999, Luo et al. 1999, Strochein et al. 1999). Higher levels of phosphorylated SMAD2 and SMAD3, however, may target SKI and SKIL for degradation (Strochein et al. 1999, Sun et al. 1999 PNAS, Bonni et al. 2001) through recruitment of SMURF2 (Bonni et al. 2001) or RNF111 i.e. Arkadia (Levy et al. 2007) ubiquitin ligases to SKI/SKIL by SMAD2/3. Therefore,the ratio of SMAD2/3 and SKI/SKIL determines the outcome: inhibition of SMAD2/3:SMAD4-mediated transcription or degradation of SKI/SKIL. SKI and SKIL are overexpressed in various cancer types and their oncogenic effect is connected with their ability to inhibit signaling by TGF-beta receptor complex.  SMAD4 can be monoubiquitinated by a nuclear ubiquitin ligase TRIM33 (Ecto, Ectodermin, Tif1-gamma). Monoubiquitination of SMAD4 disrupts SMAD2/3:SMAD4 heterotrimers and leads to SMAD4 translocation to the cytosol. In the cytosol, SMAD4 can be deubiquitinated by USP9X (FAM), reversing TRIM33-mediated negative regulation (Dupont et al. 2009). Phosphorylation of the linker region of SMAD2 and SMAD3 by CDK8 or CDK9 primes SMAD2/3:SMAD4 complex for ubiquitination by NEDD4L and SMURF ubiquitin ligases. NEDD4L ubiquitinates SMAD2/3 and targets SMAD2/3:SMAD4 heterotrimer for degradation (Gao et al. 2009). SMURF2 monoubiquitinates SMAD2/3, leading to disruption of SMAD2/3:SMAD4 complexes (Tang et al. 2011).  Transcriptional repressors TGIF1 and TGIF2 bind SMAD2/3:SMAD4 complexes and inhibit SMAD-mediated transcription by recruitment of histone deacetylase HDAC1 to SMAD-binding promoter elements (Wotton et al. 1999, Melhuish et al. 2001). PARP1 can attach poly ADP-ribosyl chains to SMAD3 and SMAD4 within SMAD2/3:SMAD4 heterotrimers. PARylated SMAD2/3:SMAD4 complexes are unable to bind SMAD-binding DNA elements (SBEs) (Lonn et al. 2010).  Phosphorylated SMAD2 and SMAD3 can be dephosphorylated by PPM1A protein phosphatase, leading to dissociation of SMAD2/3 complexes and translocation of unphosphorylated SMAD2/3 to the cytosol (Lin et al. 2006). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway16">
 <bp:pathwayOrder rdf:resource="#PathwayStep105" />
 <bp:pathwayOrder rdf:resource="#PathwayStep106" />
 <bp:pathwayOrder rdf:resource="#PathwayStep107" />
 <bp:pathwayOrder rdf:resource="#PathwayStep108" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction91" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction90" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction93" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction92" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence105" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2 (AP-2) family regulates transcription of cell cycle factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2A and TFAP2C play opposing roles in transcriptional regulation of the CDKN1A (p21) gene locus. While TFAP2A stimulates transcription of the CDKN1A cyclin-dependent kinase inhibitor (Zeng et al. 1997, Williams et al. 2009, Scibetta et al. 2010), TFAP2C, in cooperation with MYC and histone demethylase KDM5B, represses CDKN1A transcription (Williams et al. 2009, Scibetta et al. 2010, Wong et al. 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway15">
 <bp:pathwayOrder rdf:resource="#PathwayStep128" />
 <bp:pathwayOrder rdf:resource="#PathwayStep129" />
 <bp:pathwayOrder rdf:resource="#PathwayStep134" />
 <bp:pathwayOrder rdf:resource="#PathwayStep145" />
 <bp:pathwayOrder rdf:resource="#PathwayStep102" />
 <bp:pathwayOrder rdf:resource="#PathwayStep103" />
 <bp:pathwayOrder rdf:resource="#PathwayStep104" />
 <bp:pathwayOrder rdf:resource="#PathwayStep137" />
 <bp:pathwayOrder rdf:resource="#PathwayStep109" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction89" />
 <bp:pathwayComponent rdf:resource="#Pathway21" />
 <bp:pathwayComponent rdf:resource="#Pathway20" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction112" />
 <bp:pathwayComponent rdf:resource="#Pathway16" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction88" />
 <bp:pathwayComponent rdf:resource="#Pathway18" />
 <bp:pathwayComponent rdf:resource="#Pathway17" />
 <bp:pathwayComponent rdf:resource="#Pathway19" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence102" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The AP-2 (TFAP2) family of transcription factors includes five proteins in mammals: TFAP2A (AP-2 alpha), TFAP2B (AP-2 beta), TFAP2C (AP-2 gamma), TFAP2D (AP-2 delta) and TFAP2E (AP-2 epsilon). The AP-2 family transcription factors are evolutionarily conserved in metazoans and are characterized by a helix-span-helix motif at the C-terminus, a central basic region, and the transactivation domain at the N-terminus. The helix-span-helix motif and the basic region enable dimerization and DNA binding (Eckert et al. 2005). AP-2 dimers bind palindromic GC-rich DNA response elements that match the consensus sequence 5&apos;-GCCNNNGGC-3&apos; (Williams and Tjian 1991a, Williams and Tjian 1991b). Transcriptional co-factors from the CITED family interact with the helix-span-helix (HSH) domain of TFAP2 (AP-2) family of transcription factors and recruit transcription co-activators EP300 (p300) and CREBBP (CBP) to TFAP2-bound DNA elements. CITED2 shows the highest affinity for TFAP2 proteins, followed by CITED4, while CITED1 interacts with TFAP2s with a very low affinity. Mouse embryos defective for CITED2 exhibit neural crest defects, cardiac malformations and adrenal agenesis, which can at least in part be attributed to a defective Tfap2 transactivation (Bamforth et al. 2001, Braganca et al. 2002, Braganca et al. 2003). Transcriptional activity of AP-2 dimers in inhibited by binding of KCTD1 or KCTD15 to the AP-2 transactivation domain (Ding et al. 2009, Zarelli and Dawid 2013). Transcriptional activity of TFAP2A, TFAP2B and TFAP2C is negatively regulated by SUMOylation mediated by UBE2I (UBC9) (Eloranta and Hurst 2002, Berlato et al. 2011, Impens et al. 2014, Bogachek et al. 2014). During embryonic development, AP-2 transcription factors stimulate proliferation and suppress terminal differentiation in a cell-type specific manner (Eckert et al. 2005). TFAP2A and TFAP2C directly stimulate transcription of the estrogen receptor ESR1 gene (McPherson and Weigel 1999). TFAP2A expression correlates with ESR1 expression in breast cancer, and TFAP2C is frequently overexpressed in estrogen-positive breast cancer and endometrial cancer (deConinck et al. 1995, Turner et al. 1998). TFAP2A, TFAP2C, as well as TFAP2B can directly stimulate the expression of ERBB2, another important breast cancer gene (Bosher et al. 1996). Association of TFAP2A with the YY1 transcription factor significantly increases the ERBB2 transcription rate (Begon et al. 2005). In addition to ERBB2, the expression of another receptor tyrosine kinase, KIT, is also stimulated by TFAP2A and TFAP2B (Huang et al. 1998), while the expression of the VEGF receptor tyrosine kinase ligand VEGFA is repressed by TFAP2A (Ruiz et al. 2004, Li et al. 2012). TFAP2A stimulates transcription of the transforming growth factor alpha (TGFA) gene (Wang et al. 1997). TFAP2C regulates EGFR in luminal breast cancer (De Andrade et al. 2016). TFAP2C plays a critical role in maintaining the luminal phenotype in human breast cancer and in influencing the luminal cell phenotype during normal mammary development (Cyr et al. 2015). In placenta, TFAP2A and TFAP2C directly stimulate transcription of both subunits of the human chorionic gonadotropin, CGA and CGB (Johnson et al. 1997, LiCalsi et al. 2000). TFAP2A and/or TFAP2C, in complex with CITED2, stimulate transcription of the PITX2 gene, involved in left-right patterning and heart development (Bamforth et al. 2004, Li et al. 2012). TFAP2A and TFAP2C play opposing roles in transcriptional regulation of the CDKN1A (p21) gene locus. While TFAP2A stimulates transcription of the CDKN1A cyclin-dependent kinase inhibitor (Zeng et al. 1997, Williams et al. 2009, Scibetta et al. 2010), TFAP2C represses CDKN1A transcription (Williams et al. 2009, Scibetta et al. 2010, Wong et al. 2012). Transcription of the TFAP2A gene may be inhibited by CREB and E2F1 (Melnikova et al. 2010). For review of the AP-2 family of transcription factors, please refer to Eckert et al. 2005.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway18">
 <bp:pathwayOrder rdf:resource="#PathwayStep130" />
 <bp:pathwayOrder rdf:resource="#PathwayStep131" />
 <bp:pathwayOrder rdf:resource="#PathwayStep132" />
 <bp:pathwayOrder rdf:resource="#PathwayStep133" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction114" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction113" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction116" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction115" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence130" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the TFAP2 (AP-2) family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The helix-span-helix motif and the basic region of TFAP2 (AP-2) transcription factor family members TFAP2A, TFAP2B, TFAP2C, TFAP2D and TFAP2E enable dimerization and DNA binding. AP-2 dimers bind palindromic GC-rich DNA response elements that match the consensus sequence 5&apos;-GCCNNNGGC-3&apos; (Williams and Tjian 1991a, Williams and Tjian 1991b). Most of the AP-2 binding sites slightly differ from the consensus, and individual AP-2 family members may differ in their binding site preferences (McPherson and Weigel 1999, Orso et al. 2010). Transcriptional co-factors from the CITED family interact with the helix-span-helix (HSH) domain of TFAP2 (AP-2) family of transcription factors and recruit transcription co-activators EP300 (p300) and CREBBP (CBP) to TFAP2-bound DNA elements. CITED2 shows the highest affinity for TFAP2 proteins, followed by CITED4, while CITED1 interacts with TFAP2s with a very low affinity. Mouse embryos defective for CITED2 exhibit neural crest defects, cardiac malformations and adrenal agenesis, which can at least in part be attributed to a defective Tfap2 transactivation (Bamforth et al. 2001, Braganca et al. 2002, Braganca et al. 2003). DNA binding and transcriptional activity of TFAP2B homodimers is increased by binding to YEATS4 (GAS41) (Ding et al. 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway17">
 <bp:pathwayOrder rdf:resource="#PathwayStep120" />
 <bp:pathwayOrder rdf:resource="#PathwayStep110" />
 <bp:pathwayOrder rdf:resource="#PathwayStep121" />
 <bp:pathwayOrder rdf:resource="#PathwayStep111" />
 <bp:pathwayOrder rdf:resource="#PathwayStep122" />
 <bp:pathwayOrder rdf:resource="#PathwayStep116" />
 <bp:pathwayOrder rdf:resource="#PathwayStep127" />
 <bp:pathwayOrder rdf:resource="#PathwayStep117" />
 <bp:pathwayOrder rdf:resource="#PathwayStep118" />
 <bp:pathwayOrder rdf:resource="#PathwayStep119" />
 <bp:pathwayOrder rdf:resource="#PathwayStep112" />
 <bp:pathwayOrder rdf:resource="#PathwayStep123" />
 <bp:pathwayOrder rdf:resource="#PathwayStep113" />
 <bp:pathwayOrder rdf:resource="#PathwayStep124" />
 <bp:pathwayOrder rdf:resource="#PathwayStep114" />
 <bp:pathwayOrder rdf:resource="#PathwayStep125" />
 <bp:pathwayOrder rdf:resource="#PathwayStep115" />
 <bp:pathwayOrder rdf:resource="#PathwayStep126" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction103" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction102" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction105" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction104" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction110" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction101" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction100" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction111" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction95" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction94" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction99" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction107" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction98" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction106" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction97" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction109" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction96" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction108" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence110" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2 (AP-2) family regulates transcription of growth factors and their receptors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2A and TFAP2C directly stimulate transcription of the estrogen receptor ESR1 gene (McPherson and Weigel 1999). TFAP2A expression correlates with ESR1 expression in breast cancer, and TFAP2C is frequently overexpressed in estrogen-positive breast cancer and endometrial cancer (deConinck et al. 1995, Turner et al. 1998). TFAP2A, TFAP2C, as well as TFAP2B can directly stimulate the expression of ERBB2, another important breast cancer gene (Bosher et al. 1996). Association of TFAP2A with the YY1 transcription factor significantly increases the ERBB2 transcription rate (Begon et al. 2005). In addition to ERBB2, the expression of another receptor tyrosine kinase, KIT, is also stimulated by TFAP2A and TFAP2B (Huang et al. 1998), while the expression of the VEGF receptor tyrosine kinase ligand VEGFA is repressed by TFAP2A (Ruiz et al. 2004, Li et al. 2012). TFAP2A stimulates transcription of the transforming growth factor alpha (TGFA) gene (Wang et al. 1997). TFAP2C regulates EGFR expression in luminal breast cancer (De Andrade et al. 2016). In placenta, TFAP2A and TFAP2C directly stimulate transcription of both subunits of the human chorionic gonadotropin, CGA and CGB (Johnson et al. 1997, LiCalsi et al. 2000).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway19">
 <bp:pathwayOrder rdf:resource="#PathwayStep135" />
 <bp:pathwayOrder rdf:resource="#PathwayStep136" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction118" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction117" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence135" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2 (AP-2) family regulates transcription of other transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Homodimers and possibly heterodimers of TFAP2A and TFAP2C, in complex with CITED2, stimulate transcription of the PITX2 gene, involved in left-right patterning and heart development (Bamforth et al. 2004, Li et al. 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway21">
 <bp:pathwayOrder rdf:resource="#PathwayStep149" />
 <bp:pathwayOrder rdf:resource="#PathwayStep146" />
 <bp:pathwayOrder rdf:resource="#PathwayStep147" />
 <bp:pathwayOrder rdf:resource="#PathwayStep148" />
 <bp:pathwayOrder rdf:resource="#PathwayStep150" />
 <bp:pathwayOrder rdf:resource="#PathwayStep151" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction127" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction126" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction131" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction130" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction129" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction128" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence146" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Negative regulation of activity of TFAP2 (AP-2) family transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcriptional activity of TFAP2 (AP-2) transcription factor family homo- and heterodimers in inhibited by binding of KCTD1 or KCTD15 to the AP-2 transactivation domain (Ding et al. 2009, Zarelli and Dawid 2013). Transcriptional activity of TFAP2A, TFAP2B and TFAP2C is also negatively regulated by SUMOylation mediated by UBE2I (UBC9) (Eloranta and Hurst 2002, Berlato et al. 2011, Impens et al. 2014, Bogachek et al. 2014). Binding of the tumor suppressor WWOX to TFAP2C inhibits TFAP2C translocation to the nucleus (Aqeilan et al. 2004). Transcription of the TFAP2A gene may be inhibited by CREB and E2F1 (Melnikova et al. 2010).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway20">
 <bp:pathwayOrder rdf:resource="#PathwayStep138" />
 <bp:pathwayOrder rdf:resource="#PathwayStep139" />
 <bp:pathwayOrder rdf:resource="#PathwayStep141" />
 <bp:pathwayOrder rdf:resource="#PathwayStep142" />
 <bp:pathwayOrder rdf:resource="#PathwayStep143" />
 <bp:pathwayOrder rdf:resource="#PathwayStep144" />
 <bp:pathwayOrder rdf:resource="#PathwayStep140" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction125" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction124" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction121" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction120" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction123" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction122" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction119" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence138" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">During retinoic acid-induced cell differentiation, TFAP2A, in complex with NPM1 (nucleophosmin), represses transcription of HSPD1 (Hsp60), NOP2 (p120) and MYBL2 (b-Myb). The repression of gene expression probably involves the recruitment of histone deacetylases HDAC1 and HDCA2 to target promoters by NPM1. The complex of TFAP2A and NPM1 can also be detected at the NPM1 promoter, which is in agreement with decreased NPM1 expression after retinoic acid treatment. The level of TFAP2A increases in response to the retinoic acid treatment (Liu et al. 2007). NOP2 and MYBL2 are both proliferation markers (Valdez et al. 1992, Saville and Watson 1998).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway23">
 <bp:pathwayOrder rdf:resource="#PathwayStep163" />
 <bp:pathwayOrder rdf:resource="#PathwayStep164" />
 <bp:pathwayOrder rdf:resource="#PathwayStep154" />
 <bp:pathwayOrder rdf:resource="#PathwayStep165" />
 <bp:pathwayOrder rdf:resource="#PathwayStep155" />
 <bp:pathwayOrder rdf:resource="#PathwayStep166" />
 <bp:pathwayOrder rdf:resource="#PathwayStep170" />
 <bp:pathwayOrder rdf:resource="#PathwayStep160" />
 <bp:pathwayOrder rdf:resource="#PathwayStep161" />
 <bp:pathwayOrder rdf:resource="#PathwayStep162" />
 <bp:pathwayOrder rdf:resource="#PathwayStep156" />
 <bp:pathwayOrder rdf:resource="#PathwayStep167" />
 <bp:pathwayOrder rdf:resource="#PathwayStep157" />
 <bp:pathwayOrder rdf:resource="#PathwayStep168" />
 <bp:pathwayOrder rdf:resource="#PathwayStep158" />
 <bp:pathwayOrder rdf:resource="#PathwayStep169" />
 <bp:pathwayOrder rdf:resource="#PathwayStep159" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction141" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction140" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction136" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction147" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction135" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction146" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction138" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction137" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction148" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction132" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction143" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction142" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction134" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction145" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction133" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction144" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction139" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence154" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 Regulates Transcription of DNA Repair Genes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Several DNA repair genes contain p53 response elements and their transcription is positively regulated by TP53 (p53). TP53-mediated regulation probably ensures increased protein level of DNA repair genes under genotoxic stress. TP53 directly stimulates transcription of several genes involved in DNA mismatch repair, including MSH2 (Scherer et al. 2000, Warnick et al. 2001), PMS2 and MLH1 (Chen and Sadowski 2005). TP53 also directly stimulates transcription of DDB2, involved in nucleotide excision repair (Tan and Chu 2002), and FANCC, involved in the Fanconi anemia pathway that repairs DNA interstrand crosslinks (Liebetrau et al. 1997). Other p53 targets that can influence DNA repair functions are RRM2B (Kuo et al. 2012), XPC (Fitch et al. 2003), GADD45A (Amundson et al. 2002), CDKN1A (Cazzalini et al. 2010) and PCNA (Xu and Morris 1999). Interestingly, the responsiveness of some of these DNA repair genes to p53 activation has been shown in human cells but not for orthologous mouse genes (Jegga et al. 2008, Tan and Chu 2002). Contrary to the positive modulation of nucleotide excision repair (NER) and mismatch repair (MMR), p53 can negatively modulate base excision repair (BER), by down-regulating the endonuclease APEX1 (APE1), acting in concert with SP1 (Poletto et al. 2016). Expression of several DNA repair genes is under indirect TP53 control, through TP53-mediated stimulation of cyclin K (CCNK) expression (Mori et al. 2002). CCNK is the activating cyclin for CDK12 and CDK13 (Blazek et al. 2013). The complex of CCNK and CDK12 binds and phosphorylates the C-terminal domain of the RNA polymerase II subunit POLR2A, which is necessary for efficient transcription of long DNA repair genes, including BRCA1, ATR, FANCD2, FANCI, ATM, MDC1, CHEK1 and RAD51D. Genes whose transcription is regulated by the complex of CCNK and CDK12 are mainly involved in the repair of DNA double strand breaks and/or the Fanconi anemia pathway (Blazek et al. 2011, Cheng et al. 2012, Bosken et al. 2014, Bartkowiak and Greenleaf 2015, Ekumi et al. 2015).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway22">
 <bp:pathwayOrder rdf:resource="#PathwayStep277" />
 <bp:pathwayOrder rdf:resource="#PathwayStep323" />
 <bp:pathwayOrder rdf:resource="#PathwayStep153" />
 <bp:pathwayOrder rdf:resource="#PathwayStep396" />
 <bp:pathwayOrder rdf:resource="#PathwayStep171" />
 <bp:pathwayComponent rdf:resource="#Pathway42" />
 <bp:pathwayComponent rdf:resource="#Pathway23" />
 <bp:pathwayComponent rdf:resource="#Pathway33" />
 <bp:pathwayComponent rdf:resource="#Pathway24" />
 <bp:pathwayComponent rdf:resource="#Pathway37" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence153" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcriptional Regulation by TP53</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The tumor suppressor TP53 (encoded by the gene p53) is a transcription factor. Under stress conditions, it recognizes specific responsive DNA elements and thus regulates the transcription of many genes involved in a variety of cellular processes, such as cellular metabolism, survival, senescence, apoptosis and DNA damage response. Because of its critical function, p53 is frequently mutated in around 50% of all malignant tumors. For a recent review, please refer to Vousden and Prives 2009 and Kruiswijk et al. 2015.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway25">
 <bp:pathwayOrder rdf:resource="#PathwayStep180" />
 <bp:pathwayOrder rdf:resource="#PathwayStep178" />
 <bp:pathwayOrder rdf:resource="#PathwayStep179" />
 <bp:pathwayOrder rdf:resource="#PathwayStep174" />
 <bp:pathwayOrder rdf:resource="#PathwayStep175" />
 <bp:pathwayOrder rdf:resource="#PathwayStep176" />
 <bp:pathwayOrder rdf:resource="#PathwayStep177" />
 <bp:pathwayOrder rdf:resource="#PathwayStep181" />
 <bp:pathwayOrder rdf:resource="#PathwayStep182" />
 <bp:pathwayOrder rdf:resource="#PathwayStep183" />
 <bp:pathwayOrder rdf:resource="#PathwayStep173" />
 <bp:pathwayOrder rdf:resource="#PathwayStep184" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction158" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction157" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction149" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction159" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction154" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction153" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction156" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction155" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction150" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction160" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction152" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction151" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence173" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of TP53 Activity through Methylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 (p53) undergoes methylation on several lysine and arginine residues, which modulates its transcriptional activity. PRMT5, recruited to TP53 as part of the ATM-activated complex that includes TTC5, JMY and EP300 (p300), methylates TP53 arginine residues R333, R335 and R337. PRMT5-mediated methylation promotes TP53-stimulated expression of cell cycle arrest genes (Shikama et al. 1999, Demonacos et al. 2001, Demonacos et al. 2004, Adams et al. 2008, Adams et al. 2012). SETD9 (SET9) methylates TP53 at lysine residue K372, resulting in increased stability and activity of TP53 (Chuikov et al. 2004, Couture et al. 2006, Bai et al. 2011). TP53 transcriptional activity is repressed by SMYD2-mediated methylation of TP53 at lysine residue K370 (Huang et al. 2006). Dimethylation of TP53 at lysine residue K373 by the complex of methyltransferases EHMT1 and EHMT2 also represses TP53-mediated transcription (Huang et al. 2010). The chromatin compaction factor L3MBTL1 binds TP53 monomethylated at lysine K382 by SETD8 (SET8) and, probably through changing local chromatin architecture, represses transcription of TP53 targets (West et al. 2010). The histone lysine-specific demethylase LSD1 interacts with TP53 and represses p53-mediated transcriptional activation (Huang et al. 2007). PRMT1 and CARM1 can also modulate p53 functions in a cooperative manner (An et al. 2004). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction705">
 <bp:evidence rdf:resource="#Evidence782" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSTN gene expression is stimulated by FOXO1 and p-2S-SMAD2/3:SMAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway24">
 <bp:pathwayOrder rdf:resource="#PathwayStep266" />
 <bp:pathwayOrder rdf:resource="#PathwayStep223" />
 <bp:pathwayOrder rdf:resource="#PathwayStep185" />
 <bp:pathwayOrder rdf:resource="#PathwayStep172" />
 <bp:pathwayOrder rdf:resource="#PathwayStep250" />
 <bp:pathwayComponent rdf:resource="#Pathway30" />
 <bp:pathwayComponent rdf:resource="#Pathway32" />
 <bp:pathwayComponent rdf:resource="#Pathway25" />
 <bp:pathwayComponent rdf:resource="#Pathway26" />
 <bp:pathwayComponent rdf:resource="#Pathway29" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence172" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of TP53 Activity</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Protein stability and transcriptional activity of TP53 (p53) tumor suppressor are regulated by post-translational modifications that include ubiquitination, phosphorylation, acetylation, methylation, sumoylation and prolyl-isomerization (Kruse and Gu 2009, Meek and Anderson 2009, Santiago et al. 2013, Mantovani et al. 2015). In addition to post-translational modifications, the activity of TP53 is also regulated by binding of transcription co-factors. In unstressed cells, TP53 protein levels are low due to MDM2-mediated ubiquitination of TP53, which triggers proteasome-mediated degradation. In response to stress, TP53 undergoes stabilizing phosphorylation, mainly at serine residues S15 and S20. Several different kinases can phosphorylate TP53 at these sites, but the main S15 kinases are considered to be ATM and ATR, while the main S20 kinases are considered to be CHEK2 and CHEK1. Additional phosphorylation of TP53 at serine residue S46 promotes transcription of pro-apoptotic, rather than cell cycle arrest genes. Acetylation mainly has a positive impact on transcriptional activity of TP53, while methylation can both positively and negatively regulate TP53. Some posttranslational modifications regulate interaction of TP53 with transcriptional co-factors, some of which are themselves transcriptional targets of TP53. For review of the complex network of TP53 regulation, please refer to Kruse and Gu 2009, and Meek and Anderson 2009. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction704">
 <bp:evidence rdf:resource="#Evidence781" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1,FOXO3 binds CAV1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway27">
 <bp:pathwayOrder rdf:resource="#PathwayStep190" />
 <bp:pathwayOrder rdf:resource="#PathwayStep191" />
 <bp:pathwayOrder rdf:resource="#PathwayStep196" />
 <bp:pathwayOrder rdf:resource="#PathwayStep197" />
 <bp:pathwayOrder rdf:resource="#PathwayStep198" />
 <bp:pathwayOrder rdf:resource="#PathwayStep199" />
 <bp:pathwayOrder rdf:resource="#PathwayStep210" />
 <bp:pathwayOrder rdf:resource="#PathwayStep192" />
 <bp:pathwayOrder rdf:resource="#PathwayStep193" />
 <bp:pathwayOrder rdf:resource="#PathwayStep194" />
 <bp:pathwayOrder rdf:resource="#PathwayStep195" />
 <bp:pathwayOrder rdf:resource="#PathwayStep204" />
 <bp:pathwayOrder rdf:resource="#PathwayStep205" />
 <bp:pathwayOrder rdf:resource="#PathwayStep206" />
 <bp:pathwayOrder rdf:resource="#PathwayStep207" />
 <bp:pathwayOrder rdf:resource="#PathwayStep189" />
 <bp:pathwayOrder rdf:resource="#PathwayStep200" />
 <bp:pathwayOrder rdf:resource="#PathwayStep201" />
 <bp:pathwayOrder rdf:resource="#PathwayStep202" />
 <bp:pathwayOrder rdf:resource="#PathwayStep203" />
 <bp:pathwayOrder rdf:resource="#PathwayStep208" />
 <bp:pathwayOrder rdf:resource="#PathwayStep209" />
 <bp:pathwayOrder rdf:resource="#PathwayStep187" />
 <bp:pathwayOrder rdf:resource="#PathwayStep188" />
 <bp:pathwayOrder rdf:resource="#PathwayStep215" />
 <bp:pathwayOrder rdf:resource="#PathwayStep216" />
 <bp:pathwayOrder rdf:resource="#PathwayStep211" />
 <bp:pathwayOrder rdf:resource="#PathwayStep212" />
 <bp:pathwayOrder rdf:resource="#PathwayStep213" />
 <bp:pathwayOrder rdf:resource="#PathwayStep214" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction161" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction183" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction182" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction163" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction185" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction162" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction184" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction181" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction180" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction169" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction168" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction165" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction187" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction164" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction186" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction167" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction189" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction166" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction188" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction172" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction171" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction174" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction173" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction190" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction170" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction179" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction176" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction175" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction178" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction177" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence187" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of TP53 Degradation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In unstressed cells, TP53 (p53) has a short half-life as it undergoes rapid ubiquitination and proteasome-mediated degradation. The E3 ubiquitin ligase MDM2, which is a transcriptional target of TP53, plays the main role in TP53 protein down-regulation (Wu et al. 1993). MDM2 forms homodimers and homo-oligomers, but also functions as a heterodimer/hetero-oligomer with MDM4 (MDMX) (Sharp et al. 1999, Cheng et al. 2011, Huang et al. 2011, Pant et al. 2011). The heterodimers of MDM2 and MDM4 may be especially important for downregulation of TP53 during embryonic development (Pant et al. 2011). The nuclear localization of MDM2 is positively regulated by AKT- or SGK1- mediated phosphorylation (Mayo and Donner 2001, Zhou et al. 2001, Amato et al. 2009, Lyo et al. 2010). Phosphorylation of MDM2 by CDK1 or CDK2 decreases affinity of MDM2 for TP53 (Zhang and Prives 2001). ATM and CHEK2 kinases, activated by double strand DNA breaks, phosphorylate TP53, reducing its affinity for MDM2 (Banin et al. 1998, Canman et al. 1998, Khanna et al. 1998, Chehab et al. 1999, Chehab et al. 2000). At the same time, ATM phosphorylates MDM2, preventing MDM2 dimerization (Cheng et al. 2009, Cheng et al. 2011). Both ATM and CHEK2 phosphorylate MDM4, triggering MDM2-mediated ubiquitination of MDM4 (Chen et al. 2005, Pereg et al. 2005). Cyclin G1 (CCNG1), transcriptionally induced by TP53, targets the PP2A phosphatase complex to MDM2, resulting in dephosphorylation of MDM2 at specific sites, which can have either a positive or a negative impact on MDM2 function (Okamoto et al. 2002). In contrast to MDM2, E3 ubiquitin ligases RNF34 (CARP1) and RFFL (CARP2) can ubiquitinate phosphorylated TP53 (Yang et al. 2007). In addition to ubiquitinating MDM4 (Pereg et al. 2005), MDM2 can also undergo auto-ubiquitination (Fang et al. 2000). MDM2 and MDM4 can be deubiquitinated by the ubiquitin protease USP2 (Stevenson et al. 2007, Allende-Vega et al. 2010). The ubiquitin protease USP7 can deubiquitinate TP53, but in the presence of DAXX deubiquitinates MDM2 (Li et al. 2002, Sheng et al. 2006, Tang et al. 2006). The tumor suppressor p14-ARF, expressed from the CDKN2A gene in response to oncogenic or oxidative stress, forms a tripartite complex with MDM2 and TP53, sequesters MDM2 from TP53, and thus prevents TP53 degradation (Zhang et al. 1998, Parisi et al. 2002, Voncken et al. 2005). For review of this topic, please refer to Kruse and Gu 2009. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction707">
 <bp:evidence rdf:resource="#Evidence784" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1,FOXO3,FOXO4 binds RBL2 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway26">
 <bp:pathwayOrder rdf:resource="#PathwayStep217" />
 <bp:pathwayOrder rdf:resource="#PathwayStep186" />
 <bp:pathwayComponent rdf:resource="#Pathway27" />
 <bp:pathwayComponent rdf:resource="#Pathway28" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence186" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of TP53 Expression and Degradation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 (p53) tumor suppressor protein is a transcription factor that functions as a homotetramer (Jeffrey et al. 1995). The protein levels of TP53 are low in unstressed cells due to MDM2-mediated ubiquitination that triggers proteasome-mediated degradation of TP53 (Wu et al. 1993). The E3 ubiquitin ligase MDM2 functions as a homodimer/homo-oligomer or a heterodimer/hetero-oligomer with MDM4 (MDMX) (Linares et al. 2003, Toledo and Wahl 2007, Cheng et al. 2011, Wade et al. 2013). Activating phosphorylation of TP53 at serine residues S15 and S20 in response to genotoxic stress disrupts TP53 interaction with MDM2. In contrast to MDM2, E3 ubiquitin ligases RNF34 (CARP1) and RFFL (CARP2) can ubiquitinate phosphorylated TP53 (Yang et al. 2007). Binding of MDM2 to TP53 is also inhibited by the tumor suppressor p14-ARF, transcribed from the CDKN2A gene in response to oncogenic signaling or oxidative stress (Zhang et al. 1998, Parisi et al. 2002, Voncken et al. 2005). Ubiquitin-dependant degradation of TP53 can also be promoted by PIRH2 (Leng et al. 2003) and COP1 (Dornan et al. 2004) ubiquitin ligases. HAUSP (USP7) can deubiquitinate TP53, contributing to TP53 stabilization (Li et al. 2002). While post-translational regulation plays a prominent role, TP53 activity is also controlled at the level of promoter function (reviewed in Saldana-Meyer and Recillas-Targa 2011), mRNA stability and translation efficiency (Mahmoudi et al. 2009, Le et al. 2009, Takagi et al. 2005).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction706">
 <bp:evidence rdf:resource="#Evidence783" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO:SMAD complex binds CDKN1A gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway29">
 <bp:pathwayOrder rdf:resource="#PathwayStep230" />
 <bp:pathwayOrder rdf:resource="#PathwayStep231" />
 <bp:pathwayOrder rdf:resource="#PathwayStep232" />
 <bp:pathwayOrder rdf:resource="#PathwayStep226" />
 <bp:pathwayOrder rdf:resource="#PathwayStep248" />
 <bp:pathwayOrder rdf:resource="#PathwayStep227" />
 <bp:pathwayOrder rdf:resource="#PathwayStep249" />
 <bp:pathwayOrder rdf:resource="#PathwayStep228" />
 <bp:pathwayOrder rdf:resource="#PathwayStep229" />
 <bp:pathwayOrder rdf:resource="#PathwayStep244" />
 <bp:pathwayOrder rdf:resource="#PathwayStep245" />
 <bp:pathwayOrder rdf:resource="#PathwayStep224" />
 <bp:pathwayOrder rdf:resource="#PathwayStep246" />
 <bp:pathwayOrder rdf:resource="#PathwayStep225" />
 <bp:pathwayOrder rdf:resource="#PathwayStep247" />
 <bp:pathwayOrder rdf:resource="#PathwayStep240" />
 <bp:pathwayOrder rdf:resource="#PathwayStep241" />
 <bp:pathwayOrder rdf:resource="#PathwayStep242" />
 <bp:pathwayOrder rdf:resource="#PathwayStep243" />
 <bp:pathwayOrder rdf:resource="#PathwayStep237" />
 <bp:pathwayOrder rdf:resource="#PathwayStep238" />
 <bp:pathwayOrder rdf:resource="#PathwayStep239" />
 <bp:pathwayOrder rdf:resource="#PathwayStep233" />
 <bp:pathwayOrder rdf:resource="#PathwayStep234" />
 <bp:pathwayOrder rdf:resource="#PathwayStep235" />
 <bp:pathwayOrder rdf:resource="#PathwayStep236" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction202" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction201" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction204" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction203" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction220" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction200" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction221" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction209" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction206" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction205" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction208" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction207" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction196" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction213" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction212" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction215" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction214" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction198" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction197" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction211" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction199" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction210" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction217" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction216" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction219" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction218" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence224" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of TP53 Activity through Phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of TP53 (p53) at the N-terminal serine residues S15 and S20 plays a critical role in protein stabilization as phosphorylation at these sites interferes with binding of the ubiquitin ligase MDM2 to TP53. Several different kinases can phosphorylate TP53 at S15 and S20. In response to double strand DNA breaks, S15 is phosphorylated by ATM (Banin et al. 1998, Canman et al. 1998, Khanna et al. 1998), and S20 by CHEK2 (Chehab et al. 1999, Chehab et al. 2000, Hirao et al. 2000). DNA damage or other types of genotoxic stress, such as stalled replication forks, can trigger ATR-mediated phosphorylation of TP53 at S15 (Lakin et al. 1999, Tibbetts et al. 1999) and CHEK1-mediated phosphorylation of TP53 at S20 (Shieh et al. 2000). In response to various types of cell stress, NUAK1 (Hou et al. 2011), CDK5 (Zhang et al. 2002, Lee et al. 2007, Lee et al. 2008), AMPK (Jones et al. 2005) and TP53RK (Abe et al. 2001, Facchin et al. 2003) can phosphorylate TP53 at S15, while PLK3 (Xie, Wang et al. 2001, Xie, Wu et al. 2001) can phosphorylate TP53 at S20. Phosphorylation of TP53 at serine residue S46 promotes transcription of TP53-regulated apoptotic genes rather than cell cycle arrest genes. Several kinases can phosphorylate S46 of TP53, including ATM-activated DYRK2, which, like TP53, is targeted for degradation by MDM2 (Taira et al. 2007, Taira et al. 2010). TP53 is also phosphorylated at S46 by HIPK2 in the presence of the TP53 transcriptional target TP53INP1 (D&apos;Orazi et al. 2002, Hofmann et al. 2002, Tomasini et al. 2003). CDK5, in addition to phosphorylating TP53 at S15, also phosphorylates it at S33 and S46, which promotes neuronal cell death (Lee et al. 2007). MAPKAPK5 (PRAK) phosphorylates TP53 at serine residue S37, promoting cell cycle arrest and cellular senescence in response to oncogenic RAS signaling (Sun et al. 2007). NUAK1 phosphorylates TP53 at S15 and S392, and phosphorylation at S392 may contribute to TP53-mediated transcriptional activation of cell cycle arrest genes (Hou et al. 2011). S392 of TP53 is also phosphorylated by the complex of casein kinase II (CK2) bound to the FACT complex, enhancing transcriptional activity of TP53 in response to UV irradiation (Keller et al. 2001, Keller and Lu 2002). The activity of TP53 is inhibited by phosphorylation at serine residue S315, which enhances MDM2 binding and degradation of TP53. S315 of TP53 is phosphorylated by Aurora kinase A (AURKA) (Katayama et al. 2004) and CDK2 (Luciani et al. 2000). Interaction with MDM2 and the consequent TP53 degradation is also increased by phosphorylation of TP53 threonine residue T55 by the transcription initiation factor complex TFIID (Li et al. 2004). Aurora kinase B (AURKB) has been shown to phosphorylate TP53 at serine residue S269 and threonine residue T284, which is possibly facilitated by the binding of the NIR co-repressor. AURKB-mediated phosphorylation was reported to inhibit TP53 transcriptional activity through an unknown mechanism (Wu et al. 2011). A putative direct interaction between TP53 and AURKB has also been described and linked to TP53 phosphorylation and S183, T211 and S215 and TP53 degradation (Gully et al. 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction701">
 <bp:evidence rdf:resource="#Evidence777" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1 binds SREBF1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway28">
 <bp:pathwayOrder rdf:resource="#PathwayStep218" />
 <bp:pathwayOrder rdf:resource="#PathwayStep222" />
 <bp:pathwayOrder rdf:resource="#PathwayStep220" />
 <bp:pathwayOrder rdf:resource="#PathwayStep221" />
 <bp:pathwayOrder rdf:resource="#PathwayStep219" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction194" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction193" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction195" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction192" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction191" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence218" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of TP53 Expression</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcription of the TP53 (p53) gene is negatively regulated by the TP53 transcriptional target PRDM1 (BLIMP1), which binds to the promoter region of TP53 and probably induces repressive methylation (Yan et al. 2007). TP53 functions as a homotetramer (Jeffrey et al. 1995, Waterman et al. 1995).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction700">
 <bp:evidence rdf:resource="#Evidence776" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AGRP gene expression is stimulated by FOXO1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction703">
 <bp:evidence rdf:resource="#Evidence780" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1,FOXO3,FOXO4 bind CDKN1A gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction702">
 <bp:evidence rdf:resource="#Evidence779" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BTG1 gene expression is stimulated by FOXO3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction709">
 <bp:evidence rdf:resource="#Evidence786" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDKN1B gene expression is stimulated by FOXO1,FOXO3,FOXO4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction708">
 <bp:evidence rdf:resource="#Evidence785" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO3 binds BTG1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway30">
 <bp:pathwayOrder rdf:resource="#PathwayStep251" />
 <bp:pathwayOrder rdf:resource="#PathwayStep252" />
 <bp:pathwayOrder rdf:resource="#PathwayStep263" />
 <bp:pathwayOrder rdf:resource="#PathwayStep253" />
 <bp:pathwayOrder rdf:resource="#PathwayStep264" />
 <bp:pathwayOrder rdf:resource="#PathwayStep254" />
 <bp:pathwayOrder rdf:resource="#PathwayStep265" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction224" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction235" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction223" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction234" />
 <bp:pathwayComponent rdf:resource="#Pathway31" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction222" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction233" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence251" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of TP53 Activity through Acetylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcriptional activity of TP53 is positively regulated by acetylation of several of its lysine residues. BRD7 binds TP53 and promotes acetylation of TP53 lysine residue K382 by acetyltransferase EP300 (p300). Acetylation of K382 enhances TP53 binding to target promoters, including CDKN1A (p21), MDM2, SERPINE1, TIGAR, TNFRSF10C and NDRG1 (Bensaad et al. 2010, Burrows et al. 2010. Drost et al. 2010). The histone acetyltransferase KAT6A, in the presence of PML, also acetylates TP53 at K382, and, in addition, acetylates K120 of TP53. KAT6A-mediated acetylation increases transcriptional activation of CDKN1A by TP53 (Rokudai et al. 2013). Acetylation of K382 can be reversed by the action of the NuRD complex, containing the TP53-binding MTA2 subunit, resulting in inhibition of TP53 transcriptional activity (Luo et al. 2000). Acetylation of lysine K120 in the DNA binding domain of TP53 by the MYST family acetyltransferases KAT8 (hMOF) and KAT5 (TIP60) can modulate the decision between cell cycle arrest and apoptosis (Sykes et al. 2006, Tang et al. 2006). Studies with acetylation-defective knock-in mutant mice indicate that lysine acetylation in the p53 DNA binding domain acts in part by uncoupling transactivation and transrepression of gene targets, while retaining ability to modulate energy metabolism and production of reactive oxygen species (ROS) and influencing ferroptosis (Li et al. 2012, Jiang et al. 2015).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction710">
 <bp:evidence rdf:resource="#Evidence787" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CAV1 gene expression is stimulated by FOXO1,FOXO3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway32">
 <bp:pathwayOrder rdf:resource="#PathwayStep267" />
 <bp:pathwayOrder rdf:resource="#PathwayStep268" />
 <bp:pathwayOrder rdf:resource="#PathwayStep269" />
 <bp:pathwayOrder rdf:resource="#PathwayStep273" />
 <bp:pathwayOrder rdf:resource="#PathwayStep274" />
 <bp:pathwayOrder rdf:resource="#PathwayStep275" />
 <bp:pathwayOrder rdf:resource="#PathwayStep276" />
 <bp:pathwayOrder rdf:resource="#PathwayStep270" />
 <bp:pathwayOrder rdf:resource="#PathwayStep271" />
 <bp:pathwayOrder rdf:resource="#PathwayStep272" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction245" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction237" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction236" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction242" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction241" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction244" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction243" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction240" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction239" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction238" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence267" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of TP53 Activity through Association with Co-factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Association of TP53 (p53) with various transcriptional co-factors can promote, inhibit or provide specificity towards either transcription of cell cycle arrest genes or transcription of cell death genes. Binding of the zinc finger protein ZNF385A (HZF), which is a transcriptional target of TP53, stimulates transcription of cell cycle arrest genes, such as CDKN1A (Das et al. 2007). Binding of POU4F1 (BRN3A) to TP53 also stimulates transcription of cell cycle arrest genes while inhibiting transcription of pro-apoptotic genes (Budhram-Mahadeo et al. 1999, Hudson et al. 2005). Binding of ASPP family proteins PPP1R13B (ASPP1) or TP53BP2 (ASPP2) to TP53 stimulates transcription of pro-apoptotic TP53 targets (Samuels-Lev et al. 2001, Bergamaschi et al. 2004). Binding of the ASPP family member PPP1R13L (iASSP) inhibits TP53-mediated activation of pro-apoptotic genes probably by interfering with binding of stimulatory ASPPs to TP53 (Bergamaschi et al. 2003). Transcription of pro-apoptotic genes is also stimulated by binding of TP53 to POU4F2 (BRN3B) (Budrham-Mahadeo et al. 2006, Budhram-Mahadeo et al. 2014) or to hCAS/CSE1L (Tanaka et al. 2007). Binding of co-factors to TP53 can also affect protein stability. For example, PHF20 binds to TP53 dimethylated on lysine residues K370 and K382 by unidentified protein lysine methyltransferase(s) and interferes with MDM2 binding, resulting in prolonged TP53 half-life (Cui et al. 2012). Long noncoding RNAs can contribute to p53-dependent transcriptional responses (Huarte et al. 2010). For a general review on this topic, see Espinosa 2008, Beckerman and Prives 2010, Murray-Zmijewski et al. 2008, An et al. 2004 and Barsotti and Prives 2010. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway31">
 <bp:pathwayOrder rdf:resource="#PathwayStep259" />
 <bp:pathwayOrder rdf:resource="#PathwayStep255" />
 <bp:pathwayOrder rdf:resource="#PathwayStep256" />
 <bp:pathwayOrder rdf:resource="#PathwayStep257" />
 <bp:pathwayOrder rdf:resource="#PathwayStep258" />
 <bp:pathwayOrder rdf:resource="#PathwayStep262" />
 <bp:pathwayOrder rdf:resource="#PathwayStep260" />
 <bp:pathwayOrder rdf:resource="#PathwayStep261" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction226" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction225" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction231" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction230" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction232" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction228" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction227" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction229" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence255" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI5P Regulates TP53 Acetylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Under conditions of cellular stress, nuclear levels of phosphatidylinositol-5-phosphate (PI5P) increase and, through interaction with ING2, result in nuclear retention/accumulation of ING2. ING2 binds TP53 (p53) and recruits histone acetyltransferase EP300 (p300) to TP53, leading to TP53 acetylation. Increased nuclear PI5P levels positively regulate TP53 acetylation (Ciruela et al. 2000, Gozani et al. 2003, Jones et al. 2006, Zou et al. 2007, Bultsma et al. 2010).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway34">
 <bp:pathwayOrder rdf:resource="#PathwayStep290" />
 <bp:pathwayOrder rdf:resource="#PathwayStep284" />
 <bp:pathwayOrder rdf:resource="#PathwayStep295" />
 <bp:pathwayOrder rdf:resource="#PathwayStep285" />
 <bp:pathwayOrder rdf:resource="#PathwayStep286" />
 <bp:pathwayOrder rdf:resource="#PathwayStep287" />
 <bp:pathwayOrder rdf:resource="#PathwayStep280" />
 <bp:pathwayOrder rdf:resource="#PathwayStep291" />
 <bp:pathwayOrder rdf:resource="#PathwayStep281" />
 <bp:pathwayOrder rdf:resource="#PathwayStep292" />
 <bp:pathwayOrder rdf:resource="#PathwayStep282" />
 <bp:pathwayOrder rdf:resource="#PathwayStep293" />
 <bp:pathwayOrder rdf:resource="#PathwayStep283" />
 <bp:pathwayOrder rdf:resource="#PathwayStep294" />
 <bp:pathwayOrder rdf:resource="#PathwayStep288" />
 <bp:pathwayOrder rdf:resource="#PathwayStep289" />
 <bp:pathwayOrder rdf:resource="#PathwayStep279" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction260" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction251" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction262" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction250" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction261" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction246" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction257" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction256" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction248" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction259" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction247" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction258" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction253" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction252" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction255" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction254" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction249" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence279" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The most prominent TP53 target involved in G1 arrest is the inhibitor of cyclin-dependent kinases CDKN1A (p21). CDKN1A is one of the earliest genes induced by TP53 (El-Deiry et al. 1993). CDKN1A binds and inactivates CDK2 in complex with cyclin A (CCNA) or E (CCNE), thus preventing G1/S transition (Harper et al. 1993). Considering its impact on the cell cycle outcome, CDKN1A expression levels are tightly regulated. For instance, under prolonged stress, TP53 can induce the transcription of an RNA binding protein PCBP4, which can bind and destabilize CDKN1A mRNA, thus alleviating G1 arrest and directing the affected cell towards G2 arrest and, possibly, apoptosis (Zhu and Chen 2000, Scoumanne et al. 2011). Expression of E2F7 is directly induced by TP53. E2F7 contributes to G1 cell cycle arrest by repressing transcription of E2F1, a transcription factor that promotes expression of many genes needed for G1/S transition (Aksoy et al. 2012, Carvajal et al. 2012). ARID3A is a direct transcriptional target of TP53 (Ma et al. 2003) that may promote G1 arrest by cooperating with TP53 in induction of CDKN1A transcription (Lestari et al. 2012). However, ARID3A may also promote G1/S transition by stimulating transcriptional activity of E2F1 (Suzuki et al. 1998, Peeper et al. 2002). TP53 has co-factors that are key determinants of transcriptional selectivity within the p53 network. For instance, the zinc finger transcription factor ZNF385A (HZF) is a direct transcriptional target of TP53 that can form a complex with TP53 and facilitate TP53-mediated induction of CDKN1A, strongly favouring cell cycle arrest over apoptosis (Das et al. 2007). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway33">
 <bp:pathwayOrder rdf:resource="#PathwayStep278" />
 <bp:pathwayOrder rdf:resource="#PathwayStep311" />
 <bp:pathwayOrder rdf:resource="#PathwayStep296" />
 <bp:pathwayComponent rdf:resource="#Pathway34" />
 <bp:pathwayComponent rdf:resource="#Pathway36" />
 <bp:pathwayComponent rdf:resource="#Pathway35" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence278" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 Regulates Transcription of Cell Cycle Genes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Under a variety of stress conditions, TP53 (p53), stabilized by stress-induced phosphorylation at least on S15 and S20 serine residues, can induce the transcription of genes involved in cell cycle arrest. Cell cycle arrest provides cells an opportunity to repair the damage before division, thus preventing the transmission of genetic errors to daughter cells. In addition, it allows cells to attempt a recovery from the damage and survive, preventing premature cell death. TP53 controls transcription of genes involved in both G1 and G2 cell cycle arrest. The most prominent TP53 target involved in G1 arrest is the inhibitor of cyclin-dependent kinases CDKN1A (p21). CDKN1A is one of the earliest genes induced by TP53 (El-Deiry et al. 1993). CDKN1A binds and inactivates CDK2 in complex with cyclin A (CCNA) or E (CCNE), thus preventing G1/S transition (Harper et al. 1993). Nevertheless, under prolonged stress, the cell destiny may be diverted towards an apoptotic outcome. For instance, in case of an irreversible damage, TP53 can induce transcription of an RNA binding protein PCBP4, which can bind and destabilize CDKN1A mRNA, thus alleviating G1 arrest and directing the affected cell towards G2 arrest and, possibly, apoptosis (Zhu and Chen 2000, Scoumanne et al. 2011). Expression of E2F7 is directly induced by TP53. E2F7 contributes to G1 cell cycle arrest by repressing transcription of E2F1, a transcription factor that promotes expression of many genes needed for G1/S transition (Aksoy et al. 2012, Carvajal et al. 2012). ARID3A is a direct transcriptional target of TP53 (Ma et al. 2003) that may promote G1 arrest by cooperating with TP53 in induction of CDKN1A transcription (Lestari et al. 2012). However, ARID3A may also promote G1/S transition by stimulating transcriptional activity of E2F1 (Suzuki et al. 1998, Peeper et al. 2002). TP53 contributes to the establishment of G2 arrest by inducing transcription of GADD45A and SFN, and by inhibiting transcription of CDC25C. TP53 induces GADD45A transcription in cooperation with chromatin modifying enzymes EP300, PRMT1 and CARM1 (An et al. 2004). GADD45A binds Aurora kinase A (AURKA), inhibiting its catalytic activity and preventing AURKA-mediated G2/M transition (Shao et al. 2006, Sanchez et al. 2010). GADD45A also forms a complex with PCNA. PCNA is involved in both normal and repair DNA synthesis. The effect of GADD45 interaction with PCNA, if any, on S phase progression, G2 arrest and DNA repair is not known (Smith et al. 1994, Hall et al. 1995, Sanchez et al. 2010, Kim et al. 2013). SFN (14-3-3-sigma) is induced by TP53 (Hermeking et al. 1997) and contributes to G2 arrest by binding to the complex of CDK1 and CCNB1 (cyclin B1) and preventing its translocation to the nucleus. Phosphorylation of a number of nuclear proteins by the complex of CDK1 and CCNB1 is needed for G2/M transition (Chan et al. 1999). While promoting G2 arrest, SFN can simultaneously inhibit apoptosis by binding to BAX and preventing its translocation to mitochondria, a step involved in cytochrome C release (Samuel et al. 2001). TP53 binds the promoter of the CDC25C gene in cooperation with the transcriptional repressor E2F4 and represses CDC25C transcription, thus maintaining G2 arrest (St Clair et al. 2004, Benson et al. 2014). Several direct transcriptional targets of TP53 are involved in cell cycle arrest but their mechanism of action is still unknown. BTG2 is induced by TP53, leading to cessation of cellular proliferation (Rouault et al. 1996, Duriez et al. 2002). BTG2 binds to the CCR4-NOT complex and promotes mRNA deadenylation activity of this complex. Interaction between BTG2 and CCR4-NOT is needed for the antiproliferative activity of BTG2, but the underlying mechanism has not been elucidated (Rouault et al. 1998, Mauxion et al. 2008, Horiuchi et al. 2009, Doidge et al. 2012, Ezzeddine et al. 2012). Two polo-like kinases, PLK2 and PLK3, are direct transcriptional targets of TP53. TP53-mediated induction of PLK2 may be important for prevention of mitotic catastrophe after spindle damage (Burns et al. 2003). PLK2 is involved in the regulation of centrosome duplication through phosphorylation of centrosome-related proteins CENPJ (Chang et al. 2010) and NPM1 (Krause and Hoffmann 2010). PLK2 is frequently transcriptionally silenced through promoter methylation in B-cell malignancies (Syed et al. 2006). Induction of PLK3 transcription by TP53 (Jen and Cheung 2005) may be important for coordination of M phase events through PLK3-mediated nuclear accumulation of CDC25C (Bahassi et al. 2004). RGCC is induced by TP53 and implicated in cell cycle regulation, possibly through its association with PLK1 (Saigusa et al. 2007). PLAGL1 (ZAC1) is a zinc finger protein directly transcriptionally induced by TP53 (Rozenfeld-Granot et al. 2002). PLAGL1 expression is frequently lost in cancer (Varrault et al. 1998) and PLAGL1 has been implicated in both cell cycle arrest and apoptosis (Spengler et al. 1997), but its mechanism of action remains unknown. The zinc finger transcription factor ZNF385A (HZF) is a direct transcriptional target of TP53 that can form a complex with TP53 and facilitate TP53-mediated induction of CDKN1A and SFN (14-3-3 sigma) transcription (Das et al. 2007). For a review of the role of TP53 in cell cycle arrest and cell cycle transcriptional targets of TP53, please refer to Riley et al. 2008, Murray-Zmijewski et al. 2008, Bieging et al. 2014, Kruiswijk et al. 2015.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway36">
 <bp:pathwayOrder rdf:resource="#PathwayStep314" />
 <bp:pathwayOrder rdf:resource="#PathwayStep315" />
 <bp:pathwayOrder rdf:resource="#PathwayStep316" />
 <bp:pathwayOrder rdf:resource="#PathwayStep317" />
 <bp:pathwayOrder rdf:resource="#PathwayStep321" />
 <bp:pathwayOrder rdf:resource="#PathwayStep322" />
 <bp:pathwayOrder rdf:resource="#PathwayStep312" />
 <bp:pathwayOrder rdf:resource="#PathwayStep313" />
 <bp:pathwayOrder rdf:resource="#PathwayStep320" />
 <bp:pathwayOrder rdf:resource="#PathwayStep318" />
 <bp:pathwayOrder rdf:resource="#PathwayStep319" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction279" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction278" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction286" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction285" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction277" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction287" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction282" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction281" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction284" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction283" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction280" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence312" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 contributes to the establishment of G2 arrest by inducing transcription of GADD45A and SFN, and by inhibiting transcription of CDC25C. TP53 induces GADD45A transcription in cooperation with chromatin modifying enzymes EP300, PRMT1 and CARM1 (An et al. 2004). GADD45A binds Aurora kinase A (AURKA), inhibiting its catalytic activity and preventing AURKA-mediated G2/M transition (Shao et al. 2006, Sanchez et al. 2010). GADD45A also forms a complex with PCNA. PCNA is involved in both normal and repair DNA synthesis. The effect of GADD45 interaction with PCNA, if any, on S phase progression, G2 arrest and DNA repair is not known (Smith et al. 1994, Hall et al. 1995, Sanchez et al. 2010, Kim et al. 2013). SFN (14-3-3-sigma) is induced by TP53 (Hermeking et al. 1997) and contributes to G2 arrest by binding to the complex of CDK1 and CCNB1 (cyclin B1) and preventing its translocation to the nucleus. Phosphorylation of a number of nuclear proteins by the complex of CDK1 and CCNB1 is needed for G2/M transition (Chan et al. 1999). While promoting G2 arrest, SFN can simultaneously inhibit apoptosis by binding to BAX and preventing its translocation to mitochondria, a step involved in cytochrome C release (Samuel et al. 2001). TP53 binds the promoter of the CDC25C gene in cooperation with the transcriptional repressor E2F4 and represses CDC25C transcription, thus maintaining G2 arrest (St Clair et al. 2004, Benson et al. 2014). The zinc finger transcription factor ZNF385A (HZF) is a direct transcriptional target of TP53 that can form a complex with TP53 and facilitate TP53-mediated induction of SFN transcription (Das et al. 2007).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction716">
 <bp:evidence rdf:resource="#Evidence793" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KLF4 gene expression is stimulated by FOXO1,FOXO3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway35">
 <bp:pathwayOrder rdf:resource="#PathwayStep297" />
 <bp:pathwayOrder rdf:resource="#PathwayStep298" />
 <bp:pathwayOrder rdf:resource="#PathwayStep303" />
 <bp:pathwayOrder rdf:resource="#PathwayStep304" />
 <bp:pathwayOrder rdf:resource="#PathwayStep305" />
 <bp:pathwayOrder rdf:resource="#PathwayStep306" />
 <bp:pathwayOrder rdf:resource="#PathwayStep299" />
 <bp:pathwayOrder rdf:resource="#PathwayStep310" />
 <bp:pathwayOrder rdf:resource="#PathwayStep300" />
 <bp:pathwayOrder rdf:resource="#PathwayStep301" />
 <bp:pathwayOrder rdf:resource="#PathwayStep302" />
 <bp:pathwayOrder rdf:resource="#PathwayStep307" />
 <bp:pathwayOrder rdf:resource="#PathwayStep308" />
 <bp:pathwayOrder rdf:resource="#PathwayStep309" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction271" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction270" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction273" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction272" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction268" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction267" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction269" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction264" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction275" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction263" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction274" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction266" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction265" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction276" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence297" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BTG2 is induced by TP53, leading to cessation of cellular proliferation (Rouault et al. 1996, Duriez et al. 2002). BTG2 binds to the CCR4-NOT complex and promotes mRNA deadenylation activity of this complex. Interaction between BTG2 and CCR4-NOT is needed for the antiproliferative activity of BTG2, but the underlying mechanism has not been elucidated (Rouault et al. 1998, Mauxion et al. 2008, Horiuchi et al. 2009, Doidge et al. 2012, Ezzeddine et al. 2012). Two polo-like kinases, PLK2 and PLK3, are direct transcriptional targets of TP53. TP53-mediated induction of PLK2 may be important for prevention of mitotic catastrophe after spindle damage (Burns et al. 2003). PLK2 is involved in the regulation of centrosome duplication through phosphorylation of centrosome-related proteins CENPJ (Chang et al. 2010) and NPM1 (Krause and Hoffmann 2010). PLK2 is frequently transcriptionally silenced through promoter methylation in B-cell malignancies (Syed et al. 2006). Induction of PLK3 transcription by TP53 (Jen and Cheung 2005) may be important for coordination of M phase events through PLK3-mediated nuclear accumulation of CDC25C (Bahassi et al. 2004). RGCC is induced by TP53 and implicated in cell cycle regulation, possibly through its association with PLK1 (Saigusa et al. 2007). PLAGL1 (ZAC1) is a zinc finger protein directly transcriptionally induced by TP53 (Rozenfeld-Granot et al. 2002). PLAGL1 expression is frequently lost in cancer (Varrault et al. 1998) and PLAGL1 has been implicated in both cell cycle arrest and apoptosis (Spengler et al. 1997), but its mechanism of action remains unknown.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction715">
 <bp:evidence rdf:resource="#Evidence792" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GADD45A gene expression is stimulated by FOXO3,FOXO4,(FOXO1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway38">
 <bp:pathwayOrder rdf:resource="#PathwayStep340" />
 <bp:pathwayOrder rdf:resource="#PathwayStep330" />
 <bp:pathwayOrder rdf:resource="#PathwayStep341" />
 <bp:pathwayOrder rdf:resource="#PathwayStep331" />
 <bp:pathwayOrder rdf:resource="#PathwayStep325" />
 <bp:pathwayOrder rdf:resource="#PathwayStep336" />
 <bp:pathwayOrder rdf:resource="#PathwayStep326" />
 <bp:pathwayOrder rdf:resource="#PathwayStep337" />
 <bp:pathwayOrder rdf:resource="#PathwayStep327" />
 <bp:pathwayOrder rdf:resource="#PathwayStep338" />
 <bp:pathwayOrder rdf:resource="#PathwayStep328" />
 <bp:pathwayOrder rdf:resource="#PathwayStep339" />
 <bp:pathwayOrder rdf:resource="#PathwayStep332" />
 <bp:pathwayOrder rdf:resource="#PathwayStep333" />
 <bp:pathwayOrder rdf:resource="#PathwayStep334" />
 <bp:pathwayOrder rdf:resource="#PathwayStep335" />
 <bp:pathwayOrder rdf:resource="#PathwayStep329" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction293" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction292" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction295" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction294" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction291" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction290" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction301" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction289" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction300" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction303" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction302" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction297" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction296" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction288" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction299" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction298" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction304" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence325" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 Regulates Transcription of Caspase Activators and Caspases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 (p53) transcriptionally regulates cytosolic caspase activators, such as APAF1, PIDD1, and NLRC4, and caspases themselves, such as CASP1, CASP6 and CASP10. These caspases and their activators are involved either in the intrinsic apoptosis pathway or in the extrinsic apoptosis pathway triggerred by death receptors or the inflammation-related cell death pyroptosis (Lin et al. 2000, Robles et al. 2001, Gupta et al. 2001, MacLachlan and El-Deiry 2002, Rikhof et al. 2003, Sadasivam et al. 2005, Brough and Rothwell 2007).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction718">
 <bp:evidence rdf:resource="#Evidence795" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1 and p-2S-SMAD2/3:SMAD4 bind MSTN gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway37">
 <bp:pathwayOrder rdf:resource="#PathwayStep388" />
 <bp:pathwayOrder rdf:resource="#PathwayStep324" />
 <bp:pathwayOrder rdf:resource="#PathwayStep362" />
 <bp:pathwayOrder rdf:resource="#PathwayStep342" />
 <bp:pathwayComponent rdf:resource="#Pathway41" />
 <bp:pathwayComponent rdf:resource="#Pathway40" />
 <bp:pathwayComponent rdf:resource="#Pathway38" />
 <bp:pathwayComponent rdf:resource="#Pathway39" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence324" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 Regulates Transcription of Cell Death Genes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The tumor suppressor TP53 (p53) exerts its tumor suppressive role in part by regulating transcription of a number of genes involved in cell death, mainly apoptotic cell death. The majority of apoptotic genes that are transcriptional targets of TP53 promote apoptosis, but there are also several TP53 target genes that inhibit apoptosis, providing cells with an opportunity to attempt to repair the damage and/or recover from stress.   Pro-apoptotic transcriptional targets of TP53 involve TRAIL death receptors TNFRSF10A (DR4), TNFRSF10B (DR5), TNFRSF10C (DcR1) and TNFRSF10D (DcR2), as well as the FASL/CD95L death receptor FAS (CD95). TRAIL receptors and FAS induce pro-apoptotic signaling in response to external stimuli via extrinsic apoptosis pathway (Wu et al. 1997, Takimoto et al. 2000, Guan et al. 2001, Liu et al. 2004, Ruiz de Almodovar et al. 2004, Liu et al. 2005, Schilling et al. 2009, Wilson et al. 2013). IGFBP3 is a transcriptional target of TP53 that may serve as a ligand for a novel death receptor TMEM219 (Buckbinder et al. 1995, Ingermann et al. 2010). TP53 regulates expression of a number of genes involved in the intrinsic apoptosis pathway, triggered by the cellular stress. Some of TP53 targets, such as BAX, BID, PMAIP1 (NOXA), BBC3 (PUMA) and probably BNIP3L, AIFM2, STEAP3, TRIAP1 and TP53AIP1, regulate the permeability of the mitochondrial membrane and/or cytochrome C release (Miyashita and Reed 1995, Oda et al. 2000, Samuels-Lev et al. 2001, Nakano and Vousden 2001, Sax et al. 2002, Passer et al. 2003, Bergamaschi et al. 2004, Li et al. 2004, Fei et al. 2004, Wu et al. 2004, Park and Nakamura 2005, Patel et al. 2008, Wang et al. 2012, Wilson et al. 2013). Other pro-apoptotic genes, either involved in the intrinsic apoptosis pathway, extrinsic apoptosis pathway or pyroptosis (inflammation-related cell death), which are transcriptionally regulated by TP53 are cytosolic caspase activators, such as APAF1, PIDD1, and NLRC4, and caspases themselves, such as CASP1, CASP6 and CASP10 (Lin et al. 2000, Robles et al. 2001, Gupta et al. 2001, MacLachlan and El-Deiry 2002, Rikhof et al. 2003, Sadasivam et al. 2005, Brough and Rothwell 2007). It is uncertain how exactly some of the pro-apoptotic TP53 targets, such as TP53I3 (PIG3), RABGGTA, BCL2L14, BCL6, NDRG1 and PERP contribute to apoptosis (Attardi et al. 2000, Guo et al. 2001, Samuels-Lev et al. 2001, Contente et al. 2002, Ihrie et al. 2003, Bergamaschi et al. 2004, Stein et al. 2004, Phan and Dalla-Favera 2004, Jen and Cheung 2005, Margalit et al. 2006, Zhang et al. 2007, Saito et al. 2009, Davies et al. 2009, Giam et al. 2012). TP53 is stabilized in response to cellular stress by phosphorylation on at least serine residues S15 and S20. Since TP53 stabilization precedes the activation of cell death genes, the TP53 tetramer phosphorylated at S15 and S20 is shown as a regulator of pro-apoptotic/pro-cell death genes. Some pro-apoptotic TP53 target genes, such as TP53AIP1, require additional phosphorylation of TP53 at serine residue S46 (Oda et al. 2000, Taira et al. 2007). Phosphorylation of TP53 at S46 is regulated by another TP53 pro-apoptotic target, TP53INP1 (Okamura et al. 2001, Tomasini et al. 2003). Additional post-translational modifications of TP53 may be involved in transcriptional regulation of genes presented in this pathway and this information will be included as evidence becomes available. Activation of some pro-apoptotic TP53 targets, such as BAX, FAS, BBC3 (PUMA) and TP53I3 (PIG3) requires the presence of the complex of TP53 and an ASPP protein, either PPP1R13B (ASPP1) or TP53BP2 (ASPP2) (Samuels-Lev et al. 2001, Bergamaschi et al. 2004, Patel et al. 2008, Wilson et al. 2013), indicating how the interaction with specific co-factors modulates the cellular response/outcome. TP53 family members TP63 and or TP73 can also activate some of the pro-apoptotic TP53 targets, such as FAS, BAX, BBC3 (PUMA), TP53I3 (PIG3), CASP1 and PERP (Bergamaschi et al. 2004, Jain et al. 2005, Ihrie et al. 2005, Patel et al. 2008, Schilling et al. 2009, Celardo et al. 2013).   For a review of the role of TP53 in apoptosis and pro-apoptotic transcriptional targets of TP53, please refer to Riley et al. 2008, Murray-Zmijewski et al. 2008, Bieging et al. 2014, Kruiswijk et al. 2015.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction717">
 <bp:evidence rdf:resource="#Evidence794" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PCBP4 modulates CDKN1A translation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction712">
 <bp:evidence rdf:resource="#Evidence789" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1,FOXO3 bind KLF4 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway39">
 <bp:pathwayOrder rdf:resource="#PathwayStep350" />
 <bp:pathwayOrder rdf:resource="#PathwayStep361" />
 <bp:pathwayOrder rdf:resource="#PathwayStep351" />
 <bp:pathwayOrder rdf:resource="#PathwayStep352" />
 <bp:pathwayOrder rdf:resource="#PathwayStep353" />
 <bp:pathwayOrder rdf:resource="#PathwayStep360" />
 <bp:pathwayOrder rdf:resource="#PathwayStep347" />
 <bp:pathwayOrder rdf:resource="#PathwayStep358" />
 <bp:pathwayOrder rdf:resource="#PathwayStep348" />
 <bp:pathwayOrder rdf:resource="#PathwayStep359" />
 <bp:pathwayOrder rdf:resource="#PathwayStep349" />
 <bp:pathwayOrder rdf:resource="#PathwayStep343" />
 <bp:pathwayOrder rdf:resource="#PathwayStep354" />
 <bp:pathwayOrder rdf:resource="#PathwayStep344" />
 <bp:pathwayOrder rdf:resource="#PathwayStep355" />
 <bp:pathwayOrder rdf:resource="#PathwayStep345" />
 <bp:pathwayOrder rdf:resource="#PathwayStep356" />
 <bp:pathwayOrder rdf:resource="#PathwayStep346" />
 <bp:pathwayOrder rdf:resource="#PathwayStep357" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction312" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction323" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction311" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction322" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction314" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction313" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction310" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction321" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction320" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction309" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction308" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction319" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction305" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction316" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction315" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction307" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction318" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction306" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction317" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence343" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The exact mechanisms of action of several other pro-apoptotic TP53 (p53) targets, such as TP53I3 (PIG3), RABGGTA, BCL2L14, BCL6, NDRG1 and PERP, remain uncertain (Attardi et al. 2000, Guo et al. 2001, Samuels-Lev et al. 2001, Contente et al. 2002, Ihrie et al. 2003, Bergamaschi et al. 2004, Stein et al. 2004, Phan and Dalla-Favera 2004, Jen and Cheung 2005, Margalit et al. 2006, Zhang et al. 2007, Saito et al. 2009, Davies et al. 2009, Giam et al. 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction711">
 <bp:evidence rdf:resource="#Evidence788" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PCBP4 binds the CDKN1A mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction714">
 <bp:evidence rdf:resource="#Evidence791" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1,FOXO3,(FOXO4) binds CCNG2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction713">
 <bp:evidence rdf:resource="#Evidence790" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO3,FOXO4,(FOXO1) bind GADD45A gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction719">
 <bp:evidence rdf:resource="#Evidence796" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXG1 binds FOXO:SMAD complexes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway41">
 <bp:pathwayOrder rdf:resource="#PathwayStep389" />
 <bp:pathwayOrder rdf:resource="#PathwayStep394" />
 <bp:pathwayOrder rdf:resource="#PathwayStep395" />
 <bp:pathwayOrder rdf:resource="#PathwayStep390" />
 <bp:pathwayOrder rdf:resource="#PathwayStep391" />
 <bp:pathwayOrder rdf:resource="#PathwayStep392" />
 <bp:pathwayOrder rdf:resource="#PathwayStep393" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction355" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction352" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction351" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction354" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction353" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction350" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction349" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence389" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 Regulates Transcription of Death Receptors and Ligands</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pro-apoptotic transcriptional targets of TP53 are TRAIL death receptors TNFRSF10A (DR4), TNFRSF10B (DR5), TNFRSF10C (DcR1) and TNFRSF10D (DcR2), as well as the FASL/CD95L death receptor FAS (CD95). TRAIL receptors and FAS induce pro-apoptotic signaling in response to external stimuli via extrinsic apoptosis pathway (Wu et al. 1997, Takimoto et al. 2000, Guan et al. 2001, Liu et al. 2004, Ruiz de Almodovar et al. 2004, Liu et al. 2005, Schilling et al. 2009, Wilson et al. 2013). IGFBP3 is a transcriptional target of TP53 that may serve as a ligand for a novel death receptor TMEM219 (Buckbinder et al. 1995, Ingermann et al. 2010).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction721">
 <bp:evidence rdf:resource="#Evidence798" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDKN1A gene transcription is stimulated by FOXO1,FOXO3,FOXO4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway40">
 <bp:pathwayOrder rdf:resource="#PathwayStep372" />
 <bp:pathwayOrder rdf:resource="#PathwayStep373" />
 <bp:pathwayOrder rdf:resource="#PathwayStep374" />
 <bp:pathwayOrder rdf:resource="#PathwayStep375" />
 <bp:pathwayOrder rdf:resource="#PathwayStep370" />
 <bp:pathwayOrder rdf:resource="#PathwayStep371" />
 <bp:pathwayOrder rdf:resource="#PathwayStep369" />
 <bp:pathwayOrder rdf:resource="#PathwayStep365" />
 <bp:pathwayOrder rdf:resource="#PathwayStep387" />
 <bp:pathwayOrder rdf:resource="#PathwayStep366" />
 <bp:pathwayOrder rdf:resource="#PathwayStep367" />
 <bp:pathwayOrder rdf:resource="#PathwayStep368" />
 <bp:pathwayOrder rdf:resource="#PathwayStep383" />
 <bp:pathwayOrder rdf:resource="#PathwayStep384" />
 <bp:pathwayOrder rdf:resource="#PathwayStep363" />
 <bp:pathwayOrder rdf:resource="#PathwayStep385" />
 <bp:pathwayOrder rdf:resource="#PathwayStep364" />
 <bp:pathwayOrder rdf:resource="#PathwayStep386" />
 <bp:pathwayOrder rdf:resource="#PathwayStep380" />
 <bp:pathwayOrder rdf:resource="#PathwayStep381" />
 <bp:pathwayOrder rdf:resource="#PathwayStep382" />
 <bp:pathwayOrder rdf:resource="#PathwayStep376" />
 <bp:pathwayOrder rdf:resource="#PathwayStep377" />
 <bp:pathwayOrder rdf:resource="#PathwayStep378" />
 <bp:pathwayOrder rdf:resource="#PathwayStep379" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction345" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction344" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction325" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction347" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction324" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction346" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction341" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction340" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction343" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction342" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction327" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction326" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction348" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction329" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction328" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction334" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction333" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction336" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction335" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction330" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction332" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction331" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction338" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction337" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction339" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence363" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 Regulates Transcription of Genes Involved in Cytochrome C Release</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Apoptotic transcriptional targets of TP53 include genes that regulate the permeability of the mitochondrial membrane and/or cytochrome C release, such as BAX, BID, PMAIP1 (NOXA), BBC3 (PUMA) and probably BNIP3L, AIFM2, STEAP3, TRIAP1 and TP53AIP1 (Miyashita and Reed 1995, Oda et al. 2000, Samuels-Lev et al. 2001, Nakano and Vousden 2001, Sax et al. 2002, Passer et al. 2003, Bergamaschi et al. 2004, Li et al. 2004, Fei et al. 2004, Wu et al. 2004, Park and Nakamura 2005, Patel et al. 2008, Wang et al. 2012, Wilson et al. 2013), thus promoting the activation of the apoptotic pathway. Transcriptional activation of TP53AIP1 requires phosphorylation of TP53 at serine residue S46 (Oda et al. 2000, Taira et al. 2007). Phosphorylation of TP53 at S46 is regulated by another TP53 pro-apoptotic target, TP53INP1 (Okamura et al. 2001, Tomasini et al. 2003).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction720">
 <bp:evidence rdf:resource="#Evidence797" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CCNG2 gene expression is stimulated by FOXO1,FOXO3,(FOXO4)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway43">
 <bp:pathwayOrder rdf:resource="#PathwayStep448" />
 <bp:pathwayOrder rdf:resource="#PathwayStep438" />
 <bp:pathwayOrder rdf:resource="#PathwayStep475" />
 <bp:pathwayOrder rdf:resource="#PathwayStep432" />
 <bp:pathwayOrder rdf:resource="#PathwayStep465" />
 <bp:pathwayOrder rdf:resource="#PathwayStep456" />
 <bp:pathwayOrder rdf:resource="#PathwayStep441" />
 <bp:pathwayOrder rdf:resource="#PathwayStep485" />
 <bp:pathwayOrder rdf:resource="#PathwayStep481" />
 <bp:pathwayComponent rdf:resource="#Pathway50" />
 <bp:pathwayComponent rdf:resource="#Pathway52" />
 <bp:pathwayComponent rdf:resource="#Pathway51" />
 <bp:pathwayComponent rdf:resource="#Pathway45" />
 <bp:pathwayComponent rdf:resource="#Pathway44" />
 <bp:pathwayComponent rdf:resource="#Pathway47" />
 <bp:pathwayComponent rdf:resource="#Pathway46" />
 <bp:pathwayComponent rdf:resource="#Pathway49" />
 <bp:pathwayComponent rdf:resource="#Pathway48" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence432" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcriptional regulation by RUNX3</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The transcription factor RUNX3 is a RUNX family member. All RUNX family members, RUNX1, RUNX2 and RUNX3, possess a highly conserved Runt domain, involved in DNA binding. For a more detailed description of the structure of RUNX proteins, please refer to the pathway &apos;Transcriptional regulation by RUNX1&apos;. Similar to RUNX1 and RUNX2, RUNX3 forms a transcriptionally active heterodimer with CBFB (CBF-beta). Studies in mice have shown that RUNX3 plays a role in neurogenesis and development of T lymphocytes. RUNX3 is implicated as a tumor suppressor gene in various human malignancies. During nervous system formation, the Cbfb:Runx3 complex is involved in development of mouse proprioceptive dorsal root ganglion neurons by regulating expression of Ntrk3 (Neurotrophic tyrosine kinase receptor type 3) and possibly other genes (Inoue et al. 2002, Kramer et al. 2006, Nakamura et al. 2008, Dykes et al. 2011, Ogihara et al. 2016). It is not yet known whether RUNX3 is involved in human neuronal development and neuronal disorders. RUNX3 plays a major role in immune response. RUNX3 regulates development of T lymphocytes. In mouse hematopoietic stem cells, expression of Runx3 is regulated by the transcription factor TAL1 (Landry et al. 2008). RUNX3 promotes the CD8+ lineage fate in developing thymocytes. In the CD4+ thymocyte lineage in mice, the transcription factor ThPOK induces transcription of SOCS family members, which repress Runx3 expression (Luckey et al. 2014). RUNX3, along with RUNX1 and ETS1, is implicated in regulation of transcription of the CD6 gene, encoding a lymphocyte surface receptor expressed on developing and mature T cells (Arman et al. 2009). RUNX3 and ThPOK regulate intestinal CD4+ T cell immunity in a TGF-beta and retinoic acid-dependent manner, which is important for cellular defense against intestinal pathogens (Reis et al. 2013). Besides T lymphocytes, RUNX3 is a key transcription factor in the commitment of innate lymphoid cells ILC1 and ILC3 (Ebihara et al. 2015). RUNX3 regulates expression of CD11A and CD49D integrin genes, involved in immune and inflammatory responses (Dominguez-Soto et al. 2005). RUNX3 is involved in mouse TGF-beta-mediated dendritic cell function and its deficiency is linked to airway inflammation (Fainaru et al. 2004). In addition to its developmental role, RUNX3 is implicated as a tumor suppressor. The loss of RUNX3 expression and function was first causally linked to the genesis and progression of human gastric cancer (Li et al. 2002). Expression of RUNX3 increases in human pancreatic islet of Langerhans cells but not in pancreatic adenocarcinoma cells in response to differentiation stimulus (serum withdrawal) (Levkovitz et al. 2010). Hypermethylation of the RUNX3 gene is associated with an increased risk for progression of Barrett&apos;s esophagus to esophageal adenocarcinoma (Schulmann et al. 2005). Hypermethylation-mediated silencing of the RUNX3 gene expression is also frequent in granulosa cell tumors (Dhillon et al. 2004) and has also been reported in colon cancer (Weisenberger et al. 2006), breast cancer (Lau et al. 2006, Huang et al. 2012), bladder cancer (Wolff et al. 2008) and gastric cancer (Li et al. 2002). In colorectal cancer, RUNX3 is one of the five markers in a gene panel used to classify CpG island methylator phenotype (CIMP+) (Weisenberger et al. 2006). RUNX3 and CBFB are frequently downregulated in gastric cancer. RUNX3 cooperates with TGF-beta to maintain homeostasis in the stomach and is involved in TGF-beta-induced cell cycle arrest of stomach epithelial cells. Runx3 knockout mice exhibit decreased sensitivity to TGF-beta and develop gastric epithelial hyperplasia (Li et al. 2002, Chi et al. 2005). RUNX3-mediated inhibition of binding of TEADs:YAP1 complexes to target promoters is also implicated in gastric cancer suppression (Qiao et al. 2016). RUNX3 is a negative regulator of NOTCH signaling and RUNX3-mediated inhibition of NOTCH activity may play a tumor suppressor role in hepatocellular carcinoma (Gao et al. 2010, Nishina et al. 2011). In addition to RUNX3 silencing through promoter hypermethylation in breast cancer (Lau et al. 2006), Runx3+/- mice are predisposed to breast cancer development. RUNX3 downregulates estrogen receptor alpha (ESR1) protein levels in a proteasome-dependent manner (Huang et al. 2012). Besides its tumor suppressor role, mainly manifested through its negative effect on cell proliferation, RUNX3 can promote cancer cell invasion by stimulating expression of genes involved in metastasis, such as osteopontin (SPP1) (Whittle et al. 2015).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway42">
 <bp:pathwayOrder rdf:resource="#PathwayStep397" />
 <bp:pathwayOrder rdf:resource="#PathwayStep430" />
 <bp:pathwayOrder rdf:resource="#PathwayStep402" />
 <bp:pathwayOrder rdf:resource="#PathwayStep424" />
 <bp:pathwayOrder rdf:resource="#PathwayStep403" />
 <bp:pathwayOrder rdf:resource="#PathwayStep425" />
 <bp:pathwayOrder rdf:resource="#PathwayStep404" />
 <bp:pathwayOrder rdf:resource="#PathwayStep426" />
 <bp:pathwayOrder rdf:resource="#PathwayStep405" />
 <bp:pathwayOrder rdf:resource="#PathwayStep427" />
 <bp:pathwayOrder rdf:resource="#PathwayStep420" />
 <bp:pathwayOrder rdf:resource="#PathwayStep421" />
 <bp:pathwayOrder rdf:resource="#PathwayStep400" />
 <bp:pathwayOrder rdf:resource="#PathwayStep422" />
 <bp:pathwayOrder rdf:resource="#PathwayStep401" />
 <bp:pathwayOrder rdf:resource="#PathwayStep423" />
 <bp:pathwayOrder rdf:resource="#PathwayStep406" />
 <bp:pathwayOrder rdf:resource="#PathwayStep428" />
 <bp:pathwayOrder rdf:resource="#PathwayStep407" />
 <bp:pathwayOrder rdf:resource="#PathwayStep429" />
 <bp:pathwayOrder rdf:resource="#PathwayStep408" />
 <bp:pathwayOrder rdf:resource="#PathwayStep409" />
 <bp:pathwayOrder rdf:resource="#PathwayStep413" />
 <bp:pathwayOrder rdf:resource="#PathwayStep414" />
 <bp:pathwayOrder rdf:resource="#PathwayStep415" />
 <bp:pathwayOrder rdf:resource="#PathwayStep416" />
 <bp:pathwayOrder rdf:resource="#PathwayStep398" />
 <bp:pathwayOrder rdf:resource="#PathwayStep399" />
 <bp:pathwayOrder rdf:resource="#PathwayStep410" />
 <bp:pathwayOrder rdf:resource="#PathwayStep411" />
 <bp:pathwayOrder rdf:resource="#PathwayStep412" />
 <bp:pathwayOrder rdf:resource="#PathwayStep417" />
 <bp:pathwayOrder rdf:resource="#PathwayStep418" />
 <bp:pathwayOrder rdf:resource="#PathwayStep419" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction381" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction380" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction361" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction383" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction360" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction382" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction367" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction389" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction366" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction388" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction369" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction368" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction363" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction385" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction362" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction384" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction365" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction387" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction364" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction386" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction370" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction372" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction371" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction356" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction378" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction377" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction358" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction357" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction379" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction374" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction373" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction376" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction375" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction359" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence397" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 Regulates Metabolic Genes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">While the p53 tumor suppressor protein (TP53) is known to inhibit cell growth by inducing apoptosis, senescence and cell cycle arrest, recent studies have found that p53 is also able to influence cell metabolism to prevent tumor development. TP53 regulates transcription of many genes involved in the metabolism of carbohydrates, nucleotides and amino acids, protein synthesis and aerobic respiration. TP53 stimulates transcription of TIGAR, a D-fructose 2,6-bisphosphatase. TIGAR activity decreases glycolytic rate and lowers ROS (reactive oxygen species) levels in cells (Bensaad et al. 2006). TP53 may also negatively regulate the rate of glycolysis by inhibiting the expression of glucose transporters GLUT1, GLUT3 and GLUT4 (Kondoh et al. 2005, Schwartzenberg-Bar-Yoseph et al. 2004, Kawauchi et al. 2008). TP53 negatively regulates several key points in PI3K/AKT signaling and downstream mTOR signaling, decreasing the rate of protein synthesis and, hence, cellular growth. TP53 directly stimulates transcription of the tumor suppressor PTEN, which acts to inhibit PI3K-mediated activation of AKT (Stambolic et al. 2001). TP53 stimulates transcription of sestrin genes, SESN1, SESN2, and SESN3 (Velasco-Miguel et al. 1999, Budanov et al. 2002, Brynczka et al. 2007). One of sestrin functions may be to reduce and reactivate overoxidized peroxiredoxin PRDX1, thereby reducing ROS levels (Budanov et al. 2004, Papadia et al. 2008, Essler et al. 2009). Another function of sestrins is to bind the activated AMPK complex and protect it from AKT-mediated inactivation. By enhancing AMPK activity, sestrins negatively regulate mTOR signaling (Budanov and Karin 2008, Cam et al. 2014). The expression of DDIT4 (REDD1), another negative regulator of mTOR signaling, is directly stimulated by TP63 and TP53. DDIT4 prevents AKT-mediated inactivation of TSC1:TSC2 complex, thus inhibiting mTOR cascade (Cam et al. 2014, Ellisen et al. 2002, DeYoung et al. 2008). TP53 may also be involved, directly or indirectly, in regulation of expression of other participants of PI3K/AKT/mTOR signaling, such as PIK3CA (Singh et al. 2002), TSC2 and AMPKB (Feng et al. 2007).  TP53 regulates mitochondrial metabolism through several routes. TP53 stimulates transcription of SCO2 gene, which encodes a mitochondrial cytochrome c oxidase assembly protein (Matoba et al. 2006). TP53 stimulates transcription of RRM2B gene, which encodes a subunit of the ribonucleotide reductase complex, responsible for the conversion of ribonucleotides to deoxyribonucleotides and essential for the maintenance of mitochondrial DNA content in the cell (Tanaka et al. 2000, Bourdon et al. 2007, Kulawiec et al. 2009). TP53 also transactivates mitochondrial transcription factor A (TFAM), a nuclear-encoded gene important for mitochondrial DNA (mtDNA) transcription and maintenance (Park et al. 2009). Finally, TP53 stimulates transcription of the mitochondrial glutaminase GLS2, leading to increased mitochondrial respiration rate and reduced ROS levels (Hu et al. 2010).  The great majority of tumor cells generate energy through aerobic glycolysis, rather than the much more efficient aerobic mitochondrial respiration, and this metabolic change is known as the Warburg effect (Warburg 1956). Since the majority of tumor cells have impaired TP53 function, and TP53 regulates a number of genes involved in glycolysis and mitochondrial respiration, it is likely that TP53 inactivation plays an important role in the metabolic derangement of cancer cells such as the Warburg effect and the concomitant increased tumorigenicity (reviewed by Feng and Levine 2010). On the other hand, some mutations of TP53 in Li-Fraumeni syndrome may result in the retention of its wild-type metabolic activities while losing cell cycle and apoptosis functions (Wang et al. 2013). Consistent with such human data, some mutations of p53, unlike p53 null state, retain the ability to regulate energy metabolism while being inactive in regulating its classic gene targets involved in cell cycle, apoptosis and senescence. Retention of metabolic and antioxidant functions of p53 protects p53 mutant mice from early onset tumorigenesis (Li et al. 2012). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway45">
 <bp:pathwayOrder rdf:resource="#PathwayStep440" />
 <bp:pathwayOrder rdf:resource="#PathwayStep439" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction396" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction395" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence439" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 regulates BCL2L11 (BIM) transcription</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In response to TGF-beta signaling, RUNX3, in cooperation with activated SMADs and FOXO3A, induces transcription of the pro-apoptotic gene BCL2L11 (BIM) (Wildey et al. 2003, Yano et al. 2006, Yamamura et al. 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway44">
 <bp:pathwayOrder rdf:resource="#PathwayStep435" />
 <bp:pathwayOrder rdf:resource="#PathwayStep436" />
 <bp:pathwayOrder rdf:resource="#PathwayStep437" />
 <bp:pathwayOrder rdf:resource="#PathwayStep433" />
 <bp:pathwayOrder rdf:resource="#PathwayStep434" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction392" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction391" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction394" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction393" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction390" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence433" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 Regulates Immune Response and Cell Migration</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3-mediated transcription regulates development of immune system cells. RUNX3 is necessary for the development of innate lymphoid cells (ILCs) of ILC1 and ILC3 lineages, which reside in the mucosa and are involved in response to external pathogens. RUNX3 exerts its role in the development of ILC1 and ILC3 lineages by stimulating expression of the RORC (RORgamma) gene, encoding nuclear retinoid-related orphan receptor-gamma (Ebihara et al. 2015). RUNX3 regulates transcription of integrin genes ITGAL (CD11a) and ITGA4 (CD49d), involved in transendothelial migration of leukocytes during immune and inflammatory responses as well as co-stimulation of T cells (Domniguez-Soto et al. 2005). The RUNX3 splicing isoform p33 lacks the Runt domain and is unable to transactivate integrin genes. The p33 isoform is induced during maturation of monocyte-derived dendritic cells (MDDC), leading to reduced expression of genes involved in inflammatory responses, such as IL8 (interleukin-8) (Puig-Kroger et al. 2010). RUNX3 positively regulates transcription of the SPP1 (osteopontin) gene, which contributes to invasiveness of pancreatic cancer cells (Whittle et al. 2015).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway47">
 <bp:pathwayOrder rdf:resource="#PathwayStep449" />
 <bp:pathwayOrder rdf:resource="#PathwayStep453" />
 <bp:pathwayOrder rdf:resource="#PathwayStep454" />
 <bp:pathwayOrder rdf:resource="#PathwayStep455" />
 <bp:pathwayOrder rdf:resource="#PathwayStep450" />
 <bp:pathwayOrder rdf:resource="#PathwayStep451" />
 <bp:pathwayOrder rdf:resource="#PathwayStep452" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction408" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction407" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction409" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction404" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction403" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction406" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction405" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence449" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 regulates NOTCH signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 negatively regulates NOTCH signaling, which contributes to the tumor suppressor role of RUNX3 in hepatocellular carcinoma. RUNX3 binds the promoter of the JAG1 gene, encoding NOTCH ligand JAG1 and inhibits its transcription (Nishina et al. 2011). In addition, RUNX3 also binds to the NOTCH1 coactivator complex at the promoter of HES1, a NOTCH target gene, and inhibits HES1 transcription (Gao et al. 2010).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction727">
 <bp:evidence rdf:resource="#Evidence805" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-Y and CREBBP,EP300 constitutively bind BCL2L11 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway46">
 <bp:pathwayOrder rdf:resource="#PathwayStep446" />
 <bp:pathwayOrder rdf:resource="#PathwayStep447" />
 <bp:pathwayOrder rdf:resource="#PathwayStep442" />
 <bp:pathwayOrder rdf:resource="#PathwayStep443" />
 <bp:pathwayOrder rdf:resource="#PathwayStep444" />
 <bp:pathwayOrder rdf:resource="#PathwayStep445" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction400" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction399" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction402" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction401" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction398" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction397" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence442" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 regulates CDKN1A transcription</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 contributes to the upregulation of the CDKN1A (p21) gene transcription in response to TGF-beta (TGFB1) signaling. RUNX3 binds to SMAD3 and SMAD4, and cooperates with the activated SMAD3:SMAD4 complex in transactivation of CDKN1A. Runx3 knockout mice exhibit decreased sensitivity to TGF-beta and develop gastric epithelial hyperplasia (Chi et al. 2005). In response to TGF-beta signaling, the CBFB:RUNX3 complex binds to the tumor suppressor ZFHX3 (ATBF1) and, through an unknown mechanism, this complex positively regulates the CDKN1A transcription (Mabuchi et al. 2010). In addition, RUNX3 may act as a TP53 co-factor, stimulating TP53-mediated transcription of target genes, including CDKN1A (p21) (Yamada et al. 2010).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction726">
 <bp:evidence rdf:resource="#Evidence804" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BCL2L11 gene expression is stimulated by FOXO1,FOXO3,(FOXO4) and NF-Y</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway49">
 <bp:pathwayOrder rdf:resource="#PathwayStep468" />
 <bp:pathwayOrder rdf:resource="#PathwayStep469" />
 <bp:pathwayOrder rdf:resource="#PathwayStep466" />
 <bp:pathwayOrder rdf:resource="#PathwayStep467" />
 <bp:pathwayOrder rdf:resource="#PathwayStep471" />
 <bp:pathwayOrder rdf:resource="#PathwayStep472" />
 <bp:pathwayOrder rdf:resource="#PathwayStep473" />
 <bp:pathwayOrder rdf:resource="#PathwayStep474" />
 <bp:pathwayOrder rdf:resource="#PathwayStep470" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction422" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction421" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction424" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction423" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction420" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction419" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction418" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction426" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction425" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence466" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of RUNX3 expression and activity</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3, like other RUNX family members, is transcribed from two promoters - the proximal P2 promoter and the distal P1 promoter. The P2 promoter is positioned within a large CpG island that is frequently methylated in solid tumors, resulting in epigenetic inactivation of the RUNX3 gene (reviewed by Levanon and Groner 2004). RUNX3 transcription is affected by SMAD4 levels. RUNX3 may directly upregulate its own transcription through a positive feedback loop (Whittle et al. 2015). Under hypoxic conditions, RUNX3 transcription is downregulated. Hypoxic silencing of RUNX3 involves hypoxia-induced upregulation of the histone methyltransferase G9a and histone deacetylase HDAC1, which leads to increased dimethylation of histone H3 at lysine residue K9 (K10 when taking into account the initiator methionine) and reduced acetylation of histone H3 at the RUNX3 promoter (Lee et al. 2009). RUNX3 protein levels are inversely related to the levels of microRNA miR-130b. Based on in silico analysis, RUNX3 is predicted to be the target of miR-130b, but binding assays and 3&apos;UTR reporter assays have not been done to confirm this (Lai et al. 2010, Paudel et al. 2016). Similar to RUNX1 and RUNX2, RUNX3 forms a transcriptionally active heterodimer with CBFB (CBF-beta) (Kim et al. 2013). RUNX3 activity can be regulated by changes in RUNX3 localization. SRC protein tyrosine kinase phosphorylates RUNX3 on multiple tyrosine residues, inhibiting its translocation from the cytosol to the nucleus and thus inhibiting RUNX3-mediated transcription (Goh et al. 2010). Subcellular localization of RUNX3 may be affected by PIM1-mediated phosphorylation (Kim et al. 2008). The P1 and P2 promoters regulate RUNX3 transcription in a cell-type/differentiation dependent manner, giving rise to the p44 and p46 isoforms of RUNX3, respectively. Several splicing isoforms have also been reported. One example is the generation of a 33 kDa protein isoform (p33) by alternative splicing. The RUNX3 p33 isoform lacks the Runt domain and is unable to transactivate the regulatory regions of integrin genes. The p33 isoform is induced during maturation of monocyte-derived dendritic cells (MDDC), leading to reduced expression of genes involved in inflammatory responses, such as IL8 (interleukin-8) (Puig-Kroger et al. 2010). E3 ubiquitin ligases MDM2 (Chi et al. 2009), SMURF1 and SMURF2 (Jin et al. 2004) are implicated in RUNX3 polyubiquitination and degradation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction729">
 <bp:evidence rdf:resource="#Evidence807" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BBC3 gene expression is stimulated by FOXO3,(FOXO1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway48">
 <bp:pathwayOrder rdf:resource="#PathwayStep457" />
 <bp:pathwayOrder rdf:resource="#PathwayStep458" />
 <bp:pathwayOrder rdf:resource="#PathwayStep459" />
 <bp:pathwayOrder rdf:resource="#PathwayStep464" />
 <bp:pathwayOrder rdf:resource="#PathwayStep460" />
 <bp:pathwayOrder rdf:resource="#PathwayStep461" />
 <bp:pathwayOrder rdf:resource="#PathwayStep462" />
 <bp:pathwayOrder rdf:resource="#PathwayStep463" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction411" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction410" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction413" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction412" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction415" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction414" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction417" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction416" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence457" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 regulates p14-ARF</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Acetylation of RUNX3 by the histone acetyl transferase p300 (EP300) and the subsequent association of acetylated RUNX3 with BRD2 correlates with upregulation of p14-ARF transcription from the CDKN2A locus. Cyclin D1 (CCND1) negatively regulates RUNX3-facilitated induction of p14-ARF by recruiting histone deacetylase HDAC4 to RUNX3, leading to RUNX3 deacetylation (Lee et al. 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction728">
 <bp:evidence rdf:resource="#Evidence806" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PINK1 gene expression is stimulated by FOXO1,FOXO3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction723">
 <bp:evidence rdf:resource="#Evidence800" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RBL2 gene expression is stimulated by FOXO1,FOXO3,FOXO4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction722">
 <bp:evidence rdf:resource="#Evidence799" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1,FOXO3,FOXO4 bind p-2S-SMAD2/3:SMAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction725">
 <bp:evidence rdf:resource="#Evidence803" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO3,(FOXO1) bind BBC3 gene first intron</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction724">
 <bp:evidence rdf:resource="#Evidence802" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FASLG gene expression is stimulated by FOXO1,FOXO3,(FOXO4)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway50">
 <bp:pathwayOrder rdf:resource="#PathwayStep479" />
 <bp:pathwayOrder rdf:resource="#PathwayStep476" />
 <bp:pathwayOrder rdf:resource="#PathwayStep477" />
 <bp:pathwayOrder rdf:resource="#PathwayStep478" />
 <bp:pathwayOrder rdf:resource="#PathwayStep480" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction431" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction430" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction429" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction428" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction427" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence476" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 regulates WNT signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 binds to complexes of beta-catenin (CTNNB1) and TCF/LEF family members. Binding of RUNX3 to CTNNB1:TCF/LEF complexes prevents their loading onto cyclin D1 (CCND1) and MYC gene promoters and interferes with WNT signaling-mediated activation of CCND1 and MYC1 transcription. RUNX3 therefore inhibits WNT-induced cellular proliferation (Ito et al. 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction730">
 <bp:evidence rdf:resource="#Evidence808" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO3,FOXO4,(FOXO1) bind BCL6 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway52">
 <bp:pathwayOrder rdf:resource="#PathwayStep486" />
 <bp:pathwayOrder rdf:resource="#PathwayStep487" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction435" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction436" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence486" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 regulates RUNX1-mediated transcription</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 binds to Runx response elements in the distal (P1) promoter of the RUNX1 gene, repressing RUNX1 transcription (Spender et al. 2005).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction732">
 <bp:evidence rdf:resource="#Evidence810" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BCL6 gene expression is stimulated by FOXO3,FOXO4,(FOXO1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway51">
 <bp:pathwayOrder rdf:resource="#PathwayStep482" />
 <bp:pathwayOrder rdf:resource="#PathwayStep483" />
 <bp:pathwayOrder rdf:resource="#PathwayStep484" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction433" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction432" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction434" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence482" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 regulates YAP1-mediated transcription</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Association of RUNX3 with the TEADs:YAP1 complex inhibits loading of the TEADs:YAP1 to the CTGF promoter, thus negatively regulating transcription of the CTGF gene which encodes the Connective tissue growth factor (Yagi et al. 1999, Zhao et al. 2008, Qiao et al. 2016).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction731">
 <bp:evidence rdf:resource="#Evidence809" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1,FOXO3,(FOXO4) bind FASLG gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway54">
 <bp:pathwayOrder rdf:resource="#PathwayStep493" />
 <bp:pathwayOrder rdf:resource="#PathwayStep494" />
 <bp:pathwayOrder rdf:resource="#PathwayStep495" />
 <bp:pathwayOrder rdf:resource="#PathwayStep496" />
 <bp:pathwayOrder rdf:resource="#PathwayStep501" />
 <bp:pathwayOrder rdf:resource="#PathwayStep502" />
 <bp:pathwayOrder rdf:resource="#PathwayStep503" />
 <bp:pathwayOrder rdf:resource="#PathwayStep504" />
 <bp:pathwayOrder rdf:resource="#PathwayStep500" />
 <bp:pathwayOrder rdf:resource="#PathwayStep509" />
 <bp:pathwayOrder rdf:resource="#PathwayStep505" />
 <bp:pathwayOrder rdf:resource="#PathwayStep506" />
 <bp:pathwayOrder rdf:resource="#PathwayStep507" />
 <bp:pathwayOrder rdf:resource="#PathwayStep508" />
 <bp:pathwayOrder rdf:resource="#PathwayStep512" />
 <bp:pathwayOrder rdf:resource="#PathwayStep513" />
 <bp:pathwayOrder rdf:resource="#PathwayStep514" />
 <bp:pathwayOrder rdf:resource="#PathwayStep515" />
 <bp:pathwayOrder rdf:resource="#PathwayStep497" />
 <bp:pathwayOrder rdf:resource="#PathwayStep498" />
 <bp:pathwayOrder rdf:resource="#PathwayStep499" />
 <bp:pathwayOrder rdf:resource="#PathwayStep510" />
 <bp:pathwayOrder rdf:resource="#PathwayStep511" />
 <bp:pathwayOrder rdf:resource="#PathwayStep516" />
 <bp:pathwayOrder rdf:resource="#PathwayStep517" />
 <bp:pathwayOrder rdf:resource="#PathwayStep518" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction460" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction444" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction443" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction465" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction446" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction445" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction440" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction462" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction461" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction442" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction464" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction441" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction463" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction448" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction447" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction449" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction455" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction454" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction457" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction456" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction451" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction450" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction453" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction452" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction459" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction458" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence493" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 regulates neuronal receptors and channels</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptors directly transcriptionally regulated by MECP2 include glutamate receptor GRIA2 (Qiu et al. 2012), NMDA receptor subunits GRIN2A (Durand et al. 2012) and GRIN2B (Lee et al. 2008), opioid receptors OPRK1 (Chahrour et al. 2008) and OPRM1 (Hwang et al. 2009, Hwang et al. 2010, Samaco et al. 2012), GPRIN1 (Chahrour et al. 2008), MET (Plummer et al. 2013), and NOTCH1 (Li et al. 2014). Channels/transporters regulated by MECP2 include TRPC3 (Li et al. 2012) and SLC2A3 (Chen et al. 2013). MECP2 also regulates transcription of FKBP5, involved in trafficking of glucocorticoid receptors (Nuber et al. 2005, Urdinguio et al. 2008) and is implicated in regulation of expression of SEMA3F (semaphorin 3F) in mouse olfactory neurons (Degano et al. 2009). In zebrafish, Mecp2 is implicated in sensory axon guidance by direct stimulation of transcription of Sema5b and Robo2 (Leong et al. 2015). MECP2 may indirectly regulate signaling by neuronal receptor tyrosine kinases by regulating transcription of protein tyrosine phosphatases, PTPN1 (Krishnan et al. 2015) and PTPN4 (Williamson et al. 2015).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway53">
 <bp:pathwayOrder rdf:resource="#PathwayStep570" />
 <bp:pathwayOrder rdf:resource="#PathwayStep490" />
 <bp:pathwayOrder rdf:resource="#PathwayStep491" />
 <bp:pathwayOrder rdf:resource="#PathwayStep492" />
 <bp:pathwayOrder rdf:resource="#PathwayStep556" />
 <bp:pathwayOrder rdf:resource="#PathwayStep557" />
 <bp:pathwayOrder rdf:resource="#PathwayStep568" />
 <bp:pathwayOrder rdf:resource="#PathwayStep536" />
 <bp:pathwayOrder rdf:resource="#PathwayStep558" />
 <bp:pathwayOrder rdf:resource="#PathwayStep569" />
 <bp:pathwayOrder rdf:resource="#PathwayStep537" />
 <bp:pathwayOrder rdf:resource="#PathwayStep559" />
 <bp:pathwayOrder rdf:resource="#PathwayStep520" />
 <bp:pathwayOrder rdf:resource="#PathwayStep521" />
 <bp:pathwayOrder rdf:resource="#PathwayStep554" />
 <bp:pathwayOrder rdf:resource="#PathwayStep489" />
 <bp:pathwayOrder rdf:resource="#PathwayStep522" />
 <bp:pathwayOrder rdf:resource="#PathwayStep555" />
 <bp:pathwayOrder rdf:resource="#PathwayStep527" />
 <bp:pathwayOrder rdf:resource="#PathwayStep538" />
 <bp:pathwayOrder rdf:resource="#PathwayStep539" />
 <bp:pathwayOrder rdf:resource="#PathwayStep519" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction482" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction481" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction466" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction499" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction498" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction468" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction501" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction512" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction467" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction500" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction511" />
 <bp:pathwayComponent rdf:resource="#Pathway54" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction483" />
 <bp:pathwayComponent rdf:resource="#Pathway56" />
 <bp:pathwayComponent rdf:resource="#Pathway55" />
 <bp:pathwayComponent rdf:resource="#Pathway58" />
 <bp:pathwayComponent rdf:resource="#Pathway57" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction437" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction502" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction513" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction439" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction438" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence489" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcriptional Regulation by MECP2</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 is an X chromosome gene whose loss-of-function mutations are an underlying cause of the majority of Rett syndrome cases. The MECP2 gene locus consists of four exons. Both exon 1 and exon 2 contain translation start sites. Alternative splicing of the second exon results in expression of two MECP2 transcript isoforms, MECP2_e1 (MECP2B or MECP2alpha) and MECP2_e2 (MECP2A or MECP2beta). The N-terminus of the MECP2_e1 isoform, in which exon 2 is spliced out, is encoded by exon 1. The N-terminus of the MECP2_e2 isoforms, which includes both exon 1 and exon 2, is encoded by exon 2, as the exon 2 translation start site is used. Exons 3 and 4 are present in both isoforms. The MECP2_e2 isoform was cloned first and is therefore more extensively studied. The MECP2_e1 isoform is more abundant in the brain (Mnatzakanian et al. 2004, Kriaucionis and Bird 2004, Kaddoum et al. 2013). Mecp2 isoforms show different expression patterns during mouse brain development and in adult brain regions (Dragich et al. 2007, Olson et al. 2014). While Rett syndrome mutations mainly occur in exons 3 and 4 of MECP2, thereby affecting both MECP2 isoforms (Mnatzakanian et al. 2004), some mutations occur in exon 1, affecting MECP2_e1 only. No mutations have been described in exon 2 (Gianakopoulos et al. 2012). Knockout of Mecp2_e1 isoform in mice, through a naturally occurring Rett syndrome point mutation which affects the first translation codon of MECP2_e1, recapitulates Rett-like phenotype. Knockout of Mecp2_e2 isoform in mice does not result in impairment of neurologic functions (Yasui et al. 2014). In Mecp2 null mice, transgenic expression of either Mecp2_e1 or Mecp2_e2 prevents development of Rett-like phenotype, with Mecp2_e1 rescuing more Rett-like symptoms than Mecp2_e2. This indicates that both splice variants can fulfill basic Mecp2 functions in the mouse brain (Kerr et al. 2012). Changes in gene expression upon over-expression of either MECP2_e1 or MECP2_e2 imply overlapping as well as distinct target genes (Orlic-Milacic et al. 2014). Methyl-CpG-binding protein 2 encoded by the MECP2 gene binds to methylated CpG sequences in the DNA. The binding is not generic, however, but is affected by the underlying DNA sequence (Yoon et al. 2003). MECP2 binds to DNA containing 5 methylcytosine (5mC DNA), a DNA modification associated with transcriptional repression (Mellen et al. 2012), both in the context of CpG islands and outside of CpG islands (Chen et al. 2015). In addition, MECP2 binds to DNA containing 5 hydroxymethylcytosine (5hmC DNA), a DNA modification associated with transcriptional activation (Mellen et al. 2012). MECP2 binds to DNA as a monomer, occupying about 11 bp of the DNA. Binding of one MECP2 molecule facilitates binding of the second MECP2 molecule, and therefore clustering can occur at target sites. MECP2 binding to chromatin may be facilitated by nucleosome methylation (Ghosh et al. 2010). MECP2 was initially proposed to act as a generic repressor of gene transcription. However, high throughput studies of MECP2-induced changes in gene expression in mouse hippocampus (Chahrour et al. 2008), and mouse and human cell lines (Orlic-Milacic et al. 2014) indicate that more genes are up-regulated than down-regulated when MECP2 is overexpressed. At least for some genes directly upregulated by MECP2, it was shown that a complex of MECP2 and CREB1 was involved in transcriptional stimulation (Chahrour et al. 2008, Chen et al. 2013). MECP2 expression is the highest in postmitotic neurons compared to other cell types, with MECP2 being almost as abundant as core histones. Phosphorylation of MECP2 in response to neuronal activity regulates binding of MECP2 to DNA, suggesting that MECP2 may remodel chromatin in a neuronal activity-dependent manner. The resulting changes in gene expression would then modulate synaptic plasticity and behavior (reviewed by Ebert and Greenberg 2013). In human embryonic stem cell derived Rett syndrome neurons, loss of MECP2 is associated with a significant reduction in transcription of neuronally active genes, as well as the reduction in nascent protein synthesis. The reduction in nascent protein synthesis can at least in part be attributed to the decreased activity of the PI3K/AKT/mTOR signaling pathway. Neuronal morphology (reduced soma size) and the level of protein synthesis in Rett neurons can be ameliorated by treating the cells with growth factors which activate the PI3K/AKT/mTOR cascade or by inhibition of PTEN, the negative regulator of AKT activation. Mitochondrial gene expression is also downregulated in Rett neurons, which is associated with a reduced capacity of the mitochondrial electron transport chain (Ricciardi et al. 2011, Li et al. 2013). Treatment of Mecp2 null mice with IGF1 (insulin-like growth factor 1) reverses or ameliorates some Rett-like features such as locomotion, respiratory difficulties and irregular heart rate (Tropea et al. 2009). MECP2 regulates expression of a number of ligands and receptors involved in neuronal development and function. Ligands regulated by MECP2 include BDNF (reviewed by Li and Pozzo-Miller 2014, and KhorshidAhmad et al. 2016), CRH (McGill et al. 2006, Samaco et al. 2012), SST (Somatostatin) (Chahrour et al. 2008), and DLL1 (Li et al. 2014). MECP2 also regulates transcription of genes involved in the synthesis of the neurotransmitter GABA &#8211; GAD1 (Chao et al. 2010) and GAD2 (Chao et al. 2010, He et al. 2014). MECP2 may be involved in direct stimulation of transcription from the GLUD1 gene promoter, encoding mitochondrial glutamate dehydrogenase 1, which may be involved in the turnover of the neurotransmitter glutamate (Livide et al. 2015). Receptors regulated by MECP2 include glutamate receptor GRIA2 (Qiu et al. 2012), NMDA receptor subunits GRIN2A (Durand et al. 2012) and GRIN2B (Lee et al. 2008), opioid receptors OPRK1 (Chahrour et al. 2008) and OPRM1 (Hwang et al. 2009, Hwang et al. 2010, Samaco et al. 2012), GPRIN1 (Chahrour et al. 2008), MET (Plummer et al. 2013), NOTCH1 (Li et al. 2014). Channels/transporters regulated by MECP2 include TRPC3 (Li et al. 2012) and SLC2A3 (Chen et al. 2013). MECP2 regulates transcription of FKBP5, involved in trafficking of glucocorticoid receptors (Nuber et al. 2005, Urdinguio et al. 2008). MECP2 is implicated in regulation of expression of SEMA3F (semaphorin 3F) in mouse olfactory neurons (Degano et al. 2009). In zebrafish, Mecp2 is implicated in sensory axon guidance by direct stimulation of transcription of Sema5b and Robo2 (Leong et al. 2015). MECP2 may indirectly regulate signaling by neuronal receptor tyrosine kinases by regulating transcription of protein tyrosine phosphatases, PTPN1 (Krishnan et al. 2015) and PTPN4 (Williamson et al. 2015). MECP2 regulates transcription of several transcription factors involved in functioning of the nervous system, such as CREB1, MEF2C, RBFOX1 (Chahrour et al. 2008) and PPARG (Mann et al. 2010, Joss-Moore et al. 2011). MECP2 associates with transcription and chromatin remodeling factors, such as CREB1 (Chahrour et al. 2008, Chen et al. 2013), the HDAC1/2-containing SIN3A co-repressor complex (Nan et al. 1998), and the NCoR/SMRT complex (Lyst et al. 2013, Ebert et al. 2013). There are contradictory reports on the interaction of MECP2 with the SWI/SNF chromatin-remodeling complex (Harikrishnan et al. 2005, Hu et al. 2006). Interaction of MECP2 with the DNA methyltransferase DNMT1 has been reported, with a concomitant increase in enzymatic activity of DNMT1 (Kimura and Shiota 2003). In addition to DNA binding-dependent regulation of gene expression by MECP2, MECP2 may influence gene expression by interaction with components of the DROSHA microprocessor complex and the consequent change in the levels of mature microRNAs (Cheng et al. 2014, Tsujimura et al. 2015). Increased MECP2 promoter methylation is observed in both male and female autism patients (Nagarajan et al. 2008). Regulatory elements that undergo methylation are found in the promoter and the first intron of MECP2 and their methylation was shown to regulate Mecp2 expression in mice (Liyanage et al. 2013). Mouse Mecp2 promoter methylation was shown to be affected by stress (Franklin et al. 2010). The Rett-like phenotype of Mecp2 null mice is reversible (Guy et al. 2007), but appropriate levels of Mecp2 expression need to be achieved (Alvarez-Saavedra et al. 2007). When Mecp2 expression is restored in astrocytes of Mecp2 null mice, amelioration of Rett symptoms occurs, involving non-cell-autonomous positive effect on mutant neurons and increasing level of the excitatory glutamate transporter VGLUT1 (Lioy et al. 2011). Microglia derived from Mecp2 null mice releases higher than normal levels of glutamate, which has toxic effect on neurons. Increased glutamate secretion may be due to increased levels of glutaminase (Gls), involved in glutamate synthesis, and increased levels of connexin-32 (Gjb1), involved in glutamate release, in Mecp2 null microglia (Maezawa and Jin 2010). Targeted deletion of Mecp2 from Sim1-expressing neurons of the mouse hypothalamus recapitulates some Rett syndrome-like features and highlights the role of Mecp2 in feeding behavior and response to stress (Fyffe et al. 2008). Mecp2 overexpression, similar to MECP2 duplication syndrome, causes neurologic phenotype similar to Rett (Collins et al. 2004, Luikenhuis et al. 2004, Van Esch et al. 2005, Alvarez-Saavedra 2007, Van Esch et al. 2012). The phenotype of the mouse model of the MECP2 duplication syndrome in adult mice is reversible when Mecp2 expression levels are corrected (Sztainberg et al. 2015). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway56">
 <bp:pathwayOrder rdf:resource="#PathwayStep534" />
 <bp:pathwayOrder rdf:resource="#PathwayStep535" />
 <bp:pathwayOrder rdf:resource="#PathwayStep530" />
 <bp:pathwayOrder rdf:resource="#PathwayStep531" />
 <bp:pathwayOrder rdf:resource="#PathwayStep532" />
 <bp:pathwayOrder rdf:resource="#PathwayStep533" />
 <bp:pathwayOrder rdf:resource="#PathwayStep528" />
 <bp:pathwayOrder rdf:resource="#PathwayStep529" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction477" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction476" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction479" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction478" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction473" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction475" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction474" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction480" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence528" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 regulates transcription of neuronal ligands</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ligands regulated by MECP2 include BDNF (reviewed by Li and Pozzo Miller 2014, and KhorshidAhmad et al. 2016), CRH (McGill et al. 2006, Samaco et al. 2012), SST (Somatostatin) (Chahrour et al. 2008), and DLL1 (Li et al. 2014). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway55">
 <bp:pathwayOrder rdf:resource="#PathwayStep523" />
 <bp:pathwayOrder rdf:resource="#PathwayStep524" />
 <bp:pathwayOrder rdf:resource="#PathwayStep525" />
 <bp:pathwayOrder rdf:resource="#PathwayStep526" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction472" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction471" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction470" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction469" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence523" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 regulates transcription of genes involved in GABA signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 regulates expression of several genes involved in GABA (gamma-aminobutyric acid) signaling. Transcription of GAD1 (GAD67) and GAD2 (GAD65) genes is directly positively regulated by MECP2. GAD1 and GAD2 are components of the glutamic acid decarboxylase complex involved in production of the neurotransmitter GABA. Mice lacking Mecp2 from GABA-releasing neurons have decreased GABA levels and exhibit multiple Rett syndrome features (Chao et al. 2010). Mecp2 deletion in mouse GABAergic parvalbumin-expressing (PV) cells, cortical interneurons playing a key role in visual experience-induced ocular dominance plasticity, does not result in Rett-like phenotype, other than defects in motor coordination and motor learning. While functions of the visual cortex are preserved in mice lacking Mecp2 in GABAergic PV cells, the visual input-induced spiking responses are decreased. Mecp2 loss impairs maturation of membrane functions of cortical GABAergic PV cells. Mecp2 may be needed for PV cell-mediated cortical GABA inhibition. Mecp2-deficient cortical PV cells show reduced mRNA levels of several genes involved in GABA signaling, such as Parvalbumin, Gad2, Calretinin, Gabra1 and Gabra2, as well as reduced levels of Glu3, a glutamate receptor subunit, and Kv3.1, a potassium channel (He et al. 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway58">
 <bp:pathwayOrder rdf:resource="#PathwayStep567" />
 <bp:pathwayOrder rdf:resource="#PathwayStep563" />
 <bp:pathwayOrder rdf:resource="#PathwayStep564" />
 <bp:pathwayOrder rdf:resource="#PathwayStep565" />
 <bp:pathwayOrder rdf:resource="#PathwayStep566" />
 <bp:pathwayOrder rdf:resource="#PathwayStep560" />
 <bp:pathwayOrder rdf:resource="#PathwayStep561" />
 <bp:pathwayOrder rdf:resource="#PathwayStep562" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction510" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction507" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction506" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction509" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction508" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction503" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction505" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction504" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence560" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 regulates transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 regulates transcription of several transcription factors involved in functioning of the nervous system, such as CREB1, MEF2C, RBFOX1 (Chahrour et al. 2008) and PPARG (Mann et al. 2010, Joss Moore et al. 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction738">
 <bp:evidence rdf:resource="#Evidence816" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1,FOXO3,(FOXO4) bind BCL2L11 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway57">
 <bp:pathwayOrder rdf:resource="#PathwayStep550" />
 <bp:pathwayOrder rdf:resource="#PathwayStep540" />
 <bp:pathwayOrder rdf:resource="#PathwayStep551" />
 <bp:pathwayOrder rdf:resource="#PathwayStep545" />
 <bp:pathwayOrder rdf:resource="#PathwayStep546" />
 <bp:pathwayOrder rdf:resource="#PathwayStep547" />
 <bp:pathwayOrder rdf:resource="#PathwayStep548" />
 <bp:pathwayOrder rdf:resource="#PathwayStep541" />
 <bp:pathwayOrder rdf:resource="#PathwayStep552" />
 <bp:pathwayOrder rdf:resource="#PathwayStep542" />
 <bp:pathwayOrder rdf:resource="#PathwayStep553" />
 <bp:pathwayOrder rdf:resource="#PathwayStep543" />
 <bp:pathwayOrder rdf:resource="#PathwayStep544" />
 <bp:pathwayOrder rdf:resource="#PathwayStep549" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction491" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction490" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction493" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction492" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction488" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction487" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction489" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction484" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction495" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction494" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction486" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction497" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction485" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction496" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence540" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of MECP2 expression and activity</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcription of the MECP2 gene is known to be regulated by methylation of the promoter and the first intron, but the responsible methyltransferases are not known (Nagarajan et al. 2008, Franklin et al. 2010, Liyanage et al. 2013). Translation of MECP2 mRNA is negatively regulated by the microRNA miR-132. Transcription of miR-132 is regulated by BDNF signaling, through an unknown mechanism (Klein et al. 2007, Su et al. 2015). Binding of MECP2 to other proteins and to DNA is regulated by posttranslational modifications, of which phosphorylation has been best studied. Calcium dependent protein kinases, PKA and CaMK IV, activated by neuronal membrane depolarization, phosphorylate MECP2 at threonine residue T308 (corresponding to T320 in the longer MECP2 splicing isoform, MECP2_e1). Phosphorylation at T308 correlates with neuronal activity and inhibits binding of MECP2 to the nuclear receptor co-repressor complex (NCoR/SMRT) (Ebert et al. 2013). In resting neurons, MECP2 is phosphorylated at serine residue S80, which results in a decreased association of MECP2 with chromatin. Nuclear serine/threonine protein kinase HIPK2 phosphorylates MECP2 on serine residue S80 (Bracaglia et al. 2009). In activity-induced neurons, upon neuronal membrane depolarization, MECP2 S80 becomes dephosphorylated, and MECP2 acquires phosphorylation on serine S423 (corresponding to mouse Mecp2 serine S421). CaMK IV is one of the kinases that can phosphorylate MECP2 on S423. Phosphorylation of MECP2 at S423 increases MECP2 binding to chromatin (Zhou et al. 2006, Tao et al. 2009, Qiu et al. 2012). AURKB phosphorylates MECP2 at serine residue S423 in dividing adult neuronal progenitor cells (Li et al. 2014). Besides binding to the NCoR/SMRT co-repressor complex (Lyst et al. 2013, Ebert et al. 2013), MECP2 binds the SIN3A co-repressor complex. This interaction involves the transcriptional repressor domain of MECP2 and the amino terminal part of the HDAC interaction domain (HID) of SIN3A. HDAC1 and HDAC2 are part of the SIN3A co-repressor complex that co-immunoprecipitates with MECP2 (Nan et al. 1998). While binding of MECP2 to SIN3A at target genes is associated with transcriptional repression, binding to CREB1 at target genes is associated with transcriptional activation (Chahrour et al. 2008, Chen et al. 2013). Function of MECP2 can be affected by binding to FOXG1, another gene mutated in Rett syndrome besides MECP2 and CDKL5 (Dastidar et al. 2012), and HTT (Huntingtin) (McFarland et al. 2013). The subnuclear localization of MECP2 may be affected by binding to the Lamin B receptor (LBR) (Guarda et al. 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction737">
 <bp:evidence rdf:resource="#Evidence815" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1,FOXO3 bind PINK1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway59">
 <bp:pathwayOrder rdf:resource="#PathwayStep608" />
 <bp:pathwayOrder rdf:resource="#PathwayStep572" />
 <bp:pathwayComponent rdf:resource="#Pathway61" />
 <bp:pathwayComponent rdf:resource="#Pathway60" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence572" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcriptional Regulation by NPAS4</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 (Neuronal PAS domain containing protein 4) is a calcium dependent transcription factor predominantly expressed in neurons that regulates activation of genes involved in neuronal circuit formation, function, and plasticity (Ooe et al. 2004; Lin et al. 2008; Ramamoorthi et al. 2011; Maya-Vetencourt 2013; Sun and Lin 2016; Weng et al. 2018). NPAS4 possesses a conserved basic helix loop helix (bHLH) motif and a PAS domain (Fahim et al. 2018). NPAS4 is among the most rapidly induced immediate early genes (IEGs), which are activated after sensory and behavioral experience and thought to be crucial for formation of long term memory (Ramamoorthi et al. 2011; Sun et al. 2016; Heslin and Coutellier 2018; Weng et al. 2018). NPAS4 is activated within minutes of neuronal stimulation to regulate the formation of inhibitory synapses (Lin et al. 2008). Transcriptional targets of NPAS4 include transcription factors and proteins involved in signal transduction and protein trafficking (Lin et al. 2008). NPAS4 regulates development of glutamatergic and GABAergic synapses essential for information processing and memory formation (Lin et al. 2008, Weng et al. 2018). NPAS4 induced gene expression programs differ between excitatory and inhibitory neurons (Spiegel et al. 2014), leading to a circuit wide homeostatic response. Besides directly regulating function of neurons, NPAS4 may be involved in the regulation of neuroinflammation and neuronal apoptosis (Zhang et al. 2009; Choy et al. 2015; Fan et al. 2016; Zhang et al. 2021). NPAS4 is expressed in the pancreatic beta cells and regulates their function under stress conditions (Sabatini et al. 2018). For review, please refer to Sun and Lin 2016, and Fu et al. 2020.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction739">
 <bp:evidence rdf:resource="#Evidence818" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated CEBPB and NFKB complex bind IL6 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction734">
 <bp:evidence rdf:resource="#Evidence812" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1,FOXO3 bind CITED2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction733">
 <bp:evidence rdf:resource="#Evidence811" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STK11 gene transcription is stimulated by FOXO3,FOXO4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction736">
 <bp:evidence rdf:resource="#Evidence814" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CITED2 gene expression is stimulated by FOXO1,FOXO3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction735">
 <bp:evidence rdf:resource="#Evidence813" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO3,FOXO4 bind STK11 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway70">
 <bp:pathwayOrder rdf:resource="#PathwayStep710" />
 <bp:pathwayOrder rdf:resource="#PathwayStep711" />
 <bp:pathwayOrder rdf:resource="#PathwayStep712" />
 <bp:pathwayOrder rdf:resource="#PathwayStep713" />
 <bp:pathwayOrder rdf:resource="#PathwayStep709" />
 <bp:pathwayOrder rdf:resource="#PathwayStep714" />
 <bp:pathwayOrder rdf:resource="#PathwayStep715" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction642" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction641" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction644" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction643" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction640" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction646" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction645" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence709" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 regulates genes involved in cell migration</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 regulates expression of several genes implicated in cell migration during normal development and bone metastasis of breast cancer cells. RUNX2 stimulates transcription of the ITGA5 gene, encoding Integrin alpha 5. Integrin alpha-5 promotes adhesion of breast cancer cells to the bone, thus facilitating formation of bone metastases (Li et al. 2016). ITGA5 is implicated in migration of human dental pulp stem cells (Xu et al. 2015). In zebrafish, Integrin alpha-5 coordinates cell migration during development of sensory organs (Bhat et al. 2011). During mouse retinal angiogenesis, Integrin alpha-5 regulates migration of endothelial cells (Stenzel et al. 2011). The ITGBL1 gene encodes Integrin beta like protein 1, which is implicated in regulation of TGF-beta signaling and RUNX2-induced bone metastasis of breast cancer (Li et al. 2015). RUNX2 mediated transcription of the MMP13 gene, encoding Colagenase 3 (Matrix metalloproteinase 13), is stimulated by AKT mediated phosphorylation of RUNX2 and is implicated in invasiveness of breast cancer cells (Pande et al. 2013). MMP13 is involved in migration of innate immune system cells in response to injury (Zhang et al. 2008) and in remodelling of skeletal tissues (Ortega et al. 2003). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway61">
 <bp:pathwayOrder rdf:resource="#PathwayStep612" />
 <bp:pathwayOrder rdf:resource="#PathwayStep609" />
 <bp:pathwayComponent rdf:resource="#Pathway63" />
 <bp:pathwayComponent rdf:resource="#Pathway62" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence609" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NPAS4 gene expression</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 is predominantly expressed in neuronal cells. In neurons, expression of NPAS4 is regulated by Ca2+, which ties NPAS4 level to neuronal activity (Lin et al. 2008; Zhang et al. 2009; Kim et al. 2010; Mellstr&#246;m et al. 2014; Lobos et al. 2021).  NPAS4 expression is regulated by signaling pathways activated downstream of the N-methyl-D-aspartate (NMDA) receptor and L-type Ca2+ channel (Coba et al. 2008; Lin et al. 2008; Horvath et al. 2021).  In vivo, NPAS4 expression is activated by visual stimulation (Lin et al. 2008), contextual learning (Ramamoorthi et al. 2011), as well as pharmacologically induced generalized seizure (Flood et al. 2004). Chronic stress induces downregulation of NPAS4 gene expression in the hippocampus (Furukawa-Hibi et al. 2015), so does social isolation (Ibi et al. 2008). Adult female mice who were exposed to early maternal separation (early life stress) show upregulation of NPAS4 in the prefrontal cortex later in life (Ryabushkina et al. 2020). NPAS4 is thought to have a neuroprotective effect and is downregulated during neurodegeneration (Ooe et al. 2009; Zhang et al. 2009; Louis Sam Titus et al 2019). NPAS4 level is reduced in the hippocampus of aged, memory-impaired mice (Qiu et al. 2016). Studies in mice indicate that NPAS4 affects synaptic connections in excitatory and inhibitory neurons, neural circuit plasticity, and memory formation (reviewed by Sun and Lin 2016). NPAS4 may be involved in the functioning of the circadian system (Unfried et al. 2010; West et al. 2013; Xu et al. 2021).  Npas4 mRNA levels are downregulated upon infection with Zika virus through an unknown mechanism (Alpuche-Lazcano et al. 2021).  Besides neuronal cells, NPAS4 is also expressed in pancreatic beta cells, where its levels are regulated by intracellular calcium, as in the nervous system (Speckmann et al. 2016).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep963">
 <bp:stepProcess rdf:resource="#BiochemicalReaction872" />
 <bp:stepProcess rdf:resource="#Catalysis145" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway60">
 <bp:pathwayOrder rdf:resource="#PathwayStep592" />
 <bp:pathwayOrder rdf:resource="#PathwayStep593" />
 <bp:pathwayOrder rdf:resource="#PathwayStep594" />
 <bp:pathwayOrder rdf:resource="#PathwayStep573" />
 <bp:pathwayOrder rdf:resource="#PathwayStep595" />
 <bp:pathwayOrder rdf:resource="#PathwayStep590" />
 <bp:pathwayOrder rdf:resource="#PathwayStep591" />
 <bp:pathwayOrder rdf:resource="#PathwayStep589" />
 <bp:pathwayOrder rdf:resource="#PathwayStep600" />
 <bp:pathwayOrder rdf:resource="#PathwayStep601" />
 <bp:pathwayOrder rdf:resource="#PathwayStep602" />
 <bp:pathwayOrder rdf:resource="#PathwayStep603" />
 <bp:pathwayOrder rdf:resource="#PathwayStep585" />
 <bp:pathwayOrder rdf:resource="#PathwayStep586" />
 <bp:pathwayOrder rdf:resource="#PathwayStep587" />
 <bp:pathwayOrder rdf:resource="#PathwayStep588" />
 <bp:pathwayOrder rdf:resource="#PathwayStep604" />
 <bp:pathwayOrder rdf:resource="#PathwayStep605" />
 <bp:pathwayOrder rdf:resource="#PathwayStep606" />
 <bp:pathwayOrder rdf:resource="#PathwayStep607" />
 <bp:pathwayOrder rdf:resource="#PathwayStep581" />
 <bp:pathwayOrder rdf:resource="#PathwayStep582" />
 <bp:pathwayOrder rdf:resource="#PathwayStep583" />
 <bp:pathwayOrder rdf:resource="#PathwayStep584" />
 <bp:pathwayOrder rdf:resource="#PathwayStep580" />
 <bp:pathwayOrder rdf:resource="#PathwayStep578" />
 <bp:pathwayOrder rdf:resource="#PathwayStep579" />
 <bp:pathwayOrder rdf:resource="#PathwayStep574" />
 <bp:pathwayOrder rdf:resource="#PathwayStep596" />
 <bp:pathwayOrder rdf:resource="#PathwayStep575" />
 <bp:pathwayOrder rdf:resource="#PathwayStep597" />
 <bp:pathwayOrder rdf:resource="#PathwayStep576" />
 <bp:pathwayOrder rdf:resource="#PathwayStep598" />
 <bp:pathwayOrder rdf:resource="#PathwayStep577" />
 <bp:pathwayOrder rdf:resource="#PathwayStep599" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction521" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction543" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction520" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction542" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction523" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction545" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction522" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction544" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction541" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction540" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction529" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction528" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction525" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction547" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction524" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction546" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction527" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction526" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction548" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction532" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction531" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction534" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction533" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction530" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction518" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction517" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction539" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction519" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction514" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction536" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction535" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction516" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction538" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction515" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction537" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence573" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 regulates expression of target genes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 is a basic helix loop helix (bHLH) transcription factor that needs to dimerize with another bHLH protein, either ARNT, ARNT2 or ARNTL, in order to be able to bind to target DNA (Ooe et al. 2004; Ooe et al. 2009).  NPAS4 is implicated as a transcriptional regulator of genes involved in neuronal development such as CDK5 (Yun et al. 2013), CDK5R1 (Yun et al. 2013), RBFOX3 (NeuN) (Yun et al. 2013), BDNF (Pruunsild et al. 2011) and RET (Sribudiani et al. 2011), genes involved in synaptogenesis and synaptic transmission such as NPTX2 (Lin et al. 2008),  MDM2 (Yoshihara et al. 2014; Lv et al. 2021), FOS (Ramamoorthi et al. 2011), IQSEC3 (Kim et al. 2021), PLK2 (Weng et al. 2018) and possibly other genes (Lin et al. 2008; Shan et al. 2018), circadian rhythm-related genes such as NAMPT (West et al. 2013), and genes involved in neuroprotection upon injury such as GEM (Takahashi et al. 2021), SYT10 (Woitecki et al. 2016) and possibly other genes (Qiu et al. 2013). In pancreatic beta-cell, NPAS4 is implicated as a regulator of insulin synthesis under stress conditions (Sabatini et al. 2013).  The circadian clock regulated gene CRY1 was identified as NPAS4 target gene in sheep brain (West et al. 2013). The DBNL gene, encoding Drebrin, a dendrytic cytoskeleton modulator, was identified as a gene directly upregulated by Npas4 (Ooe et al. 2004)  NPAS4 is expressed in endothelial cells and may play a role in angiogenesis (Esser et al. 2017). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep964">
 <bp:stepProcess rdf:resource="#BiochemicalReaction873" />
 <bp:stepProcess rdf:resource="#Catalysis146" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway63">
 <bp:pathwayOrder rdf:resource="#PathwayStep613" />
 <bp:pathwayOrder rdf:resource="#PathwayStep614" />
 <bp:pathwayOrder rdf:resource="#PathwayStep620" />
 <bp:pathwayOrder rdf:resource="#PathwayStep621" />
 <bp:pathwayOrder rdf:resource="#PathwayStep619" />
 <bp:pathwayOrder rdf:resource="#PathwayStep615" />
 <bp:pathwayOrder rdf:resource="#PathwayStep616" />
 <bp:pathwayOrder rdf:resource="#PathwayStep617" />
 <bp:pathwayOrder rdf:resource="#PathwayStep618" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction554" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction553" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction556" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction555" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction552" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction551" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction558" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction557" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction559" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence613" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NPAS4 gene transcription</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcription of the NPAS4 gene is positively regulated by neuronal stimulation-related increase in intracellular calcium levels (Lin et al. 2008; Zhang et al. 2009, Mellstr&#246;m et al. 2014; Lobos et al. 2021).  In the absence of neuronal activity induced calcium influx, KCNIP3 (DREAM) binds to the promoter of the NPAS4 gene and represses NPAS4 transcription (Mellstr&#246;m et al. 2014). In non-neuronal cells, REST protein represses transcription of the NPAS4 gene (Bersten et al. 2014). In neuronal cells, REST may have a dual effect on NPAS4 expression: acting as a positive regulator of NPAS4 transcription early upon neuronal excitation and as a negative regulator at later time points, allowing NPAS4 to return to basal levels (Prestigio et al. 2021). Binding of agonist activated glucocorticoid receptor NR3C1 (also known as GR) to evolutionarily conserved glucocorticoid response elements (GREs) upstream of the NPAS4 gene transcription start site is responsible for stress-induced repression of NPAS4 gene transcription (Furukawa Hibi et al. 2012). Chronic restraint stress as well as corticosterone injection also reduce Npas4 gene expression in the mouse hippocampus (Yun et al. 2010). Though mechanisms remain to be delineated, HDAC5 was reported by multiple studies to contribute to NPAS4 gene repression (Taniguchi et al. 2017, Hashikawa-Hobara et al. 2021; Lv et al. 2021; Rein et al. 2022). In addition, HDAC3 was reported as the NPAS4 gene repressor during neurodegeneration (Louis Sam Titus et al. 2019).  SRF (Serum response factor) stimulates NPAS4 gene transcription upon neuronal excitation (Kuzniewska et al. 2016, L&#246;sing et al. 2017, F&#246;rstner and Kn&#246;ll 2019). NPAS4 gene transcription is positively regulated by PI3K/AKT signaling (Ooe et al. 2009; Speckmann et al. 2016), and only partially dependent on ERK (MAPK) signaling (Bl&#252;thgen et al. 2017). NPAS4 may be one of the EGR1 target genes (Han et al. 2014). Neuronal activity stimulation may trigger the formation of DNA double strand breaks (DSBs) in the promoters of a subset of early-response genes, including FOS, NPAS4, and EGR1, which may contribute to their transcriptional activation (Madabushi et al. 2015). NPAS4 appears to be a downstream target involved in amyloid precursor protein (APP)-dependent regulation of inhibitory synaptic transmission (Opsomer et al. 2020). TET1, a methylcytosine dioxygenase that catalyzes oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) and promotes DNA demethylation is implicated in transcriptional activation of NPAS4 gene through demethylation of hypermethylated CpG dinucleotides in the NPAS4 gene promoter region (Rudenko et al. 2013). Transcriptional activation of the NPAS4 gene is associated with the appearance of H3K4me3 mark and 5hmC mark at the NPAS4 gene promoter (Webb et al. 2017).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep965">
 <bp:stepProcess rdf:resource="#BiochemicalReaction874" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway62">
 <bp:pathwayOrder rdf:resource="#PathwayStep611" />
 <bp:pathwayOrder rdf:resource="#PathwayStep610" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction550" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction549" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence610" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NPAS4 mRNA translation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The 3&apos;UTR of NPAS4 mRNA is highly conserved between mouse, rat and human (&gt;95% identity across ~700 bp of the 3&apos;UTR sequence). Of the three putative microRNAs, miR-224, miR-203 and miR-132/212, that were predicted to target the 3&apos;UTR of NPAS4 mRNA by multiple computational algorithms, miR-224 and miR-203 were able to significantly downregulate expression of the NPAS4 3&#8217;UTR reporter construct (Bersten et al. 2014). Downregulation of Npas4 expression by miR-224 was also shown in mouse (Choy et al. 2017). Npas4 was also reported as a target gene of miR-1 (Forget et al. 2021), miR-142 (Ji et al. 2019) and miR-744 (Choy et al. 2017). Only microRNAs that were reported to target Npas4 mRNA by at least two studies are shown in the diagram. The circulatory RNA circ_0003420 was also reported to target NPAS4 mRNA and contribute to its degradation (Xiong et al. 2021).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep966">
 <bp:stepProcess rdf:resource="#BiochemicalReaction875" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway65">
 <bp:pathwayOrder rdf:resource="#PathwayStep671" />
 <bp:pathwayOrder rdf:resource="#PathwayStep672" />
 <bp:pathwayOrder rdf:resource="#PathwayStep634" />
 <bp:pathwayOrder rdf:resource="#PathwayStep635" />
 <bp:pathwayOrder rdf:resource="#PathwayStep636" />
 <bp:pathwayOrder rdf:resource="#PathwayStep673" />
 <bp:pathwayOrder rdf:resource="#PathwayStep674" />
 <bp:pathwayOrder rdf:resource="#PathwayStep675" />
 <bp:pathwayOrder rdf:resource="#PathwayStep720" />
 <bp:pathwayOrder rdf:resource="#PathwayStep707" />
 <bp:pathwayOrder rdf:resource="#PathwayStep708" />
 <bp:pathwayOrder rdf:resource="#PathwayStep705" />
 <bp:pathwayOrder rdf:resource="#PathwayStep716" />
 <bp:pathwayOrder rdf:resource="#PathwayStep706" />
 <bp:pathwayOrder rdf:resource="#PathwayStep717" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction570" />
 <bp:pathwayComponent rdf:resource="#Pathway70" />
 <bp:pathwayComponent rdf:resource="#Pathway71" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction571" />
 <bp:pathwayComponent rdf:resource="#Pathway66" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction650" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction606" />
 <bp:pathwayComponent rdf:resource="#Pathway69" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction639" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction605" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction638" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction607" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction604" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction637" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction647" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence634" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcriptional regulation by RUNX2</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 (CBFA1 or AML3) transcription factor, similar to other RUNX family members, RUNX1 and RUNX3, can function in complex with CBFB (CBF-beta) (Kundu et al. 2002, Yoshida et al. 2002, Otto et al. 2002). RUNX2 mainly regulates transcription of genes involved in skeletal development (reviewed in Karsenty 2008). RUNX2 is involved in development of both intramembraneous and endochondral bones through regulation of osteoblast differentiation and chondrocyte maturation, respectively. RUNX2 stimulates transcription of the BGLAP gene (Ducy and Karsenty 1995, Ducy et al. 1997), which encodes Osteocalcin, a bone-derived hormone which is one of the most abundant non-collagenous proteins of the bone extracellular matrix (reviewed in Karsenty and Olson 2016). RUNX2 directly controls the expression of most genes associated with osteoblast differentiation and function (Sato et al. 1998, Ducy et al. 1999, Roce et al. 2005). RUNX2-mediated transcriptional regulation of several genes involved in GPCR (G protein coupled receptor) signaling is implicated in the control of growth of osteoblast progenitors (Teplyuk et al. 2009). RUNX2 promotes chondrocyte maturation by stimulating transcription of the IHH gene, encoding Indian hedgehog (Takeda et al. 2001, Yoshida et al. 2004). Germline loss-of-function mutations of the RUNX2 gene are associated with cleidocranial dysplasia syndrome (CCD), an autosomal skeletal disorder (reviewed in Jaruga et al. 2016). The function of RUNX2 is frequently disrupted in osteosarcoma (reviewed in Mortus et al. 2014). Vitamin D3 is implicated in regulation of transcriptional activity of the RUNX2:CBFB complex (Underwood et al. 2012). RUNX2 expression is regulated by estrogen signaling, and RUNX2 is implicated in breast cancer development and metastasis (reviewed in Wysokinski et al. 2014). Besides estrogen receptor alpha (ESR1) and estrogen-related receptor alpha (ERRA) (Kammerer et al. 2013), RUNX2 transcription is also regulated by TWIST1 (Yang, Yang et al. 2011), glucocorticoid receptor (NR3C1) (Zhang et al. 2012), NKX3-2 (BAPX1) (Tribioli and Lufkin 1999, Lengner et al. 2005), DLX5 (Robledo et al. 2002, Lee et al. 2005) and MSX2 (Lee et al. 2005). RUNX2 can autoregulate, by directly inhibiting its own transcription (Drissi et al. 2000). Several E3 ubiquitin ligases target RUNX2 for proteasome-mediated degradation: STUB1 (CHIP) (Li et al. 2008), SMURF1 (Zhao et al. 2003, Yang et al. 2014), WWP1 (Jones et al. 2006), and SKP2 (Thacker et al. 2016). Besides formation of RUNX2:CBFB heterodimers, transcriptional activity of RUNX2 is regulated by binding to a number of other transcription factors, for example SOX9 (Zhou et al. 2006, TWIST1 (Bialek et al. 2004) and RB1 (Thomas et al. 2001). RUNX2 regulates expression of several genes implicated in cell migration during normal development and bone metastasis of breast cancer cells. RUNX2 stimulates transcription of the ITGA5 gene, encoding Integrin alpha 5 (Li et al. 2016) and the ITGBL1 gene, encoding Integrin beta like protein 1 (Li et al. 2015). RUNX2 mediated transcription of the MMP13 gene, encoding Colagenase 3 (Matrix metalloproteinase 13), is stimulated by AKT mediated phosphorylation of RUNX2 (Pande et al. 2013). RUNX2 is implicated in positive regulation of AKT signaling by stimulating expression of AKT-activating TORC2 complex components MTOR and RICTOR, which may contribute to survival of breast cancer cells (Tandon et al. 2014). RUNX2 inhibits CDKN1A transcription, thus preventing CDKN1A-induced cell cycle arrest. Phosphorylation of RUNX2 by CDK4 in response to high glucose enhances RUNX2-mediated repression of the CDKN1A gene in endothelial cells (Pierce et al. 2012). In mice, Runx2-mediated repression of Cdkn1a may contribute to the development of acute myeloid leukemia (AML) (Kuo et al. 2009). RUNX2 can stimulate transcription of the LGALS3 gene, encoding Galectin-3 (Vladimirova et al. 2008, Zhang et al. 2009). Galectin 3 is expressed in myeloid progenitors and its levels increase during the maturation process (Le Marer 2000). For a review of RUNX2 function, please refer to Long 2012 and Ito et al. 2015.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway64">
 <bp:pathwayOrder rdf:resource="#PathwayStep624" />
 <bp:pathwayOrder rdf:resource="#PathwayStep625" />
 <bp:pathwayOrder rdf:resource="#PathwayStep630" />
 <bp:pathwayOrder rdf:resource="#PathwayStep631" />
 <bp:pathwayOrder rdf:resource="#PathwayStep632" />
 <bp:pathwayOrder rdf:resource="#PathwayStep626" />
 <bp:pathwayOrder rdf:resource="#PathwayStep627" />
 <bp:pathwayOrder rdf:resource="#PathwayStep628" />
 <bp:pathwayOrder rdf:resource="#PathwayStep629" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction565" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction564" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction567" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction566" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction561" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction563" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction562" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction569" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction568" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence624" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">YAP1- and WWTR1 (TAZ)-stimulated gene expression</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">YAP1 and WWTR1 (TAZ) are transcriptional co-activators, both homologues of the Drosophila Yorkie protein. They both interact with members of the TEAD family of transcription factors, and WWTR1 interacts as well with TBX5 and RUNX2, to promote gene expression. Their transcriptional targets include genes critical to regulation of cell proliferation and apoptosis. Their subcellular location is regulated by the Hippo signaling cascade: phosphorylation mediated by this cascade leads to the cytosolic sequestration of both proteins (Murakami et al. 2005; Oh and Irvine 2010).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep960">
 <bp:stepProcess rdf:resource="#BiochemicalReaction870" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway67">
 <bp:pathwayOrder rdf:resource="#PathwayStep640" />
 <bp:pathwayOrder rdf:resource="#PathwayStep641" />
 <bp:pathwayOrder rdf:resource="#PathwayStep642" />
 <bp:pathwayOrder rdf:resource="#PathwayStep639" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction576" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction575" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction574" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction573" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence639" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 regulates chondrocyte maturation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In addition to regulating osteoblast differentiation, RUNX2 regulates skeletal development by regulating maturation of chondrocytes (Takeda et al. 2001). Chondrocyte maturation happens during the process of endochondral ossification. Expression of the parathyroid hormone receptor (PTHR1) and Indian hedgehog (IHH) are hallmarks of chondrocyte maturation. Mice that are double knockouts for Runx2 and Runx3 show a complete absence of chondrocyte maturation and, hence, aberrant limb growth. Based on mouse studies, RUNX2 directly regulates transcription of the IHH gene. RUNX2 binding sites in the IHH gene promoter are conserved in humans (Yoshida et al. 2004). Also based on mouse studies, RUNX2 positively regulates transcription of NELL1 (neural EGFL-like 1), a key functional mediator of chondrogenesis, but direct binding of RUNX2 to the NELL1 gene locus has not been demonstrated (Li et al. 2017). Runx2 binding sites exist in the enhancer of the mouse Col10a1 gene, encoding type X collagen, a marker of hypertrophic chondrocytes, which is critical for endochondral bone formation. While Runx2 binding is required, it is not sufficient to trigger Col10a1 transcription (Gu et al. 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep961">
 <bp:stepProcess rdf:resource="#Pathway92" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway66">
 <bp:pathwayOrder rdf:resource="#PathwayStep644" />
 <bp:pathwayOrder rdf:resource="#PathwayStep669" />
 <bp:pathwayOrder rdf:resource="#PathwayStep643" />
 <bp:pathwayOrder rdf:resource="#PathwayStep670" />
 <bp:pathwayOrder rdf:resource="#PathwayStep637" />
 <bp:pathwayOrder rdf:resource="#PathwayStep638" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction577" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction572" />
 <bp:pathwayComponent rdf:resource="#Pathway67" />
 <bp:pathwayComponent rdf:resource="#Pathway68" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction602" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction603" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence637" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 regulates bone development</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 is required for the development of both intramembraneous and endochondral bones through regulation of osteoblast differentiation and chondrocyte maturation, respectively. In its absence, intramembraneous ossification is blocked while endochondral ossification is arrested at the cartilaginous stage (Otto et al. 1997, Komori et al. 1997). In mice and humans, RUNX2 haploinsufficiency causes Cleidocranial dysplasia, a generalized bone disorder (Otto et al. 1997, Lee et al. 1997). RUNX2 stimulates transcription of most of the genes constituting the bone extracellular matrix and of BGLAP gene, which encodes Osteocalcin, a bone-derived hormone controlling glucose metabolism, male fertility and cognition (Ducy et al. 1997). RUNX2 promotes chondrocyte maturation by stimulating transcription of the IHH gene, encoding Indian hedgehog (Takeda et al. 2001, Yoshida et al. 2004). In response to BMP2 signaling, RUNX2 forms a complex with SMAD1:SMAD4 heterotrimer in the nucleus and stimulates transcription of SMAD6 (Wang et al. 2007). RBM14, a negative regulator of RUNX2 transcriptional activity, is frequently overexpressed in osteosarcoma (Li et al. 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep962">
 <bp:stepProcess rdf:resource="#BiochemicalReaction871" />
 <bp:stepProcess rdf:resource="#Catalysis144" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway69">
 <bp:pathwayOrder rdf:resource="#PathwayStep691" />
 <bp:pathwayOrder rdf:resource="#PathwayStep692" />
 <bp:pathwayOrder rdf:resource="#PathwayStep693" />
 <bp:pathwayOrder rdf:resource="#PathwayStep694" />
 <bp:pathwayOrder rdf:resource="#PathwayStep690" />
 <bp:pathwayOrder rdf:resource="#PathwayStep688" />
 <bp:pathwayOrder rdf:resource="#PathwayStep689" />
 <bp:pathwayOrder rdf:resource="#PathwayStep700" />
 <bp:pathwayOrder rdf:resource="#PathwayStep701" />
 <bp:pathwayOrder rdf:resource="#PathwayStep702" />
 <bp:pathwayOrder rdf:resource="#PathwayStep684" />
 <bp:pathwayOrder rdf:resource="#PathwayStep685" />
 <bp:pathwayOrder rdf:resource="#PathwayStep686" />
 <bp:pathwayOrder rdf:resource="#PathwayStep687" />
 <bp:pathwayOrder rdf:resource="#PathwayStep703" />
 <bp:pathwayOrder rdf:resource="#PathwayStep704" />
 <bp:pathwayOrder rdf:resource="#PathwayStep680" />
 <bp:pathwayOrder rdf:resource="#PathwayStep681" />
 <bp:pathwayOrder rdf:resource="#PathwayStep682" />
 <bp:pathwayOrder rdf:resource="#PathwayStep683" />
 <bp:pathwayOrder rdf:resource="#PathwayStep677" />
 <bp:pathwayOrder rdf:resource="#PathwayStep699" />
 <bp:pathwayOrder rdf:resource="#PathwayStep678" />
 <bp:pathwayOrder rdf:resource="#PathwayStep679" />
 <bp:pathwayOrder rdf:resource="#PathwayStep695" />
 <bp:pathwayOrder rdf:resource="#PathwayStep696" />
 <bp:pathwayOrder rdf:resource="#PathwayStep697" />
 <bp:pathwayOrder rdf:resource="#PathwayStep676" />
 <bp:pathwayOrder rdf:resource="#PathwayStep698" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction620" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction622" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction621" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction628" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction627" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction608" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction629" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction624" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction623" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction626" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction625" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction609" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction631" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction630" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction611" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction633" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction610" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction632" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction617" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction616" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction619" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction618" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction613" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction635" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction612" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction634" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction615" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction614" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction636" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence676" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of RUNX2 expression and activity</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Several transcription factors have been implicated in regulation of the RUNX2 gene transcription. Similar to the RUNX1 gene, the RUNX2 gene expression can be regulated from the proximal P2 promoter or the distal P1 promoter (reviewed in Li and Xiao 2007). Activated estrogen receptor alpha (ESR1) binds estrogen response elements (EREs) in the P2 promoter and stimulates RUNX2 transcription (Kammerer et al. 2013). Estrogen-related receptor alpha (ERRA) binds EREs or estrogen-related response elements (ERREs) in the P2 promoter of RUNX2. When ERRA is bound to its co-factor PPARG1CA (PGC1A), it stimulates RUNX2 transcription. When bound to its co-factor PPARG1CB (PGC1B), ERRA represses RUNX2 transcription (Kammerer et al. 2013). TWIST1, a basic helix-loop-helix (bHLH) transcription factor, stimulates RUNX2 transcription by binding to the E1-box in the P2 promoter (Yang, Yang et al. 2011). TWIST proteins also interact with the DNA-binding domain of RUNX2 to modulate its activity during skeletogenesis (Bialek et al. 2004). Schnurri-3 (SHN3) is another protein that interacts with RUNX2 to decrease its availability in the nucleus and therefore its activity (Jones et al. 2006). In contrast, RUNX2 and SATB2 interact to enhance the expression of osteoblast-specific genes (Dobreva et al. 2006). Formation of the heterodimer with CBFB (CBF-beta) also enhances the transcriptional activity of RUNX2 (Kundu et al. 2002, Yoshida et al. 2002, Otto et al. 2002). Transcription of RUNX2 from the proximal promoter is inhibited by binding of the glucocorticoid receptor (NR3C1) activated by dexamethasone (DEXA) to a glucocorticoid receptor response element (GRE), which is also present in the human promoter (Zhang et al. 2012). NKX3-2 (BAPX1), required for embryonic development of the axial skeleton (Tribioli and Lufkin 1999), binds the distal (P1) promoter of the RUNX2 gene and inhibits its transcription (Lengner et al. 2005). RUNX2-P1 transcription is also autoinhibited by RUNX2-P1, which binds to RUNX2 response elements in the P1 promoter of RUNX2 (Drissi et al. 2000). In contrast, binding of RUNX2-P2 to the proximal P2 promoter autoactivates transcription of RUNX2-P2 (Ducy et al. 1999). Binding of a homeodomain transcription factor DLX5, and possibly DLX6, to the RUNX2 P1 promoter stimulates RUNX2 transcription (Robledo et al. 2002, Lee et al. 2005). The homeobox transcription factor MSX2 can bind to DLX5 sites in the promoter of RUNX2 and inhibit transcription of RUNX2-P1 (Lee et al. 2005). Translocation of RUNX2 protein to the nucleus is inhibited by binding to non-activated STAT1 (Kim et al. 2003). Several E3 ubiquitin ligases were shown to polyubiquitinate RUNX2, targeting it for proteasome-mediated degradation: STUB1 (CHIP) (Li et al. 2008), SMURF1 (Zhao et al. 2003, Yang et al. 2014), WWP1 (Jones et al. 2006), and SKP2 (Thacker et al. 2016).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway68">
 <bp:pathwayOrder rdf:resource="#PathwayStep660" />
 <bp:pathwayOrder rdf:resource="#PathwayStep650" />
 <bp:pathwayOrder rdf:resource="#PathwayStep661" />
 <bp:pathwayOrder rdf:resource="#PathwayStep655" />
 <bp:pathwayOrder rdf:resource="#PathwayStep666" />
 <bp:pathwayOrder rdf:resource="#PathwayStep645" />
 <bp:pathwayOrder rdf:resource="#PathwayStep656" />
 <bp:pathwayOrder rdf:resource="#PathwayStep667" />
 <bp:pathwayOrder rdf:resource="#PathwayStep646" />
 <bp:pathwayOrder rdf:resource="#PathwayStep657" />
 <bp:pathwayOrder rdf:resource="#PathwayStep668" />
 <bp:pathwayOrder rdf:resource="#PathwayStep647" />
 <bp:pathwayOrder rdf:resource="#PathwayStep658" />
 <bp:pathwayOrder rdf:resource="#PathwayStep651" />
 <bp:pathwayOrder rdf:resource="#PathwayStep662" />
 <bp:pathwayOrder rdf:resource="#PathwayStep652" />
 <bp:pathwayOrder rdf:resource="#PathwayStep663" />
 <bp:pathwayOrder rdf:resource="#PathwayStep653" />
 <bp:pathwayOrder rdf:resource="#PathwayStep664" />
 <bp:pathwayOrder rdf:resource="#PathwayStep654" />
 <bp:pathwayOrder rdf:resource="#PathwayStep665" />
 <bp:pathwayOrder rdf:resource="#PathwayStep648" />
 <bp:pathwayOrder rdf:resource="#PathwayStep659" />
 <bp:pathwayOrder rdf:resource="#PathwayStep649" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction590" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction581" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction592" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction580" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction591" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction587" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction598" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction586" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction597" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction578" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction589" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction600" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction588" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction599" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction583" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction594" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction582" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction593" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction585" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction596" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction584" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction595" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction579" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction601" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence645" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 regulates osteoblast differentiation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The complex of RUNX2 and CBFB regulates transcription of genes involved in differentiation of osteoblasts. RUNX2 stimulates transcription of the BGLAP gene, encoding osteocalcin (Ducy and Karsenty 1995, Ducy et al. 1997). Binding of the RUNX2:CBFB complex to the BGLAP gene promoter is increased when RUNX2 is phosphorylated on serine residue S451 (Wee et al. 2002). Osteocalcin, a bone-derived hormone, is one of the most abundant non-collagenous proteins of the bone extracellular matrix (reviewed in Karsenty and Olson 2016). Association of the activated androgen receptor (AR) with RUNX2 prevents binding of RUNX2 to the BGLAP promoter (Baniwal et al. 2009). When YAP1, tyrosine phosphorylated by SRC and/or YES1, binds to RUNX2 at the BGLAP gene promoter, transcription of the BGLAP gene is inhibited (Zaidi et al. 2004). Signaling by SRC is known to inhibit osteoblast differentiation (Marzia et al. 2000). Simultaneous binding of RUNX2 and SP7 (Osterix, also known as OSX) to adjacent RUNX2 and SP7 binding sites, respectively, in the UCMA promoter, synergistically activates UCMA transcription. UCMA stimulates osteoblast differentiation and formation of mineralized nodules (Lee et al. 2015). The SCF(SKP2) E3 ubiquitin ligase complex inhibits differentiation of osteoblasts by polyubiquitinating RUNX2 and targeting it for proteasome-mediated degradation (Thacker et al. 2016). This process is inhibited by glucose uptake in osteoblasts (Wei et al. 2015).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep967">
 <bp:stepProcess rdf:resource="#BiochemicalReaction876" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep968">
 <bp:stepProcess rdf:resource="#BiochemicalReaction877" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep969">
 <bp:stepProcess rdf:resource="#BiochemicalReaction878" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep980">
 <bp:stepProcess rdf:resource="#BiochemicalReaction888" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway81">
 <bp:pathwayOrder rdf:resource="#PathwayStep832" />
 <bp:pathwayOrder rdf:resource="#PathwayStep833" />
 <bp:pathwayOrder rdf:resource="#PathwayStep834" />
 <bp:pathwayOrder rdf:resource="#PathwayStep835" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction752" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction754" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction753" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction755" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence832" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 regulates transcription of genes involved in WNT signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The RUNX1:CBFB complex directly regulates transcription of at least two components of WNT signaling. In association with its co-factor FOXP3, the RUNX1:CBFB complex stimulates transcription of the RSPO3 gene, encoding a WNT ligand that is implicated as a breast cancer oncogene (Recouvreux et al. 2016). In association with the activated estrogen receptor alpha (ESR1), the RUNX1:CBFB complex stimulates the expression of AXIN1, which functions as a regulator of WNT signaling (Stender et al. 2010). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway80">
 <bp:pathwayOrder rdf:resource="#PathwayStep831" />
 <bp:pathwayOrder rdf:resource="#PathwayStep952" />
 <bp:pathwayOrder rdf:resource="#PathwayStep932" />
 <bp:pathwayOrder rdf:resource="#PathwayStep845" />
 <bp:pathwayOrder rdf:resource="#PathwayStep961" />
 <bp:pathwayOrder rdf:resource="#PathwayStep885" />
 <bp:pathwayOrder rdf:resource="#PathwayStep918" />
 <bp:pathwayOrder rdf:resource="#PathwayStep892" />
 <bp:pathwayOrder rdf:resource="#PathwayStep879" />
 <bp:pathwayOrder rdf:resource="#PathwayStep836" />
 <bp:pathwayOrder rdf:resource="#PathwayStep913" />
 <bp:pathwayOrder rdf:resource="#PathwayStep926" />
 <bp:pathwayComponent rdf:resource="#Pathway83" />
 <bp:pathwayComponent rdf:resource="#Pathway82" />
 <bp:pathwayComponent rdf:resource="#Pathway85" />
 <bp:pathwayComponent rdf:resource="#Pathway84" />
 <bp:pathwayComponent rdf:resource="#Pathway87" />
 <bp:pathwayComponent rdf:resource="#Pathway86" />
 <bp:pathwayComponent rdf:resource="#Pathway89" />
 <bp:pathwayComponent rdf:resource="#Pathway88" />
 <bp:pathwayComponent rdf:resource="#Pathway90" />
 <bp:pathwayComponent rdf:resource="#Pathway81" />
 <bp:pathwayComponent rdf:resource="#Pathway92" />
 <bp:pathwayComponent rdf:resource="#Pathway91" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence831" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcriptional regulation by RUNX1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The RUNX1 (AML1) transcription factor is a master regulator of hematopoiesis (Ichikawa et al. 2004) that is frequently translocated in acute myeloid leukemia (AML), resulting in formation of fusion proteins with altered transactivation profiles (Lam and Zhang 2012, Ichikawa et al. 2013). In addition to RUNX1, its heterodimerization partner CBFB is also frequently mutated in AML (Shigesada et al. 2004, Mangan and Speck 2011). The core domain of CBFB binds to the Runt domain of RUNX1, resulting in formation of the RUNX1:CBFB heterodimer. CBFB does not interact with DNA directly. The Runt domain of RUNX1 mediated both DNA binding and heterodimerization with CBFB (Tahirov et al. 2001), while RUNX1 regions that flank the Runt domain are involved in transactivation (reviewed in Zhang et al. 2003) and negative regulation (autoinhibition). CBFB facilitates RUNX1 binding to DNA by stabilizing Runt domain regions that interact with the major and minor grooves of the DNA (Tahirov et al. 2001, Backstrom et al. 2002, Bartfeld et al. 2002). The transactivation domain of RUNX1 is located C-terminally to the Runt domain and is followed by the negative regulatory domain. Autoinhibiton of RUNX1 is relieved by interaction with CBFB (Kanno et al. 1998). Transcriptional targets of the RUNX1:CBFB complex involve genes that regulate self-renewal of hematopoietic stem cells (HSCs) (Zhao et al. 2014), as well as commitment and differentiation of many hematopoietic progenitors, including myeloid (Friedman 2009) and megakaryocytic progenitors (Goldfarb 2009), regulatory T lymphocytes (Wong et al. 2011) and B lymphocytes (Boller and Grosschedl 2014). RUNX1 binds to promoters of many genes involved in ribosomal biogenesis (Ribi) and is thought to stimulate their transcription. RUNX1 loss-of-function decreases ribosome biogenesis and translation in hematopoietic stem and progenitor cells (HSPCs). RUNX1 loss-of-function is therefore associated with a slow growth, but at the same time it results in reduced apoptosis and increases resistance of cells to genotoxic and endoplasmic reticulum stress, conferring an overall selective advantage to RUNX1 deficient HSPCs (Cai et al. 2015). RUNX1 is implicated as a tumor suppressor in breast cancer. RUNX1 forms a complex with the activated estrogen receptor alpha (ESR1) and regulates expression of estrogen-responsive genes (Chimge and Frenkel 2013). RUNX1 is overexpressed in epithelial ovarian carcinoma where it may contribute to cell proliferation, migration and invasion (Keita et al. 2013). RUNX1 may cooperate with TP53 in transcriptional activation of TP53 target genes upon DNA damage (Wu et al. 2013). RUNX1 is needed for the maintenance of skeletal musculature (Wang et al. 2005). During mouse embryonic development, Runx1 is expressed in most nociceptive sensory neurons, which are involved in the perception of pain. In adult mice, Runx1 is expressed only in nociceptive sensory neurons that express the Ret receptor and is involved in regulation of expression of genes encoding ion channels (sodium-gated, ATP-gated and hydrogen ion-gated) and receptors (thermal receptors, opioid receptor MOR and the Mrgpr class of G protein coupled receptors). Mice lacking Runx1 show defective perception of thermal and neuropathic pain (Chen CL et al. 2006). Runx1 is thought to activate the neuronal differentiation of nociceptive dorsal root ganglion cells during embryonal development possibly through repression of Hes1 expression (Kobayashi et al. 2012). In chick and mouse embryos, Runx1 expression is restricted to the dorso-medial domain of the dorsal root ganglion, to TrkA-positive cutaneous sensory neurons. Runx3 expression in chick and mouse embryos is restricted to ventro-lateral domain of the dorsal root ganglion, to TrkC-positive proprioceptive neurons (Chen AI et al. 2006, Kramer et al. 2006). RUNX1 mediated regulation of neuronally expressed genes will be annotated when mechanistic details become available.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway72">
 <bp:pathwayOrder rdf:resource="#PathwayStep723" />
 <bp:pathwayOrder rdf:resource="#PathwayStep724" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction653" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction652" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence723" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear Receptor transcription pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">A classic example of bifunctional transcription factors is the family of Nuclear Receptor (NR) proteins.  These are DNA-binding transcription factors that bind certain hormones, vitamins, and other small, diffusible signaling molecules.  The non-liganded NRs recruit specific corepressor complexes of the NCOR/SMRT type, to mediate transcriptional repression of the target genes to which they are bound.  During signaling, ligand binding to a specific domain the NR proteins induces a conformational change that results in the exchange of the associated CoR complex, and its replacement by a specific coactivator complex of the TRAP / DRIP / Mediator type.  These coactivator complexes typically nucleate around a MED1 coactivator protein that is directly bound to the NR transcription factor. A general feature of the 49 human NR proteins is that in the unliganded state, they each bind directly to an NCOR corepressor protein, either NCOR1 or NCOR2 (NCOR2 was previously named &quot;SMRT&quot;).  This NCOR protein nucleates the assembly of additional, specific corepressor proteins, depending on the cell and DNA context.  The NR-NCOR interaction is mediated by a specific protein interaction domain (PID) present in the NRs that binds to specific cognate PID(s) present in the NCOR proteins.  Thus, the human NRs each take part in an NR-NCOR binding reaction in the absence of binding by their ligand. A second general feature of the NR proteins is that they each contain an additional, but different PID that mediates specific binding interactions with MED1 proteins.  In the ligand-bound state, NRs each take part in an NR-MED1 binding reaction to form an NR-MED1 complex.  The bound MED1 then functions to nucleate the assembly of additional specific coactivator proteins, depending on the cell and DNA context, such as what specific target gene promoter they are bound to, and in what cell type. The formation of specific MED1-containing coactivator complexes on specific NR proteins has been well-characterized for a number of the human NR proteins (see Table 1 in (Bourbon, 2004)).  For example, binding of thyroid hormone (TH) to the human TH Receptor (THRA or THRB) was found to result in the recruitment of a specific complex of Thyroid Receptor Associated Proteins - the TRAP coactivator complex - of which the TRAP220 subunit was later identified to be the Mediator 1 (MED1) homologue. Similarly, binding of Vitamin D to the human Vitamin D3 Receptor was found to result in the recruitment of a specific complex of D Receptor Interacting Proteins - the DRIP coactivator complex, of which the DRIP205 subunit was later identified to be human MED1.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep974">
 <bp:stepProcess rdf:resource="#BiochemicalReaction883" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway71">
 <bp:pathwayOrder rdf:resource="#PathwayStep718" />
 <bp:pathwayOrder rdf:resource="#PathwayStep719" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction649" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction648" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence718" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 regulates genes involved in differentiation of myeloid cells</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Both RUNX2 and RUNX1 can stimulate transcription of the LGALS3 gene, encoding Galectin-3 (Vladimirova et al. 2008, Zhang et al. 2009). Galectin 3 is expressed in myeloid progenitors and its levels increase during the maturation process (Le Marer 2000). Galectin 3 is highly expressed in pituitary tumors and glioma (Vladimirova et al. 2008, Zhang et al. 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep975">
 <bp:stepProcess rdf:resource="#BiochemicalReaction884" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway74">
 <bp:pathwayOrder rdf:resource="#PathwayStep732" />
 <bp:pathwayOrder rdf:resource="#PathwayStep733" />
 <bp:pathwayOrder rdf:resource="#PathwayStep734" />
 <bp:pathwayOrder rdf:resource="#PathwayStep735" />
 <bp:pathwayOrder rdf:resource="#PathwayStep730" />
 <bp:pathwayOrder rdf:resource="#PathwayStep731" />
 <bp:pathwayOrder rdf:resource="#PathwayStep729" />
 <bp:pathwayOrder rdf:resource="#PathwayStep727" />
 <bp:pathwayOrder rdf:resource="#PathwayStep728" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction655" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction654" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction660" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction662" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction661" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction657" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction656" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction659" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction658" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence727" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of FOXO transcriptional activity by acetylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Oxidative stress induces acetylation of FOXO transcription factors, which changes the preference of FOXO transcription factors for target DNA sequences. Histone deacetylases SIRT1 and SIRT3 deacetylate FOXO transcription factors (Brunet et al. 2004, Daitoku et al. 2004, Motta et al. 2004, Dansen et al. 2009, Kim et al. 2010, Tseng et al. 2013, reviewed by Hisahara et al. 2005). Acetylation can also regulate FOXO localization, overriding phosphorylation (Frescas et al. 2005, Bertaggia et al. 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep976">
 <bp:stepProcess rdf:resource="#BiochemicalReaction885" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway73">
 <bp:pathwayOrder rdf:resource="#PathwayStep777" />
 <bp:pathwayOrder rdf:resource="#PathwayStep800" />
 <bp:pathwayOrder rdf:resource="#PathwayStep742" />
 <bp:pathwayOrder rdf:resource="#PathwayStep736" />
 <bp:pathwayOrder rdf:resource="#PathwayStep726" />
 <bp:pathwayComponent rdf:resource="#Pathway74" />
 <bp:pathwayComponent rdf:resource="#Pathway76" />
 <bp:pathwayComponent rdf:resource="#Pathway75" />
 <bp:pathwayComponent rdf:resource="#Pathway78" />
 <bp:pathwayComponent rdf:resource="#Pathway77" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence726" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO-mediated transcription</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The family of FOXO transcription factors includes FOXO1, FOXO3, FOXO4 and FOXO6. FOXO transcription factors integrate pathways that regulate cell survival, growth, differentiation and metabolism in response to environmental changes, such as growth factor deprivation, starvation and oxidative stress (reviewed by Accili and Arden 2004, Calnan and Brunet 2008, Eijkelenboom and Burgering 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep977">
 <bp:stepProcess rdf:resource="#Pathway93" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway76">
 <bp:pathwayOrder rdf:resource="#PathwayStep770" />
 <bp:pathwayOrder rdf:resource="#PathwayStep771" />
 <bp:pathwayOrder rdf:resource="#PathwayStep743" />
 <bp:pathwayOrder rdf:resource="#PathwayStep765" />
 <bp:pathwayOrder rdf:resource="#PathwayStep744" />
 <bp:pathwayOrder rdf:resource="#PathwayStep766" />
 <bp:pathwayOrder rdf:resource="#PathwayStep745" />
 <bp:pathwayOrder rdf:resource="#PathwayStep767" />
 <bp:pathwayOrder rdf:resource="#PathwayStep746" />
 <bp:pathwayOrder rdf:resource="#PathwayStep768" />
 <bp:pathwayOrder rdf:resource="#PathwayStep761" />
 <bp:pathwayOrder rdf:resource="#PathwayStep762" />
 <bp:pathwayOrder rdf:resource="#PathwayStep763" />
 <bp:pathwayOrder rdf:resource="#PathwayStep764" />
 <bp:pathwayOrder rdf:resource="#PathwayStep747" />
 <bp:pathwayOrder rdf:resource="#PathwayStep769" />
 <bp:pathwayOrder rdf:resource="#PathwayStep748" />
 <bp:pathwayOrder rdf:resource="#PathwayStep749" />
 <bp:pathwayOrder rdf:resource="#PathwayStep760" />
 <bp:pathwayOrder rdf:resource="#PathwayStep754" />
 <bp:pathwayOrder rdf:resource="#PathwayStep776" />
 <bp:pathwayOrder rdf:resource="#PathwayStep755" />
 <bp:pathwayOrder rdf:resource="#PathwayStep756" />
 <bp:pathwayOrder rdf:resource="#PathwayStep757" />
 <bp:pathwayOrder rdf:resource="#PathwayStep750" />
 <bp:pathwayOrder rdf:resource="#PathwayStep772" />
 <bp:pathwayOrder rdf:resource="#PathwayStep751" />
 <bp:pathwayOrder rdf:resource="#PathwayStep773" />
 <bp:pathwayOrder rdf:resource="#PathwayStep752" />
 <bp:pathwayOrder rdf:resource="#PathwayStep774" />
 <bp:pathwayOrder rdf:resource="#PathwayStep753" />
 <bp:pathwayOrder rdf:resource="#PathwayStep775" />
 <bp:pathwayOrder rdf:resource="#PathwayStep758" />
 <bp:pathwayOrder rdf:resource="#PathwayStep759" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction680" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction686" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction685" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction688" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction687" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction682" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction681" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction684" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction683" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction668" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction701" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction689" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction700" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction669" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction691" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction690" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction675" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction697" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction674" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction696" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction677" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction699" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction676" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction698" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction671" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction693" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction670" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction692" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction673" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction695" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction672" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction694" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction679" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction678" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence743" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO6, the least studied member of the FOXO family, directly stimulates transcription of PLXNA4 gene, encoding a co-factor for the semaphorin SEMA3A receptor. FOXO6-mediated regulation of PLXNA4 expression plays an important role in radial glia migration during cortical development (Paap et al. 2016). FOXO-mediated up-regulation of genes involved in reduction of the oxidative stress burden is not specific to neurons, but plays an important role in neuronal survival and neurodegenerative diseases. FOXO3 and FOXO4, and possibly FOXO1, directly stimulate transcription of the SOD2 gene, encoding mitochondrial manganese-dependent superoxide dismutase, which converts superoxide to the less harmful hydrogen peroxide and oxygen (Kops et al. 2002, Hori et al. 2013, Araujo et al. 2011, Guan et al. 2016). FOXO4 stimulates SOD2 gene transcription in collaboration with ATXN3, a protein involved in spinocerebellar ataxia type 3 (SCA3) (Araujo et al. 2011). FOXO3 and FOXO6, and possibly FOXO1, directly stimulate transcription of the CAT gene, encoding catalase, an enzyme that converts hydrogen peroxide to water and oxygen, thus protecting cells from the oxidative stress (Awad et al. 2014, Kim et al. 2014, Rangarajan et al. 2015, Song et al. 2016, Liao et al. 2016, Guo et al. 2016). FOXO transcription factors regulate transcription of several genes whose protein products are secreted from hypothalamic neurons to control appetite and food intake: NPY gene, AGRP gene and POMC gene. At low insulin levels, characteristic of starvation, FOXO transcription factors bind to insulin responsive elements (IRES) in the regulatory regions of NPY, AGRP and POMC gene. FOXO1 directly stimulates transcription of the NPY gene, encoding neuropeptide-Y (Kim et al. 2006, Hong et al. 2012), and the AGRP gene, encoding Agouti-related protein (Kitamura et al. 2006, Kim et al. 2006), which both stimulate food intake. At the same time, FOXO1 directly represses transcription of the POMC gene, encoding melanocyte stimulating hormone alpha , which suppresses food intake (Kitamura et al. 2006, Kim et al. 2006). When, upon food intake, blood insulin levels rise, insulin-mediated activation of PI3K/AKT signaling inhibits FOXO transcriptional activity. In liver cells, FOXO transcription factors regulate transcription of genes involved in gluconeogenesis: G6PC gene, encoding glucose-6-phosphatase and PCK1 gene, encoding phosphoenolpyruvate carboxykinase. Actions of G6PC and PCK1 enable steady glucose blood levels during fasting. FOXO1, FOXO3 and FOXO4 directly stimulate PCK1 gene transcription (Hall et al. 2000, Yang et al. 2002, Puigserver et al. 2003), while all four FOXOs, FOXO1, FOXO3, FOXO4 and FOXO6 directly stimulate G6PC gene transcription (Yang et al. 2002, Puigserver et al. 2003, Onuma et al. 2006, Kim et al. 2011). FOXO-mediated induction of G6PC and PCK1 genes is negatively regulated by insulin-induced PI3K/AKT signaling. FOXO1, FOXO3 and FOXO4 directly stimulate transcription of the IGFBP1 gene, encoding insulin growth factor binding protein 2 (Tang et al. 1999, Kops et al. 1999, Hall et al. 2000, Yang et al. 2002), which increases sensitivity of cells to insulin. FOXO1 and FOXO3 directly stimulate transcription of the ABCA6 (ATP-binding cassette sub-family A member 6) gene, encoding a putative transporter protein that is thought to be involved in lipid homeostasis (Gai et al. 2013). The GCK (glucokinase) gene is another gene involved in lipid homeostasis that is regulated by FOXOs. FOXO1, acting with the SIN3A:HDAC complex, directly represses the GCK gene transcription, thus repressing lipogenesis in the absence of insulin (Langlet et al. 2017). The SREBF1 (SREBP1) gene, which encodes a transcriptional activator required for lipid homeostasis, is directly transcriptionally repressed by FOXO1 (Deng et al. 2012). Transcription of the RETN gene, encoding resistin, an adipocyte specific hormone that suppresses insulin-mediated uptake of glucose by adipose cells, is directly stimulated by FOXO1 (Liu et al. 2014). Transcription of two genes encoding E3 ubiquitin ligases FBXO32 (Atrogin-1) and TRIM63 (MURF1), involved in degradation of muscle proteins and muscle wasting during starvation, is positively regulated by FOXO transcription factors (Sandri et al. 2004, Waddell et al. 2008, Raffaello et al. 2010, Senf et al. 2011, Bollinger et al. 2014, Wang et al. 2017).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep970">
 <bp:stepProcess rdf:resource="#BiochemicalReaction879" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway75">
 <bp:pathwayOrder rdf:resource="#PathwayStep740" />
 <bp:pathwayOrder rdf:resource="#PathwayStep741" />
 <bp:pathwayOrder rdf:resource="#PathwayStep737" />
 <bp:pathwayOrder rdf:resource="#PathwayStep738" />
 <bp:pathwayOrder rdf:resource="#PathwayStep739" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction664" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction663" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction666" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction665" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction667" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence737" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of localization of FOXO transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Localization of FOXO transcription factors FOXO1, FOXO3 and FOXO4 is regulated by AKT-mediated phosphorylation. In the absence of PI3K/AKT signaling, FOXO1, FOXO3 and FOXO4 localize to the nucleus. AKT-mediated phosphorylation induces a conformational change that exposes a nuclear export signal (NES) and promotes translocation of FOXO1, FOXO3 and FOXO4 to the cytosol (Rena et al. 1999, Brunet et al. 1999, Kops et al. 1999). AKT-phosphorylated FOXO1, FOXO3 and FOXO4 bind to 14-3-3 proteins, which contributes to their retention in the cytosol (Rena et al. 2001, Brunet et al. 1999, Arimoto Ishida et al. 2004, Obsilova et al. 2005, Boura et al. 2007, Silhan et al. 2009). FOXO6 lacks the NES sequence and is exclusively nuclear, but phosphorylation in response to PI3K/AKT signaling affects the transcriptional activity of FOXO6 (Jacobs et al. 2003, van der Heide et al. 2005).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep971">
 <bp:stepProcess rdf:resource="#BiochemicalReaction880" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway78">
 <bp:pathwayOrder rdf:resource="#PathwayStep810" />
 <bp:pathwayOrder rdf:resource="#PathwayStep811" />
 <bp:pathwayOrder rdf:resource="#PathwayStep801" />
 <bp:pathwayOrder rdf:resource="#PathwayStep812" />
 <bp:pathwayOrder rdf:resource="#PathwayStep806" />
 <bp:pathwayOrder rdf:resource="#PathwayStep807" />
 <bp:pathwayOrder rdf:resource="#PathwayStep808" />
 <bp:pathwayOrder rdf:resource="#PathwayStep809" />
 <bp:pathwayOrder rdf:resource="#PathwayStep802" />
 <bp:pathwayOrder rdf:resource="#PathwayStep813" />
 <bp:pathwayOrder rdf:resource="#PathwayStep803" />
 <bp:pathwayOrder rdf:resource="#PathwayStep814" />
 <bp:pathwayOrder rdf:resource="#PathwayStep804" />
 <bp:pathwayOrder rdf:resource="#PathwayStep815" />
 <bp:pathwayOrder rdf:resource="#PathwayStep805" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction730" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction732" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction731" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction727" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction738" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction726" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction737" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction729" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction728" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction734" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction733" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction725" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction736" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction724" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction735" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence801" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO-mediated transcription of cell death genes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO transcription factors promote expression of several pro-apoptotic genes, such as FASLG (Brunet et al. 1999, Ciechomska et al. 2003, Chen et al. 2013, Li et al. 2015), PINK1 (Mei et al. 2009, Sengupta et al. 2011), BCL2L11 (BIM) (Gilley et al. 2003, Urbich et al. 2005, Chuang et al. 2007, Hughes et al. 2011, Chen et al. 2013, Wang et al. 2016), BCL6 (Tang et al. 2002, Fernandez de Mattos et al. 2004, Shore et al. 2006) and BBC3 (PUMA) (Dudgeon et al. 2010, Hughes et al. 2011, Liu et al. 2015, Wu et al. 2016, Liu et al. 2017, Fitzwalter et al. 2018). FOXO-mediated induction of cell death genes is important during development, for example during nervous system development, where FOXO promotes neuronal death upon NGF withdrawal (Gilley et al. 2003), and also contributes to the tumor-suppressive role of FOXO factors (Arimoto Ishida et al. 2004). FOXO1 transcriptional activity is implicated in the cell death of enteric nervous system (ENS) precursors. RET signaling, which activates PI3K/AKT signaling, leading to inhibition of FOXO mediated transcription, ensures survival of ENS precursors (Srinivasan et al. 2005). Transcription of the STK11 (LKB1) gene, encoding Serine/threonine-protein kinase STK11 (also known as Liver kinase B1), which regulates diverse cellular processes, including apoptosis, is directly stimulated by FOXO3 and FOXO4 (Lutzner et al. 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep972">
 <bp:stepProcess rdf:resource="#BiochemicalReaction881" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway77">
 <bp:pathwayOrder rdf:resource="#PathwayStep790" />
 <bp:pathwayOrder rdf:resource="#PathwayStep780" />
 <bp:pathwayOrder rdf:resource="#PathwayStep791" />
 <bp:pathwayOrder rdf:resource="#PathwayStep781" />
 <bp:pathwayOrder rdf:resource="#PathwayStep792" />
 <bp:pathwayOrder rdf:resource="#PathwayStep782" />
 <bp:pathwayOrder rdf:resource="#PathwayStep793" />
 <bp:pathwayOrder rdf:resource="#PathwayStep787" />
 <bp:pathwayOrder rdf:resource="#PathwayStep798" />
 <bp:pathwayOrder rdf:resource="#PathwayStep788" />
 <bp:pathwayOrder rdf:resource="#PathwayStep799" />
 <bp:pathwayOrder rdf:resource="#PathwayStep778" />
 <bp:pathwayOrder rdf:resource="#PathwayStep789" />
 <bp:pathwayOrder rdf:resource="#PathwayStep779" />
 <bp:pathwayOrder rdf:resource="#PathwayStep783" />
 <bp:pathwayOrder rdf:resource="#PathwayStep794" />
 <bp:pathwayOrder rdf:resource="#PathwayStep784" />
 <bp:pathwayOrder rdf:resource="#PathwayStep795" />
 <bp:pathwayOrder rdf:resource="#PathwayStep785" />
 <bp:pathwayOrder rdf:resource="#PathwayStep796" />
 <bp:pathwayOrder rdf:resource="#PathwayStep786" />
 <bp:pathwayOrder rdf:resource="#PathwayStep797" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction709" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction708" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction719" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction710" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction721" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction720" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction705" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction716" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction704" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction715" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction707" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction718" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction706" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction717" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction712" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction723" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction711" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction722" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction703" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction714" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction702" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction713" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence778" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO-mediated transcription of cell cycle genes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO transcription factors induce expression of several genes that negatively regulate proliferation of different cell types, such as erythroid progenitors (Bakker et al. 2004, Wang et al. 2015) and neuroepithelial progenitor cells in the telencephalon (Seoane et al. 2004). Transcription of cyclin-dependent kinase (CDK) inhibitors CDKN1A (p21Cip1) is directly stimulated by FOXO1, FOXO3 and FOXO4 (Seoane et al. 2004, Tinkum et al. 2013). FOXO transcription factors can cooperate with the SMAD2/3:SMAD4 complex to induce CDKN1A transcription in response to TGF-beta signaling (Seoane et al. 2004). FOXO transcription factors FOXO1, FOXO3 and FOXO4 stimulate transcription of the CDKN1B (p27Kip1) gene, but direct binding of FOXOs to the CDKN1B gene locus has not been demonstrated (Dijkers et al. 2000, Medema et al. 2000, Lees et al. 2008). FOXO3 and FOXO4, and possibly FOXO1, directly stimulate transcription of the GADD45A  gene (Tran et al. 2002, Furukawa Hibi et al. 2002, Hughes et al. 2011, Sengupta et al. 2011, Ju et al. 2014). Transcription of the retinoblastoma family protein RBL2 (p130), involved in the maintenance of quiescent (G0) state, is directly stimulated by FOXO1, FOXO3 and FOXO4 (Kops et al. 2002, Chen et al. 2006). Transcription of the anti-proliferative protein CCNG2 is directly stimulated by FOXO1 and FOXO3, and possibly FOXO4 (Martinez Gac et al. 2004, Chen et al. 2006). Transcription of the anti-proliferative protein BTG1 is directly stimulated by FOXO3 (Bakker et al. 2004, Bakker et al. 2007, Wang et al. 2015). Transcription of CAV1, encoding caveolin-1, involved in negative regulation of growth factor receptor signaling and establishment of quiescent cell phenotype, is directly stimulated by FOXO1 and FOXO3 (van den Heuvel et al. 2005, Roy et al. 2008, Nho et al. 2013, Sisci et al. 2013). FOXO1 and FOXO3 promote transcription of the KLF4 gene, encoding a transcription factor Krueppel-like factor 4, which inhibits proliferation of mouse B cells (Yusuf et al. 2008).  FOXO1, together with the p-2S-SMAD2/3:SMAD4 complex, stimulates transcription of the MSTN gene, encoding myostatin, a TGF-beta family member that stimulates differentiation of myoblasts (Allen and Unterman 2007).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep973">
 <bp:stepProcess rdf:resource="#BiochemicalReaction882" />
 <bp:stepProcess rdf:resource="#Catalysis147" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway79">
 <bp:pathwayOrder rdf:resource="#PathwayStep820" />
 <bp:pathwayOrder rdf:resource="#PathwayStep821" />
 <bp:pathwayOrder rdf:resource="#PathwayStep822" />
 <bp:pathwayOrder rdf:resource="#PathwayStep823" />
 <bp:pathwayOrder rdf:resource="#PathwayStep817" />
 <bp:pathwayOrder rdf:resource="#PathwayStep828" />
 <bp:pathwayOrder rdf:resource="#PathwayStep818" />
 <bp:pathwayOrder rdf:resource="#PathwayStep829" />
 <bp:pathwayOrder rdf:resource="#PathwayStep819" />
 <bp:pathwayOrder rdf:resource="#PathwayStep824" />
 <bp:pathwayOrder rdf:resource="#PathwayStep825" />
 <bp:pathwayOrder rdf:resource="#PathwayStep826" />
 <bp:pathwayOrder rdf:resource="#PathwayStep827" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction741" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction740" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction751" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction743" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction742" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction750" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction749" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction748" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction739" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction745" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction744" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction747" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction746" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence817" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcriptional Regulation by VENTX</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The VENTX (also known as VENT homeobox or VENTX2) gene is a member of the homeobox family of transcription factors. The ortholog of VENTX was first described in Xenopus where it participates in BMP and Nanog signaling pathways and controls dorsoventral mesoderm patterning (Onichtchouk et al. 1996, Scerbo et al. 2012). The zebrafish ortholog of VENTX is also involved in dorsoventral patterning in the early embryo (Imai et al. 2001). Rodents lack the VENTX ortholog (Zhong and Holland 2011). VENTX is expressed in human blood cells (Moretti et al. 2001) and appears to play an important role in hematopoiesis. The role of VENTX in hematopoiesis was first suggested based on its role in mesoderm patterning in Xenopus and zebrafish (Davidson and Zon 2000). VENTX promotes cell cycle arrest and differentiation of hematopoietic stem cells and/or progenitor cells (Wu, Gao, Ke, Giese and Zhu 2011, Wu et al. 2014). Ventx suppression leads to expansion of hematopoietic stem cells and multi-progenitor cells (Gao et, J. Biol.Chem, 2012). VENTX induces transcription of cell cycle inhibitors TP53 (p53) and p16INK4A  and activates tumor suppressor pathways regulated by TP53 and p16INK4A (Wu, Gao, Ke, Hager et al. 2011), as well as macrophage colony stimulating factor receptor (CSF1R) (Wu, Gao, Ke, Giese and Zhu 2011) and inhibits transcription of cyclin D1 (CCND1) (Gao et al. 2010) and Interleukin-6 (IL6) (Wu et al. 2014). Chromatin immunoprecipitation showed that EGR3 transcription factor directly binds to the promoter of IL6 and IL8 genes (Baron VT et al, BJC 2015). While VENTX expression may suppress lymphocytic leukemia (Gao et al. 2010), high levels of VENTX have been reported in acute myeloid leukemia cells, with a positive effect on their proliferation (Rawat et al. 2010). Another homeobox transcription factor that regulates differentiation of hematopoietic stemm cells is DLX4 (Bon et al. 2015). Studies on colon cancer showed that VentX regulates tumor associated macrophages and reverts immune suppression in tumor microenvironment (Le et al. 2018). MEK1 is required for Xenopus Ventx2 asymmetric distribution during blastula cell division. Ventx2 inhibition by MEK1 is required for embryonic cell commitment (Scerbo et al, eLife, 2017). VENTX induces TP53-independent apoptosis in cancer cells (Gao H, Oncotarget, 2016). During  Xenopus embryonic development, VENTX ortholog regulates transcription of the sox3 gene (Rogers et al. 2007) as well as the early neuronal gene zic3 (Umair et al. 2018).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep978">
 <bp:stepProcess rdf:resource="#BiochemicalReaction886" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep979">
 <bp:stepProcess rdf:resource="#BiochemicalReaction887" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway90">
 <bp:pathwayOrder rdf:resource="#PathwayStep941" />
 <bp:pathwayOrder rdf:resource="#PathwayStep942" />
 <bp:pathwayOrder rdf:resource="#PathwayStep943" />
 <bp:pathwayOrder rdf:resource="#PathwayStep933" />
 <bp:pathwayOrder rdf:resource="#PathwayStep944" />
 <bp:pathwayOrder rdf:resource="#PathwayStep950" />
 <bp:pathwayOrder rdf:resource="#PathwayStep940" />
 <bp:pathwayOrder rdf:resource="#PathwayStep951" />
 <bp:pathwayOrder rdf:resource="#PathwayStep938" />
 <bp:pathwayOrder rdf:resource="#PathwayStep949" />
 <bp:pathwayOrder rdf:resource="#PathwayStep939" />
 <bp:pathwayOrder rdf:resource="#PathwayStep934" />
 <bp:pathwayOrder rdf:resource="#PathwayStep945" />
 <bp:pathwayOrder rdf:resource="#PathwayStep935" />
 <bp:pathwayOrder rdf:resource="#PathwayStep946" />
 <bp:pathwayOrder rdf:resource="#PathwayStep936" />
 <bp:pathwayOrder rdf:resource="#PathwayStep947" />
 <bp:pathwayOrder rdf:resource="#PathwayStep937" />
 <bp:pathwayOrder rdf:resource="#PathwayStep948" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction851" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction862" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction850" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction861" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction853" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction852" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction860" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction848" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction859" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction847" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction858" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction849" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction844" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction855" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction854" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction846" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction857" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction845" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction856" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence933" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of RUNX1 Expression and Activity</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">At the level of transcription, expression of the RUNX1 transcription factor is regulated by two alternative promoters: a distal promoter, P1, and a proximal promoter, P2. P1 is more than 7 kb upstream of P2 (Ghozi et al. 1996). In mice, the Runx1 gene is preferentially transcribed from the proximal P2 promoter during generation of hematopoietic cells from hemogenic endothelium. In fully committed hematopoietic progenitors, the Runx1 gene is preferentially transcribed from the distal P1 promoter (Sroczynska et al. 2009, Bee et al. 2010). In human T cells, RUNX1 is preferentially transcribed from P1 throughout development, while developing natural killer cells transcribe RUNX1 predominantly from P2. Developing B cells transcribe low levels of RUNX1 from both promoters (Telfer and Rothenberg 2001). RUNX1 mRNAs transcribed from alternative promoters differ in their 5&apos;UTRs and splicing isoforms of RUNX1 have also been described. The function of alternative splice isoforms and alternative 5&apos;UTRs has not been fully elucidated (Challen and Goodell 2010, Komeno et al. 2014). During zebrafish hematopoiesis, RUNX1 expression increases in response to NOTCH signaling, but direct transcriptional regulation of RUNX1 by NOTCH has not been demonstrated (Burns et al. 2005). RUNX1 transcription also increases in response to WNT signaling. BothTCF7 and TCF4 bind the RUNX1 promoter (Wu et al. 2012, Hoverter et al. 2012), and RUNX1 transcription driven by the TCF binding element (TBE) in response to WNT3A treatment is inhibited by the dominant-negative mutant of TCF4 (Medina et al. 2016). In developing mouse ovary, Runx1 expression is positively regulated by Wnt4 signaling (Naillat et al. 2015). Studies in mouse hematopoietic stem and progenitor cells imply that RUNX1 may be a direct transcriptional target of HOXB4 (Oshima et al. 2011). Conserved cis-regulatory elements were recently identified in intron 5 of RUNX1. The RUNX1 breakpoints observed in acute myeloid leukemia (AML) with translocation (8;21), which result in expression of a fusion RUNX1-ETO protein, cluster in intron 5, in proximity to these not yet fully characterized cis regulatory elements (Rebolledo-Jaramillo et al. 2014). At the level of translation, RUNX1 expression is regulated by various microRNAs which bind to the 3&apos;UTR of RUNX1 mRNA and inhibit its translation through endonucleolytic and/or nonendonucleolytic mechanisms. MicroRNAs that target RUNX1 include miR-378 (Browne et al. 2016), miR-302b (Ge et al. 2014), miR-18a (Miao et al. 2015), miR-675 (Zhuang et al. 2014), miR-27a (Ben-Ami et al. 2009), miR-17, miR-20a, miR106 (Fontana et al. 2007) and miR-215 (Li et al. 2016). At the posttranslational level, RUNX1 activity is regulated by postranslational modifications and binding to co-factors. SRC family kinases phosphorylate RUNX1 on multiple tyrosine residues in the negative regulatory domain, involved in autoinhibition of RUNX1. RUNX1 tyrosine phosphorylation correlates with reduced binding of RUNX1 to GATA1 and increased binding of RUNX1 to the SWI/SNF complex, leading to inhibition of RUNX1-mediated differentiation of T-cells and megakaryocytes. SHP2 (PTPN11) tyrosine phosphatase binds to RUNX1 and dephosphorylates it (Huang et al. 2012). Formation of the complex with CBFB is necessary for the transcriptional activity of RUNX1 (Wang et al. 1996). Binding of CCND3 and probably other two cyclin D family members, CCND1 and CCND2, to RUNX1 inhibits its association with CBFB (Peterson et al. 2005), while binding to CDK6 interferes with binding of RUNX1 to DNA without affecting formation of the RUNX1:CBFB complex. Binding of RUNX1 to PML plays a role in subnuclear targeting of RUNX1 (Nguyen et al. 2005). RUNX1 activity and protein levels vary during the cell cycle. RUNX1 protein levels increase from G1 to S and from S to G2 phases, with no increase in RUNX1 mRNA levels. CDK1-mediated phosphorylation of RUNX1 at the G2/M transition is implicated in reduction of RUNX1 transactivation potency and may promote RUNX1 protein degradation by the anaphase promoting complex (reviewed by Friedman 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway92">
 <bp:pathwayOrder rdf:resource="#PathwayStep963" />
 <bp:pathwayOrder rdf:resource="#PathwayStep974" />
 <bp:pathwayOrder rdf:resource="#PathwayStep964" />
 <bp:pathwayOrder rdf:resource="#PathwayStep975" />
 <bp:pathwayOrder rdf:resource="#PathwayStep965" />
 <bp:pathwayOrder rdf:resource="#PathwayStep976" />
 <bp:pathwayOrder rdf:resource="#PathwayStep966" />
 <bp:pathwayOrder rdf:resource="#PathwayStep970" />
 <bp:pathwayOrder rdf:resource="#PathwayStep971" />
 <bp:pathwayOrder rdf:resource="#PathwayStep972" />
 <bp:pathwayOrder rdf:resource="#PathwayStep962" />
 <bp:pathwayOrder rdf:resource="#PathwayStep973" />
 <bp:pathwayOrder rdf:resource="#PathwayStep967" />
 <bp:pathwayOrder rdf:resource="#PathwayStep968" />
 <bp:pathwayOrder rdf:resource="#PathwayStep969" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction873" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction884" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction872" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction883" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction875" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction874" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction885" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction880" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction871" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction882" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction881" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction877" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction876" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction879" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction878" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence962" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 regulates transcription of genes involved in differentiation of HSCs</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The RUNX1:CBFB complex regulates transcription of the SPI1 (PU.1) gene, involved in differentiation of hematopoietic stem cells (HSCs). RUNX1 recruits histone methyltransferase KMT2A (MLL) to the SPI1 gene locus, leading to generation of the activating H3K4Me3 mark on nucleosomes associated with the SPI1 promoter and the upstream regulatory element (Huang et al. 2011). SPI1 transactivation represses self-renewal and proliferation of HSCs (Fukuchi et al. 2008) and is needed for commitment of HSCs to specific hematopoietic lineages (Imperato et al. 2015). As a component of the TAL1 transcription factor complex, involved in acute T cell lymphoblastic leukemia (T-ALL), RUNX1 can promote growth and inhibit apoptosis of hematopoietic stem cells by stimulating transcription of the MYB gene and possibly the TRIB2 gene (Sanda et al. 2012, Mansour et al. 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway91">
 <bp:pathwayOrder rdf:resource="#PathwayStep953" />
 <bp:pathwayOrder rdf:resource="#PathwayStep954" />
 <bp:pathwayOrder rdf:resource="#PathwayStep955" />
 <bp:pathwayOrder rdf:resource="#PathwayStep960" />
 <bp:pathwayOrder rdf:resource="#PathwayStep956" />
 <bp:pathwayOrder rdf:resource="#PathwayStep957" />
 <bp:pathwayOrder rdf:resource="#PathwayStep958" />
 <bp:pathwayOrder rdf:resource="#PathwayStep959" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction864" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction863" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction870" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction869" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction866" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction865" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction868" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction867" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence953" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 regulates estrogen receptor mediated transcription</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The RUNX1:CBFB complex can associate with the activated estrogen receptor alpha (ESR1) through direct interaction between RUNX1 and ESR1. The RUNX1:CBFB complex is thus involved in transcriptional regulation of estrogen responsive genes, including GPAM, KCTD6 and AXIN1 (Stender et al. 2010). High GPAM expression correlates with better overall survival in breast cancer (Brockmoller et al. 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway83">
 <bp:pathwayOrder rdf:resource="#PathwayStep870" />
 <bp:pathwayOrder rdf:resource="#PathwayStep864" />
 <bp:pathwayOrder rdf:resource="#PathwayStep865" />
 <bp:pathwayOrder rdf:resource="#PathwayStep866" />
 <bp:pathwayOrder rdf:resource="#PathwayStep867" />
 <bp:pathwayOrder rdf:resource="#PathwayStep860" />
 <bp:pathwayOrder rdf:resource="#PathwayStep861" />
 <bp:pathwayOrder rdf:resource="#PathwayStep862" />
 <bp:pathwayOrder rdf:resource="#PathwayStep863" />
 <bp:pathwayOrder rdf:resource="#PathwayStep846" />
 <bp:pathwayOrder rdf:resource="#PathwayStep868" />
 <bp:pathwayOrder rdf:resource="#PathwayStep847" />
 <bp:pathwayOrder rdf:resource="#PathwayStep869" />
 <bp:pathwayOrder rdf:resource="#PathwayStep848" />
 <bp:pathwayOrder rdf:resource="#PathwayStep849" />
 <bp:pathwayOrder rdf:resource="#PathwayStep853" />
 <bp:pathwayOrder rdf:resource="#PathwayStep875" />
 <bp:pathwayOrder rdf:resource="#PathwayStep854" />
 <bp:pathwayOrder rdf:resource="#PathwayStep876" />
 <bp:pathwayOrder rdf:resource="#PathwayStep855" />
 <bp:pathwayOrder rdf:resource="#PathwayStep877" />
 <bp:pathwayOrder rdf:resource="#PathwayStep856" />
 <bp:pathwayOrder rdf:resource="#PathwayStep878" />
 <bp:pathwayOrder rdf:resource="#PathwayStep871" />
 <bp:pathwayOrder rdf:resource="#PathwayStep850" />
 <bp:pathwayOrder rdf:resource="#PathwayStep872" />
 <bp:pathwayOrder rdf:resource="#PathwayStep851" />
 <bp:pathwayOrder rdf:resource="#PathwayStep873" />
 <bp:pathwayOrder rdf:resource="#PathwayStep852" />
 <bp:pathwayOrder rdf:resource="#PathwayStep874" />
 <bp:pathwayOrder rdf:resource="#PathwayStep857" />
 <bp:pathwayOrder rdf:resource="#PathwayStep858" />
 <bp:pathwayOrder rdf:resource="#PathwayStep859" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction785" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction784" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction765" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction787" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction764" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction786" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction781" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction780" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction783" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction782" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction767" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction789" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction766" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction788" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction769" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction768" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction790" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction774" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction796" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction773" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction795" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction776" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction775" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction770" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction792" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction791" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction772" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction794" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction771" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction793" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction778" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction777" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction779" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence846" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In human hematopoietic progenitors, RUNX1 and its partner CBFB are up-regulated at the onset of megakaryocytic differentiation and down-regulated at the onset of erythroid differentiation. The complex of RUNX1 and CBFB cooperates with the transcription factor GATA1 in the transactivation of megakaryocyte-specific genes. In addition, RUNX1 and GATA1 physically interact (Elagib et al. 2003), and this interaction involves the zinc finger domain of GATA1 (Xu et al. 2006). Other components of the RUNX1:CBFB activating complex at megakaryocytic promoters are GATA1 heterodimerization partner, ZFPM1 (FOG1), histone acetyltransferases EP300 (p300) and KAT2B (PCAF), the WDR5-containing histone methyltransferase MLL complex and the arginine methyltransferase PRMT1 (Herglotz et al. 2013). In the absence of PRMT1, the transcriptional repressor complex can form at megakaryocytic promoters, as RUNX1 that is not arginine methylated can bind to SIN3A/SIN3B co-repressors (Zhao et al. 2008). Besides SIN3A/SIN3B, the RUNX1:CBFB repressor complex at megakaryocytic promoters also includes histone deacetylase HDAC1 and histone arginine methyltransferase PRMT6 (Herglotz et al. 2013). Megakaryocytic promoters regulated by the described RUNX1:CBFB activating and repressing complexes include ITGA2B, GP1BA, THBS1 and MIR27A (Herglotz et al. 2013). ITGA2B is only expressed in maturing megakaryocytes and platelets and is involved in platelet aggregation (Block and Poncz 1995). GP1BA is expressed at the cell surface membrane of maturing megakaryocytes and platelets and participates in formation of platelet plugs (Cauwenberghs et al. 2000, Jilma-Stohlawetz et al. 2003, Debili et al. 1990). THBS1 homotrimers contribute to stabilization of the platelet aggregate (Bonnefoy and Hoylaerts 2008). MIR27A is a negative regulator of RUNX1 mRNA translation and may be involved in erythroid/megakaryocytic lineage determination (Ben-Ami et al. 2009). The RUNX1:CBFB complex stimulates transcription of the PF4 gene, encoding a component of platelet alpha granules (Aneja et al. 2011), the NR4A3 gene, associated with the familial platelet disorder (FPD) (Bluteau et al. 2011), the PRKCQ gene, associated with inherited thrombocytopenia (Jalagadugula et al. 2011), the MYL9 gene, involved in thrombopoiesis (Jalagadugula et al. 2010), and the NFE2 gene, a regulator of erythroid and megakaryocytic maturation and differentiation (Wang et al. 2010). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep941">
 <bp:stepProcess rdf:resource="#BiochemicalReaction852" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway82">
 <bp:pathwayOrder rdf:resource="#PathwayStep842" />
 <bp:pathwayOrder rdf:resource="#PathwayStep843" />
 <bp:pathwayOrder rdf:resource="#PathwayStep844" />
 <bp:pathwayOrder rdf:resource="#PathwayStep840" />
 <bp:pathwayOrder rdf:resource="#PathwayStep841" />
 <bp:pathwayOrder rdf:resource="#PathwayStep839" />
 <bp:pathwayOrder rdf:resource="#PathwayStep837" />
 <bp:pathwayOrder rdf:resource="#PathwayStep838" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction763" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction762" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction761" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction760" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction759" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction756" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction758" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction757" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence837" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 regulates transcription of genes involved in differentiation of keratinocytes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The RUNX1:CBFB complex directly inhibits transcription of the SERPINB13 gene (Nomura et al. 2005), a gene involved in keratinocyte differentiation that is frequently down-regulated in head and neck cancers (Boyapati et al. 2011). RUNX1 also inhibits transcription of STAT3 inhibitors SOCS3 and SOCS4, resulting in elevated STAT3 activity. RUNX1-mediated increase in STAT3 activity, first discovered in keratinocytes, is thought to be involved in the maintenance of epithelial stem cells and contributes to development of epithelial cancers, including squamous cell carcinoma (SCC) of the skin (Scheitz et al. 2012). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep942">
 <bp:stepProcess rdf:resource="#BiochemicalReaction853" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway85">
 <bp:pathwayOrder rdf:resource="#PathwayStep886" />
 <bp:pathwayOrder rdf:resource="#PathwayStep887" />
 <bp:pathwayOrder rdf:resource="#PathwayStep888" />
 <bp:pathwayOrder rdf:resource="#PathwayStep889" />
 <bp:pathwayOrder rdf:resource="#PathwayStep890" />
 <bp:pathwayOrder rdf:resource="#PathwayStep891" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction807" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction804" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction803" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction806" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction805" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction802" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence886" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 regulates expression of components of tight junctions</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The RUNX1 transcription factor, which functions as part of the RUNX1:CBFB complex, was shown to directly transcriptionally regulate expression of several genes that encode components of tight junctions. Namely, RUNX1 binds to promoters of TJP1 (encoding ZO-1), OCLDN (encoding Occludin) and CLDN5 (encoding Claudin-5) and stimulates their transcription. Downregulation of RUNX1 by microRNA miR-18a negatively regulates expression of these three tight junction genes, which may affect the permeability of blood-tumor barrier in glioma (Miao et al. 2015).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep943">
 <bp:stepProcess rdf:resource="#BiochemicalReaction854" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway84">
 <bp:pathwayOrder rdf:resource="#PathwayStep882" />
 <bp:pathwayOrder rdf:resource="#PathwayStep883" />
 <bp:pathwayOrder rdf:resource="#PathwayStep884" />
 <bp:pathwayOrder rdf:resource="#PathwayStep880" />
 <bp:pathwayOrder rdf:resource="#PathwayStep881" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction798" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction797" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction800" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction799" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction801" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence880" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The transcriptional activity of the RUNX1:CBFB complex is regulated by interaction with co-factors and posttranslational modifications of RUNX1. Protein serine/threonine kinase HIPK2 can phosphorylate RUNX1 and affect transcriptional activity of the RUNX1:CBFB complex during hematopoiesis. Some CBFB mutations found in leukemia interfere with HIPK2-mediated phosphorylation of RUNX1. HIPK2 can simultaneously phosphorylate RUNX1 and EP300 (p300) bound to the RUNX1:CBFB1 complex (Aikawa et al. 2006, Wee et al. 2008). The RUNX1:CBFB complex can associate with the polycomb repressor complex 1 (PRC1). PRC1 complexes are found at many RUNX1 target promoters and can act either as co-activators or co-repressors in the transactivation of RUNX1 targets (Yu et al. 2011). RUNX1 recruits the SWI/SNF chromatin remodeling complex to many RUNX1 target promoters by directly interacting with several SWI/SNF subunits (Bakshi et al. 2010). Other co-factors of the RUNX1:CBFB complex are annotated in the context of transcriptional regulation of specific genes. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep944">
 <bp:stepProcess rdf:resource="#BiochemicalReaction855" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway87">
 <bp:pathwayOrder rdf:resource="#PathwayStep916" />
 <bp:pathwayOrder rdf:resource="#PathwayStep917" />
 <bp:pathwayOrder rdf:resource="#PathwayStep914" />
 <bp:pathwayOrder rdf:resource="#PathwayStep915" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction831" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction830" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction829" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction828" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence914" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 regulates transcription of genes involved in BCR signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The RUNX1:CBFB complex, in association with transcription co-factors ELF1 (MEF), ELF2 (NERF2) or PAX5 (BSAP) stimulates transcription of the BLK gene, encoding a B-cell specific tyrosine kinase involved in B cell receptor (BCR) signaling, B cell development and differentiation (Libermann et al. 1999, Cho et al. 2004).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway86">
 <bp:pathwayOrder rdf:resource="#PathwayStep909" />
 <bp:pathwayOrder rdf:resource="#PathwayStep897" />
 <bp:pathwayOrder rdf:resource="#PathwayStep898" />
 <bp:pathwayOrder rdf:resource="#PathwayStep899" />
 <bp:pathwayOrder rdf:resource="#PathwayStep910" />
 <bp:pathwayOrder rdf:resource="#PathwayStep900" />
 <bp:pathwayOrder rdf:resource="#PathwayStep911" />
 <bp:pathwayOrder rdf:resource="#PathwayStep893" />
 <bp:pathwayOrder rdf:resource="#PathwayStep894" />
 <bp:pathwayOrder rdf:resource="#PathwayStep895" />
 <bp:pathwayOrder rdf:resource="#PathwayStep896" />
 <bp:pathwayOrder rdf:resource="#PathwayStep905" />
 <bp:pathwayOrder rdf:resource="#PathwayStep906" />
 <bp:pathwayOrder rdf:resource="#PathwayStep907" />
 <bp:pathwayOrder rdf:resource="#PathwayStep908" />
 <bp:pathwayOrder rdf:resource="#PathwayStep901" />
 <bp:pathwayOrder rdf:resource="#PathwayStep912" />
 <bp:pathwayOrder rdf:resource="#PathwayStep902" />
 <bp:pathwayOrder rdf:resource="#PathwayStep903" />
 <bp:pathwayOrder rdf:resource="#PathwayStep904" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction808" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction819" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction818" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction809" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction820" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction815" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction826" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction814" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction825" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction817" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction816" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction827" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction811" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction822" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction810" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction821" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction813" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction824" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction812" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction823" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence893" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The complex of CBFB and RUNX1 (AML1) controls transcription of the FOXP3 gene. FOXP3 is a transcription factor that acts as a key regulator of development and function of regulatory T lymphocytes (Tregs). Tregs are CD25+CD4+ T lymphocytes involved in suppression of aberrant immune responses seen in autoimmune diseases and allergies. FOXP3 can bind to RUNX1 and control transcriptional activity of the RUNX1:CBFB complex. RUNX1 stimulates transcription of IL2 and IFNG1 (IFN-gamma), and the expression of these two genes is repressed upon binding of FOXP3 to RUNX1. The complex of FOXP3 and RUNX1, on the other hand, stimulates transcription of cell surface markers of Tregs, such as CD25, CTLA-4 and GITR. In the absence of FOXP3, RUNX1 represses transcription of these genes (Shevach 2000, Maloy and Powrie 2001, Sakaguchi 2004, Ono et al. 2007, Kitoh et al. 2009). The RUNX1:CBFB complex directly stimulates transcription of the CR1 gene, encoding Complement receptor type 1 (CD35) (Kim et al. 1999, Rho et al. 2002). Expression of CR1 on the surface of activated T cells contributes to generation of Tregs (Torok et al. 2015).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway89">
 <bp:pathwayOrder rdf:resource="#PathwayStep930" />
 <bp:pathwayOrder rdf:resource="#PathwayStep931" />
 <bp:pathwayOrder rdf:resource="#PathwayStep927" />
 <bp:pathwayOrder rdf:resource="#PathwayStep928" />
 <bp:pathwayOrder rdf:resource="#PathwayStep929" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction840" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction842" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction841" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction839" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction843" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence927" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 regulates transcription of genes involved in interleukin signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The RUNX1:CBFB complex regulates transcription of at least a couple of genes involved in interleukin signaling. The LIFR gene, a direct transcriptional target of the RUNX1:CBFB complex (Qadi et al. 2016), encodes the receptor for the leukemia inhibitory factor (LIF), a member of the interleukin-6 family. LIFR is implicated in hematopoiesis, embryo implantation, placental formation and nervous system development (Nicola et al. 2015). In association with its co-activator ELF1, the RUNX1:CBFB complex stimulates transcription of the IL3 gene, encoding interleukin-3 (Mao et al. 1999).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway88">
 <bp:pathwayOrder rdf:resource="#PathwayStep920" />
 <bp:pathwayOrder rdf:resource="#PathwayStep921" />
 <bp:pathwayOrder rdf:resource="#PathwayStep922" />
 <bp:pathwayOrder rdf:resource="#PathwayStep919" />
 <bp:pathwayOrder rdf:resource="#PathwayStep923" />
 <bp:pathwayOrder rdf:resource="#PathwayStep924" />
 <bp:pathwayOrder rdf:resource="#PathwayStep925" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction837" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction836" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction838" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction833" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction832" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction835" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction834" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence919" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 regulates transcription of genes involved in differentiation of myeloid cells</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The RUNX1:CBFB complex regulates expression of genes involved in differentiation of myeloid progenitors which can commit to hematopoietic lineages that lead to generation of platelets, erythrocytes, leukocytes or monocytes. The RUNX1:CBFB complex recruits histone acetyltransferase CREBBP (CBP) to the promoter of the CSF2 gene, encoding Granulocyte-macrophage colony stimulating factor (GM-CSF), thus inducing GM-CSF expression (Oakford et al. 2010). GM-CSF induces growth, differentiation and survival of macrophages, granulocytes, erythrocytes and megakaryocytes from myeloid progenitors (Barreda et al. 2004). The RUNX1:CBFB complex directly stimulates transcription of the LGALS3 gene, encoding galectin-3 (Zhang et al. 2009). Galectin-3 is expressed in myeloid progenitors and its levels increase during the maturation process (Le Marer 2000). The PRKCB gene, encoding protein kinase C-beta, which regulates apoptosis of myeloid cells, is directly transactivated by the RUNX1:CBFB complex (Hu et al. 2004). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep940">
 <bp:stepProcess rdf:resource="#BiochemicalReaction851" />
 <bp:stepProcess rdf:resource="#Catalysis143" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep949">
 <bp:stepProcess rdf:resource="#BiochemicalReaction860" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep945">
 <bp:stepProcess rdf:resource="#BiochemicalReaction856" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep946">
 <bp:stepProcess rdf:resource="#BiochemicalReaction857" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep947">
 <bp:stepProcess rdf:resource="#BiochemicalReaction858" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep948">
 <bp:stepProcess rdf:resource="#BiochemicalReaction859" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep952">
 <bp:stepProcess rdf:resource="#Pathway91" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway94">
 <bp:pathwayOrder rdf:resource="#PathwayStep1014" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1013" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1022" />
 <bp:pathwayComponent rdf:resource="#Pathway96" />
 <bp:pathwayComponent rdf:resource="#Pathway95" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction920" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1013" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase II Transcription Initiation And Promoter Clearance</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The transcription cycle is divided in three major phases: initiation, elongation, and termination. Transcription initiation include promoter DNA binding, DNA melting, and initial synthesis of short RNA transcripts. Many changes must occur to the RNA polymerase II (pol II) transcription complex as it makes the transition from initiation into transcript elongation. During this intermediate phase of transcription, contact with initiation factors is lost and stable association with the nascent transcript is established. These changes collectively comprise promoter clearance.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep953">
 <bp:stepProcess rdf:resource="#BiochemicalReaction863" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway93">
 <bp:pathwayOrder rdf:resource="#PathwayStep990" />
 <bp:pathwayOrder rdf:resource="#PathwayStep991" />
 <bp:pathwayOrder rdf:resource="#PathwayStep985" />
 <bp:pathwayOrder rdf:resource="#PathwayStep986" />
 <bp:pathwayOrder rdf:resource="#PathwayStep987" />
 <bp:pathwayOrder rdf:resource="#PathwayStep988" />
 <bp:pathwayOrder rdf:resource="#PathwayStep981" />
 <bp:pathwayOrder rdf:resource="#PathwayStep982" />
 <bp:pathwayOrder rdf:resource="#PathwayStep983" />
 <bp:pathwayOrder rdf:resource="#PathwayStep984" />
 <bp:pathwayOrder rdf:resource="#PathwayStep989" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1010" />
 <bp:pathwayOrder rdf:resource="#PathwayStep980" />
 <bp:pathwayOrder rdf:resource="#PathwayStep996" />
 <bp:pathwayOrder rdf:resource="#PathwayStep997" />
 <bp:pathwayOrder rdf:resource="#PathwayStep998" />
 <bp:pathwayOrder rdf:resource="#PathwayStep999" />
 <bp:pathwayOrder rdf:resource="#PathwayStep992" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1009" />
 <bp:pathwayOrder rdf:resource="#PathwayStep993" />
 <bp:pathwayOrder rdf:resource="#PathwayStep994" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1007" />
 <bp:pathwayOrder rdf:resource="#PathwayStep995" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1008" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1005" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1006" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1003" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1004" />
 <bp:pathwayOrder rdf:resource="#PathwayStep978" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1001" />
 <bp:pathwayOrder rdf:resource="#PathwayStep979" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1002" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1000" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction918" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction917" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction886" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction903" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction902" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction905" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction904" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction888" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction887" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction901" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction889" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction900" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction907" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction906" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction909" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction908" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction895" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction894" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction897" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction896" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction891" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction890" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction893" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction892" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction914" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction913" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction916" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction915" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction899" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction910" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction898" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction912" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction911" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence978" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcriptional Regulation by E2F6</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">E2F6, similar to other E2F proteins, possesses the DNA binding domain, the dimerization domain and the marked box. E2F6, however, does not have a pocket protein binding domain and thus does not interact with the retinoblastoma family members RB1, RBL1 (p107) and RBL2 (p130) (Gaubatz et al. 1998, Trimarchi et al. 1998, Cartwright et al. 1998). E2F6 lacks the transactivation domain and acts as a transcriptional repressor (Gaubatz et al. 1998, Trimarchi et al. 1998, Cartwright et al. 1998). E2F6 forms a heterodimer with TFDP1 (DP-1) (Trimarchi et al. 1998, Ogawa et al. 2002, Cartwright et al. 1998) or TFDP2 (DP-2) (Gaubatz et al. 1998, Trimarchi et al. 1998, Cartwright et al. 1998). E2f6 knockout mice are viable and embryonic fibroblasts derived from these mice proliferate normally. Although E2f6 knockout mice appear healthy, they are affected by homeotic transformations of the axial skeleton, involving vertebrae and ribs. Similar skeletal defects have been reported in mice harboring mutations in polycomb genes, suggesting that E2F6 may function in recruitment of polycomb repressor complex(es) to target promoters (Storre et al. 2002). E2F6 mediates repression of E2F responsive genes. While E2F6 was suggested to maintain G0 state in quiescent cells (Gaubatz et al. 1998, Ogawa et al. 2002), this finding has been challenged (Giangrande et al. 2004, Bertoli et al. 2013, Bertoli et al. 2016). Instead, E2F6-mediated gene repression in proliferating (non-quiescent) cells is thought to repress E2F targets involved in G1/S transition during S phase of the cell cycle. E2F6 does not affect E2F targets involved in G2/M transition (Oberley et al. 2003, Giangrande et al. 2004, Attwooll et al. 2005, Trojer et al. 2011, Bertoli et al. 2013). In the context of the E2F6.com-1 complex, E2F6 was shown to bind to promoters of E2F1, MYC, CDC25A and TK1 genes (Ogawa et al. 2002). E2F6 also binds the promoters of CDC6, RRM1 (RR1), PCNA and TYMS (TS) genes (Giangrande et al. 2004), as well as the promoter of the DHFR gene (Gaubatz et al. 1998). While transcriptional repression by the E2F6.com 1 complex may be associated with histone methyltransferase activity (Ogawa et al. 2002), E2F6 can also repress transcription independently of H3K9 methylation (Oberley et al. 2003). During S phase, E2F6 is involved in the DNA replication stress checkpoint (Bertoli et al. 2013, Bertoli et al. 2016). Under replication stress, CHEK1-mediated phosphorylation prevents association of E2F6 with its target promoters, allowing transcription of E2F target genes whose expression is needed for resolution of stalled replication forks and restart of DNA synthesis. Inability to induce transcription of E2F target genes (due to CHEK1 inhibition or E2F6 overexpression) leads to replication stress induced DNA damage (Bertoli et al. 2013, Bertoli et al. 2016). E2F6 represses transcription of a number of E2F targets involved in DNA synthesis and repair, such as RRM2, RAD51, BRCA1, and RBBP8 (Oberley et al. 2003, Bertoli et al. 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep954">
 <bp:stepProcess rdf:resource="#BiochemicalReaction864" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway96">
 <bp:pathwayOrder rdf:resource="#PathwayStep1025" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1023" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1024" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction930" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction929" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction928" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1023" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase II Transcription Initiation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of the open  complex exposes the template strand to the catalytic center of the RNA polymerase II enzyme. This facilitates formation of the first phosphodiester bond, which marks transcription initiation. As a result of this, the TFIIB basal transcription factor dissociates from the initiation complex. The open transcription initiation complex is unstable and can revert to the closed state. Initiation at this stage requires continued (d)ATP-hydrolysis by TFIIH. Dinucleotide transcripts are not stably associated with the transcription complex. Upon dissociation they form abortive products. The transcription complex is also sensitive to inhibition by small oligo-nucleotides.  Dinucleotides complementary to position -1 and +1 in the template can also direct first phosphodiester bond formation. This reaction is independent on the basal transcription factors TFIIE  and TFIIH and does not involve open complex formation.  This reaction is sensitive to inhibition by single-stranded oligonucleotides.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep955">
 <bp:stepProcess rdf:resource="#BiochemicalReaction865" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway95">
 <bp:pathwayOrder rdf:resource="#PathwayStep1020" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1018" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1019" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1016" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1017" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1015" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1021" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction925" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction924" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction927" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction926" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction921" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction923" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction922" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1015" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase II Promoter Escape</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase II promoter escape occurs after the first phosphodiester bond has been created.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway98">
 <bp:pathwayOrder rdf:resource="#PathwayStep1181" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1139" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1045" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1166" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1145" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1131" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1055" />
 <bp:pathwayComponent rdf:resource="#Pathway102" />
 <bp:pathwayComponent rdf:resource="#Pathway113" />
 <bp:pathwayComponent rdf:resource="#Pathway99" />
 <bp:pathwayComponent rdf:resource="#Pathway109" />
 <bp:pathwayComponent rdf:resource="#Pathway116" />
 <bp:pathwayComponent rdf:resource="#Pathway108" />
 <bp:pathwayComponent rdf:resource="#Pathway107" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1045" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Epigenetic regulation of gene expression</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Epigenetic processes regulate gene expression by modulating the frequency, rate, or extent of gene expression in a mitotically or meiotically heritable way that does not entail a change in the DNA sequence. Originally the definition applied only to heritability across generations but later also encompassed the heritable changes that occur during cellular differentiation within one organism.  Molecular analysis shows epigenetic changes comprise covalent modifications, such as methylation and acetylation, to DNA and histones. RNA interference has been implicated in the initiation of some epigenetic changes, for example transcriptional silencing of transposons. Proteins which bind to the modified DNA and histones are then responsible for repressing transcription and for maintaining the epigenetic modifications during cell division. During differentiation, patterns of gene expression are established by polycomb complexes PRC1 and PRC2. PRC2 methylates histones and DNA to produce the initial marks of repression: trimethylated lysine-27 on histone H3 (H3K27me3) and 5-methylcytosine in DNA. PRC2, through its component EZH2 or, in some complexes, EZH1 trimethylates lysine-27 of histone H3. The H3K27me3 produced by PRC2 is bound by the Polycomb subunit of PRC1. PRC1 ubiquitinates histone H2A and maintains repression. PRC2 and other epigenetic systems modulate gene expression through DNA methyation, the transfer of a methyl group from S-adenosylmethionine to the 5 position of cytosine in DNA by a family of DNA methyltransferases (DNMTs): DNMT1, DNMT3A, and DNMT3B. In the reverse process TET1,2,3 and TDG demethylate DNA through the oxidation of the methyl group of 5-methylcytosine by TET enzymes and the excision of the oxidized product (5-formylcytosine or 5-carboxylcytosine) by TDG. Ribosomal RNA (rRNA) genes are activated and deactivated according to the metabolic requirements of the cell. Positive epigenetic regulation of rRNA expression occurs through chromatin modifications produced by activators such as ERCC6 (CSB), the B-WICH complex, and histone acetylases such as KAT2B (PCAF). Negative epigenetic regulation of rRNA expression occurs through chromatin modifications produced by repressors such as the eNoSC complex, SIRT1, and the NoRC complex.  WDR5 is a component of six histone methyltransferases and three histone acetyltransferases involved in epigenetic regulation of gene expression (reviewed in Guarnaccia and Tansey 2018).  Endogenous retroelements are transposable elements that transpose to new genomic locations via an RNA intermediate and reverse transcription. Retroelements are silenced epigenetically in the human genome by mechanisms that include PIWI-interacting small RNAs (piRNAs) that transcriptionally silence retroelements through an RNA interference mechanism, KRAB-ZFP zinc finger-type repressors that bind specific DNA sequences in retroelements, and the HUSH complex that recognizes retroelements through nascent RNA or through existing histone H3 lysine-9 trimethylation (Almeida et al. 2022).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway97">
 <bp:pathwayOrder rdf:resource="#PathwayStep1030" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1041" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1031" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1042" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1040" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1029" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1027" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1038" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1028" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1039" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1036" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1037" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1034" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1035" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1032" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1043" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1033" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction939" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction941" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction940" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction936" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction947" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction935" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction946" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction938" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction937" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction932" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction943" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction931" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction942" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction934" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction945" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction933" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction944" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1027" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase II Pre-transcription Events</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">For initiation, Pol II assembles with the general transcription factors TFIIB, TFIID, TFIIE, TFIIF and TFIIH, which are collectively known as the general transcription factors, at promoter DNA to form the pre-initiation complex (PIC). Until the nascent transcript is about 15 nucleotides long, the early transcribing complex is functionally unstable. In the beginning, short RNAs are frequently released and Pol II has to restart transcription (abortive cycling). There is a decline in the level of abortive transcription when the RNA reaches a length of about four nucleotides, and this transition is termed escape commitment</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep950">
 <bp:stepProcess rdf:resource="#BiochemicalReaction861" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep951">
 <bp:stepProcess rdf:resource="#BiochemicalReaction862" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway99">
 <bp:pathwayOrder rdf:resource="#PathwayStep1050" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1046" />
 <bp:pathwayComponent rdf:resource="#Pathway101" />
 <bp:pathwayComponent rdf:resource="#Pathway100" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1046" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Positive epigenetic regulation of rRNA expression</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transcription of rRNA genes is controlled by epigenetic activation and repression according to the metabolic requirements of the cell (reviewed in Percipalle and Farrants 2006, McStay and Grummt 2008, Goodfellow and Zomerdijk 2012, Grummt and Langst 2013). Depending on the growth state of the cell, about half of the approximately 400 rRNA genes are expressed and these have the modifications characteristic of active chromatin: unmethylated DNA and acetylated histones. Repressed genes generally have methylated DNA and histone H3 methylated at lysine-9. Regulators of activation include ERCC6 (CSB), histone acetylases such as KAT2B (PCAF), and the B-WICH complex. Dysregulation of RNA polymerase I transcription plays a role in disease (reviewed in Hannan et al. 2013). The B-WICH complex positively regulates rRNA expression by remodeling chromatin and recruiting histone acetyltransferases that modify histones to transcriptionally active states ERCC6 (CSB) and EHMT2(G9a) positively regulate rRNA expression by ERCC6 recruiting the histone methyltransferase EHMT2 (also known as G9a) which dimethylates histone H3 at lysine-9 within the transcribed regions of rRNA genes. ERCC6 (CSB) and KAT2B (PCAF) positively regulate rRNA expression by ERCC6 recruiting the histone acetyltransferase KAT2B to the promoter where KAT2B acetylates histone H4 at several lysine residues and histone H3 at lysine-9. The acetylated chromatin facilitates the assembly of RNA polymerase I initiation complex.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep956">
 <bp:stepProcess rdf:resource="#BiochemicalReaction866" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep957">
 <bp:stepProcess rdf:resource="#BiochemicalReaction867" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep958">
 <bp:stepProcess rdf:resource="#BiochemicalReaction868" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep959">
 <bp:stepProcess rdf:resource="#BiochemicalReaction869" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep920">
 <bp:stepProcess rdf:resource="#BiochemicalReaction833" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep921">
 <bp:stepProcess rdf:resource="#BiochemicalReaction834" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep922">
 <bp:stepProcess rdf:resource="#BiochemicalReaction835" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep927">
 <bp:stepProcess rdf:resource="#BiochemicalReaction839" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep928">
 <bp:stepProcess rdf:resource="#BiochemicalReaction840" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep929">
 <bp:stepProcess rdf:resource="#BiochemicalReaction841" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep923">
 <bp:stepProcess rdf:resource="#BiochemicalReaction836" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep924">
 <bp:stepProcess rdf:resource="#BiochemicalReaction837" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep925">
 <bp:stepProcess rdf:resource="#BiochemicalReaction838" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep926">
 <bp:stepProcess rdf:resource="#Pathway89" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep930">
 <bp:stepProcess rdf:resource="#BiochemicalReaction842" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep931">
 <bp:stepProcess rdf:resource="#BiochemicalReaction843" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep932">
 <bp:stepProcess rdf:resource="#Pathway90" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep933">
 <bp:stepProcess rdf:resource="#BiochemicalReaction844" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep938">
 <bp:stepProcess rdf:resource="#BiochemicalReaction849" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep939">
 <bp:stepProcess rdf:resource="#BiochemicalReaction850" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep934">
 <bp:stepProcess rdf:resource="#BiochemicalReaction845" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep935">
 <bp:stepProcess rdf:resource="#BiochemicalReaction846" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep936">
 <bp:stepProcess rdf:resource="#BiochemicalReaction847" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep937">
 <bp:stepProcess rdf:resource="#Catalysis142" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction848" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep909">
 <bp:stepProcess rdf:resource="#BiochemicalReaction824" />
</bp:PathwayStep>

<bp:BioSource rdf:ID="BioSource1">
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Homo sapiens</bp:name>
</bp:BioSource>

<bp:PathwayStep rdf:ID="PathwayStep900">
 <bp:stepProcess rdf:resource="#BiochemicalReaction815" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep905">
 <bp:stepProcess rdf:resource="#BiochemicalReaction820" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep906">
 <bp:stepProcess rdf:resource="#BiochemicalReaction821" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep907">
 <bp:stepProcess rdf:resource="#BiochemicalReaction822" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep908">
 <bp:stepProcess rdf:resource="#BiochemicalReaction823" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep901">
 <bp:stepProcess rdf:resource="#BiochemicalReaction816" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep902">
 <bp:stepProcess rdf:resource="#BiochemicalReaction817" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep903">
 <bp:stepProcess rdf:resource="#BiochemicalReaction818" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep904">
 <bp:stepProcess rdf:resource="#BiochemicalReaction819" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep910">
 <bp:stepProcess rdf:resource="#BiochemicalReaction825" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep911">
 <bp:stepProcess rdf:resource="#BiochemicalReaction826" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep916">
 <bp:stepProcess rdf:resource="#BiochemicalReaction830" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep917">
 <bp:stepProcess rdf:resource="#BiochemicalReaction831" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep918">
 <bp:stepProcess rdf:resource="#Pathway88" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep919">
 <bp:stepProcess rdf:resource="#BiochemicalReaction832" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep912">
 <bp:stepProcess rdf:resource="#BiochemicalReaction827" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep913">
 <bp:stepProcess rdf:resource="#Pathway87" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep914">
 <bp:stepProcess rdf:resource="#BiochemicalReaction828" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep915">
 <bp:stepProcess rdf:resource="#BiochemicalReaction829" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep100">
 <bp:stepProcess rdf:resource="#BiochemicalReaction87" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence500">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence501">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence504">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence505">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence502">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence503">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence511">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence512">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence510">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence515">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence516">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence513">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence514">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence508">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence509">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence506">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence507">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence522">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence523">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence520">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence521">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence526">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence527">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence524">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence525">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence519">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence517">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence518">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence533">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence534">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence531">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence532">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence537">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence538">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence535">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence536">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence530">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence528">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence529">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence544">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence545">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence542">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence543">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence548">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence549">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence546">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence547">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep990">
 <bp:stepProcess rdf:resource="#BiochemicalReaction898" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep991">
 <bp:stepProcess rdf:resource="#BiochemicalReaction899" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence540">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence541">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep985">
 <bp:stepProcess rdf:resource="#BiochemicalReaction893" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep986">
 <bp:stepProcess rdf:resource="#BiochemicalReaction894" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep987">
 <bp:stepProcess rdf:resource="#BiochemicalReaction895" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep988">
 <bp:stepProcess rdf:resource="#BiochemicalReaction896" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep981">
 <bp:stepProcess rdf:resource="#BiochemicalReaction889" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep982">
 <bp:stepProcess rdf:resource="#BiochemicalReaction890" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep983">
 <bp:stepProcess rdf:resource="#BiochemicalReaction891" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep984">
 <bp:stepProcess rdf:resource="#BiochemicalReaction892" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence539">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep989">
 <bp:stepProcess rdf:resource="#BiochemicalReaction897" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence555">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence556">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence553">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence554">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence559">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence557">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence558">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence551">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence552">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence550">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep996">
 <bp:stepProcess rdf:resource="#BiochemicalReaction904" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep997">
 <bp:stepProcess rdf:resource="#BiochemicalReaction905" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep998">
 <bp:stepProcess rdf:resource="#BiochemicalReaction906" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep999">
 <bp:stepProcess rdf:resource="#BiochemicalReaction907" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep992">
 <bp:stepProcess rdf:resource="#BiochemicalReaction900" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep993">
 <bp:stepProcess rdf:resource="#BiochemicalReaction901" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep994">
 <bp:stepProcess rdf:resource="#BiochemicalReaction902" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep995">
 <bp:stepProcess rdf:resource="#BiochemicalReaction903" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence566">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1294">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence567">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1293">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence564">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1292">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence565">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1291">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1290">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence568">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence569">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep174">
 <bp:stepProcess rdf:resource="#BiochemicalReaction150" />
 <bp:stepProcess rdf:resource="#Catalysis23" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep175">
 <bp:stepProcess rdf:resource="#BiochemicalReaction151" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep176">
 <bp:stepProcess rdf:resource="#BiochemicalReaction152" />
 <bp:stepProcess rdf:resource="#Catalysis24" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep177">
 <bp:stepProcess rdf:resource="#BiochemicalReaction153" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1299">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep170">
 <bp:stepProcess rdf:resource="#BiochemicalReaction148" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence562">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1298">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep171">
 <bp:stepProcess rdf:resource="#Pathway24" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence563">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1297">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep172">
 <bp:stepProcess rdf:resource="#Pathway25" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence560">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1296">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep173">
 <bp:stepProcess rdf:resource="#BiochemicalReaction149" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence561">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1295">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction620">
 <bp:evidence rdf:resource="#Evidence689" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds STUB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction622">
 <bp:evidence rdf:resource="#Evidence691" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STUB1 polyubiquitinates RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction621">
 <bp:evidence rdf:resource="#Evidence690" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds GSK3B</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep167">
 <bp:stepProcess rdf:resource="#BiochemicalReaction145" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep168">
 <bp:stepProcess rdf:resource="#BiochemicalReaction146" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep169">
 <bp:stepProcess rdf:resource="#BiochemicalReaction147" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction628">
 <bp:evidence rdf:resource="#Evidence697" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GSK3B phosphorylates RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction627">
 <bp:evidence rdf:resource="#Evidence696" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Proteasome degrades polyubiquitinated RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction629">
 <bp:evidence rdf:resource="#Evidence698" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESRRA:PPARG1CB binds the RUNX2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction624">
 <bp:evidence rdf:resource="#Evidence693" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF(SKP2) complex binds RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction623">
 <bp:evidence rdf:resource="#Evidence692" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Proteasome degrades PolyUb-RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction626">
 <bp:evidence rdf:resource="#Evidence695" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMURF1 gene expression is stimulated by RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction625">
 <bp:evidence rdf:resource="#Evidence694" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds SMURF1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence577">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1283">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence578">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1282">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence575">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1281">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep180">
 <bp:stepProcess rdf:resource="#BiochemicalReaction156" />
 <bp:stepProcess rdf:resource="#Catalysis27" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence576">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1280">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence579">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep185">
 <bp:stepProcess rdf:resource="#Pathway26" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep186">
 <bp:stepProcess rdf:resource="#Pathway27" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence570">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep187">
 <bp:stepProcess rdf:resource="#BiochemicalReaction161" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1289">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep188">
 <bp:stepProcess rdf:resource="#Catalysis31" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction162" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1288">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep181">
 <bp:stepProcess rdf:resource="#BiochemicalReaction157" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence573">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1287">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep182">
 <bp:stepProcess rdf:resource="#BiochemicalReaction158" />
 <bp:stepProcess rdf:resource="#Catalysis28" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence574">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1286">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep183">
 <bp:stepProcess rdf:resource="#BiochemicalReaction159" />
 <bp:stepProcess rdf:resource="#Catalysis29" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence571">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1285">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep184">
 <bp:stepProcess rdf:resource="#Catalysis30" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction160" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence572">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1284">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction631">
 <bp:evidence rdf:resource="#Evidence700" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds SMURF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction630">
 <bp:evidence rdf:resource="#Evidence699" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds to HIVEP3 and WWP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction633">
 <bp:evidence rdf:resource="#Evidence702" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF(SKP2) polyubiquitinates RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction632">
 <bp:evidence rdf:resource="#Evidence701" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMURF1 polyubiquitinates RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep178">
 <bp:stepProcess rdf:resource="#BiochemicalReaction154" />
 <bp:stepProcess rdf:resource="#Catalysis25" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep179">
 <bp:stepProcess rdf:resource="#BiochemicalReaction155" />
 <bp:stepProcess rdf:resource="#Catalysis26" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction639">
 <bp:evidence rdf:resource="#Evidence708" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds CDKN1A gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction638">
 <bp:evidence rdf:resource="#Evidence707" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds SOX9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction635">
 <bp:evidence rdf:resource="#Evidence704" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 gene expression from proximal (P2) promoter is stimulated by ESR1:estrogen, ESRRA:PPARG1CA, TWIST1 and RUNX2-P2, and inhibited by ESRRA:PPARG1CB and DEXA:NR3C1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction634">
 <bp:evidence rdf:resource="#Evidence703" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DEXA:NR3C1 complex binds RUNX2 gene proximal promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction637">
 <bp:evidence rdf:resource="#Evidence706" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds CBFB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction636">
 <bp:evidence rdf:resource="#Evidence705" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence588">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence589">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence586">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence587">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep152">
 <bp:stepProcess rdf:resource="#Pathway22" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence580">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep153">
 <bp:stepProcess rdf:resource="#Pathway23" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence581">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep154">
 <bp:stepProcess rdf:resource="#BiochemicalReaction132" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep155">
 <bp:stepProcess rdf:resource="#BiochemicalReaction133" />
 <bp:stepProcess rdf:resource="#Catalysis22" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence584">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence585">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep150">
 <bp:stepProcess rdf:resource="#BiochemicalReaction130" />
 <bp:stepProcess rdf:resource="#Catalysis21" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence582">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep151">
 <bp:stepProcess rdf:resource="#BiochemicalReaction131" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence583">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep149">
 <bp:stepProcess rdf:resource="#Catalysis20" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction129" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction642">
 <bp:evidence rdf:resource="#Evidence712" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ITGBL1 gene expression is stimulated by RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction641">
 <bp:evidence rdf:resource="#Evidence711" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2:CBFB binds the ITGA5 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction644">
 <bp:evidence rdf:resource="#Evidence714" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2:CBFB binds the MMP13 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction643">
 <bp:evidence rdf:resource="#Evidence713" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ITGA5 gene expression is stimulated by RUNX2:CBFB</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep145">
 <bp:stepProcess rdf:resource="#Pathway21" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep146">
 <bp:stepProcess rdf:resource="#BiochemicalReaction126" />
 <bp:stepProcess rdf:resource="#Catalysis19" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep147">
 <bp:stepProcess rdf:resource="#BiochemicalReaction127" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction640">
 <bp:evidence rdf:resource="#Evidence710" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MMP13 gene expression is stimulated by RUNX2:CBFB</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep148">
 <bp:stepProcess rdf:resource="#BiochemicalReaction128" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction649">
 <bp:evidence rdf:resource="#Evidence720" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LGALS3 gene expression is stimulated by RUNX1 and RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction646">
 <bp:evidence rdf:resource="#Evidence716" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2:CBFB binds the ITGBL1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction645">
 <bp:evidence rdf:resource="#Evidence715" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated AKT phosphorylates RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction648">
 <bp:evidence rdf:resource="#Evidence719" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2:CBFB binds the LGALS3 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction647">
 <bp:evidence rdf:resource="#Evidence717" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds TWIST1,(TWIST2)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence599">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence597">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence598">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep163">
 <bp:stepProcess rdf:resource="#BiochemicalReaction141" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence591">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep164">
 <bp:stepProcess rdf:resource="#BiochemicalReaction142" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence592">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep165">
 <bp:stepProcess rdf:resource="#BiochemicalReaction143" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep166">
 <bp:stepProcess rdf:resource="#BiochemicalReaction144" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence590">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence595">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep160">
 <bp:stepProcess rdf:resource="#BiochemicalReaction138" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence596">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep161">
 <bp:stepProcess rdf:resource="#BiochemicalReaction139" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence593">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep162">
 <bp:stepProcess rdf:resource="#BiochemicalReaction140" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence594">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction653">
 <bp:evidence rdf:resource="#Evidence725" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of NR-NCOR Corepressor Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction652">
 <bp:evidence rdf:resource="#Evidence724" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of NR-MED1 Coactivator Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction655">
 <bp:evidence rdf:resource="#Evidence729" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EP300,CREBBP acetylate FOXO4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction654">
 <bp:evidence rdf:resource="#Evidence728" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ROS oxidize FOXO4 cysteine residues</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep156">
 <bp:stepProcess rdf:resource="#BiochemicalReaction134" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep157">
 <bp:stepProcess rdf:resource="#BiochemicalReaction135" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep158">
 <bp:stepProcess rdf:resource="#BiochemicalReaction136" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction651">
 <bp:evidence rdf:resource="#Evidence722" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of DRIP coactivator complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep159">
 <bp:stepProcess rdf:resource="#BiochemicalReaction137" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction650">
 <bp:evidence rdf:resource="#Evidence721" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PPM1D dephosphorylates RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction657">
 <bp:evidence rdf:resource="#Evidence731" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TXN disrupts FOXO4 complex with EP300</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction656">
 <bp:evidence rdf:resource="#Evidence730" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SIRT1,SIRT3 deacetylate FOXO3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction659">
 <bp:evidence rdf:resource="#Evidence733" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREBBP binds FOXO1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction658">
 <bp:evidence rdf:resource="#Evidence732" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREBBP acetylates FOXO1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep130">
 <bp:stepProcess rdf:resource="#BiochemicalReaction113" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep131">
 <bp:stepProcess rdf:resource="#BiochemicalReaction114" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep132">
 <bp:stepProcess rdf:resource="#BiochemicalReaction115" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep133">
 <bp:stepProcess rdf:resource="#BiochemicalReaction116" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep127">
 <bp:stepProcess rdf:resource="#BiochemicalReaction111" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction664">
 <bp:evidence rdf:resource="#Evidence739" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">14-3-3 proteins bind AKT-phosphorylated FOXO4</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep128">
 <bp:stepProcess rdf:resource="#BiochemicalReaction112" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction663">
 <bp:evidence rdf:resource="#Evidence738" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT-phosphorylated FOXO1,FOXO3,FOXO4 translocate to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep129">
 <bp:stepProcess rdf:resource="#Pathway18" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction666">
 <bp:evidence rdf:resource="#Evidence741" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">14-3-3 proteins bind AKT-phosphorylated FOXO3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction665">
 <bp:evidence rdf:resource="#Evidence740" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">14-3-3 proteins bind AKT-phosphorylated FOXO1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep123">
 <bp:stepProcess rdf:resource="#BiochemicalReaction107" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction660">
 <bp:evidence rdf:resource="#Evidence734" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KAT2B,EP300 acetylate FOXO3 under oxidative stress</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep124">
 <bp:stepProcess rdf:resource="#BiochemicalReaction108" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep125">
 <bp:stepProcess rdf:resource="#BiochemicalReaction109" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction662">
 <bp:evidence rdf:resource="#Evidence736" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SIRT1 deacetylates FOXO1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep126">
 <bp:stepProcess rdf:resource="#BiochemicalReaction110" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction661">
 <bp:evidence rdf:resource="#Evidence735" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EP300,CREBBP bind SOH-C481-FOXO4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction668">
 <bp:evidence rdf:resource="#Evidence744" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CAT gene expression is stimulated by FOXO3,FOXO6,(FOXO1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction667">
 <bp:evidence rdf:resource="#Evidence742" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AKT phosphorylates FOXO transcription factors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction669">
 <bp:evidence rdf:resource="#Evidence745" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1 binds POMC gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep141">
 <bp:stepProcess rdf:resource="#BiochemicalReaction122" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep142">
 <bp:stepProcess rdf:resource="#BiochemicalReaction123" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep143">
 <bp:stepProcess rdf:resource="#BiochemicalReaction124" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep144">
 <bp:stepProcess rdf:resource="#BiochemicalReaction125" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep140">
 <bp:stepProcess rdf:resource="#BiochemicalReaction121" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep138">
 <bp:stepProcess rdf:resource="#BiochemicalReaction119" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction675">
 <bp:evidence rdf:resource="#Evidence751" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IGFBP1 gene expression is stimulated by FOXO1,FOXO3,FOXO4</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep139">
 <bp:stepProcess rdf:resource="#BiochemicalReaction120" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction674">
 <bp:evidence rdf:resource="#Evidence750" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SREBF1 gene expression is inhibited by FOXO1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction677">
 <bp:evidence rdf:resource="#Evidence753" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1,FOXO1:PPARGC1A,FOXO3,FOXO4,FOXO6 bind G6PC gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction676">
 <bp:evidence rdf:resource="#Evidence752" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1,FOXO3 bind ABCA6 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep134">
 <bp:stepProcess rdf:resource="#Pathway19" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction671">
 <bp:evidence rdf:resource="#Evidence747" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1,FOXO3 and SMAD3 bind TRIM63 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep135">
 <bp:stepProcess rdf:resource="#BiochemicalReaction117" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction670">
 <bp:evidence rdf:resource="#Evidence746" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO3,FOXO6,(FOXO1) binds CAT gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep136">
 <bp:stepProcess rdf:resource="#BiochemicalReaction118" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction673">
 <bp:evidence rdf:resource="#Evidence749" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIM63 gene expression is stimulated by FOXO1 and FOXO3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep137">
 <bp:stepProcess rdf:resource="#Pathway20" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction672">
 <bp:evidence rdf:resource="#Evidence748" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G6PC gene expression is stimulated by FOXO1,FOXO3,FOXO4,FOXO6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction679">
 <bp:evidence rdf:resource="#Evidence755" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RETN gene expression is stimulated by FOXO1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction678">
 <bp:evidence rdf:resource="#Evidence754" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO4 binds ATXN3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep110">
 <bp:stepProcess rdf:resource="#BiochemicalReaction94" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction680">
 <bp:evidence rdf:resource="#Evidence756" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1 binds NPY gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep111">
 <bp:stepProcess rdf:resource="#BiochemicalReaction95" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep105">
 <bp:stepProcess rdf:resource="#BiochemicalReaction90" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction686">
 <bp:evidence rdf:resource="#Evidence762" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FBXO32 gene expression is stimulated by FOXO1,FOXO3,(FOXO4)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep106">
 <bp:stepProcess rdf:resource="#BiochemicalReaction91" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction685">
 <bp:evidence rdf:resource="#Evidence761" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PCK1 gene expression is stimulated by FOXO1:PPARGC1A</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep107">
 <bp:stepProcess rdf:resource="#BiochemicalReaction92" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction688">
 <bp:evidence rdf:resource="#Evidence764" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1,FOXO3,FOXO4 bind IGFBP1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep108">
 <bp:stepProcess rdf:resource="#BiochemicalReaction93" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction687">
 <bp:evidence rdf:resource="#Evidence763" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1:PPARGC1A,FOXO4 binds PCK1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep101">
 <bp:stepProcess rdf:resource="#Pathway15" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction682">
 <bp:evidence rdf:resource="#Evidence758" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPY gene expression is stimulated by FOXO1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep102">
 <bp:stepProcess rdf:resource="#BiochemicalReaction88" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction681">
 <bp:evidence rdf:resource="#Evidence757" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ABCA6 gene expression is stimulated by FOXO1,FOXO3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep103">
 <bp:stepProcess rdf:resource="#BiochemicalReaction89" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction684">
 <bp:evidence rdf:resource="#Evidence760" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1 and SIN3A:HDAC complex bind GCK gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep104">
 <bp:stepProcess rdf:resource="#Pathway16" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction683">
 <bp:evidence rdf:resource="#Evidence759" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1 binds PPARGC1A</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep109">
 <bp:stepProcess rdf:resource="#Pathway17" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction689">
 <bp:evidence rdf:resource="#Evidence765" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO3 binds SOD2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep120">
 <bp:stepProcess rdf:resource="#BiochemicalReaction104" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep121">
 <bp:stepProcess rdf:resource="#BiochemicalReaction105" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction691">
 <bp:evidence rdf:resource="#Evidence767" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1 and NR3C1 bind TRIM63 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep122">
 <bp:stepProcess rdf:resource="#BiochemicalReaction106" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction690">
 <bp:evidence rdf:resource="#Evidence766" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1,FOXO3,(FOXO4) bind FBXO32 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep116">
 <bp:stepProcess rdf:resource="#BiochemicalReaction100" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction697">
 <bp:evidence rdf:resource="#Evidence773" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO4:ATXN3 binds SOD2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep117">
 <bp:stepProcess rdf:resource="#BiochemicalReaction101" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction696">
 <bp:evidence rdf:resource="#Evidence772" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1 binds AGRP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep118">
 <bp:stepProcess rdf:resource="#BiochemicalReaction102" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction699">
 <bp:evidence rdf:resource="#Evidence775" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLXNA4 gene expression is stimulated by FOXO6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep119">
 <bp:stepProcess rdf:resource="#BiochemicalReaction103" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction698">
 <bp:evidence rdf:resource="#Evidence774" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOD2 gene expression is stimulated by FOXO4, FOXO3 and FOXO1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep112">
 <bp:stepProcess rdf:resource="#BiochemicalReaction96" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction693">
 <bp:evidence rdf:resource="#Evidence769" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO6 binds PLXNA4 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep113">
 <bp:stepProcess rdf:resource="#BiochemicalReaction97" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction692">
 <bp:evidence rdf:resource="#Evidence768" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">POMC gene expression is inhibited by FOXO1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep114">
 <bp:stepProcess rdf:resource="#BiochemicalReaction98" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction695">
 <bp:evidence rdf:resource="#Evidence771" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXO1 binds RETN gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep115">
 <bp:stepProcess rdf:resource="#BiochemicalReaction99" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction694">
 <bp:evidence rdf:resource="#Evidence770" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GCK gene expression is inhibited by FOXO1, SIN3A and HDACs</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1052">
 <bp:stepProcess rdf:resource="#BiochemicalReaction952" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1053">
 <bp:stepProcess rdf:resource="#BiochemicalReaction953" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1050">
 <bp:stepProcess rdf:resource="#Pathway101" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1051">
 <bp:stepProcess rdf:resource="#BiochemicalReaction951" />
 <bp:stepProcess rdf:resource="#Catalysis158" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1149">
 <bp:evidence rdf:resource="#Evidence1287" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Abortive Initiation At Type 1 Open Promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1146">
 <bp:evidence rdf:resource="#Evidence1284" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Simple Start Sequence Initiation At Type 1 Promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1145">
 <bp:evidence rdf:resource="#Evidence1283" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Promoter Opening at Type 3 Promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1148">
 <bp:evidence rdf:resource="#Evidence1286" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Abortive Initiation At Type 3 Open Promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1147">
 <bp:evidence rdf:resource="#Evidence1285" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Promoter Opening at Type 2 Promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1153">
 <bp:evidence rdf:resource="#Evidence1291" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Productive Transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1152">
 <bp:evidence rdf:resource="#Evidence1290" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Transcriptional Pause at Terminator Sequence</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1155">
 <bp:evidence rdf:resource="#Evidence1294" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Termination and release of transcribed RNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1154">
 <bp:evidence rdf:resource="#Evidence1292" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Retractive RNase Activity at U-tract Pause Sites</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1151">
 <bp:evidence rdf:resource="#Evidence1289" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Termination and release of transcribed RNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1150">
 <bp:evidence rdf:resource="#Evidence1288" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Abortive Initiation At Type 2 Open Promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1058">
 <bp:stepProcess rdf:resource="#Catalysis159" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction956" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1059">
 <bp:stepProcess rdf:resource="#BiochemicalReaction957" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1056">
 <bp:stepProcess rdf:resource="#Pathway103" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1057">
 <bp:stepProcess rdf:resource="#BiochemicalReaction955" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1054">
 <bp:stepProcess rdf:resource="#BiochemicalReaction954" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1055">
 <bp:stepProcess rdf:resource="#Pathway102" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1041">
 <bp:stepProcess rdf:resource="#BiochemicalReaction945" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1042">
 <bp:stepProcess rdf:resource="#BiochemicalReaction946" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1040">
 <bp:stepProcess rdf:resource="#BiochemicalReaction944" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1139">
 <bp:evidence rdf:resource="#Evidence1276" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of TFIIIC to Type 2 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1138">
 <bp:evidence rdf:resource="#Evidence1275" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of TFIIIB to TFIIC: Type 2 Promoter Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1135">
 <bp:evidence rdf:resource="#Evidence1271" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of RNA Polymerase III to TFIIIB:SNAPc:Type 3 Promoter Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1134">
 <bp:evidence rdf:resource="#Evidence1270" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of SNAPc, Oct-1, and Staf to Type 3 Promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1137">
 <bp:evidence rdf:resource="#Evidence1273" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of TFIIIB to SNAPc:Oct-1:Staf:Type 3 Promoter Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1136">
 <bp:evidence rdf:resource="#Evidence1272" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Promoter Opening at Type 3 Promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1142">
 <bp:evidence rdf:resource="#Evidence1280" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Simple Start Sequence Initiation At Type 3 Promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1141">
 <bp:evidence rdf:resource="#Evidence1278" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Promoter Opening at Type 2 Promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1144">
 <bp:evidence rdf:resource="#Evidence1282" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Simple Start Sequence Initiation At Type 2 Promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1143">
 <bp:evidence rdf:resource="#Evidence1281" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Promoter Opening at Type 1 Promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1140">
 <bp:evidence rdf:resource="#Evidence1277" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of RNA Polymerase III to the TFIIIB:TFIIIC: Type 2 Promoter Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1049">
 <bp:stepProcess rdf:resource="#BiochemicalReaction950" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1047">
 <bp:stepProcess rdf:resource="#BiochemicalReaction948" />
 <bp:stepProcess rdf:resource="#Catalysis157" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1048">
 <bp:stepProcess rdf:resource="#BiochemicalReaction949" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1045">
 <bp:stepProcess rdf:resource="#Pathway99" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1046">
 <bp:stepProcess rdf:resource="#Pathway100" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1043">
 <bp:stepProcess rdf:resource="#BiochemicalReaction947" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1044">
 <bp:stepProcess rdf:resource="#Pathway98" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1074">
 <bp:stepProcess rdf:resource="#BiochemicalReaction972" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1075">
 <bp:stepProcess rdf:resource="#BiochemicalReaction973" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1072">
 <bp:stepProcess rdf:resource="#BiochemicalReaction970" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1073">
 <bp:stepProcess rdf:resource="#BiochemicalReaction971" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1070">
 <bp:stepProcess rdf:resource="#BiochemicalReaction968" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1071">
 <bp:stepProcess rdf:resource="#BiochemicalReaction969" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction804">
 <bp:evidence rdf:resource="#Evidence889" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TJP1 (ZO-1) gene expression is stimulated by RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction803">
 <bp:evidence rdf:resource="#Evidence888" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OCLN (Occludin) gene expression is stimulated by RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction806">
 <bp:evidence rdf:resource="#Evidence891" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds the OCLN gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction805">
 <bp:evidence rdf:resource="#Evidence890" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds the CLDN5 (Claudin-5) gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction800">
 <bp:evidence rdf:resource="#Evidence884" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds the SWI/SNF complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1078">
 <bp:stepProcess rdf:resource="#BiochemicalReaction976" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1079">
 <bp:stepProcess rdf:resource="#BiochemicalReaction977" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction802">
 <bp:evidence rdf:resource="#Evidence887" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLDN5 (Claudin-5) gene expression is stimulated by RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1076">
 <bp:stepProcess rdf:resource="#BiochemicalReaction974" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction801">
 <bp:evidence rdf:resource="#Evidence885" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HIPK2 phosphorylates RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1077">
 <bp:stepProcess rdf:resource="#BiochemicalReaction975" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1063">
 <bp:stepProcess rdf:resource="#BiochemicalReaction961" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1064">
 <bp:stepProcess rdf:resource="#BiochemicalReaction962" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1061">
 <bp:stepProcess rdf:resource="#BiochemicalReaction959" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1062">
 <bp:stepProcess rdf:resource="#BiochemicalReaction960" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction808">
 <bp:evidence rdf:resource="#Evidence894" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFNG gene expression is stimulated by RUNX1 and inhibited by FOXP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction807">
 <bp:evidence rdf:resource="#Evidence892" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds the TJP1 (ZO-1) gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1060">
 <bp:stepProcess rdf:resource="#BiochemicalReaction958" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction809">
 <bp:evidence rdf:resource="#Evidence895" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 and FOXP3 bind the IFNG gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1157">
 <bp:evidence rdf:resource="#Evidence1297" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Resumption of RNA Polymerase III Productive Transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1156">
 <bp:evidence rdf:resource="#Evidence1295" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Transcriptional Pause at Terminator Sequence</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1159">
 <bp:evidence rdf:resource="#Evidence1299" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Initiation of RNA Polymerase III Productive Transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1158">
 <bp:evidence rdf:resource="#Evidence1298" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Productive Transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction815">
 <bp:evidence rdf:resource="#Evidence901" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL2RA (CD25) gene expression is stimulated by FOXP3 and inhibited by RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction814">
 <bp:evidence rdf:resource="#Evidence900" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXP3 in complex with RUNX1 binds to the TNFRSF18 (GITR) gene intron 1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction817">
 <bp:evidence rdf:resource="#Evidence903" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds FOXP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1069">
 <bp:stepProcess rdf:resource="#BiochemicalReaction967" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction816">
 <bp:evidence rdf:resource="#Evidence902" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNFRSF18 (GITR) gene expression is stimulated by FOXP3 and inhibited by RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction811">
 <bp:evidence rdf:resource="#Evidence897" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds the promoter of the CTLA4 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1067">
 <bp:stepProcess rdf:resource="#BiochemicalReaction965" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction810">
 <bp:evidence rdf:resource="#Evidence896" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 and NFATC2 bind the IL2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1068">
 <bp:stepProcess rdf:resource="#BiochemicalReaction966" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction813">
 <bp:evidence rdf:resource="#Evidence899" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds the IFNG promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1065">
 <bp:stepProcess rdf:resource="#BiochemicalReaction963" />
 <bp:stepProcess rdf:resource="#Catalysis160" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction812">
 <bp:evidence rdf:resource="#Evidence898" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CR1 gene expression is stimulated by RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1066">
 <bp:stepProcess rdf:resource="#BiochemicalReaction964" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction819">
 <bp:evidence rdf:resource="#Evidence905" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXP3 gene expression is stimulated by RUNX1:CBFB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction818">
 <bp:evidence rdf:resource="#Evidence904" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds intron 1 of IL2RA (CD25) gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1109">
 <bp:evidence rdf:resource="#Evidence1240" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MeR-PIWIL4:2&apos;-O-methyl-piRNA:TDRD9:MAEL:TDRKH dissociates and MeR-PIWIL4:2&apos;-O-methylpiRNA, TDRD9, MAEL translocate from cytosol to nucleus in an unknown association and order of events</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1106">
 <bp:evidence rdf:resource="#Evidence1236" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AGO1,2:small RNA complexes interact with chromatin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1105">
 <bp:evidence rdf:resource="#Evidence1235" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNRC6A:AGO2:miRNA is transported into the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1108">
 <bp:evidence rdf:resource="#Evidence1238" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Importin-8 imports AGO2:miRNA into the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1107">
 <bp:evidence rdf:resource="#Evidence1237" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Importin-8 binds AGO2:miRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1102">
 <bp:evidence rdf:resource="#Evidence1231" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Endonucleolytic RISC hydrolyzes target RNAs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1101">
 <bp:evidence rdf:resource="#Evidence1230" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RISC binds inexactly matching target RNAs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1104">
 <bp:evidence rdf:resource="#Evidence1234" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNRC6A binds AGO2:miRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1103">
 <bp:evidence rdf:resource="#Evidence1232" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nonendonucleolytic RISC binds exactly matching target RNAs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction820">
 <bp:evidence rdf:resource="#Evidence906" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1:CBFB binds FOXP3 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1111">
 <bp:evidence rdf:resource="#Evidence1242" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complexed PIWIL2 binds cleaved transposon RNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1110">
 <bp:evidence rdf:resource="#Evidence1241" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Unknown nuclease cleaves cleaved transposon RNA in 6xMeR-PIWIL2:cleaved transposon RNA:TDRD1:TDRD12:DDX4:ASZ:MOV10L1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1018">
 <bp:stepProcess rdf:resource="#Catalysis153" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction924" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1019">
 <bp:stepProcess rdf:resource="#Catalysis154" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction925" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction826">
 <bp:evidence rdf:resource="#Evidence912" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds the CR1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1016">
 <bp:stepProcess rdf:resource="#Catalysis151" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction922" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction825">
 <bp:evidence rdf:resource="#Evidence911" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1, FOXP3 and NFATC2 bind the IL2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1017">
 <bp:stepProcess rdf:resource="#Catalysis152" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction923" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction828">
 <bp:evidence rdf:resource="#Evidence915" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds PAX5 (BSAP)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1014">
 <bp:stepProcess rdf:resource="#Pathway95" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction827">
 <bp:evidence rdf:resource="#Evidence913" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXP3 in complex with RUNX1 binds the CTLA4 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1015">
 <bp:stepProcess rdf:resource="#Catalysis150" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction921" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction822">
 <bp:evidence rdf:resource="#Evidence908" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CTLA4 gene expression is stimulated by FOXP3 and inhibited by RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1012">
 <bp:stepProcess rdf:resource="#Pathway94" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction821">
 <bp:evidence rdf:resource="#Evidence907" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds to TNFRSF18 (GITR) gene promoter and intron 1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1013">
 <bp:stepProcess rdf:resource="#Catalysis149" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction920" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction824">
 <bp:evidence rdf:resource="#Evidence910" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL2 gene expression is stimulated by RUNX1 and NFATC2 and repressed by FOXP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1010">
 <bp:stepProcess rdf:resource="#BiochemicalReaction918" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction823">
 <bp:evidence rdf:resource="#Evidence909" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FOXP3 in complex with RUNX1 binds intron 1 of the IL2RA (CD25) gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1011">
 <bp:stepProcess rdf:resource="#BiochemicalReaction919" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction829">
 <bp:evidence rdf:resource="#Evidence916" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 and ELF1, ELF2 or PAX5 bind the BLK gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction831">
 <bp:evidence rdf:resource="#Evidence918" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BLK gene expression is stimulated by the complex of RUNX1 and ELF1, ELF2 or PAX5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1100">
 <bp:evidence rdf:resource="#Evidence1228" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pol II mediated transcription of microRNA genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction830">
 <bp:evidence rdf:resource="#Evidence917" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds ELF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1009">
 <bp:stepProcess rdf:resource="#BiochemicalReaction917" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1007">
 <bp:stepProcess rdf:resource="#Catalysis148" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction915" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1008">
 <bp:stepProcess rdf:resource="#BiochemicalReaction916" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction837">
 <bp:evidence rdf:resource="#Evidence925" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSF2 (GM-CSF) gene expression is stimulated by RUNX1 and CREBBP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1005">
 <bp:stepProcess rdf:resource="#BiochemicalReaction913" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction836">
 <bp:evidence rdf:resource="#Evidence924" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LGALS3 gene expression is stimulated by RUNX1 and RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1006">
 <bp:stepProcess rdf:resource="#BiochemicalReaction914" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction839">
 <bp:evidence rdf:resource="#Evidence928" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL3 gene transcription is stimulated by RUNX1 and ELF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1003">
 <bp:stepProcess rdf:resource="#BiochemicalReaction911" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction838">
 <bp:evidence rdf:resource="#Evidence926" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRKCB gene expression is stimulated by RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1004">
 <bp:stepProcess rdf:resource="#BiochemicalReaction912" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction833">
 <bp:evidence rdf:resource="#Evidence921" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1:CBFB binds the LGALS3 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1001">
 <bp:stepProcess rdf:resource="#BiochemicalReaction909" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction832">
 <bp:evidence rdf:resource="#Evidence920" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1:CBFB binds CREBBP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1002">
 <bp:stepProcess rdf:resource="#BiochemicalReaction910" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction835">
 <bp:evidence rdf:resource="#Evidence923" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds the PRKCB gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction834">
 <bp:evidence rdf:resource="#Evidence922" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1:CBFB:CREBBP binds the CSF2 (GM-CSF) gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1000">
 <bp:stepProcess rdf:resource="#BiochemicalReaction908" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1030">
 <bp:stepProcess rdf:resource="#BiochemicalReaction934" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1031">
 <bp:stepProcess rdf:resource="#BiochemicalReaction935" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep190">
 <bp:stepProcess rdf:resource="#BiochemicalReaction164" />
 <bp:stepProcess rdf:resource="#Catalysis32" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep191">
 <bp:stepProcess rdf:resource="#BiochemicalReaction165" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep196">
 <bp:stepProcess rdf:resource="#BiochemicalReaction170" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1128">
 <bp:evidence rdf:resource="#Evidence1260" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DICER1 cleaves tRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep197">
 <bp:stepProcess rdf:resource="#BiochemicalReaction171" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1127">
 <bp:evidence rdf:resource="#Evidence1259" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ANG cleaves tRNA to yield tRNA halves</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep198">
 <bp:stepProcess rdf:resource="#BiochemicalReaction172" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep199">
 <bp:stepProcess rdf:resource="#Catalysis36" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction173" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1129">
 <bp:evidence rdf:resource="#Evidence1264" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase III Promoter Opening at Type 1 Promoters</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep192">
 <bp:stepProcess rdf:resource="#BiochemicalReaction166" />
 <bp:stepProcess rdf:resource="#Catalysis33" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1124">
 <bp:evidence rdf:resource="#Evidence1255" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HENMT1 methylates 2&apos; hydroxyl at 3&apos; end of piRNA in MeR-PIWIL4:piRNA:TDRD9:MAEL:TDRKH</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep193">
 <bp:stepProcess rdf:resource="#BiochemicalReaction167" />
 <bp:stepProcess rdf:resource="#Catalysis34" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1123">
 <bp:evidence rdf:resource="#Evidence1254" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complexed PIWIL2 binds  pre-piRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep194">
 <bp:stepProcess rdf:resource="#BiochemicalReaction168" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1126">
 <bp:evidence rdf:resource="#Evidence1258" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ELAC2 cleaves pre-tRNA to yield 3&apos; trailer (type II tRF or tRF-1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep195">
 <bp:stepProcess rdf:resource="#BiochemicalReaction169" />
 <bp:stepProcess rdf:resource="#Catalysis35" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1125">
 <bp:evidence rdf:resource="#Evidence1257" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DICER1 cleaves tRNA Lys TTT 3 in tRNA:HIV RNA hybrid</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction840">
 <bp:evidence rdf:resource="#Evidence929" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LIFR gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1131">
 <bp:evidence rdf:resource="#Evidence1266" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of  RNA polymerase III to TFIIIB:TFIIIC:TFIIIA:Type 1 Promoter Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1130">
 <bp:evidence rdf:resource="#Evidence1265" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of TFIIIB to TFIIIC:TFIIIA:Type I Promoter complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction842">
 <bp:evidence rdf:resource="#Evidence931" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1:CBFB binds the LIFR gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1133">
 <bp:evidence rdf:resource="#Evidence1268" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of TFIIIA To type 1 Promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction841">
 <bp:evidence rdf:resource="#Evidence930" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds ELF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1132">
 <bp:evidence rdf:resource="#Evidence1267" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of TFIIIC to TFIIIA:Type I Promoter complex </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep189">
 <bp:stepProcess rdf:resource="#BiochemicalReaction163" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction848">
 <bp:evidence rdf:resource="#Evidence938" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC phosphorylates RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1038">
 <bp:stepProcess rdf:resource="#BiochemicalReaction942" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction847">
 <bp:evidence rdf:resource="#Evidence937" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-27a binds RUNX1 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1039">
 <bp:stepProcess rdf:resource="#BiochemicalReaction943" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1036">
 <bp:stepProcess rdf:resource="#BiochemicalReaction940" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction849">
 <bp:evidence rdf:resource="#Evidence939" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">H19 is cleaved to produce miR-675</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1037">
 <bp:stepProcess rdf:resource="#BiochemicalReaction941" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction844">
 <bp:evidence rdf:resource="#Evidence934" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-17 binds RUNX1 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1034">
 <bp:stepProcess rdf:resource="#BiochemicalReaction938" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction843">
 <bp:evidence rdf:resource="#Evidence932" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 and ELF1 bind the IL3 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1035">
 <bp:stepProcess rdf:resource="#BiochemicalReaction939" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction846">
 <bp:evidence rdf:resource="#Evidence936" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-106a binds RUNX1 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1032">
 <bp:stepProcess rdf:resource="#BiochemicalReaction936" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction845">
 <bp:evidence rdf:resource="#Evidence935" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 mRNA translation is inhibited by miR-17, miR-18a, miR-20a, miR-27a, miR-106a, miR-215, miR-302b, miR-378 and miR-675</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1033">
 <bp:stepProcess rdf:resource="#BiochemicalReaction937" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1020">
 <bp:stepProcess rdf:resource="#BiochemicalReaction926" />
 <bp:stepProcess rdf:resource="#Catalysis155" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1117">
 <bp:evidence rdf:resource="#Evidence1248" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complexed PIWIL4 binds cleaved transposon RNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1116">
 <bp:evidence rdf:resource="#Evidence1247" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Primary piRNA transcript translocates from nucleoplasm to cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1119">
 <bp:evidence rdf:resource="#Evidence1250" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Unknown nuclease cleaves cleaved transposon RNA bound in MeR-PIWIL4:cleaved transposon RNA:TDRD9:MAEL:TDRKH</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1118">
 <bp:evidence rdf:resource="#Evidence1249" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Unknown nuclease cleaves pre-piRNA in ASZ1:DDX4:MOV10L1:6xMeR-PIWIL2:pre-piRNA:TDRD1:TDRD12</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1113">
 <bp:evidence rdf:resource="#Evidence1244" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complexed PIWIL1 binds pre-piRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1112">
 <bp:evidence rdf:resource="#Evidence1243" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HENMT1 methylates 2&apos; hydroxyl at 3&apos; end of piRNA in 6xMeR-PIWIL2:piRNA:TDRD1:TDRD12:DDX4:ASZ:MOV10L1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1115">
 <bp:evidence rdf:resource="#Evidence1246" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA polymerase II polymerizes primary piRNA transcript</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1114">
 <bp:evidence rdf:resource="#Evidence1245" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Unknown nuclease cleaves pre-piRNA in 4xMeR-PIWIL1:pre-piRNA:TDRD6:TDRKH</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction851">
 <bp:evidence rdf:resource="#Evidence941" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN11 dephosphorylates RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1120">
 <bp:evidence rdf:resource="#Evidence1251" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLD6 dimer cleaves primary piRNA transcript to pre-piRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction850">
 <bp:evidence rdf:resource="#Evidence940" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDK6 binds RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction853">
 <bp:evidence rdf:resource="#Evidence943" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBFB binds RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1122">
 <bp:evidence rdf:resource="#Evidence1253" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complexed PIWIL2:2&apos;-O-methyl-piRNA cleaves transposon RNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction852">
 <bp:evidence rdf:resource="#Evidence942" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PML binds RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1121">
 <bp:evidence rdf:resource="#Evidence1252" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HENMT1 methylates 2&apos; hydroxyl at 3&apos; end of piRNA in 4xMeR-PIWIL1:piRNA:TDRD6:TDRKH</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1029">
 <bp:stepProcess rdf:resource="#BiochemicalReaction933" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction859">
 <bp:evidence rdf:resource="#Evidence949" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1027">
 <bp:stepProcess rdf:resource="#BiochemicalReaction931" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction858">
 <bp:evidence rdf:resource="#Evidence948" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN11 binds p-7Y-RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1028">
 <bp:stepProcess rdf:resource="#BiochemicalReaction932" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1025">
 <bp:stepProcess rdf:resource="#BiochemicalReaction930" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1026">
 <bp:stepProcess rdf:resource="#Pathway97" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction855">
 <bp:evidence rdf:resource="#Evidence945" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-215 binds RUNX1 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1023">
 <bp:stepProcess rdf:resource="#BiochemicalReaction928" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction854">
 <bp:evidence rdf:resource="#Evidence944" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-302b binds RUNX1 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1024">
 <bp:stepProcess rdf:resource="#BiochemicalReaction929" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction857">
 <bp:evidence rdf:resource="#Evidence947" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-675 binds RUNX1 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1021">
 <bp:stepProcess rdf:resource="#BiochemicalReaction927" />
 <bp:stepProcess rdf:resource="#Catalysis156" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction856">
 <bp:evidence rdf:resource="#Evidence946" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-18a binds RUNX1 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1022">
 <bp:stepProcess rdf:resource="#Pathway96" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction59">
 <bp:evidence rdf:resource="#Evidence72" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP9X (FAM) binds to ubiquitinated SMAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction58">
 <bp:evidence rdf:resource="#Evidence71" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitinated SMAD4 translocates from the nucleus to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence600">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction57">
 <bp:evidence rdf:resource="#Evidence69" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Degradation of Ub-SMAD7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction56">
 <bp:evidence rdf:resource="#Evidence68" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated SMAD2 and SMAD3 form a complex with SMAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence603">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence604">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence601">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence602">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep210">
 <bp:stepProcess rdf:resource="#Catalysis42" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction184" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep204">
 <bp:stepProcess rdf:resource="#BiochemicalReaction178" />
 <bp:stepProcess rdf:resource="#Catalysis39" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep205">
 <bp:stepProcess rdf:resource="#BiochemicalReaction179" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep206">
 <bp:stepProcess rdf:resource="#BiochemicalReaction180" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep207">
 <bp:stepProcess rdf:resource="#Catalysis40" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction181" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep200">
 <bp:stepProcess rdf:resource="#Catalysis37" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction174" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep201">
 <bp:stepProcess rdf:resource="#BiochemicalReaction175" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep202">
 <bp:stepProcess rdf:resource="#BiochemicalReaction176" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep203">
 <bp:stepProcess rdf:resource="#BiochemicalReaction177" />
 <bp:stepProcess rdf:resource="#Catalysis38" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction62">
 <bp:evidence rdf:resource="#Evidence75" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEDD4L binds phosphorylated linker region of SMAD2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction61">
 <bp:evidence rdf:resource="#Evidence74" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIM33 (Ectodermin) binds SMAD heterotrimer in the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction60">
 <bp:evidence rdf:resource="#Evidence73" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT1 stimulates SMAD7 gene transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction66">
 <bp:evidence rdf:resource="#Evidence79" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Degradation of SMAD2/3:SMAD4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep208">
 <bp:stepProcess rdf:resource="#Catalysis41" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction182" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction65">
 <bp:evidence rdf:resource="#Evidence78" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD2/3 activation induces binding of RNF111/SMURF2 to SKI/SKIL</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep209">
 <bp:stepProcess rdf:resource="#BiochemicalReaction183" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction64">
 <bp:evidence rdf:resource="#Evidence77" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD7 binds SERPINE1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction63">
 <bp:evidence rdf:resource="#Evidence76" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGIF recruits HDAC1 to SMAD2/3:SMAD4 heterotrimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction48">
 <bp:evidence rdf:resource="#Evidence60" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWTR1:SMAD translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence610">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction47">
 <bp:evidence rdf:resource="#Evidence59" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MEN1 binds SMAD2/3:SMAD4 heterotrimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence611">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction46">
 <bp:evidence rdf:resource="#Evidence58" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNF111 binds SMAD7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction45">
 <bp:evidence rdf:resource="#Evidence57" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The SMAD2/3:SMAD4 complex transfers to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence614">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence615">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence612">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction49">
 <bp:evidence rdf:resource="#Evidence61" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-2S-SMAD2,3:SMAD4 binds JUNB gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence613">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep220">
 <bp:stepProcess rdf:resource="#BiochemicalReaction193" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep221">
 <bp:stepProcess rdf:resource="#BiochemicalReaction194" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep215">
 <bp:stepProcess rdf:resource="#BiochemicalReaction189" />
 <bp:stepProcess rdf:resource="#Catalysis45" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep216">
 <bp:stepProcess rdf:resource="#BiochemicalReaction190" />
 <bp:stepProcess rdf:resource="#Catalysis46" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep217">
 <bp:stepProcess rdf:resource="#Pathway28" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep218">
 <bp:stepProcess rdf:resource="#BiochemicalReaction191" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep211">
 <bp:stepProcess rdf:resource="#BiochemicalReaction185" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep212">
 <bp:stepProcess rdf:resource="#BiochemicalReaction186" />
 <bp:stepProcess rdf:resource="#Catalysis43" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep213">
 <bp:stepProcess rdf:resource="#BiochemicalReaction187" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep214">
 <bp:stepProcess rdf:resource="#BiochemicalReaction188" />
 <bp:stepProcess rdf:resource="#Catalysis44" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction51">
 <bp:evidence rdf:resource="#Evidence63" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MYC trancscription is negatively regulated by SMAD2/3:SMAD4:RBL1:E2F4/5:DP1/2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence607">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction50">
 <bp:evidence rdf:resource="#Evidence62" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">COL1A2 gene expression is stimulated by p-2S-SMAD3:p-2S-SMAD3:SMAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence608">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence605">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence606">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction55">
 <bp:evidence rdf:resource="#Evidence67" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD2/3:SMAD4 complex positively regulates JUNB transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep219">
 <bp:stepProcess rdf:resource="#BiochemicalReaction192" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction54">
 <bp:evidence rdf:resource="#Evidence66" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWTR1:SMAD stimulates transcription of SERPINE1 while TGIF:SMAD and SMAD7 inhibit it</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction53">
 <bp:evidence rdf:resource="#Evidence65" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of SMAD2 and SMAD3 linker regions by CDK8 or CDK9</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence609">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction52">
 <bp:evidence rdf:resource="#Evidence64" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD2/3:SMAD4 heterotrimer forms a complex with RBL1, E2F4/5 and DP1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction37">
 <bp:evidence rdf:resource="#Evidence49" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD2/3:SMAD4:SP1 complex stimulates transcription of CDKN2B</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence621">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction36">
 <bp:evidence rdf:resource="#Evidence48" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWTR1 binds SMAD2/3:SMAD4 heterotrimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence622">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction35">
 <bp:evidence rdf:resource="#Evidence47" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-2S-SMAD3:p-2S-SMAD3:SMAD4 forms a complex with SP1 and EP300 at the COL1A2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction34">
 <bp:evidence rdf:resource="#Evidence46" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNF111 ubiquitinates SMAD7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence620">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence625">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence626">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction39">
 <bp:evidence rdf:resource="#Evidence51" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FURIN gene transcription is stimulated by SMAD2/SMAD3:SMAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence623">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction38">
 <bp:evidence rdf:resource="#Evidence50" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-2S-SMAD2,3:SMAD4:SP1 binds CDKN2B gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence624">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction40">
 <bp:evidence rdf:resource="#Evidence52" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWTR1:p-2S-SMAD2,3:SMAD4 binds SERPINE1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence618">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence619">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence616">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence617">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction44">
 <bp:evidence rdf:resource="#Evidence56" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FURIN translocates to the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction43">
 <bp:evidence rdf:resource="#Evidence55" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD2/3:SMAD4 heterotrimer binds SP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction42">
 <bp:evidence rdf:resource="#Evidence54" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-2S-SMAD2,3:SMAD4:RBL1:E2F4,5:DP1,2 binds MYC gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction41">
 <bp:evidence rdf:resource="#Evidence53" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">YBX1 binds COL1A2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction26">
 <bp:evidence rdf:resource="#Evidence35" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pre-snRNA is elongated and capped with 7-methylguanosine</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence632">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction25">
 <bp:evidence rdf:resource="#Evidence34" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SNAPc binds PSE of snRNA gene (U1, U2, U4, U4atac, U5, U11, U12)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence633">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction24">
 <bp:evidence rdf:resource="#Evidence33" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBCAP complex binds 7-methylguanosine cap of snRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence630">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction23">
 <bp:evidence rdf:resource="#Evidence32" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pre-snRNA transcript initiation, Integrator binding, LEC binding</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence631">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence636">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction29">
 <bp:evidence rdf:resource="#Evidence38" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Integrator complex processes the 3&apos; end of snRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence637">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction28">
 <bp:evidence rdf:resource="#Evidence37" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RPAP2 binds RNA polymerase II phosphorylated at serine-7 residues of heptad repeats in the C-terminal domain</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence634">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction27">
 <bp:evidence rdf:resource="#Evidence36" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA polymerase II binds initiation factors at promoter of snRNA gene (U1, U2, U4, U4atac, U5, U11, U12)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence635">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence629">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence627">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence628">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction33">
 <bp:evidence rdf:resource="#Evidence42" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">POU2F1 (OCT1) or POU2F2 (OCT2), SP1, and ZNF143 (STAF) bind the DSE of snRNA gene (U1, U2, U4, U4atac, U5, U11, U12)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction32">
 <bp:evidence rdf:resource="#Evidence41" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDK7 phosphorylates serine-5 and serine-7 of heptad repeats in C-terminal domain of RNA polymerase II at snRNA promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction31">
 <bp:evidence rdf:resource="#Evidence40" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dephosphorylation and dissociation of RNA polymerase II at 3&apos; end of snRNA gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction30">
 <bp:evidence rdf:resource="#Evidence39" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">General transcription factors bind SNAPc:POU2F1:ZNF143:snRNA gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence643">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence644">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence641">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence642">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence647">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence648">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence645">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence646">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence640">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence638">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence639">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence654">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence655">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence652">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction89">
 <bp:evidence rdf:resource="#Evidence104" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The APOE gene transcription is stimulated by the complex of TFAP2A homodimer and DEK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence653">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence658">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence659">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence656">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence657">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence650">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence651">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction91">
 <bp:evidence rdf:resource="#Evidence107" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2A homodimer binds CDKN1A (p21) gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction90">
 <bp:evidence rdf:resource="#Evidence106" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDKN1A gene expression is stimulated by TFAP2A and repressed by TFAP2C</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction95">
 <bp:evidence rdf:resource="#Evidence112" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2A,(TFAP2B,TFAP2C) homo- and heterodimers bind the ERBB2 gene promoter and recruit YY1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction94">
 <bp:evidence rdf:resource="#Evidence111" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TGFA gene expression is stimulated by the TFAP2A homodimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction93">
 <bp:evidence rdf:resource="#Evidence109" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2C homodimer binds MYC and KDM5B</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence649">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction92">
 <bp:evidence rdf:resource="#Evidence108" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2C homodimer binds the CDKN1A (p21) gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction99">
 <bp:evidence rdf:resource="#Evidence116" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2A,TFAP2C homodimers stimulate CGB3 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction98">
 <bp:evidence rdf:resource="#Evidence115" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CGA and CGB3 bind to form Human chorionic gonadotropin (hCG)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction97">
 <bp:evidence rdf:resource="#Evidence114" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2A homodimer binds the VEGFA gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction96">
 <bp:evidence rdf:resource="#Evidence113" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2C homodimer binds the EGFR gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis2">
 <bp:controlled rdf:resource="#BiochemicalReaction10" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence665">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis1">
 <bp:controlled rdf:resource="#BiochemicalReaction3" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence666">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis4">
 <bp:controlled rdf:resource="#BiochemicalReaction19" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction79">
 <bp:evidence rdf:resource="#Evidence92" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMURF2 monoubiquitinates SMAD3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence663">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis3">
 <bp:controlled rdf:resource="#BiochemicalReaction15" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction78">
 <bp:evidence rdf:resource="#Evidence91" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitin-dependent degradation of the SMAD complex terminates TGF-beta signaling</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence664">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis6">
 <bp:controlled rdf:resource="#BiochemicalReaction26" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence669">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis5">
 <bp:controlled rdf:resource="#BiochemicalReaction23" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis8">
 <bp:controlled rdf:resource="#BiochemicalReaction32" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence667">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis7">
 <bp:controlled rdf:resource="#BiochemicalReaction29" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence668">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis9">
 <bp:controlled rdf:resource="#BiochemicalReaction34" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence661">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence662">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence660">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction80">
 <bp:evidence rdf:resource="#Evidence93" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Degradation of ubiquitinated SKI/SKIL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction84">
 <bp:evidence rdf:resource="#Evidence97" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWTR1:SMAD stimulates transcription of SMAD7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction83">
 <bp:evidence rdf:resource="#Evidence96" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIM33 monoubiquitinates SMAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction82">
 <bp:evidence rdf:resource="#Evidence95" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK1 and MAPK3 phosphorylate SMAD2 and SMAD3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction81">
 <bp:evidence rdf:resource="#Evidence94" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ATP1B4 binds SNW1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction88">
 <bp:evidence rdf:resource="#Evidence103" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TFAP2A in complex with DEK binds the APOE gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction87">
 <bp:evidence rdf:resource="#Evidence101" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of CSL-NICD coactivator complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction86">
 <bp:evidence rdf:resource="#Evidence100" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of CSL NCOR corepressor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction85">
 <bp:evidence rdf:resource="#Evidence98" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of ARC coactivator complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence676">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction69">
 <bp:evidence rdf:resource="#Evidence82" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PARP1 ADP-ribosylates SMAD3 and SMAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence677">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction68">
 <bp:evidence rdf:resource="#Evidence81" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of SKI/SKIL by RNF111/SMURF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence674">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction67">
 <bp:evidence rdf:resource="#Evidence80" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEDD4L ubiquitinates SMAD2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence675">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence678">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence679">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence672">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence673">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence670">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence671">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction73">
 <bp:evidence rdf:resource="#Evidence86" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dephosphorylated SMAD2/3 translocates to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction72">
 <bp:evidence rdf:resource="#Evidence85" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWTR1:p-2S-SMAD2,3:SMAD4 binds SMAD7 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction71">
 <bp:evidence rdf:resource="#Evidence84" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PPM1A protein phosphatase binds phosphorylated SMAD2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction70">
 <bp:evidence rdf:resource="#Evidence83" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PPM1A dephosphorylates nuclear SMAD2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction77">
 <bp:evidence rdf:resource="#Evidence90" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMURF2 binds SMAD3 phosphorylated in the linker region</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction76">
 <bp:evidence rdf:resource="#Evidence89" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SKI/SKIL binds SMAD complex, suppressing TGF-beta signaling</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction75">
 <bp:evidence rdf:resource="#Evidence88" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP9X (FAM) deubiquitinates SMAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction74">
 <bp:evidence rdf:resource="#Evidence87" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PARP1 binds SMAD2/3:SMAD4 heterotrimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence687">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence688">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence685">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep290">
 <bp:stepProcess rdf:resource="#BiochemicalReaction257" />
 <bp:stepProcess rdf:resource="#Catalysis76" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence686">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence689">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep295">
 <bp:stepProcess rdf:resource="#BiochemicalReaction262" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep296">
 <bp:stepProcess rdf:resource="#Pathway35" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence680">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep297">
 <bp:stepProcess rdf:resource="#BiochemicalReaction263" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep298">
 <bp:stepProcess rdf:resource="#BiochemicalReaction264" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep291">
 <bp:stepProcess rdf:resource="#BiochemicalReaction258" />
 <bp:stepProcess rdf:resource="#Catalysis77" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence683">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep292">
 <bp:stepProcess rdf:resource="#BiochemicalReaction259" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence684">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep293">
 <bp:stepProcess rdf:resource="#BiochemicalReaction260" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence681">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep294">
 <bp:stepProcess rdf:resource="#BiochemicalReaction261" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence682">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction741">
 <bp:evidence rdf:resource="#Evidence820" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VENTX binds the IL6 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction740">
 <bp:evidence rdf:resource="#Evidence819" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of CCND1 is stimulated by CTNNB1:TCF4,LEF1 and inhibited by VENTX:TCF4,LEF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction743">
 <bp:evidence rdf:resource="#Evidence822" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VENTX binds the CDKN2A gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction742">
 <bp:evidence rdf:resource="#Evidence821" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VENTX stimulates p16-INK4A transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep288">
 <bp:stepProcess rdf:resource="#BiochemicalReaction255" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep289">
 <bp:stepProcess rdf:resource="#BiochemicalReaction256" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction749">
 <bp:evidence rdf:resource="#Evidence828" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VENTX stimulates TP53 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction748">
 <bp:evidence rdf:resource="#Evidence827" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-24 binds p16INK4A and p14ARF mRNAs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction745">
 <bp:evidence rdf:resource="#Evidence824" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VENTX disrupts binding of CTNNB1 (beta-catenin) to TCF4 or LEF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction744">
 <bp:evidence rdf:resource="#Evidence823" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translation of p16INK4A mRNA is inhibited by miR-24</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction747">
 <bp:evidence rdf:resource="#Evidence826" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VENTX binds the CSF1R (M-CSF-R) gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction746">
 <bp:evidence rdf:resource="#Evidence825" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of IL6 transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence698">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence699">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence696">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence697">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence690">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence691">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence694">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence695">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence692">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence693">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction752">
 <bp:evidence rdf:resource="#Evidence833" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 and ESR1 bind the AXIN1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction751">
 <bp:evidence rdf:resource="#Evidence830" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VENTX binds the TP53 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction754">
 <bp:evidence rdf:resource="#Evidence835" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AXIN1 gene expression is inhibited by ESR1 and stimulated by RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction753">
 <bp:evidence rdf:resource="#Evidence834" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 and FOXP3 stimulate the RSPO3 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep299">
 <bp:stepProcess rdf:resource="#BiochemicalReaction265" />
 <bp:stepProcess rdf:resource="#Catalysis78" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction750">
 <bp:evidence rdf:resource="#Evidence829" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VENTX stimulates CSF1R (M-CSF-R) expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction759">
 <bp:evidence rdf:resource="#Evidence841" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SERPINB13 gene expression is inhibited by RUNX1:CBFB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction756">
 <bp:evidence rdf:resource="#Evidence838" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOCS4 gene expression is inhibited by RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction755">
 <bp:evidence rdf:resource="#Evidence836" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 and FOXP3 bind the RSPO3 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction758">
 <bp:evidence rdf:resource="#Evidence840" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds the SOCS3 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction757">
 <bp:evidence rdf:resource="#Evidence839" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1:CBFB binds the SERPINB13 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep273">
 <bp:stepProcess rdf:resource="#BiochemicalReaction242" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep274">
 <bp:stepProcess rdf:resource="#BiochemicalReaction243" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep275">
 <bp:stepProcess rdf:resource="#Catalysis75" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction244" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep276">
 <bp:stepProcess rdf:resource="#BiochemicalReaction245" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep270">
 <bp:stepProcess rdf:resource="#BiochemicalReaction239" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep271">
 <bp:stepProcess rdf:resource="#BiochemicalReaction240" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep272">
 <bp:stepProcess rdf:resource="#BiochemicalReaction241" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep15">
 <bp:stepProcess rdf:resource="#BiochemicalReaction11" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction763">
 <bp:evidence rdf:resource="#Evidence845" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SERPINB13 binds CTSK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep16">
 <bp:stepProcess rdf:resource="#BiochemicalReaction12" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction762">
 <bp:evidence rdf:resource="#Evidence844" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SERPINB13 binds cathepsin L</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep13">
 <bp:stepProcess rdf:resource="#Pathway5" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction765">
 <bp:evidence rdf:resource="#Evidence848" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MIR27A gene transcription is stimulated by the complex containing RUNX1, PRMT1 and GATA1 and inhibited by the complex of RUNX1, SIN3A and PRMT6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep14">
 <bp:stepProcess rdf:resource="#Catalysis2" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction10" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction764">
 <bp:evidence rdf:resource="#Evidence847" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRMT6 arginine methylates H3K4me2-Nucleosome at the ITGA2B gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep11">
 <bp:stepProcess rdf:resource="#BiochemicalReaction8" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep266">
 <bp:stepProcess rdf:resource="#Pathway32" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep12">
 <bp:stepProcess rdf:resource="#BiochemicalReaction9" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep267">
 <bp:stepProcess rdf:resource="#BiochemicalReaction236" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep268">
 <bp:stepProcess rdf:resource="#BiochemicalReaction237" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction761">
 <bp:evidence rdf:resource="#Evidence843" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOCS3 gene expression is inhibited by RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep10">
 <bp:stepProcess rdf:resource="#BiochemicalReaction7" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep269">
 <bp:stepProcess rdf:resource="#BiochemicalReaction238" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction760">
 <bp:evidence rdf:resource="#Evidence842" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds the SOCS4 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep19">
 <bp:stepProcess rdf:resource="#Pathway6" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction767">
 <bp:evidence rdf:resource="#Evidence850" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRMT1 arginine-methylates RUNX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction766">
 <bp:evidence rdf:resource="#Evidence849" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 and GATA1 bind the promoter of the MIR27A gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep17">
 <bp:stepProcess rdf:resource="#BiochemicalReaction13" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction769">
 <bp:evidence rdf:resource="#Evidence852" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1:CBFB binds the NFE2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep18">
 <bp:stepProcess rdf:resource="#BiochemicalReaction14" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction768">
 <bp:evidence rdf:resource="#Evidence851" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1:CBFB binds the PF4 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep284">
 <bp:stepProcess rdf:resource="#BiochemicalReaction251" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep285">
 <bp:stepProcess rdf:resource="#BiochemicalReaction252" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep286">
 <bp:stepProcess rdf:resource="#BiochemicalReaction253" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep287">
 <bp:stepProcess rdf:resource="#BiochemicalReaction254" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep280">
 <bp:stepProcess rdf:resource="#BiochemicalReaction247" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep281">
 <bp:stepProcess rdf:resource="#BiochemicalReaction248" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep282">
 <bp:stepProcess rdf:resource="#BiochemicalReaction249" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep283">
 <bp:stepProcess rdf:resource="#BiochemicalReaction250" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep26">
 <bp:stepProcess rdf:resource="#Catalysis4" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction19" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction774">
 <bp:evidence rdf:resource="#Evidence857" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1:CBFB, SIN3A(SIN3B), PRMT6 and HDAC1 bind the MIR27A gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep27">
 <bp:stepProcess rdf:resource="#BiochemicalReaction20" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction773">
 <bp:evidence rdf:resource="#Evidence856" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1:CBFB, SIN3A(SIN3B), PRMT6 and HDAC1 bind the THBS1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep24">
 <bp:stepProcess rdf:resource="#Pathway8" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction776">
 <bp:evidence rdf:resource="#Evidence859" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds PRMT1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep25">
 <bp:stepProcess rdf:resource="#BiochemicalReaction18" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction775">
 <bp:evidence rdf:resource="#Evidence858" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 and GATA1 bind the promoter of the THBS1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep22">
 <bp:stepProcess rdf:resource="#BiochemicalReaction16" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep277">
 <bp:stepProcess rdf:resource="#Pathway33" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction770">
 <bp:evidence rdf:resource="#Evidence853" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRMT6 arginine methylates H3K4me2-Nucleosome at the MIR27A gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep23">
 <bp:stepProcess rdf:resource="#BiochemicalReaction17" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep278">
 <bp:stepProcess rdf:resource="#Pathway34" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep20">
 <bp:stepProcess rdf:resource="#Pathway7" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep279">
 <bp:stepProcess rdf:resource="#BiochemicalReaction246" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction772">
 <bp:evidence rdf:resource="#Evidence855" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Core MLL complex methylates H3K4Me2-Nucleosome at the MIR27A gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep21">
 <bp:stepProcess rdf:resource="#BiochemicalReaction15" />
 <bp:stepProcess rdf:resource="#Catalysis3" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction771">
 <bp:evidence rdf:resource="#Evidence854" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MYL9 gene transcription is stimulated by RUNX1:CBFB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction778">
 <bp:evidence rdf:resource="#Evidence861" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1:CBFB binds the MYL9 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction777">
 <bp:evidence rdf:resource="#Evidence860" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1:CBFB, SIN3A(SIN3B), PRMT6 and HDAC1 bind the GP1BA promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep28">
 <bp:stepProcess rdf:resource="#BiochemicalReaction21" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep29">
 <bp:stepProcess rdf:resource="#BiochemicalReaction22" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction779">
 <bp:evidence rdf:resource="#Evidence862" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 and GATA1 bind the promoter of the GP1BA gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction15">
 <bp:evidence rdf:resource="#Evidence22" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hyperphosphorylation (Ser2) of RNA Pol II CTD by P-TEFb complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1096">
 <bp:stepProcess rdf:resource="#BiochemicalReaction991" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction14">
 <bp:evidence rdf:resource="#Evidence19" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SPT5 subunit of Pol II binds the RNA triphosphatase (RTP)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1097">
 <bp:stepProcess rdf:resource="#BiochemicalReaction992" />
 <bp:stepProcess rdf:resource="#Catalysis161" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction13">
 <bp:evidence rdf:resource="#Evidence18" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Extrusion of 5&apos;-end of 30 nt long transcript through the pore in Pol II complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1094">
 <bp:stepProcess rdf:resource="#BiochemicalReaction989" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction12">
 <bp:evidence rdf:resource="#Evidence17" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA Polymerase II CTD (phosphorylated) binds to CE</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1095">
 <bp:stepProcess rdf:resource="#BiochemicalReaction990" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction19">
 <bp:evidence rdf:resource="#Evidence27" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hypophosphorylation of RNA Pol II CTD by FCP1P protein</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1092">
 <bp:stepProcess rdf:resource="#BiochemicalReaction987" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction18">
 <bp:evidence rdf:resource="#Evidence26" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DSIF complex binds to RNA Pol II (hypophosphorylated)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1093">
 <bp:stepProcess rdf:resource="#BiochemicalReaction988" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction17">
 <bp:evidence rdf:resource="#Evidence24" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Separation of elongating transcript from template</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1090">
 <bp:stepProcess rdf:resource="#BiochemicalReaction985" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction16">
 <bp:evidence rdf:resource="#Evidence23" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of elongation factors to form elongation complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1091">
 <bp:stepProcess rdf:resource="#BiochemicalReaction986" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep251">
 <bp:stepProcess rdf:resource="#BiochemicalReaction222" />
 <bp:stepProcess rdf:resource="#Catalysis67" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep30">
 <bp:stepProcess rdf:resource="#Pathway9" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep252">
 <bp:stepProcess rdf:resource="#BiochemicalReaction223" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep253">
 <bp:stepProcess rdf:resource="#BiochemicalReaction224" />
 <bp:stepProcess rdf:resource="#Catalysis68" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep254">
 <bp:stepProcess rdf:resource="#Pathway31" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep250">
 <bp:stepProcess rdf:resource="#Pathway30" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep37">
 <bp:stepProcess rdf:resource="#BiochemicalReaction29" />
 <bp:stepProcess rdf:resource="#Catalysis7" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep248">
 <bp:stepProcess rdf:resource="#BiochemicalReaction220" />
 <bp:stepProcess rdf:resource="#Catalysis65" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction785">
 <bp:evidence rdf:resource="#Evidence868" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">THBS1 gene transcription is stimulated by the complex containing RUNX1, PRMT1 and GATA1 and inhibited by the complex of RUNX1, SIN3A and PRMT6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep38">
 <bp:stepProcess rdf:resource="#BiochemicalReaction30" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep249">
 <bp:stepProcess rdf:resource="#BiochemicalReaction221" />
 <bp:stepProcess rdf:resource="#Catalysis66" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction784">
 <bp:evidence rdf:resource="#Evidence867" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFE2 gene expression is stimulated by RUNX1:CBFB</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep35">
 <bp:stepProcess rdf:resource="#BiochemicalReaction27" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction787">
 <bp:evidence rdf:resource="#Evidence870" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1:CBFB binds the PRKCQ gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep36">
 <bp:stepProcess rdf:resource="#BiochemicalReaction28" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction786">
 <bp:evidence rdf:resource="#Evidence869" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1:CBFB binds the NR4A3 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep33">
 <bp:stepProcess rdf:resource="#BiochemicalReaction25" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep244">
 <bp:stepProcess rdf:resource="#Catalysis61" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction216" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction781">
 <bp:evidence rdf:resource="#Evidence864" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRKCQ gene expression is stimulated by RUNX1:CBFB</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep34">
 <bp:stepProcess rdf:resource="#BiochemicalReaction26" />
 <bp:stepProcess rdf:resource="#Catalysis6" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep245">
 <bp:stepProcess rdf:resource="#Catalysis62" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction217" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction780">
 <bp:evidence rdf:resource="#Evidence863" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Core MLL complex methylates H3K4Me2-Nucleosome at the GP1BA gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep31">
 <bp:stepProcess rdf:resource="#BiochemicalReaction23" />
 <bp:stepProcess rdf:resource="#Catalysis5" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep246">
 <bp:stepProcess rdf:resource="#Catalysis63" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction218" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction783">
 <bp:evidence rdf:resource="#Evidence866" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Core MLL complex methylates H3K4Me2-Nucleosome at the ITGA2B gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep32">
 <bp:stepProcess rdf:resource="#BiochemicalReaction24" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep247">
 <bp:stepProcess rdf:resource="#Catalysis64" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction219" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction782">
 <bp:evidence rdf:resource="#Evidence865" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRMT6 arginine methylates H3K4me2-Nucleosome at the GP1BA gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction22">
 <bp:evidence rdf:resource="#Evidence30" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Addition of nucleotides leads to transcript elongation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction789">
 <bp:evidence rdf:resource="#Evidence872" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 and GATA1 bind the promoter of the ITGA2B gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction21">
 <bp:evidence rdf:resource="#Evidence29" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pol II elongation complex moves on the template as transcript elongates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction788">
 <bp:evidence rdf:resource="#Evidence871" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Core MLL complex methylates H3K4Me2-Nucleosome at the THBS1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction20">
 <bp:evidence rdf:resource="#Evidence28" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of DSIF:NELF:early elongation complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep39">
 <bp:stepProcess rdf:resource="#BiochemicalReaction31" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1098">
 <bp:stepProcess rdf:resource="#BiochemicalReaction993" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1099">
 <bp:stepProcess rdf:resource="#BiochemicalReaction994" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1085">
 <bp:stepProcess rdf:resource="#BiochemicalReaction983" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1086">
 <bp:stepProcess rdf:resource="#BiochemicalReaction984" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1083">
 <bp:stepProcess rdf:resource="#BiochemicalReaction981" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1084">
 <bp:stepProcess rdf:resource="#BiochemicalReaction982" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1081">
 <bp:stepProcess rdf:resource="#BiochemicalReaction979" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1082">
 <bp:stepProcess rdf:resource="#BiochemicalReaction980" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1080">
 <bp:stepProcess rdf:resource="#BiochemicalReaction978" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep40">
 <bp:stepProcess rdf:resource="#Catalysis8" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction32" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep262">
 <bp:stepProcess rdf:resource="#BiochemicalReaction232" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep41">
 <bp:stepProcess rdf:resource="#BiochemicalReaction33" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep263">
 <bp:stepProcess rdf:resource="#BiochemicalReaction233" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep264">
 <bp:stepProcess rdf:resource="#Catalysis73" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction234" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction790">
 <bp:evidence rdf:resource="#Evidence873" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRMT6 arginine methylates H3K4me2-Nucleosome at the THBS1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep265">
 <bp:stepProcess rdf:resource="#BiochemicalReaction235" />
 <bp:stepProcess rdf:resource="#Catalysis74" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep260">
 <bp:stepProcess rdf:resource="#BiochemicalReaction230" />
 <bp:stepProcess rdf:resource="#Catalysis71" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep261">
 <bp:stepProcess rdf:resource="#Catalysis72" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction231" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep48">
 <bp:stepProcess rdf:resource="#BiochemicalReaction37" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep259">
 <bp:stepProcess rdf:resource="#BiochemicalReaction229" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction796">
 <bp:evidence rdf:resource="#Evidence879" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GP1BA gene transcription is stimulated by the complex containing RUNX1, PRMT1 and GATA1 and inhibited by the complex of RUNX1, SIN3A and PRMT6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep49">
 <bp:stepProcess rdf:resource="#BiochemicalReaction38" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction795">
 <bp:evidence rdf:resource="#Evidence878" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds SIN3A,(SIN3B) co-repressor</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep46">
 <bp:stepProcess rdf:resource="#BiochemicalReaction35" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction798">
 <bp:evidence rdf:resource="#Evidence882" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 binds PRC1 complexes</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep47">
 <bp:stepProcess rdf:resource="#BiochemicalReaction36" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction797">
 <bp:evidence rdf:resource="#Evidence881" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1:CBFB binds EP300</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep44">
 <bp:stepProcess rdf:resource="#Pathway12" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep255">
 <bp:stepProcess rdf:resource="#BiochemicalReaction225" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction792">
 <bp:evidence rdf:resource="#Evidence875" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1:CBFB, SIN3A(SIN3B), PRMT6 and HDAC1 bind the ITGA2B promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep45">
 <bp:stepProcess rdf:resource="#BiochemicalReaction34" />
 <bp:stepProcess rdf:resource="#Catalysis9" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep256">
 <bp:stepProcess rdf:resource="#BiochemicalReaction226" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction791">
 <bp:evidence rdf:resource="#Evidence874" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PF4 gene transcription is stimulated by RUNX1:CBFB</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep42">
 <bp:stepProcess rdf:resource="#Pathway10" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep257">
 <bp:stepProcess rdf:resource="#Catalysis69" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction227" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction794">
 <bp:evidence rdf:resource="#Evidence877" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ITGA2B gene transcription is stimulated by the complex of RUNX1, GATA1 and PRMT1 and inhibited by the complex of RUNX1, SIN3A and PRMT6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep43">
 <bp:stepProcess rdf:resource="#Pathway11" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep258">
 <bp:stepProcess rdf:resource="#Catalysis70" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction228" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction793">
 <bp:evidence rdf:resource="#Evidence876" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NR4A3 gene expression is stimulated by RUNX1:CBFB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction11">
 <bp:evidence rdf:resource="#Evidence16" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of GT</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1089">
 <bp:stepProcess rdf:resource="#Pathway106" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction10">
 <bp:evidence rdf:resource="#Evidence15" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation (Ser5) of RNA pol II CTD</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction799">
 <bp:evidence rdf:resource="#Evidence883" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HIPK2 phosphorylates RUNX1 and EP300</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1087">
 <bp:stepProcess rdf:resource="#Pathway104" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1088">
 <bp:stepProcess rdf:resource="#Pathway105" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep51">
 <bp:stepProcess rdf:resource="#BiochemicalReaction40" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep52">
 <bp:stepProcess rdf:resource="#BiochemicalReaction41" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep230">
 <bp:stepProcess rdf:resource="#BiochemicalReaction202" />
 <bp:stepProcess rdf:resource="#Catalysis52" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep231">
 <bp:stepProcess rdf:resource="#Catalysis53" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction203" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep50">
 <bp:stepProcess rdf:resource="#BiochemicalReaction39" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep232">
 <bp:stepProcess rdf:resource="#BiochemicalReaction204" />
 <bp:stepProcess rdf:resource="#Catalysis54" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep59">
 <bp:stepProcess rdf:resource="#BiochemicalReaction48" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep226">
 <bp:stepProcess rdf:resource="#BiochemicalReaction198" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep227">
 <bp:stepProcess rdf:resource="#BiochemicalReaction199" />
 <bp:stepProcess rdf:resource="#Catalysis49" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep57">
 <bp:stepProcess rdf:resource="#BiochemicalReaction46" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep228">
 <bp:stepProcess rdf:resource="#Catalysis50" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction200" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep58">
 <bp:stepProcess rdf:resource="#BiochemicalReaction47" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep229">
 <bp:stepProcess rdf:resource="#Catalysis51" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction201" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep55">
 <bp:stepProcess rdf:resource="#BiochemicalReaction44" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep222">
 <bp:stepProcess rdf:resource="#BiochemicalReaction195" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep56">
 <bp:stepProcess rdf:resource="#BiochemicalReaction45" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep223">
 <bp:stepProcess rdf:resource="#Pathway29" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep53">
 <bp:stepProcess rdf:resource="#BiochemicalReaction42" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep224">
 <bp:stepProcess rdf:resource="#Catalysis47" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction196" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep54">
 <bp:stepProcess rdf:resource="#BiochemicalReaction43" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep225">
 <bp:stepProcess rdf:resource="#BiochemicalReaction197" />
 <bp:stepProcess rdf:resource="#Catalysis48" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep62">
 <bp:stepProcess rdf:resource="#BiochemicalReaction51" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep240">
 <bp:stepProcess rdf:resource="#BiochemicalReaction212" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep63">
 <bp:stepProcess rdf:resource="#BiochemicalReaction52" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep241">
 <bp:stepProcess rdf:resource="#BiochemicalReaction213" />
 <bp:stepProcess rdf:resource="#Catalysis59" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep60">
 <bp:stepProcess rdf:resource="#BiochemicalReaction49" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep242">
 <bp:stepProcess rdf:resource="#BiochemicalReaction214" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep61">
 <bp:stepProcess rdf:resource="#BiochemicalReaction50" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep243">
 <bp:stepProcess rdf:resource="#BiochemicalReaction215" />
 <bp:stepProcess rdf:resource="#Catalysis60" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep237">
 <bp:stepProcess rdf:resource="#BiochemicalReaction209" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep238">
 <bp:stepProcess rdf:resource="#BiochemicalReaction210" />
 <bp:stepProcess rdf:resource="#Catalysis58" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep68">
 <bp:stepProcess rdf:resource="#BiochemicalReaction57" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep239">
 <bp:stepProcess rdf:resource="#BiochemicalReaction211" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep69">
 <bp:stepProcess rdf:resource="#Pathway13" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep66">
 <bp:stepProcess rdf:resource="#BiochemicalReaction55" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep233">
 <bp:stepProcess rdf:resource="#BiochemicalReaction205" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep67">
 <bp:stepProcess rdf:resource="#BiochemicalReaction56" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep234">
 <bp:stepProcess rdf:resource="#BiochemicalReaction206" />
 <bp:stepProcess rdf:resource="#Catalysis55" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep64">
 <bp:stepProcess rdf:resource="#Catalysis10" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction53" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep235">
 <bp:stepProcess rdf:resource="#BiochemicalReaction207" />
 <bp:stepProcess rdf:resource="#Catalysis56" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep65">
 <bp:stepProcess rdf:resource="#BiochemicalReaction54" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep236">
 <bp:stepProcess rdf:resource="#BiochemicalReaction208" />
 <bp:stepProcess rdf:resource="#Catalysis57" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep73">
 <bp:stepProcess rdf:resource="#BiochemicalReaction61" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep74">
 <bp:stepProcess rdf:resource="#BiochemicalReaction62" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep71">
 <bp:stepProcess rdf:resource="#BiochemicalReaction59" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep72">
 <bp:stepProcess rdf:resource="#BiochemicalReaction60" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep70">
 <bp:stepProcess rdf:resource="#BiochemicalReaction58" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep79">
 <bp:stepProcess rdf:resource="#BiochemicalReaction67" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep77">
 <bp:stepProcess rdf:resource="#BiochemicalReaction65" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep78">
 <bp:stepProcess rdf:resource="#BiochemicalReaction66" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep75">
 <bp:stepProcess rdf:resource="#BiochemicalReaction63" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep76">
 <bp:stepProcess rdf:resource="#BiochemicalReaction64" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep84">
 <bp:stepProcess rdf:resource="#BiochemicalReaction72" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep85">
 <bp:stepProcess rdf:resource="#BiochemicalReaction73" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep82">
 <bp:stepProcess rdf:resource="#BiochemicalReaction70" />
 <bp:stepProcess rdf:resource="#Catalysis13" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep83">
 <bp:stepProcess rdf:resource="#BiochemicalReaction71" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep80">
 <bp:stepProcess rdf:resource="#BiochemicalReaction68" />
 <bp:stepProcess rdf:resource="#Catalysis11" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep81">
 <bp:stepProcess rdf:resource="#BiochemicalReaction69" />
 <bp:stepProcess rdf:resource="#Catalysis12" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep88">
 <bp:stepProcess rdf:resource="#BiochemicalReaction76" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep89">
 <bp:stepProcess rdf:resource="#BiochemicalReaction77" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep86">
 <bp:stepProcess rdf:resource="#BiochemicalReaction74" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep87">
 <bp:stepProcess rdf:resource="#Catalysis14" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction75" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep95">
 <bp:stepProcess rdf:resource="#Catalysis18" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction83" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep96">
 <bp:stepProcess rdf:resource="#BiochemicalReaction84" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep93">
 <bp:stepProcess rdf:resource="#BiochemicalReaction81" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep94">
 <bp:stepProcess rdf:resource="#BiochemicalReaction82" />
 <bp:stepProcess rdf:resource="#Catalysis17" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep91">
 <bp:stepProcess rdf:resource="#BiochemicalReaction79" />
 <bp:stepProcess rdf:resource="#Catalysis16" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep92">
 <bp:stepProcess rdf:resource="#BiochemicalReaction80" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep90">
 <bp:stepProcess rdf:resource="#BiochemicalReaction78" />
 <bp:stepProcess rdf:resource="#Catalysis15" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep99">
 <bp:stepProcess rdf:resource="#BiochemicalReaction86" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep97">
 <bp:stepProcess rdf:resource="#BiochemicalReaction85" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep98">
 <bp:stepProcess rdf:resource="#Pathway14" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence702">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence703">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence700">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence701">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence710">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence713">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence714">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence711">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence712">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence706">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence707">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence704">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence705">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence708">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence709">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence720">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence721">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence724">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence725">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence722">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence723">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep330">
 <bp:stepProcess rdf:resource="#BiochemicalReaction293" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction460">
 <bp:evidence rdf:resource="#Evidence514" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds the PTPN4 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep331">
 <bp:stepProcess rdf:resource="#BiochemicalReaction294" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep325">
 <bp:stepProcess rdf:resource="#BiochemicalReaction288" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction466">
 <bp:evidence rdf:resource="#Evidence520" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 and SOX2 bind MIR137 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep326">
 <bp:stepProcess rdf:resource="#BiochemicalReaction289" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction465">
 <bp:evidence rdf:resource="#Evidence519" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds PTPN1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep327">
 <bp:stepProcess rdf:resource="#BiochemicalReaction290" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction468">
 <bp:evidence rdf:resource="#Evidence522" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SGK1 gene expression is inhibited by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep328">
 <bp:stepProcess rdf:resource="#BiochemicalReaction291" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction467">
 <bp:evidence rdf:resource="#Evidence521" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PVALB gene expression is repressed by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep321">
 <bp:stepProcess rdf:resource="#BiochemicalReaction286" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction462">
 <bp:evidence rdf:resource="#Evidence516" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds MET gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep322">
 <bp:stepProcess rdf:resource="#BiochemicalReaction287" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction461">
 <bp:evidence rdf:resource="#Evidence515" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OPRK1 gene expression is stimulated by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep323">
 <bp:stepProcess rdf:resource="#Pathway37" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction464">
 <bp:evidence rdf:resource="#Evidence518" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds NOTCH1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep324">
 <bp:stepProcess rdf:resource="#Pathway38" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction463">
 <bp:evidence rdf:resource="#Evidence517" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 gene expression is inhibited by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence717">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence718">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence715">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence716">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep329">
 <bp:stepProcess rdf:resource="#Catalysis81" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction292" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction469">
 <bp:evidence rdf:resource="#Evidence524" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GAD1 gene expression is stimulated by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence719">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence731">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence732">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence730">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence735">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence736">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence733">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence734">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep340">
 <bp:stepProcess rdf:resource="#BiochemicalReaction303" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep341">
 <bp:stepProcess rdf:resource="#BiochemicalReaction304" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction471">
 <bp:evidence rdf:resource="#Evidence526" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GAD2 gene expression is stimulated by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep342">
 <bp:stepProcess rdf:resource="#Pathway39" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction470">
 <bp:evidence rdf:resource="#Evidence525" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds GAD1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep336">
 <bp:stepProcess rdf:resource="#BiochemicalReaction299" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction477">
 <bp:evidence rdf:resource="#Evidence533" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SST gene expression is stimulated by MECP2 and CREB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep337">
 <bp:stepProcess rdf:resource="#BiochemicalReaction300" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction476">
 <bp:evidence rdf:resource="#Evidence532" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2:SIN3A complex binds the promoter of the BDNF gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep338">
 <bp:stepProcess rdf:resource="#BiochemicalReaction301" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction479">
 <bp:evidence rdf:resource="#Evidence535" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds CRH gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep339">
 <bp:stepProcess rdf:resource="#BiochemicalReaction302" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction478">
 <bp:evidence rdf:resource="#Evidence534" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2:CREB1 binds SST gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep332">
 <bp:stepProcess rdf:resource="#BiochemicalReaction295" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction473">
 <bp:evidence rdf:resource="#Evidence529" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DLL1 gene expression is inhibited by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep333">
 <bp:stepProcess rdf:resource="#BiochemicalReaction296" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction472">
 <bp:evidence rdf:resource="#Evidence527" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds GAD2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep334">
 <bp:stepProcess rdf:resource="#BiochemicalReaction297" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction475">
 <bp:evidence rdf:resource="#Evidence531" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CRH gene expression is repressed by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep335">
 <bp:stepProcess rdf:resource="#Catalysis82" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction298" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction474">
 <bp:evidence rdf:resource="#Evidence530" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds DLL1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence728">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence729">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence726">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence727">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence742">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence743">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence740">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence741">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis19">
 <bp:controlled rdf:resource="#BiochemicalReaction126" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence746">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis18">
 <bp:controlled rdf:resource="#BiochemicalReaction83" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence747">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence744">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence745">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis15">
 <bp:controlled rdf:resource="#BiochemicalReaction78" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction480">
 <bp:evidence rdf:resource="#Evidence536" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BDNF gene transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis14">
 <bp:controlled rdf:resource="#BiochemicalReaction75" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis17">
 <bp:controlled rdf:resource="#BiochemicalReaction82" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction482">
 <bp:evidence rdf:resource="#Evidence538" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GAMT gene expression is stimulated by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis16">
 <bp:controlled rdf:resource="#BiochemicalReaction79" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction481">
 <bp:evidence rdf:resource="#Evidence537" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 gene expression is inhibited by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis11">
 <bp:controlled rdf:resource="#BiochemicalReaction68" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis10">
 <bp:controlled rdf:resource="#BiochemicalReaction53" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis13">
 <bp:controlled rdf:resource="#BiochemicalReaction70" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis12">
 <bp:controlled rdf:resource="#BiochemicalReaction69" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep303">
 <bp:stepProcess rdf:resource="#BiochemicalReaction269" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction488">
 <bp:evidence rdf:resource="#Evidence545" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AURKB phosphorylates MECP2 at S423</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep304">
 <bp:stepProcess rdf:resource="#BiochemicalReaction270" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction487">
 <bp:evidence rdf:resource="#Evidence544" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 mRNA translation is inhibited by miR-132</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis20">
 <bp:controlled rdf:resource="#BiochemicalReaction129" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep305">
 <bp:stepProcess rdf:resource="#BiochemicalReaction271" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep306">
 <bp:stepProcess rdf:resource="#BiochemicalReaction272" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction489">
 <bp:evidence rdf:resource="#Evidence546" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds the NCoR/SMRT complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction484">
 <bp:evidence rdf:resource="#Evidence541" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MIR132 gene expression is stimulated by p-S133-CREB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep300">
 <bp:stepProcess rdf:resource="#BiochemicalReaction266" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction483">
 <bp:evidence rdf:resource="#Evidence539" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds IRAK1 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep301">
 <bp:stepProcess rdf:resource="#BiochemicalReaction267" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction486">
 <bp:evidence rdf:resource="#Evidence543" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 mRNA binds miR-132 RISC</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep302">
 <bp:stepProcess rdf:resource="#BiochemicalReaction268" />
 <bp:stepProcess rdf:resource="#Catalysis79" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction485">
 <bp:evidence rdf:resource="#Evidence542" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 is phosphorylated at S423</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence739">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence737">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence738">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep307">
 <bp:stepProcess rdf:resource="#BiochemicalReaction273" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep308">
 <bp:stepProcess rdf:resource="#Catalysis80" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction274" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep309">
 <bp:stepProcess rdf:resource="#BiochemicalReaction275" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence753">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence754">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence751">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence752">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence757">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis29">
 <bp:controlled rdf:resource="#BiochemicalReaction159" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence758">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence755">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence756">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis26">
 <bp:controlled rdf:resource="#BiochemicalReaction155" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction491">
 <bp:evidence rdf:resource="#Evidence548" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S133-CREB1 binds MIR132 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis25">
 <bp:controlled rdf:resource="#BiochemicalReaction154" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction490">
 <bp:evidence rdf:resource="#Evidence547" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 is phosphorylated at T308</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis28">
 <bp:controlled rdf:resource="#BiochemicalReaction158" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction493">
 <bp:evidence rdf:resource="#Evidence550" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds CREB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis27">
 <bp:controlled rdf:resource="#BiochemicalReaction156" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep320">
 <bp:stepProcess rdf:resource="#BiochemicalReaction285" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction492">
 <bp:evidence rdf:resource="#Evidence549" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds LBR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis22">
 <bp:controlled rdf:resource="#BiochemicalReaction133" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis21">
 <bp:controlled rdf:resource="#BiochemicalReaction130" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence750">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis24">
 <bp:controlled rdf:resource="#BiochemicalReaction152" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis23">
 <bp:controlled rdf:resource="#BiochemicalReaction150" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep314">
 <bp:stepProcess rdf:resource="#BiochemicalReaction279" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction499">
 <bp:evidence rdf:resource="#Evidence556" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds GAMT gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep315">
 <bp:stepProcess rdf:resource="#BiochemicalReaction280" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction498">
 <bp:evidence rdf:resource="#Evidence555" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds the PVALB gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis31">
 <bp:controlled rdf:resource="#BiochemicalReaction162" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep316">
 <bp:stepProcess rdf:resource="#BiochemicalReaction281" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis30">
 <bp:controlled rdf:resource="#BiochemicalReaction160" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep317">
 <bp:stepProcess rdf:resource="#BiochemicalReaction282" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep310">
 <bp:stepProcess rdf:resource="#BiochemicalReaction276" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction495">
 <bp:evidence rdf:resource="#Evidence552" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HIPK2 phosphorylates MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep311">
 <bp:stepProcess rdf:resource="#Pathway36" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction494">
 <bp:evidence rdf:resource="#Evidence551" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds FOXG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep312">
 <bp:stepProcess rdf:resource="#BiochemicalReaction277" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction497">
 <bp:evidence rdf:resource="#Evidence554" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds HTT</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep313">
 <bp:stepProcess rdf:resource="#BiochemicalReaction278" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction496">
 <bp:evidence rdf:resource="#Evidence553" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds the SIN3A co-repressor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence748">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence749">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep318">
 <bp:stepProcess rdf:resource="#BiochemicalReaction283" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep319">
 <bp:stepProcess rdf:resource="#BiochemicalReaction284" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence764">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence765">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence762">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence763">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence768">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence769">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence766">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence767">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence760">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence761">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence759">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence775">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence776">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence773">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence774">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence779">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence777">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence778">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence771">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence772">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence770">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence786">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence787">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence784">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence785">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence788">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence789">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence782">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence783">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence780">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence781">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence797">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence798">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence795">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence796">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence799">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence790">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence793">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence794">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence791">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence792">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep394">
 <bp:stepProcess rdf:resource="#BiochemicalReaction354" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep395">
 <bp:stepProcess rdf:resource="#BiochemicalReaction355" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep396">
 <bp:stepProcess rdf:resource="#Pathway42" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep397">
 <bp:stepProcess rdf:resource="#BiochemicalReaction356" />
 <bp:stepProcess rdf:resource="#Catalysis86" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep390">
 <bp:stepProcess rdf:resource="#BiochemicalReaction350" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep391">
 <bp:stepProcess rdf:resource="#BiochemicalReaction351" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep392">
 <bp:stepProcess rdf:resource="#BiochemicalReaction352" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep393">
 <bp:stepProcess rdf:resource="#BiochemicalReaction353" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction400">
 <bp:evidence rdf:resource="#Evidence446" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDKN1A (p21) gene expression is positively regulated by RUNX3 and ZFHX3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction402">
 <bp:evidence rdf:resource="#Evidence448" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 binds ZFHX3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction401">
 <bp:evidence rdf:resource="#Evidence447" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The complex of RUNX3, SMAD3 and SMAD4 binds the CDKN1A gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep387">
 <bp:stepProcess rdf:resource="#BiochemicalReaction348" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep388">
 <bp:stepProcess rdf:resource="#Pathway41" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep389">
 <bp:stepProcess rdf:resource="#BiochemicalReaction349" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction408">
 <bp:evidence rdf:resource="#Evidence455" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JAG1 gene expression is inhibited by RUNX3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction407">
 <bp:evidence rdf:resource="#Evidence454" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HES1 gene transcription is inhibited by RUNX3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction409">
 <bp:evidence rdf:resource="#Evidence456" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 stimulates HES1 transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction404">
 <bp:evidence rdf:resource="#Evidence451" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3:NOTCH1 coactivator complex binds the HES1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction403">
 <bp:evidence rdf:resource="#Evidence450" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 binds the NOTCH1 coactivator complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction406">
 <bp:evidence rdf:resource="#Evidence453" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 binds the JAG1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction405">
 <bp:evidence rdf:resource="#Evidence452" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOTCH1 Coactivator Complex binds HES1 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction411">
 <bp:evidence rdf:resource="#Evidence459" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p14-ARF transcription is stimulated by RUNX proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction410">
 <bp:evidence rdf:resource="#Evidence458" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HDAC4 deacetylates RUNX3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction413">
 <bp:evidence rdf:resource="#Evidence461" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 binds EP300</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction412">
 <bp:evidence rdf:resource="#Evidence460" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX proteins bind the p14-ARF promoter at the CDKN2A locus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep398">
 <bp:stepProcess rdf:resource="#BiochemicalReaction357" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep399">
 <bp:stepProcess rdf:resource="#BiochemicalReaction358" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction419">
 <bp:evidence rdf:resource="#Evidence468" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMURFs ubiquitinate RUNX3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction418">
 <bp:evidence rdf:resource="#Evidence467" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction415">
 <bp:evidence rdf:resource="#Evidence463" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EP300 acetylates RUNX3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction414">
 <bp:evidence rdf:resource="#Evidence462" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CCND1 recruits HDAC4 to RUNX3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction417">
 <bp:evidence rdf:resource="#Evidence465" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Acetylated RUNX3 binds to BRD2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction416">
 <bp:evidence rdf:resource="#Evidence464" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CCND1 binds RUNX3 and displaces EP300</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep372">
 <bp:stepProcess rdf:resource="#BiochemicalReaction333" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep373">
 <bp:stepProcess rdf:resource="#BiochemicalReaction334" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep374">
 <bp:stepProcess rdf:resource="#BiochemicalReaction335" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep375">
 <bp:stepProcess rdf:resource="#BiochemicalReaction336" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep370">
 <bp:stepProcess rdf:resource="#BiochemicalReaction331" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep371">
 <bp:stepProcess rdf:resource="#BiochemicalReaction332" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep369">
 <bp:stepProcess rdf:resource="#BiochemicalReaction330" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction422">
 <bp:evidence rdf:resource="#Evidence471" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 binds SRC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction421">
 <bp:evidence rdf:resource="#Evidence470" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBFB binds RUNX3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction424">
 <bp:evidence rdf:resource="#Evidence473" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC phosphorylates RUNX3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction423">
 <bp:evidence rdf:resource="#Evidence472" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Polyubiquitinated RUNX3 translocates to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep365">
 <bp:stepProcess rdf:resource="#Catalysis84" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction326" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep366">
 <bp:stepProcess rdf:resource="#BiochemicalReaction327" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep367">
 <bp:stepProcess rdf:resource="#BiochemicalReaction328" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction420">
 <bp:evidence rdf:resource="#Evidence469" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MDM2 binds RUNX3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep368">
 <bp:stepProcess rdf:resource="#BiochemicalReaction329" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction429">
 <bp:evidence rdf:resource="#Evidence479" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of CCND1 is stimulated by CTNNB1:TCF4,LEF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction426">
 <bp:evidence rdf:resource="#Evidence475" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Polyubiquitinated RUNX3 is degraded by the proteasome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction425">
 <bp:evidence rdf:resource="#Evidence474" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MDM2 polyubiquitinates RUNX3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction428">
 <bp:evidence rdf:resource="#Evidence478" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 binds CTNNB1:TCF7L2,(LEF1,TCF7L1,TCF7)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction427">
 <bp:evidence rdf:resource="#Evidence477" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TCF7L1/TCF7L2/LEF1:CTNNB1 promote transcription of the MYC gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep383">
 <bp:stepProcess rdf:resource="#BiochemicalReaction344" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep384">
 <bp:stepProcess rdf:resource="#BiochemicalReaction345" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep385">
 <bp:stepProcess rdf:resource="#BiochemicalReaction346" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep386">
 <bp:stepProcess rdf:resource="#BiochemicalReaction347" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep380">
 <bp:stepProcess rdf:resource="#BiochemicalReaction341" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep381">
 <bp:stepProcess rdf:resource="#BiochemicalReaction342" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep382">
 <bp:stepProcess rdf:resource="#BiochemicalReaction343" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction433">
 <bp:evidence rdf:resource="#Evidence484" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TEADs:YAP1 binds CTGF gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction432">
 <bp:evidence rdf:resource="#Evidence483" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of CTGF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction435">
 <bp:evidence rdf:resource="#Evidence487" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX1 gene expression is inhibited by RUNX3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction434">
 <bp:evidence rdf:resource="#Evidence485" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 binds TEADs and YAP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep376">
 <bp:stepProcess rdf:resource="#BiochemicalReaction337" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep377">
 <bp:stepProcess rdf:resource="#BiochemicalReaction338" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep378">
 <bp:stepProcess rdf:resource="#Catalysis85" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction339" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction431">
 <bp:evidence rdf:resource="#Evidence481" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TCF7L1/TCF7L2/LEF1:CTNNB1 bind the MYC gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep379">
 <bp:stepProcess rdf:resource="#BiochemicalReaction340" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction430">
 <bp:evidence rdf:resource="#Evidence480" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CTNNB1:TCF7L2,LEF1 binds the CCND1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction437">
 <bp:evidence rdf:resource="#Evidence490" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-137 binds PTEN mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction436">
 <bp:evidence rdf:resource="#Evidence488" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX3 binds the RUNX1 promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction439">
 <bp:evidence rdf:resource="#Evidence492" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds DGCR8</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction438">
 <bp:evidence rdf:resource="#Evidence491" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTEN mRNA translation is inhibited by miR-137</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep350">
 <bp:stepProcess rdf:resource="#BiochemicalReaction312" />
 <bp:stepProcess rdf:resource="#Catalysis83" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep351">
 <bp:stepProcess rdf:resource="#BiochemicalReaction313" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep352">
 <bp:stepProcess rdf:resource="#BiochemicalReaction314" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep353">
 <bp:stepProcess rdf:resource="#BiochemicalReaction315" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep347">
 <bp:stepProcess rdf:resource="#BiochemicalReaction309" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction444">
 <bp:evidence rdf:resource="#Evidence498" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds GRIN2B gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep348">
 <bp:stepProcess rdf:resource="#BiochemicalReaction310" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction443">
 <bp:evidence rdf:resource="#Evidence497" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds OPRK1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep349">
 <bp:stepProcess rdf:resource="#BiochemicalReaction311" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction446">
 <bp:evidence rdf:resource="#Evidence500" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRIA2 gene expression is inhibited by MECP2:SIN3A complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction445">
 <bp:evidence rdf:resource="#Evidence499" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds the GRIN2A gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep343">
 <bp:stepProcess rdf:resource="#BiochemicalReaction305" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction440">
 <bp:evidence rdf:resource="#Evidence494" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FKBP5 gene expression is inhibited by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep344">
 <bp:stepProcess rdf:resource="#BiochemicalReaction306" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep345">
 <bp:stepProcess rdf:resource="#BiochemicalReaction307" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction442">
 <bp:evidence rdf:resource="#Evidence496" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OPRM1 gene expression is repressed by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep346">
 <bp:stepProcess rdf:resource="#BiochemicalReaction308" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction441">
 <bp:evidence rdf:resource="#Evidence495" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds FKBP5 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction448">
 <bp:evidence rdf:resource="#Evidence502" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2:SIN3A complex binds GRIA2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction447">
 <bp:evidence rdf:resource="#Evidence501" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2:CREB1 complex binds SLC2A3 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction449">
 <bp:evidence rdf:resource="#Evidence503" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRIN2A gene expression is stimulated by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep361">
 <bp:stepProcess rdf:resource="#BiochemicalReaction323" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep362">
 <bp:stepProcess rdf:resource="#Pathway40" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep363">
 <bp:stepProcess rdf:resource="#BiochemicalReaction324" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep364">
 <bp:stepProcess rdf:resource="#BiochemicalReaction325" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep360">
 <bp:stepProcess rdf:resource="#BiochemicalReaction322" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep358">
 <bp:stepProcess rdf:resource="#BiochemicalReaction320" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction455">
 <bp:evidence rdf:resource="#Evidence509" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN4 gene expression is stimulated by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep359">
 <bp:stepProcess rdf:resource="#BiochemicalReaction321" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction454">
 <bp:evidence rdf:resource="#Evidence508" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds the TRPC3 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction457">
 <bp:evidence rdf:resource="#Evidence511" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPN1 gene expression is inhibited by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction456">
 <bp:evidence rdf:resource="#Evidence510" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds GPRIN1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep354">
 <bp:stepProcess rdf:resource="#BiochemicalReaction316" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction451">
 <bp:evidence rdf:resource="#Evidence505" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SLC2A3 gene expression is stimulated by MECP2:CREB1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep355">
 <bp:stepProcess rdf:resource="#BiochemicalReaction317" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction450">
 <bp:evidence rdf:resource="#Evidence504" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRPC3 gene transcription is stimulated by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep356">
 <bp:stepProcess rdf:resource="#BiochemicalReaction318" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction453">
 <bp:evidence rdf:resource="#Evidence507" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2:SIN3A complex binds OPRM1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep357">
 <bp:stepProcess rdf:resource="#BiochemicalReaction319" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction452">
 <bp:evidence rdf:resource="#Evidence506" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GRIN2B gene expression is inhibited by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction459">
 <bp:evidence rdf:resource="#Evidence513" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MET gene transcription is stimulated by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction458">
 <bp:evidence rdf:resource="#Evidence512" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPRIN1 gene expression is stimulated by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction600">
 <bp:evidence rdf:resource="#Evidence668" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds ZNF521 and HDAC3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction606">
 <bp:evidence rdf:resource="#Evidence674" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BAX gene expression is stimulated by RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction605">
 <bp:evidence rdf:resource="#Evidence673" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDK1 phosphorylates RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction608">
 <bp:evidence rdf:resource="#Evidence677" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NKX3-2 binds RUNX2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction607">
 <bp:evidence rdf:resource="#Evidence675" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDK4 phosphorylates RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction602">
 <bp:evidence rdf:resource="#Evidence670" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds SMAD1 in the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction601">
 <bp:evidence rdf:resource="#Evidence669" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds tyrosine phosphorylated YAP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction604">
 <bp:evidence rdf:resource="#Evidence672" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds BAX gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction603">
 <bp:evidence rdf:resource="#Evidence671" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SMAD6 gene expression is stimulated by RUNX2 and SMAD1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction609">
 <bp:evidence rdf:resource="#Evidence678" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWP1 polyubiquitinates RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction611">
 <bp:evidence rdf:resource="#Evidence680" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds STAT1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction610">
 <bp:evidence rdf:resource="#Evidence679" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSX2 binds RUNX2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction617">
 <bp:evidence rdf:resource="#Evidence686" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ESRRA:PPARG1CA binds the RUNX2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction616">
 <bp:evidence rdf:resource="#Evidence685" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2-P1 binds RUNX2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction619">
 <bp:evidence rdf:resource="#Evidence688" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DLX5,(DLX6) binds RUNX2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction618">
 <bp:evidence rdf:resource="#Evidence687" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">26S proteasome degrades PolyUb-RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction613">
 <bp:evidence rdf:resource="#Evidence682" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated ESR1 binds the RUNX2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction612">
 <bp:evidence rdf:resource="#Evidence681" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2-P2 binds RUNX2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction615">
 <bp:evidence rdf:resource="#Evidence684" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 gene expression from distal (P1) promoter is inhibited by NKX3-2, MSX2 and RUNX2-P1, and stimulated by DLX5,(DLX6)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction614">
 <bp:evidence rdf:resource="#Evidence683" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TWIST1 binds the RUNX2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis77">
 <bp:controlled rdf:resource="#BiochemicalReaction258" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis76">
 <bp:controlled rdf:resource="#BiochemicalReaction257" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis79">
 <bp:controlled rdf:resource="#BiochemicalReaction268" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis78">
 <bp:controlled rdf:resource="#BiochemicalReaction265" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis84">
 <bp:controlled rdf:resource="#BiochemicalReaction326" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis83">
 <bp:controlled rdf:resource="#BiochemicalReaction312" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis86">
 <bp:controlled rdf:resource="#BiochemicalReaction356" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis85">
 <bp:controlled rdf:resource="#BiochemicalReaction339" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis80">
 <bp:controlled rdf:resource="#BiochemicalReaction274" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis82">
 <bp:controlled rdf:resource="#BiochemicalReaction298" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis81">
 <bp:controlled rdf:resource="#BiochemicalReaction292" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis88">
 <bp:controlled rdf:resource="#BiochemicalReaction363" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis87">
 <bp:controlled rdf:resource="#BiochemicalReaction361" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis89">
 <bp:controlled rdf:resource="#BiochemicalReaction366" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis95">
 <bp:controlled rdf:resource="#BiochemicalReaction380" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis94">
 <bp:controlled rdf:resource="#BiochemicalReaction379" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis97">
 <bp:controlled rdf:resource="#BiochemicalReaction387" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis96">
 <bp:controlled rdf:resource="#BiochemicalReaction384" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis91">
 <bp:controlled rdf:resource="#BiochemicalReaction371" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis90">
 <bp:controlled rdf:resource="#BiochemicalReaction367" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis93">
 <bp:controlled rdf:resource="#BiochemicalReaction378" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis92">
 <bp:controlled rdf:resource="#BiochemicalReaction375" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis99">
 <bp:controlled rdf:resource="#BiochemicalReaction410" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis98">
 <bp:controlled rdf:resource="#BiochemicalReaction388" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence801">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence802">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence800">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis37">
 <bp:controlled rdf:resource="#BiochemicalReaction174" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis36">
 <bp:controlled rdf:resource="#BiochemicalReaction173" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis39">
 <bp:controlled rdf:resource="#BiochemicalReaction178" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis38">
 <bp:controlled rdf:resource="#BiochemicalReaction177" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis33">
 <bp:controlled rdf:resource="#BiochemicalReaction166" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis32">
 <bp:controlled rdf:resource="#BiochemicalReaction164" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis35">
 <bp:controlled rdf:resource="#BiochemicalReaction169" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis34">
 <bp:controlled rdf:resource="#BiochemicalReaction167" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis40">
 <bp:controlled rdf:resource="#BiochemicalReaction181" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis42">
 <bp:controlled rdf:resource="#BiochemicalReaction184" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis41">
 <bp:controlled rdf:resource="#BiochemicalReaction182" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence812">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence813">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence810">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence811">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis48">
 <bp:controlled rdf:resource="#BiochemicalReaction197" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis47">
 <bp:controlled rdf:resource="#BiochemicalReaction196" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis49">
 <bp:controlled rdf:resource="#BiochemicalReaction199" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis44">
 <bp:controlled rdf:resource="#BiochemicalReaction188" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis43">
 <bp:controlled rdf:resource="#BiochemicalReaction186" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis46">
 <bp:controlled rdf:resource="#BiochemicalReaction190" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis45">
 <bp:controlled rdf:resource="#BiochemicalReaction189" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis51">
 <bp:controlled rdf:resource="#BiochemicalReaction201" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis50">
 <bp:controlled rdf:resource="#BiochemicalReaction200" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis53">
 <bp:controlled rdf:resource="#BiochemicalReaction203" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis52">
 <bp:controlled rdf:resource="#BiochemicalReaction202" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence805">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence806">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence803">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence804">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence809">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence807">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence808">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence820">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence823">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence824">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence821">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence822">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis59">
 <bp:controlled rdf:resource="#BiochemicalReaction213" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis58">
 <bp:controlled rdf:resource="#BiochemicalReaction210" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis55">
 <bp:controlled rdf:resource="#BiochemicalReaction206" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis54">
 <bp:controlled rdf:resource="#BiochemicalReaction204" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis57">
 <bp:controlled rdf:resource="#BiochemicalReaction208" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis56">
 <bp:controlled rdf:resource="#BiochemicalReaction207" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis62">
 <bp:controlled rdf:resource="#BiochemicalReaction217" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis61">
 <bp:controlled rdf:resource="#BiochemicalReaction216" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis64">
 <bp:controlled rdf:resource="#BiochemicalReaction219" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis63">
 <bp:controlled rdf:resource="#BiochemicalReaction218" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis60">
 <bp:controlled rdf:resource="#BiochemicalReaction215" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence816">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence817">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence814">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence815">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence818">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence819">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence830">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence831">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence834">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence835">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence832">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence833">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis69">
 <bp:controlled rdf:resource="#BiochemicalReaction227" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis66">
 <bp:controlled rdf:resource="#BiochemicalReaction221" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis65">
 <bp:controlled rdf:resource="#BiochemicalReaction220" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis68">
 <bp:controlled rdf:resource="#BiochemicalReaction224" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis67">
 <bp:controlled rdf:resource="#BiochemicalReaction222" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis73">
 <bp:controlled rdf:resource="#BiochemicalReaction234" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis72">
 <bp:controlled rdf:resource="#BiochemicalReaction231" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis75">
 <bp:controlled rdf:resource="#BiochemicalReaction244" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis74">
 <bp:controlled rdf:resource="#BiochemicalReaction235" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis71">
 <bp:controlled rdf:resource="#BiochemicalReaction230" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis70">
 <bp:controlled rdf:resource="#BiochemicalReaction228" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence827">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence828">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence825">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence826">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence829">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence841">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence842">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence840">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence845">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence846">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence843">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence844">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep450">
 <bp:stepProcess rdf:resource="#BiochemicalReaction404" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep451">
 <bp:stepProcess rdf:resource="#BiochemicalReaction405" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction581">
 <bp:evidence rdf:resource="#Evidence649" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWTR1 (TAZ) binds RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep452">
 <bp:stepProcess rdf:resource="#BiochemicalReaction406" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction580">
 <bp:evidence rdf:resource="#Evidence648" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC,YES1 phosphorylate YAP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep446">
 <bp:stepProcess rdf:resource="#BiochemicalReaction401" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction587">
 <bp:evidence rdf:resource="#Evidence655" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds to SATB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep447">
 <bp:stepProcess rdf:resource="#BiochemicalReaction402" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction586">
 <bp:evidence rdf:resource="#Evidence654" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 and RB1 bind the COL1A1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep448">
 <bp:stepProcess rdf:resource="#Pathway47" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction589">
 <bp:evidence rdf:resource="#Evidence657" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds HDAC6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep449">
 <bp:stepProcess rdf:resource="#BiochemicalReaction403" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction588">
 <bp:evidence rdf:resource="#Evidence656" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated ERKs phosphorylate RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep442">
 <bp:stepProcess rdf:resource="#BiochemicalReaction397" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction583">
 <bp:evidence rdf:resource="#Evidence651" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds HEY1,HEY2,HES1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep443">
 <bp:stepProcess rdf:resource="#BiochemicalReaction398" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction582">
 <bp:evidence rdf:resource="#Evidence650" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2:MAF complex binds the BGLAP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep444">
 <bp:stepProcess rdf:resource="#BiochemicalReaction399" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction585">
 <bp:evidence rdf:resource="#Evidence653" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC,YES1 bind YAP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep445">
 <bp:stepProcess rdf:resource="#BiochemicalReaction400" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction584">
 <bp:evidence rdf:resource="#Evidence652" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">UCMA gene expression is stimulated by RUNX2 and SP7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence838">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence839">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence836">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence837">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence852">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence853">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence850">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence851">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence856">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence857">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence854">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence855">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep460">
 <bp:stepProcess rdf:resource="#BiochemicalReaction413" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction590">
 <bp:evidence rdf:resource="#Evidence658" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds MAF</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep461">
 <bp:stepProcess rdf:resource="#BiochemicalReaction414" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep462">
 <bp:stepProcess rdf:resource="#BiochemicalReaction415" />
 <bp:stepProcess rdf:resource="#Catalysis100" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction592">
 <bp:evidence rdf:resource="#Evidence660" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y-YAP1 translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep463">
 <bp:stepProcess rdf:resource="#BiochemicalReaction416" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction591">
 <bp:evidence rdf:resource="#Evidence659" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated AR binds RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep457">
 <bp:stepProcess rdf:resource="#BiochemicalReaction410" />
 <bp:stepProcess rdf:resource="#Catalysis99" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction598">
 <bp:evidence rdf:resource="#Evidence666" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2:CBFB binds BGLAP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep458">
 <bp:stepProcess rdf:resource="#BiochemicalReaction411" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction597">
 <bp:evidence rdf:resource="#Evidence665" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 and RB1 bind the BGLAP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep459">
 <bp:stepProcess rdf:resource="#BiochemicalReaction412" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction599">
 <bp:evidence rdf:resource="#Evidence667" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The complex of RUNX2 and WWTR1 (TAZ) binds the BGLAP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep453">
 <bp:stepProcess rdf:resource="#BiochemicalReaction407" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction594">
 <bp:evidence rdf:resource="#Evidence662" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BGLAP gene expression is stimulated by RUNX2, WWTR1 and RB1 and inhibited by AR, YAP1 and ZNF521</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep454">
 <bp:stepProcess rdf:resource="#BiochemicalReaction408" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction593">
 <bp:evidence rdf:resource="#Evidence661" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">COL1A1 gene expression is stimulated by RUNX2 and RB1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep455">
 <bp:stepProcess rdf:resource="#BiochemicalReaction409" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction596">
 <bp:evidence rdf:resource="#Evidence664" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 and SP7 bind the UCMA gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep456">
 <bp:stepProcess rdf:resource="#Pathway48" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction595">
 <bp:evidence rdf:resource="#Evidence663" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2:CBFB:p-Y-YAP1 binds the BGLAP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence849">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence847">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence848">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence863">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence864">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence861">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence862">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence867">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence868">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence865">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence866">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep430">
 <bp:stepProcess rdf:resource="#BiochemicalReaction389" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence860">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep424">
 <bp:stepProcess rdf:resource="#BiochemicalReaction383" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep425">
 <bp:stepProcess rdf:resource="#Catalysis96" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction384" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep426">
 <bp:stepProcess rdf:resource="#BiochemicalReaction385" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep427">
 <bp:stepProcess rdf:resource="#BiochemicalReaction386" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep420">
 <bp:stepProcess rdf:resource="#Catalysis94" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction379" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep421">
 <bp:stepProcess rdf:resource="#Catalysis95" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction380" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep422">
 <bp:stepProcess rdf:resource="#BiochemicalReaction381" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep423">
 <bp:stepProcess rdf:resource="#BiochemicalReaction382" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence858">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence859">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep428">
 <bp:stepProcess rdf:resource="#Catalysis97" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction387" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep429">
 <bp:stepProcess rdf:resource="#BiochemicalReaction388" />
 <bp:stepProcess rdf:resource="#Catalysis98" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence874">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence875">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence872">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence873">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence878">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence879">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence876">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence877">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep440">
 <bp:stepProcess rdf:resource="#BiochemicalReaction396" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep441">
 <bp:stepProcess rdf:resource="#Pathway46" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence870">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence871">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep435">
 <bp:stepProcess rdf:resource="#BiochemicalReaction392" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep436">
 <bp:stepProcess rdf:resource="#BiochemicalReaction393" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep437">
 <bp:stepProcess rdf:resource="#BiochemicalReaction394" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep438">
 <bp:stepProcess rdf:resource="#Pathway45" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep431">
 <bp:stepProcess rdf:resource="#Pathway43" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep432">
 <bp:stepProcess rdf:resource="#Pathway44" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep433">
 <bp:stepProcess rdf:resource="#BiochemicalReaction390" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep434">
 <bp:stepProcess rdf:resource="#BiochemicalReaction391" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence869">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep439">
 <bp:stepProcess rdf:resource="#BiochemicalReaction395" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence885">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence886">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence883">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence884">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence889">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence887">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence888">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence881">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence882">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence880">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep402">
 <bp:stepProcess rdf:resource="#BiochemicalReaction361" />
 <bp:stepProcess rdf:resource="#Catalysis87" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep403">
 <bp:stepProcess rdf:resource="#BiochemicalReaction362" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep404">
 <bp:stepProcess rdf:resource="#BiochemicalReaction363" />
 <bp:stepProcess rdf:resource="#Catalysis88" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep405">
 <bp:stepProcess rdf:resource="#BiochemicalReaction364" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep400">
 <bp:stepProcess rdf:resource="#BiochemicalReaction359" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep401">
 <bp:stepProcess rdf:resource="#BiochemicalReaction360" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep406">
 <bp:stepProcess rdf:resource="#BiochemicalReaction365" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep407">
 <bp:stepProcess rdf:resource="#BiochemicalReaction366" />
 <bp:stepProcess rdf:resource="#Catalysis89" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep408">
 <bp:stepProcess rdf:resource="#BiochemicalReaction367" />
 <bp:stepProcess rdf:resource="#Catalysis90" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep409">
 <bp:stepProcess rdf:resource="#BiochemicalReaction368" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence896">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence897">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence894">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence895">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence898">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence899">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence892">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence893">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence890">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence891">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep413">
 <bp:stepProcess rdf:resource="#BiochemicalReaction372" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep414">
 <bp:stepProcess rdf:resource="#BiochemicalReaction373" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep415">
 <bp:stepProcess rdf:resource="#BiochemicalReaction374" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep416">
 <bp:stepProcess rdf:resource="#BiochemicalReaction375" />
 <bp:stepProcess rdf:resource="#Catalysis92" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep410">
 <bp:stepProcess rdf:resource="#BiochemicalReaction369" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep411">
 <bp:stepProcess rdf:resource="#BiochemicalReaction370" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep412">
 <bp:stepProcess rdf:resource="#Catalysis91" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction371" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep417">
 <bp:stepProcess rdf:resource="#BiochemicalReaction376" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep418">
 <bp:stepProcess rdf:resource="#BiochemicalReaction377" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep419">
 <bp:stepProcess rdf:resource="#BiochemicalReaction378" />
 <bp:stepProcess rdf:resource="#Catalysis93" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction501">
 <bp:evidence rdf:resource="#Evidence558" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds 5mC-DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction500">
 <bp:evidence rdf:resource="#Evidence557" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MIR137 gene expression is inhibited by MECP2 and SOX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction507">
 <bp:evidence rdf:resource="#Evidence565" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds MEF2C gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction506">
 <bp:evidence rdf:resource="#Evidence564" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PPARG gene expression is inhibited by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction509">
 <bp:evidence rdf:resource="#Evidence567" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds CREB1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction508">
 <bp:evidence rdf:resource="#Evidence566" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MEF2C gene expression is inhibited by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction503">
 <bp:evidence rdf:resource="#Evidence561" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds PPARG gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction502">
 <bp:evidence rdf:resource="#Evidence559" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds MOBP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction505">
 <bp:evidence rdf:resource="#Evidence563" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RBFOX1 gene expression is inhibited by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction504">
 <bp:evidence rdf:resource="#Evidence562" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB1 gene expression is stimulated by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction510">
 <bp:evidence rdf:resource="#Evidence568" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds RBFOX1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction512">
 <bp:evidence rdf:resource="#Evidence570" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds 5hmC-DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction511">
 <bp:evidence rdf:resource="#Evidence569" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MECP2 binds SGK1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction518">
 <bp:evidence rdf:resource="#Evidence578" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 stimulates IQSEC3 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction517">
 <bp:evidence rdf:resource="#Evidence577" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAGED1 binds NPAS4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction519">
 <bp:evidence rdf:resource="#Evidence579" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MDM2 gene expression is repressed by NPAS4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction514">
 <bp:evidence rdf:resource="#Evidence574" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 binds IQSEC3 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction513">
 <bp:evidence rdf:resource="#Evidence571" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MOBP gene expression is inhibited by MECP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction516">
 <bp:evidence rdf:resource="#Evidence576" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 binds INS gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction515">
 <bp:evidence rdf:resource="#Evidence575" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 binds CDK5R1 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction521">
 <bp:evidence rdf:resource="#Evidence581" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 binds ARNTL (BMAL1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction520">
 <bp:evidence rdf:resource="#Evidence580" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 stimulates PLK2 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction523">
 <bp:evidence rdf:resource="#Evidence583" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK1,(MAPK3) phosphorylates NPAS4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction522">
 <bp:evidence rdf:resource="#Evidence582" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 binds SYT10 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction529">
 <bp:evidence rdf:resource="#Evidence589" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 binds RET gene enhancer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction528">
 <bp:evidence rdf:resource="#Evidence588" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4:ARNT2 binds BDNF gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction525">
 <bp:evidence rdf:resource="#Evidence585" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 binds RBFOX3 (NeuN) gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction524">
 <bp:evidence rdf:resource="#Evidence584" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 represses INS gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction527">
 <bp:evidence rdf:resource="#Evidence587" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 binds PLK2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction526">
 <bp:evidence rdf:resource="#Evidence586" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 binds CDK5 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction532">
 <bp:evidence rdf:resource="#Evidence592" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 translocates to the cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction531">
 <bp:evidence rdf:resource="#Evidence591" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 stimulates RET gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction534">
 <bp:evidence rdf:resource="#Evidence594" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 binds FOS gene enhancer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction533">
 <bp:evidence rdf:resource="#Evidence593" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction530">
 <bp:evidence rdf:resource="#Evidence590" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RBFOX3 (NeuN) gene expression is stimulated by NPAS4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction539">
 <bp:evidence rdf:resource="#Evidence599" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 binds ARNT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction536">
 <bp:evidence rdf:resource="#Evidence596" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 stimulates FOS gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction535">
 <bp:evidence rdf:resource="#Evidence595" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 stimulates GEM gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction538">
 <bp:evidence rdf:resource="#Evidence598" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyrG-CDK5R1 binds CDK5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction537">
 <bp:evidence rdf:resource="#Evidence597" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDK5R1 gene expression is stimulated by NPAS4</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep493">
 <bp:stepProcess rdf:resource="#BiochemicalReaction440" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep494">
 <bp:stepProcess rdf:resource="#BiochemicalReaction441" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep495">
 <bp:stepProcess rdf:resource="#BiochemicalReaction442" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep496">
 <bp:stepProcess rdf:resource="#BiochemicalReaction443" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep490">
 <bp:stepProcess rdf:resource="#BiochemicalReaction438" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep491">
 <bp:stepProcess rdf:resource="#BiochemicalReaction439" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep492">
 <bp:stepProcess rdf:resource="#Pathway54" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction543">
 <bp:evidence rdf:resource="#Evidence603" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BDNF gene expression is stimulated by NPAS4:ARNT2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction542">
 <bp:evidence rdf:resource="#Evidence602" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDK5 gene expression is stimulated by NPAS4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction545">
 <bp:evidence rdf:resource="#Evidence605" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 gene transcription is stimulated by NPAS4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction544">
 <bp:evidence rdf:resource="#Evidence604" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 binds MDM2 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep486">
 <bp:stepProcess rdf:resource="#BiochemicalReaction435" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep487">
 <bp:stepProcess rdf:resource="#BiochemicalReaction436" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep488">
 <bp:stepProcess rdf:resource="#Pathway53" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction541">
 <bp:evidence rdf:resource="#Evidence601" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 stimulates SYT10 gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep489">
 <bp:stepProcess rdf:resource="#BiochemicalReaction437" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction540">
 <bp:evidence rdf:resource="#Evidence600" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 binds NAMPT gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction547">
 <bp:evidence rdf:resource="#Evidence607" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 binds NPAS4 gene enhancer elements</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction546">
 <bp:evidence rdf:resource="#Evidence606" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 binds ARNT2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction549">
 <bp:evidence rdf:resource="#Evidence611" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-224 represses NPAS4 mRNA translation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction548">
 <bp:evidence rdf:resource="#Evidence608" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 stimulates NAMPT gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction554">
 <bp:evidence rdf:resource="#Evidence617" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ca2+ binds KCNIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction553">
 <bp:evidence rdf:resource="#Evidence616" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 gene transcription is repressed by KCNIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction556">
 <bp:evidence rdf:resource="#Evidence619" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRF stimulates NPAS4 gene transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction555">
 <bp:evidence rdf:resource="#Evidence618" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REST binds promoter and the first intron of NPAS4 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep497">
 <bp:stepProcess rdf:resource="#BiochemicalReaction444" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction550">
 <bp:evidence rdf:resource="#Evidence612" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">miR-224 binds NPAS4 mRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep498">
 <bp:stepProcess rdf:resource="#BiochemicalReaction445" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep499">
 <bp:stepProcess rdf:resource="#BiochemicalReaction446" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction552">
 <bp:evidence rdf:resource="#Evidence615" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KCNIP3 binds NPAS4 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction551">
 <bp:evidence rdf:resource="#Evidence614" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NPAS4 gene transcription in non-neuronal cells is repressed by REST</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction558">
 <bp:evidence rdf:resource="#Evidence621" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRF binds NPAS4 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction557">
 <bp:evidence rdf:resource="#Evidence620" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated glucocorticoid receptor binds NPAS4 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction559">
 <bp:evidence rdf:resource="#Evidence622" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated glucocorticoid receptor represses NPAS4 gene transcription</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep471">
 <bp:stepProcess rdf:resource="#BiochemicalReaction423" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep472">
 <bp:stepProcess rdf:resource="#BiochemicalReaction424" />
 <bp:stepProcess rdf:resource="#Catalysis102" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep473">
 <bp:stepProcess rdf:resource="#BiochemicalReaction425" />
 <bp:stepProcess rdf:resource="#Catalysis103" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep474">
 <bp:stepProcess rdf:resource="#Catalysis104" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction426" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep470">
 <bp:stepProcess rdf:resource="#BiochemicalReaction422" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep468">
 <bp:stepProcess rdf:resource="#BiochemicalReaction420" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction565">
 <bp:evidence rdf:resource="#Evidence629" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">YAP1 binds TEAD1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep469">
 <bp:stepProcess rdf:resource="#BiochemicalReaction421" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction564">
 <bp:evidence rdf:resource="#Evidence628" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of CTGF</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction567">
 <bp:evidence rdf:resource="#Evidence631" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWTR1 (TAZ), TBX5, and PCAF form a complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction566">
 <bp:evidence rdf:resource="#Evidence630" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">YAP1 binds TEAD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep464">
 <bp:stepProcess rdf:resource="#BiochemicalReaction417" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction561">
 <bp:evidence rdf:resource="#Evidence625" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of NPPA (ANF)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep465">
 <bp:stepProcess rdf:resource="#Pathway49" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction560">
 <bp:evidence rdf:resource="#Evidence623" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KRAB-ZNF / KAP Interaction</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep466">
 <bp:stepProcess rdf:resource="#BiochemicalReaction418" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction563">
 <bp:evidence rdf:resource="#Evidence627" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">YAP1 binds TEAD2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep467">
 <bp:stepProcess rdf:resource="#BiochemicalReaction419" />
 <bp:stepProcess rdf:resource="#Catalysis101" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction562">
 <bp:evidence rdf:resource="#Evidence626" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWTR1 (TAZ) binds RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction569">
 <bp:evidence rdf:resource="#Evidence633" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WWTR1 (TAZ) binds TEAD</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction568">
 <bp:evidence rdf:resource="#Evidence632" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">YAP1 binds TEAD3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep482">
 <bp:stepProcess rdf:resource="#BiochemicalReaction432" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep483">
 <bp:stepProcess rdf:resource="#BiochemicalReaction433" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep484">
 <bp:stepProcess rdf:resource="#BiochemicalReaction434" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction570">
 <bp:evidence rdf:resource="#Evidence635" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds HAND2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep485">
 <bp:stepProcess rdf:resource="#Pathway52" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep480">
 <bp:stepProcess rdf:resource="#BiochemicalReaction431" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep481">
 <bp:stepProcess rdf:resource="#Pathway51" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep479">
 <bp:stepProcess rdf:resource="#BiochemicalReaction430" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction576">
 <bp:evidence rdf:resource="#Evidence643" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds the IHH gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction575">
 <bp:evidence rdf:resource="#Evidence642" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IHH gene transcription is stimulated by RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction578">
 <bp:evidence rdf:resource="#Evidence646" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds GLI3R</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction577">
 <bp:evidence rdf:resource="#Evidence644" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 and SMAD1 complex binds the SMAD6 gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep475">
 <bp:stepProcess rdf:resource="#Pathway50" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction572">
 <bp:evidence rdf:resource="#Evidence638" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RMB14 binds RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep476">
 <bp:stepProcess rdf:resource="#BiochemicalReaction427" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction571">
 <bp:evidence rdf:resource="#Evidence636" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDKN1A gene expression is inhibited by RUNX2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep477">
 <bp:stepProcess rdf:resource="#BiochemicalReaction428" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction574">
 <bp:evidence rdf:resource="#Evidence641" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds GLI2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep478">
 <bp:stepProcess rdf:resource="#BiochemicalReaction429" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction573">
 <bp:evidence rdf:resource="#Evidence640" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds HDAC4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction579">
 <bp:evidence rdf:resource="#Evidence647" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RUNX2 binds RB1</bp:displayName>
</bp:BiochemicalReaction>
</rdf:RDF>